|
Name |
Accession |
Description |
Interval |
E-value |
| PksD |
COG3321 |
Acyl transferase domain in polyketide synthase (PKS) enzymes [Secondary metabolites ... |
13-1382 |
0e+00 |
|
Acyl transferase domain in polyketide synthase (PKS) enzymes [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442550 [Multi-domain] Cd Length: 1386 Bit Score: 1087.21 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 13 IALVGMAGRFPGAPDVESFWRNLVAGVESISFFSEEELRQAG--VSEQIRRRPEYVPAKGVLEDLELFDAGFFGYSPREA 90
Cdd:COG3321 6 IAIIGMACRFPGADDPEEFWRNLRAGRDAITEVPADRWDADAyyDPDPDAPGKTYVRWGGFLDDVDEFDALFFGISPREA 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 91 SHLDPQQRLLLECSWEALEDAGLRPDQLPGW-VGVYVGAGDTSYrFQLLRGHGDPLSGSkdvaGFFGNYPDFLATRVAYK 169
Cdd:COG3321 86 EAMDPQQRLLLEVAWEALEDAGYDPESLAGSrTGVFVGASSNDY-ALLLLADPEAIDAY----ALTGNAKSVLAGRISYK 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 170 LNLRGPALGIHTACSTSLVSINMACSALRGFECDMALAGGVSLRLPARSGYLYEEGGVASKDGHCRPFDARAtgtvtgdg 249
Cdd:COG3321 161 LDLRGPSVTVDTACSSSLVAVHLACQSLRSGECDLALAGGVNLMLTPESFILFSKGGMLSPDGRCRAFDADAdgyvrgeg 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 250 vgvvvLKRLEDALKARDPIHAVIRGWALNNDGASRaGFTAPSVEGQSEVIALAHAAAGISARDITYVEAHGTGTPLGDPI 329
Cdd:COG3321 241 vgvvvLKRLSDALRDGDRIYAVIRGSAVNQDGRSN-GLTAPNGPAQAAVIRRALADAGVDPATVDYVEAHGTGTPLGDPI 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 330 EVAALTRAFRAHTADTAFCTLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERPNPALHLEQSPFFVNTQPLP 409
Cdd:COG3321 320 EAAALTAAFGQGRPADQPCAIGSVKSNIGHLEAAAGVAGLIKAVLALRHGVLPPTLHFETPNPHIDFENSPFYVNTELRP 399
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 410 WESPRGPRLAGVSSFGIGGTNAHTLFEEAPP--PPASGPTRPNQVLLLSARSTSALEHIAGRLAAHLRRHPDLELADVAF 487
Cdd:COG3321 400 WPAGGGPRRAGVSSFGFGGTNAHVVLEEAPAaaPAAAAAARPPQLLVLSAKTEEALRALAARLAAFLEAHPDLDLADVAY 479
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 488 TLQVGRARFPYRRALTCRTLAEAMER---LEAPEPRPPEPLAHEGERPPLVMLFPGQGTPLVGTARALHESEPTFRQAVE 564
Cdd:COG3321 480 TLATGRAHFEHRLAVVASSREELAAKlraLAAGEAAPGVVTGAAAAAPKVAFLFPGQGSQYVGMGRELYETEPVFRAALD 559
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 565 QCARLLRQTLGLDVREVLFPsaeqEEQARRLaAQTRVAQPALFTLEYALAQTWLGWGLQPQALAGHSLGELVAACLAGVF 644
Cdd:COG3321 560 ECDALLRPHLGWSLREVLFP----DEEESRL-DRTEVAQPALFAVEYALARLWRSWGVRPDAVIGHSVGEYAAACVAGVL 634
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 645 SLEDALQLVAARGQLMQGCPP-GAMLAVPLPEAELAALLGS--ELCIAAVNGPRACVASGPLPAVEALTAALESRGVSSR 721
Cdd:COG3321 635 SLEDALRLVAARGRLMQALPGgGAMLAVGLSEEEVEALLAGydGVSIAAVNGPRSTVVSGPAEAVEALAARLEARGIRAR 714
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 722 RLETSHAFHSASMEACQGPLTTLLRRMRLQAPRLPCVSGLTGRWLTGEEATePTYWARQLREPVRFSEALETLWSLKEPV 801
Cdd:COG3321 715 RLPVSHAFHSPLMEPALEEFRAALAGVTPRAPRIPLISNVTGTWLTGEALD-ADYWVRHLRQPVRFADAVEALLADGVRV 793
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 802 LLEVGPGTTLTALARRHPTRPARTQEVASLPvQPDTAVPCIEEAVGELWQAGLELDWSALHA-APRHRAHLPPYPFERQR 880
Cdd:COG3321 794 FLEVGPGPVLTGLVRQCLAAAGDAVVLPSLR-RGEDELAQLLTALAQLWVAGVPVDWSALYPgRGRRRVPLPTYPFQRED 872
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 881 YWIEPEAAPQPRAQQPTPASLVPPEQPSREALEDWFYVPTWEQAPATSGGGQPLAGPVLAFMDSSGLAEQVLAALWPADS 960
Cdd:COG3321 873 AAAALLAAALAAALAAAAALGALLLAALAAALAAALLALAAAAAAALALAAAALAALLALVALAAAAAALLALAAAAAAA 952
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 961 GALLTRVEPAGHyeqlsehafrlrPESEEDWDALFQALQSQGRLPRRILHAWALTAEPGPCTPDGEAVLEQGFFSLLRLA 1040
Cdd:COG3321 953 AAALAAAEAGAL------------LLLAAAAAAAAAAAAAAAAAAAAAAAAAAAALAAAAALALLAAAALLLAAAAAAAA 1020
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1041 RALGRHAPERPVQLEVLSSFVHAVGPREPLEPLKATLLGACAVLPLEYPHVQCRTIDVRPGSEPREVLVRSLAAELAAPM 1120
Cdd:COG3321 1021 LLALAALLAAAAAALAAAAAAAAAAAALAALAAAAAAAAALALALAALLLLAALAELALAAAALALAAALAAAALALALA 1100
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1121 GESPVAWRDGQRYVRRATRQRLEASRPLRSLRERGVylvaggLGGIGLVLARALAQRARARLALLTHSPFPPREQWEQWL 1200
Cdd:COG3321 1101 ALAAALLLLALLAALALAAAAAALLALAALLAAAAA------AAALAAAAAAAAALALAAAAAALAAALAAALLAAAALL 1174
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1201 EEAPAHPEPAWRSEADPSERRRTQHRIRCLLELEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAATFDDG 1280
Cdd:COG3321 1175 LALALALAAALAAALAGLAALLLAALLAALLAALLALALAALAAAAAALLAAAAAAAALALLALAAAAAAVAALAAAAAA 1254
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1281 VIQLRTHEQSSRALRTKVRGSMVLHEVLASEGLDWFALCSSLASALGSFGQADYCAANAFQDAYAHHLRRQGFTGALALD 1360
Cdd:COG3321 1255 LLAALAALALLAAAAGLAALAAAAAAAAAALALAAAAAAAAAALAALLAAAAAAAAAAAAAAAAAALAAALLAAALAALA 1334
|
1370 1380
....*....|....*....|..
gi 53747904 1361 WGTWRDTGAAMRLVARTRRGGH 1382
Cdd:COG3321 1335 AAVAAALALAAAAAAAAAAAAA 1356
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
2172-3503 |
0e+00 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 731.27 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2172 PDPAARFEPFPLTDVQEAYWVGRRSAFELGGVAAHGYFEIESPGLEVERFIQCWRQLLQRHDMLRMVVLPDGRQQVLEQV 2251
Cdd:COG1020 14 AAAPLPLSAAQQRLWLLLLLLLGSAAYNLALALLLLGLLLVAALLLLAALLARRRRALRTRLRTRAGRPVQVIQPVVAAP 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2252 PEYTPEVVELRGLSPQEAESRRLQLRERMAHQVLRSD-RWPLFELVLCRYEGGVRIHMSMDALMLDAWSSAVLRQDFAQL 2330
Cdd:COG1020 94 LPVVVLLVDLEALAEAAAEAAAAAEALAPFDLLRGPLlRLLLLLLLLLLLLLLLALHHIISDGLSDGLLLAELLRLYLAA 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2331 YHEPGRPLEPLAITFRDYVLAERRLREGEAHERARAYWWARLDTLPPPPELPLVKEPSQLEHARFTHREARLEPHRWARL 2410
Cdd:COG1020 174 YAGAPLPLPPLPIQYADYALWQREWLQGEELARQLAYWRQQLAGLPPLLELPTDRPRPAVQSYRGARVSFRLPAELTAAL 253
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2411 QERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRLplHPQVDELVGDFTSLVLLEVEAHAASTFAERASRLQA 2490
Cdd:COG1020 254 RALARRHGVTLFMVLLAAFALLLARYSGQDDVVVGTPVAGRP--RPELEGLVGFFVNTLPLRVDLSGDPSFAELLARVRE 331
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2491 QLWRDLEHGSVSAVQLIREL--VRTGRRSPgaimpvVFTSILSLDARRGPQGSLSFFEGELVYSISQTPQVWLDHGVHEE 2568
Cdd:COG1020 332 TLLAAYAHQDLPFERLVEELqpERDLSRNP------LFQVMFVLQNAPADELELPGLTLEPLELDSGTAKFDLTLTVVET 405
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2569 EGALVLAWDSVEALFPPGMVDDMFHAYQRLLGALAEEEQAWEGELPELLPPAQRELLARYNATQAPRPSGR-LEEGFFTQ 2647
Cdd:COG1020 406 GDGLRLTLEYNTDLFDAATIERMAGHLVTLLEALAADPDQPLGDLPLLTAAERQQLLAEWNATAAPYPADAtLHELFEAQ 485
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRL 2727
Cdd:COG1020 486 AARTPDAVAVVFGDQSLTYAELNARANRLAHHLRALGVGPGDLVGVCLERSLEMVVALLAVLKAGAAYVPLDPAYPAERL 565
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2728 HQLLEEGPARVVLTQSSLLHTVPwPPGVQVIAVDELEPATEAPPLPPRG-TPEHLAYVIYTSGSTGKPKGVAIEHRAALN 2806
Cdd:COG1020 566 AYMLEDAGARLVLTQSALAARLP-ELGVPVLALDALALAAEPATNPPVPvTPDDLAYVIYTSGSTGRPKGVMVEHRALVN 644
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2807 TVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVE 2886
Cdd:COG1020 645 LLAWMQRRYGLGPGDRVLQFASLSFDASVWEIFGALLSGATLVLAPPEARRDPAALAELLARHRVTVLNLTPSLLRALLD 724
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2887 YAEQRglklPAALRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEASIWSIAYPIGQVAPQWKSIPYGMPLANQRFH 2966
Cdd:COG1020 725 AAPEA----LPSLRLVLVGGEALPPELVRRWRARLPGARLVNLYGPTETTVDSTYYEVTPPDADGGSVPIGRPIANTRVY 800
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2967 VLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHP--RTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQG 3044
Cdd:COG1020 801 VLDAHLQPVPVGVPGELYIGGAGLARGYLNRPELTAERFVADPfgFPGARLYRTGDLARWLPDGNLEFLGRADDQVKIRG 880
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3045 FRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRN 3124
Cdd:COG1020 881 FRIELGEIEAALLQHPGVREAVVVAREDAPGDKRLVAYVVPEAGAAAAAALLRLALALLLPPYMVPAAVVLLLPLPLTGN 960
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3125 GKIARDQLPEPQQTQGLAAQAAAADPLVERLAALVkEALRLERVEPQDSLLDLGADSVALIRLINRLEAELQFRPRLADI 3204
Cdd:COG1020 961 GKLDRLALPAPAAAAAAAAAAPPAEEEEEEAALAL-LLLLVVVVGDDDFFFFGGGLGLLLLLALARAARLLLLLLLLLLL 1039
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3205 YENPTVQGLATLHQEKTKSQGEGGAPRLTAPRSTLLPAEEWGRFKANRPGLRRFPDGTPEVALPGSGLAPAPEELTALER 3284
Cdd:COG1020 1040 FLAAAAAAAAAAAAAAAAAAAAPLAAAAAPLPLPPLLLSLLALLLALLLLLALLALLALLLLLLLLLLLLALLLLLALLL 1119
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3285 RRSVRTYSLEPVSHEQLGRLLAPLREWEVQGSRRYLYASAGGLYPVQLYLHLKPGRARGLEPGTWYYDPSTHRLVLLSAG 3364
Cdd:COG1020 1120 ALLAALRARRAVRQEGPRLRLLVALAAALALAALLALLLAAAAAAAELLAAAALLLLLALLLLALLLLLLLLLLLLLLLL 1199
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3365 AGLDRRIHDPHQNQAIFDSAAFSLFLIARMGAVEPVYAEHALHFATLEAGLMTQLLDLGAAPsglglchigDLDFAQARG 3444
Cdd:COG1020 1200 LLLLLLLLLLLLLLLLLLLLLLLLLAAAAAALLALALLLALLALAALLALAALAALAAALLA---------LALALLALA 1270
|
1290 1300 1310 1320 1330
....*....|....*....|....*....|....*....|....*....|....*....
gi 53747904 3445 LFHLEEEHVLLHSLVGGVLPTRGQEAASVPAEGGTEARQLAQLLQQVKTLTPEAARALL 3503
Cdd:COG1020 1271 LLLLALALLLPALARARAARTARALALLLLLALLLLLALALALLLLLLLLLALLLLALL 1329
|
|
| Cyc_NRPS |
cd19535 |
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
2180-2606 |
0e+00 |
|
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Cyc (heterocyclization) domains catalyze two separate reactions in the creation of heterocyclized peptide products in nonribosomal peptide synthesis: amide bond formation followed by intramolecular cyclodehydration between a Cys, Ser, or Thr side chain and a carbonyl carbon on the peptide backbone to form a thiazoline, oxazoline, or methyloxazoline ring. Cyc-domains are homologous to standard NRPS Condensation (C) domains. C-domains typically have a conserved HHxxxD motif at the active site; Cyc-domains have an alternative, conserved DxxxxD active site motif, mutation of the aspartate residues in this motif can abolish or diminish condensation activity. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and Cyc-domains. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380458 [Multi-domain] Cd Length: 423 Bit Score: 602.56 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2180 PFPLTDVQEAYWVGRRSAFELGGVAAHGYFEIESPGLEVERFIQCWRQLLQRHDMLRMVVLPDGRQQVLEQVPEYTPEVV 2259
Cdd:cd19535 1 PFPLTDVQYAYWIGRQDDQELGGVGCHAYLEFDGEDLDPDRLERAWNKLIARHPMLRAVFLDDGTQQILPEVPWYGITVH 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2260 ELRGLSPQEAESRRLQLRERMAHQVLRSDRWPLFELVLCRY-EGGVRIHMSMDALMLDAWSSAVLRQDFAQLYHEPGRPL 2338
Cdd:cd19535 81 DLRGLSEEEAEAALEELRERLSHRVLDVERGPLFDIRLSLLpEGRTRLHLSIDLLVADALSLQILLRELAALYEDPGEPL 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2339 EPLAITFRDYVLAERRLREgEAHERARAYWWARLDTLPPPPELPLVKEPSQLEHARFTHREARLEPHRWARLQERARAHG 2418
Cdd:cd19535 161 PPLELSFRDYLLAEQALRE-TAYERARAYWQERLPTLPPAPQLPLAKDPEEIKEPRFTRREHRLSAEQWQRLKERARQHG 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2419 LTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRLPLHPQVDELVGDFTSLVLLEVEAHAASTFAERASRLQAQLWRDLEH 2498
Cdd:cd19535 240 VTPSMVLLTAYAEVLARWSGQPRFLLNLTLFNRLPLHPDVNDVVGDFTSLLLLEVDGSEGQSFLERARRLQQQLWEDLDH 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2499 GSVSAVQLIRELVRTgRRSPGAIMPVVFTSILSLDArrGPQGSLSFFeGELVYSISQTPQVWLDHGVHEEEGALVLAWDS 2578
Cdd:cd19535 320 SSYSGVVVVRRLLRR-RGGQPVLAPVVFTSNLGLPL--LDEEVREVL-GELVYMISQTPQVWLDHQVYEEDGGLLLNWDA 395
|
410 420
....*....|....*....|....*...
gi 53747904 2579 VEALFPPGMVDDMFHAYQRLLGALAEEE 2606
Cdd:cd19535 396 VDELFPEGMLDDMFDAYVRLLERLADDD 423
|
|
| A_NRPS_TlmIV_like |
cd12114 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including ... |
2652-3132 |
0e+00 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Streptoalloteichus tallysomycin biosynthesis genes; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the TLM biosynthetic gene cluster from Streptoalloteichus that consists of nine NRPS genes; the N-terminal module of TlmVI (NRPS-5) and the starter module of BlmVI (NRPS-5) are comprised of the acyl CoA ligase (AL) and acyl carrier protein (ACP)-like domains, which are thought to be involved in the biosynthesis of the beta-aminoalaninamide moiety.
Pssm-ID: 341279 [Multi-domain] Cd Length: 477 Bit Score: 576.14 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2652 PELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLL 2731
Cdd:cd12114 1 PDATAVICGDGTLTYGELAERARRVAGALKAAGVRPGDLVAVTLPKGPEQVVAVLGILAAGAAYVPVDIDQPAARREAIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2732 EEGPARVVLTQSSLLHTVPWPPGVQVIAVDELEPatEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDL 2811
Cdd:cd12114 81 ADAGARLVLTDGPDAQLDVAVFDVLILDLDALAA--PAPPPPVDVAPDDLAYVIFTSGSTGTPKGVMISHRAALNTILDI 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2812 NTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQR 2891
Cdd:cd12114 159 NRRFAVGPDDRVLALSSLSFDLSVYDIFGALSAGATLVLPDEARRRDPAHWAELIERHGVTLWNSVPALLEMLLDVLEAA 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2892 GlKLPAALRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEASIWSIAYPIGQVAPQWKSIPYGMPLANQRFHVLDGR 2971
Cdd:cd12114 239 Q-ALLPSLRLVLLSGDWIPLDLPARLRALAPDARLISLGGATEASIWSIYHPIDEVPPDWRSIPYGRPLANQRYRVLDPR 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2972 LEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHPrTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGE 3051
Cdd:cd12114 318 GRDCPDWVPGELWIGGRGVALGYLGDPELTAARFVTHP-DGERLYRTGDLGRYRPDGTLEFLGRRDGQVKVRGYRIELGE 396
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3052 IEAALAQHPALSASVVVARGEPrGVRRLVAYAVPRSGQTPAA-GELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARD 3130
Cdd:cd12114 397 IEAALQAHPGVARAVVVVLGDP-GGKRLAAFVVPDNDGTPIApDALRAFLAQTLPAYMIPSRVIALEALPLTANGKVDRA 475
|
..
gi 53747904 3131 QL 3132
Cdd:cd12114 476 AL 477
|
|
| PKS |
cd00833 |
polyketide synthases (PKSs) polymerize simple fatty acids into a large variety of different ... |
13-432 |
0e+00 |
|
polyketide synthases (PKSs) polymerize simple fatty acids into a large variety of different products, called polyketides, by successive decarboxylating Claisen condensations. PKSs can be divided into 2 groups, modular type I PKSs consisting of one or more large multifunctional proteins and iterative type II PKSs, complexes of several monofunctional subunits.
Pssm-ID: 238429 [Multi-domain] Cd Length: 421 Bit Score: 570.65 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 13 IALVGMAGRFPGAPDVESFWRNLVAGVESISFFSEEELRQAGVSEQIRRR-PEYVPAKGVLEDLELFDAGFFGYSPREAS 91
Cdd:cd00833 3 IAIVGMACRFPGAADPDEFWENLLEGRDAISEIPEDRWDADGYYPDPGKPgKTYTRRGGFLDDVDAFDAAFFGISPREAE 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 92 HLDPQQRLLLECSWEALEDAGLRPDQLPGW-VGVYVGAGDTSYRFQLLRGHGDPlsgskDVAGFFGNYPDFLATRVAYKL 170
Cdd:cd00833 83 AMDPQQRLLLEVAWEALEDAGYSPESLAGSrTGVFVGASSSDYLELLARDPDEI-----DAYAATGTSRAFLANRISYFF 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 171 NLRGPALGIHTACSTSLVSINMACSALRGFECDMALAGGVSLRLPARSGYLYEEGGVASKDGHCRPFDARATGTVTGDGV 250
Cdd:cd00833 158 DLRGPSLTVDTACSSSLVALHLACQSLRSGECDLALVGGVNLILSPDMFVGFSKAGMLSPDGRCRPFDADADGYVRGEGV 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 251 GVVVLKRLEDALKARDPIHAVIRGWALNNDGASRAGfTAPSVEGQSEVIALAHAAAGISARDITYVEAHGTGTPLGDPIE 330
Cdd:cd00833 238 GVVVLKRLSDALRDGDRIYAVIRGSAVNQDGRTKGI-TAPSGEAQAALIRRAYARAGVDPSDIDYVEAHGTGTPLGDPIE 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 331 VAALTRAFRAHTADTAFCTLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERPNPALHLEQSPFFVNTQPLPW 410
Cdd:cd00833 317 VEALAKVFGGSRSADQPLLIGSVKSNIGHLEAAAGLAGLIKVVLALEHGVIPPNLHFETPNPKIDFEESPLRVPTEARPW 396
|
410 420
....*....|....*....|..
gi 53747904 411 ESPRGPRLAGVSSFGIGGTNAH 432
Cdd:cd00833 397 PAPAGPRRAGVSSFGFGGTNAH 418
|
|
| A_NRPS |
cd05930 |
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain ... |
2652-3132 |
6.77e-142 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341253 [Multi-domain] Cd Length: 444 Bit Score: 451.21 E-value: 6.77e-142
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2652 PELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLL 2731
Cdd:cd05930 1 PDAVAVVDGDQSLTYAELDARANRLARYLRERGVGPGDLVAVLLERSLEMVVAILAVLKAGAAYVPLDPSYPAERLAYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2732 EEGPARVVLTQssllhtvpwppgvqviavdelepateapplpprgtPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDL 2811
Cdd:cd05930 81 EDSGAKLVLTD-----------------------------------PDDLAYVIYTSGSTGKPKGVMVEHRGLVNLLLWM 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2812 NTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEqr 2891
Cdd:cd05930 126 QEAYPLTPGDRVLQFTSFSFDVSVWEIFGALLAGATLVVLPEEVRKDPEALADLLAEEGITVLHLTPSLLRLLLQELE-- 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2892 gLKLPAALRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEASIWSIAYPIGQVAPQWKSIPYGMPLANQRFHVLDGR 2971
Cdd:cd05930 204 -LAALPSLRLVLVGGEALPPDLVRRWRELLPGARLVNLYGPTEATVDATYYRVPPDDEEDGRVPIGRPIPNTRVYVLDEN 282
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2972 LEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHP-RTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELG 3050
Cdd:cd05930 283 LRPVPPGVPGELYIGGAGLARGYLNRPELTAERFVPNPfGPGERMYRTGDLVRWLPDGNLEFLGRIDDQVKIRGYRIELG 362
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3051 EIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARD 3130
Cdd:cd05930 363 EIEAALLAHPGVREAAVVAREDGDGEKRLVAYVVPDEGGELDEEELRAHLAERLPDYMVPSAFVVLDALPLTPNGKVDRK 442
|
..
gi 53747904 3131 QL 3132
Cdd:cd05930 443 AL 444
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
2083-3219 |
1.83e-139 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 493.52 E-value: 1.83e-139
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2083 PPSSLEQLIEQVWRKHLGVERVQPTDSFFQLGGDSLLGIQVAADLRRHLGVELPTATLFSHPTLAALAAALRARQGEAAA 2162
Cdd:PRK12467 1027 PQTELEKRLAAIWADVLKVERVGLTDNFFELGGHSLLATQVISRVRQRLGIQVPLRTLFEHQTLAGFAQAVAAQQQGAQP 1106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2163 PTApapalvpdPAARFEPFPLTDVQEAYWVGRRsaFELGGVAAHGYFEIESPG-LEVERFIQCWRQLLQRHDMLRMV-VL 2240
Cdd:PRK12467 1107 ALP--------DVDRDQPLPLSYAQERQWFLWQ--LEPGSAAYHIPQALRLKGpLDIEALERSFDALVARHESLRTTfVQ 1176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2241 PDGR-QQVLEQVPEYTPEVVELRGLSPQEAESRrlQLRERMAHQVLRSDRWPLFELVLCRY--EGGVRIhMSMDALMLDA 2317
Cdd:PRK12467 1177 EDGRtRQVIHPVGSLTLEEPLLLAADKDEAQLK--VYVEAEARQPFDLEQGPLLRVGLLRLaaDEHVLV-LTLHHIVSDG 1253
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2318 WSSAVLRQDFAQLY--HEPGRPLE--PLAITFRDYVLAERRLREGEAHERARAYWWARLDTlppppelplvkEPSQLE-- 2391
Cdd:PRK12467 1254 WSMQVLVDELVALYaaYSQGQSLQlpALPIQYADYAVWQRQWMDAGERARQLAYWKAQLGG-----------EQPVLElp 1322
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2392 -----HARFTHREAR----LEPHRWARLQERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRLPLhpQVDELV 2462
Cdd:PRK12467 1323 tdrprPAVQSHRGARlafeLPPALAEGLRALARREGVTLFMLLLASFQTLLHRYSGQDDIRVGVPIANRNRA--ETEGLI 1400
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2463 GDFTSLVLLEVEAHAASTFAE-----RASRLQAQLWRDLEHGS-VSAVQLIRELvrtgrrSPGAIMPVVFtsilslDARR 2536
Cdd:PRK12467 1401 GFFVNTQVLRAEVDGQASFQQllqqvKQAALEAQAHQDLPFEQlVEALQPERSL------SHSPLFQVMF------NHQR 1468
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2537 GPQGSLSFFEGELVYSIS---QTPQVWLDHGVHEEEGALVLAWDSVEALFPPGMVDDMFHAYQRLLGALAEEEQAWEGEL 2613
Cdd:PRK12467 1469 DDHQAQAQLPGLSVESLSwesQTAQFDLTLDTYESSEGLQASLTYATDLFEASTIERLAGHWLNLLQGLVADPERRLGEL 1548
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2614 PELLPPAQRELLARYNATQAPRPSGRLEEGFFT-QARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVA 2692
Cdd:PRK12467 1549 DLLDEAERRQILEGWNATHTGYPLARLVHQLIEdQAAATPEAVALVFGEQELTYGELNRRANRLAHRLIALGVGPEVLVG 1628
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2693 IAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSLLHTVPWPPGVQVIAVDELEPATEA-PP 2771
Cdd:PRK12467 1629 IAVERSLEMVVGLLAILKAGGAYVPLDPEYPRERLAYMIEDSGIELLLTQSHLQARLPLPDGLRSLVLDQEDDWLEGySD 1708
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2772 LPP--RGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALV 2849
Cdd:PRK12467 1709 SNPavNLAPQNLAYVIYTSGSTGRPKGAGNRHGALVNRLCATQEAYQLSAADVVLQFTSFAFDVSVWELFWPLINGARLV 1788
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2850 LPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGlkLPAALRLVMLSGDWIPVALPDRIRALGRDVQVVSL 2929
Cdd:PRK12467 1789 IAPPGAHRDPEQLIQLIERQQVTTLHFVPSMLQQLLQMDEQVE--HPLSLRRVVCGGEALEVEALRPWLERLPDTGLFNL 1866
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2930 GGATEASIWSIAYPIGQVAPQWK-SIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRH 3008
Cdd:PRK12467 1867 YGPTETAVDVTHWTCRRKDLEGRdSVPIGQPIANLSTYILDASLNPVPIGVAGELYLGGVGLARGYLNRPALTAERFVAD 1946
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3009 P--RTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARgEPRGVRRLVAYAVPR 3086
Cdd:PRK12467 1947 PfgTVGSRLYRTGDLARYRADGVIEYLGRIDHQVKIRGFRIELGEIEARLREQGGVREAVVIAQ-DGANGKQLVAYVVPT 2025
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3087 SGQTPAA--------GELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPEPQQTQGLAAQAAAADPLVERLAAL 3158
Cdd:PRK12467 2026 DPGLVDDdeaqvalrAILKNHLKASLPEYMVPAHLVFLARMPLTPNGKLDRKALPAPDASELQQAYVAPQSELEQRLAAI 2105
|
1130 1140 1150 1160 1170 1180
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 53747904 3159 VKEALRLERVEPQDSLLDLGADSVALIRLINRL-EAELQFRPRlaDIYENPTVQGLATLHQE 3219
Cdd:PRK12467 2106 WQDVLGLEQVGLHDNFFELGGDSIISIQVVSRArQAGIRFTPK--DLFQHQTVQSLAAVAQE 2165
|
|
| PKS_KS |
smart00825 |
Beta-ketoacyl synthase; The structure of beta-ketoacyl synthase is similar to that of the ... |
13-437 |
2.93e-133 |
|
Beta-ketoacyl synthase; The structure of beta-ketoacyl synthase is similar to that of the thiolase family and also chalcone synthase. The active site of beta-ketoacyl synthase is located between the N and C-terminal domains.
Pssm-ID: 214836 [Multi-domain] Cd Length: 298 Bit Score: 419.81 E-value: 2.93e-133
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 13 IALVGMAGRFPGAPDVESFWRNLVAGvesisffseeelrqagvseqirrrpeyvpakgvLEDLELFDAGFFGYSPREASH 92
Cdd:smart00825 1 IAIVGMSCRFPGADDPEEFWDLLLAG---------------------------------LDDVDLFDAAFFGISPREAEA 47
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 93 LDPQQRLLLECSWEALEDAGLRPDQLPGW-VGVYVGAGDTSYrfqllrghgdplsgskdvagffgnypdflatrvaykln 171
Cdd:smart00825 48 MDPQQRLLLEVAWEALEDAGIDPESLRGSrTGVFVGVSSSDY-------------------------------------- 89
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 172 lrgpALGIHTACSTSLVSINMACSALRGFECDMALAGGVSLRLPARSGYLYEEGGVASKDGHCRPFDARAtgtvtgdgvg 251
Cdd:smart00825 90 ----SVTVDTACSSSLVALHLACQSLRSGECDMALAGGVNLILSPDTFVGLSRAGMLSPDGRCKTFDASAdgyvrgegvg 165
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 252 vvvLKRLEDALKARDPIHAVIRGWALNNDGASrAGFTAPSVEGQsevialahaaagisardityveahgtgtplgdpiev 331
Cdd:smart00825 166 vvvLKRLSDALRDGDPILAVIRGSAVNQDGRS-NGITAPSGPAQ------------------------------------ 208
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 332 aaltrafrahtadtafCTLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERPNPALHLEQSPFFVNTQPLPWE 411
Cdd:smart00825 209 ----------------LLIGSVKSNIGHLEAAAGVAGLIKVVLALKHGVIPPTLHFETPNPHIDLEESPLRVPTELTPWP 272
|
410 420
....*....|....*....|....*.
gi 53747904 412 SPRGPRLAGVSSFGIGGTNAHTLFEE 437
Cdd:smart00825 273 PPGRPRRAGVSSFGFGGTNAHVILEE 298
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
2216-3214 |
1.04e-132 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 471.18 E-value: 1.04e-132
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2216 LEVERFIQCWRQLLQRHDMLRMVVLPDG---RQQVLEQVPeYTPEVVELRGLSPQEAESRRLQLRERMAHQVLRSDRWPL 2292
Cdd:PRK12467 84 LDVSALRRAFDALVARHESLRTRFVQDEegfRQVIDASLS-LTIPLDDLANEQGRARESQIEAYINEEVARPFDLANGPL 162
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2293 FELVLCRYEGGVRI-HMSMDALMLDAWSSAVLRQDFAQLY--HEPGR--PLEPLAITFRDYVLAERRLREGEAHERARAY 2367
Cdd:PRK12467 163 LRVRLLRLADDEHVlVVTLHHIISDGWSMRVLVEELVQLYsaYSQGRepSLPALPIQYADYAIWQRSWLEAGERERQLAY 242
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2368 WWARLDTLPPPPELPLVKEPSQLEHARFTHREARLEPHRWARLQERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLT 2447
Cdd:PRK12467 243 WQEQLGGEHTVLELPTDRPRPAVPSYRGARLRVDLPQALSAGLKALAQREGVTLFMVLLASFQTLLHRYSGQSDIRIGVP 322
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2448 LFQRLplHPQVDELVGDFTSLVLLEVEAHAASTFAE-----RASRLQAQLWRDLEHGS-VSAVQLIRELvrtgrrSPGAI 2521
Cdd:PRK12467 323 NANRN--RVETERLIGFFVNTQVLKAEVDPQASFLEllqqvKRTALGAQAHQDLPFEQlVEALQPERSL------SHSPL 394
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2522 MPVVFTSILSLDARRGPQGS-LSFFEGELVYSISQTPQVWLDHGVHEEEGALVLAWDSVEALFPPGMVDDMFHAYQRLLG 2600
Cdd:PRK12467 395 FQVMFNHQNTATGGRDREGAqLPGLTVEELSWARHTAQFDLALDTYESAQGLWAAFTYATDLFEATTIERLATHWRNLLE 474
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2601 ALAEEEQAWEGELPELLPPAQRELLARYNATQAPRPSGRLEEGFFTQARLHPELPALLAPERTLSYGELARRAQALAARL 2680
Cdd:PRK12467 475 AIVAEPRRRLGELPLLDAEERARELVRWNAPATEYAPDCVHQLIEAQARQHPERPALVFGEQVLSYAELNRQANRLAHVL 554
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2681 RELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSLLHTVPWPPGVQVIAV 2760
Cdd:PRK12467 555 IAAGVGPDVLVGIAVERSIEMVVGLLAVLKAGGAYVPLDPEYPQDRLAYMLDDSGVRLLLTQSHLLAQLPVPAGLRSLCL 634
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2761 DELEPATEAPP---LPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYD 2837
Cdd:PRK12467 635 DEPADLLCGYSghnPEVALDPDNLAYVIYTSGSTGQPKGVAISHGALANYVCVIAERLQLAADDSMLMVSTFAFDLGVTE 714
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2838 VLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQrglKLPAALRLVMLSGDWIPVALPDRI 2917
Cdd:PRK12467 715 LFGALASGATLHLLPPDCARDAEAFAALMADQGVTVLKIVPSHLQALLQASRV---ALPRPQRALVCGGEALQVDLLARV 791
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2918 RALGRDVQVVSLGGATEASIWSIAYPIGQVAPQWKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRD 2997
Cdd:PRK12467 792 RALGPGARLINHYGPTETTVGVSTYELSDEERDFGNVPIGQPLANLGLYILDHYLNPVPVGVVGELYIGGAGLARGYHRR 871
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2998 EPLTATRFIRHP--RTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRG 3075
Cdd:PRK12467 872 PALTAERFVPDPfgADGGRLYRTGDLARYRADGVIEYLGRMDHQVKIRGFRIELGEIEARLLAQPGVREAVVLAQPGDAG 951
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3076 vRRLVAYAVPR---SGQTPAA--GELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPEPQQTQGLAAQAAAADP 3150
Cdd:PRK12467 952 -LQLVAYLVPAavaDGAEHQAtrDELKAQLRQVLPDYMVPAHLLLLDSLPLTPNGKLDRKALPKPDASAVQATFVAPQTE 1030
|
970 980 990 1000 1010 1020
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 53747904 3151 LVERLAALVKEALRLERVEPQDSLLDLGADSVALIRLINRLEAELQFRPRLADIYENPTVQGLA 3214
Cdd:PRK12467 1031 LEKRLAAIWADVLKVERVGLTDNFFELGGHSLLATQVISRVRQRLGIQVPLRTLFEHQTLAGFA 1094
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
2211-3214 |
1.12e-131 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 468.28 E-value: 1.12e-131
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2211 IESPGLEVERFIQCWRQLLQRHDMLRMVVLPDGRQ----QVLEQVPEYTPEVVELRGLSPQEAESRRLQLRERMAHQVLR 2286
Cdd:PRK12316 4131 VDVQGLDVERFRAAWQAALDRHDVLRSGFVWQGELgrplQVVHKQVSLPFAELDWRGRADLQAALDALAAAERERGFDLQ 4210
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2287 sdRWPLFELVLCRY-EGGVRIHMSMDALMLDAWSSAVLRQDFAQLYhePGRPLEPLAITFRDYVLAERRlregEAHERAR 2365
Cdd:PRK12316 4211 --RAPLLRLVLVRTaEGRHHLIYTNHHILMDGWSNSQLLGEVLERY--SGRPPAQPGGRYRDYIAWLQR----QDAAASE 4282
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2366 AYWWARL-DTLPPPPELPLVKEPSQLEHARFTHREARLEPHRWARLQERARAHGLTPSAACMAAFAEVLARWSRHPRFTL 2444
Cdd:PRK12316 4283 AFWREQLaALDEPTRLAQAIARADLRSANGYGEHVRELDATATARLREFARTQRVTLNTLVQAAWLLLLQRYTGQDTVAF 4362
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2445 NLTLFQRLPLHPQVDELVGDFTSLVLLEVEAHAASTFAERASRLQAQ--LWRDLEHGSVSAVQlirelvrtgrRSPGAIM 2522
Cdd:PRK12316 4363 GATVAGRPAELPGIEGQIGLFINTLPVIATPRAQQSVVEWLQQVQRQnlALREHEHTPLYEIQ----------RWAGQGG 4432
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2523 PVVFTSILSLDA-------RRGPQGSLSFFEgelVYSISQTP-QVWLDHGVHEeegALVLAWDSVEALFPPGMVDDMFHA 2594
Cdd:PRK12316 4433 EALFDSLLVFENypvsealQQGAPGGLRFGE---VTNHEQTNyPLTLAVGLGE---TLSLQFSYDRGHFDAATIERLARH 4506
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2595 YQRLLGALAEEEQAWEGELPELLPPAQRELLARYNATQAPRPSGR-LEEGFFTQARLHPELPALLAPERTLSYGELARRA 2673
Cdd:PRK12316 4507 LTNLLEAMAEDPQRRLGELQLLEKAEQQRIVALWNRTDAGYPATRcVHQLVAERARMTPDAVAVVFDEEKLTYAELNRRA 4586
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2674 QALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSLLHTVPWPP 2753
Cdd:PRK12316 4587 NRLAHALIARGVGPEVLVGIAMERSAEMMVGLLAVLKAGGAYVPLDPEYPRERLAYMMEDSGAALLLTQSHLLQRLPIPD 4666
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2754 GVQVIAVDELEPATEAPPLPP--RGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTF 2831
Cdd:PRK12316 4667 GLASLALDRDEDWEGFPAHDPavRLHPDNLAYVIYTSGSTGRPKGVAVSHGSLVNHLHATGERYELTPDDRVLQFMSFSF 4746
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2832 DLSVYDVLGLLGAGGALVLPAAEAEkDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGlkLPAALRLVMLSGDWIPV 2911
Cdd:PRK12316 4747 DGSHEGLYHPLINGASVVIRDDSLW-DPERLYAEIHEHRVTVLVFPPVYLQQLAEHAERDG--EPPSLRVYCFGGEAVAQ 4823
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2912 ALPDRIRALGRDVQVVSLGGATEASIWSIAYPI-GQVAPQWKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGL 2990
Cdd:PRK12316 4824 ASYDLAWRALKPVYLFNGYGPTETTVTVLLWKArDGDACGAAYMPIGTPLGNRSGYVLDGQLNPLPVGVAGELYLGGEGV 4903
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2991 AREYWRDEPLTATRFIRHP--RTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVV 3068
Cdd:PRK12316 4904 ARGYLERPALTAERFVPDPfgAPGGRLYRTGDLARYRADGVIDYLGRVDHQVKIRGFRIELGEIEARLREHPAVREAVVI 4983
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3069 ARGEPRGvRRLVAYAVPR--------SGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPEPQQTQG 3140
Cdd:PRK12316 4984 AQEGAVG-KQLVGYVVPQdpaladadEAQAELRDELKAALRERLPEYMVPAHLVFLARMPLTPNGKLDRKALPQPDASLL 5062
|
970 980 990 1000 1010 1020 1030
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 53747904 3141 LAAQAAAADPLVERLAALVKEALRLERVEPQDSLLDLGADSVALIRLINRLEAELQFRPRLADIYENPTVQGLA 3214
Cdd:PRK12316 5063 QQAYVAPRSELEQQVAAIWAEVLQLERVGLDDNFFELGGHSLLAIQVTSRIQLELGLELPLRELFQTPTLAAFV 5136
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
2017-3216 |
2.52e-131 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 467.13 E-value: 2.52e-131
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2017 PRLAGGISSEEGAEAF---LRALEQGAPQLIISPQDFSSLLRGLGGSQGVREKERLVTGRAAAAEPQALPPSS-LEQLIE 2092
Cdd:PRK12316 2443 KQLVAYVVPDDAAEDLlaeLRAWLAARLPAYMVPAHWVVLERLPLNPNGKLDRKALPKPDVSQLRQAYVAPQEgLEQRLA 2522
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2093 QVWRKHLGVERVQPTDSFFQLGGDSLLGIQVAADLRRHLGVELPTATLFSHPTLAALAAALRARQgeaaaptaPAPALVP 2172
Cdd:PRK12316 2523 AIWQAVLKVEQVGLDDHFFELGGHSLLATQVVSRVRQDLGLEVPLRILFERPTLAAFAASLESGQ--------TSRAPVL 2594
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2173 DPAARFEPFPLTDVQEAYWVGRRsaFELGGVAAHGYFEIESPG-LEVERFIQCWRQLLQRHDMLRMVVLPDGrqqvlEQV 2251
Cdd:PRK12316 2595 QKVTRVQPLPLSHAQQRQWFLWQ--LEPESAAYHLPSALHLRGvLDQAALEQAFDALVLRHETLRTRFVEVG-----EQT 2667
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2252 PEYTPEVVELRGLSPQEAESRRLQLRERMAHQVLRS---DRWPLFELVLCRYEGGV-RIHMSMDALMLDAWSSAVLRQDF 2327
Cdd:PRK12316 2668 RQVILPNMSLRIVLEDCAGVADAAIRQRVAEEIQRPfdlARGPLLRVRLLALDGQEhVLVITQHHIVSDGWSMQVMVDEL 2747
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2328 AQLYHEPGR----PLEPLAITFRDYVLAERRLREGEAHERARAYWWARLDTLPPPPELPLVKEPSQLEHARFTHREARLE 2403
Cdd:PRK12316 2748 VQAYAGARRgeqpTLPPLPLQYADYAAWQRAWMDSGEGARQLDYWRERLGGEQPVLELPLDRPRPALQSHRGARLDVALD 2827
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2404 PHRWARLQERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRLplHPQVDELVGDFTSLVLLEVEAHAASTFAE 2483
Cdd:PRK12316 2828 VALSRELLALARREGVTLFMLLLASFQVLLHRYSGQSDIRVGVPIANRN--RAETERLIGFFVNTQVLRAQVDAQLAFRD 2905
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2484 RASRLQAQLWRDLEHGSVSAVQLIRELVRTGRRSPGAIMPVVFTSILSLDArrgpQGSLSFFEGELVYSISQTPQVWLDH 2563
Cdd:PRK12316 2906 LLGQVKEQALGAQAHQDLPFEQLVEALQPERSLSHSPLFQVMYNHQSGERA----AAQLPGLHIESFAWDGAATQFDLAL 2981
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2564 GVHEEEGALVLAWDSVEALFPPGMVDDMFHAYQRLLGALAEEEQAWEGELPELLPPAQRELLARYNATQAPRPSGR-LEE 2642
Cdd:PRK12316 2982 DTWESAEGLGASLTYATDLFDARTVERLARHWQNLLRGMVENPQRSVDELAMLDAEERGQLLEAWNATAAEYPLERgVHR 3061
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2643 GFFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQ 2722
Cdd:PRK12316 3062 LFEEQVERTPDAVALAFGEQRLSYAELNRRANRLAHRLIERGVGPDVLVGVAVERSLEMVVGLLAILKAGGAYVPLDPEY 3141
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2723 PPLRLHQLLEEGPARVVLTQSSLlhTVPWPPGVQVIAVDELEPATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHR 2802
Cdd:PRK12316 3142 PEERLAYMLEDSGAQLLLSQSHL--RLPLAQGVQVLDLDRGDENYAEANPAIRTMPENLAYVIYTSGSTGKPKGVGIRHS 3219
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2803 AALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLvagRVTVWNSTPALML 2882
Cdd:PRK12316 3220 ALSNHLCWMQQAYGLGVGDRVLQFTTFSFDVFVEELFWPLMSGARVVLAGPEDWRDPALLVELI---NSEGVDVLHAYPS 3296
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2883 LLVEYAEQRGLKLPAALRLVMLSGDWIPVALPDRIRALGrdvQVVSLGGATEASIWSIAYPIgqVAPQWKSIPYGMPLAN 2962
Cdd:PRK12316 3297 MLQAFLEEEDAHRCTSLKRIVCGGEALPADLQQQVFAGL---PLYNLYGPTEATITVTHWQC--VEEGKDAVPIGRPIAN 3371
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2963 QRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHP-RTGERLYRTGDQGRMLPEGSIEFLGREDLQVK 3041
Cdd:PRK12316 3372 RACYILDGSLEPVPVGALGELYLGGEGLARGYHNRPGLTAERFVPDPfVPGERLYRTGDLARYRADGVIEYIGRVDHQVK 3451
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3042 VQGFRVELGEIEAALAQHPALSASVVVARGEprgvRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPR 3121
Cdd:PRK12316 3452 IRGFRIELGEIEARLLEHPWVREAVVLAVDG----RQLVAYVVPEDEAGDLREALKAHLKASLPEYMVPAHLLFLERMPL 3527
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3122 SRNGKIARDQLPEPQQTQGLAAQAAAADPLVERLAALVKEALRLERVEPQDSLLDLGADSVALIRLINRL-EAELQFRPR 3200
Cdd:PRK12316 3528 TPNGKLDRKALPRPDAALLQQDYVAPVNELERRLAAIWADVLKLEQVGLTDNFFELGGDSIISLQVVSRArQAGIRFTPK 3607
|
1210
....*....|....*.
gi 53747904 3201 laDIYENPTVQGLATL 3216
Cdd:PRK12316 3608 --DLFQHQTIQGLARV 3621
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
2228-3225 |
7.37e-125 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 445.94 E-value: 7.37e-125
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2228 LLQRHDMLRmVVLPDGRQQVLEQVPEYTPEVVELRGLSPQEAESRRLQLRERMAHQVLRS---DRWPLFELVLCRYEGGV 2304
Cdd:PRK12316 96 LVQRHETLR-TVFPRGADDSLAQVPLDRPLEVEFEDCSGLPEAEQEARLRDEAQRESLQPfdlCEGPLLRVRLLRLGEEE 174
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2305 RI-HMSMDALMLDAWSSAVLRQDFAQLY--HEPGRP--LEPLAITFRDYVLAERRLREGEAHERARAYWWARLDTLPPPP 2379
Cdd:PRK12316 175 HVlLLTLHHIVSDGWSMNVLIEEFSRFYsaYATGAEpgLPALPIQYADYALWQRSWLEAGEQERQLEYWRAQLGEEHPVL 254
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2380 ELPLVKEPSQLEHARFTHREARLEPHRWARLQERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRLplHPQVD 2459
Cdd:PRK12316 255 ELPTDHPRPAVPSYRGSRYEFSIDPALAEALRGTARRQGLTLFMLLLGAFNVLLHRYSGQTDIRVGVPIANRN--RAEVE 332
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2460 ELVGDFTSLVLLEVEAHAASTFAE-----RASRLQAQLWRDLEHGS-VSAVQLIRELVRTgrrspgaimPV--VFTSILS 2531
Cdd:PRK12316 333 GLIGFFVNTQVLRSVFDGRTRVATllagvKDTVLGAQAHQDLPFERlVEALKVERSLSHS---------PLfqVMYNHQP 403
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2532 LDARRGPQGSLSFFEGELVYSISQTPQVWLDHGVHEEEGALVLAWDSVEALFPPGMVDDMFHAYQRLLGALAEEEQAWEG 2611
Cdd:PRK12316 404 LVADIEALDTVAGLEFGQLEWKSRTTQFDLTLDTYEKGGRLHAALTYATDLFEARTVERMARHWQNLLRGMVENPQARVD 483
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2612 ELPELLPPAQRELLARYNATQAPRPSGR-LEEGFFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQEL 2690
Cdd:PRK12316 484 ELPMLDAEERGQLVEGWNATAAEYPLQRgVHRLFEEQVERTPEAPALAFGEETLDYAELNRRANRLAHALIERGVGPDVL 563
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2691 VAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSLLHTVPWPPGVQVIAVDELEPATEAP 2770
Cdd:PRK12316 564 VGVAMERSIEMVVALLAILKAGGAYVPLDPEYPAERLAYMLEDSGVQLLLSQSHLGRKLPLAAGVQVLDLDRPAAWLEGY 643
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2771 PLPPRGT---PEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGA 2847
Cdd:PRK12316 644 SEENPGTelnPENLAYVIYTSGSTGKPKGAGNRHRALSNRLCWMQQAYGLGVGDTVLQKTPFSFDVSVWEFFWPLMSGAR 723
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2848 LVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAeqrGLKLPAALRLVMLSGDWIPVALPDRIRALGRDVQVV 2927
Cdd:PRK12316 724 LVVAAPGDHRDPAKLVELINREGVDTLHFVPSMLQAFLQDE---DVASCTSLRRIVCSGEALPADAQEQVFAKLPQAGLY 800
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2928 SLGGATEASI----WSIAYPIGqvapqwKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTAT 3003
Cdd:PRK12316 801 NLYGPTEAAIdvthWTCVEEGG------DSVPIGRPIANLACYILDANLEPVPVGVLGELYLAGRGLARGYHGRPGLTAE 874
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3004 RFIRHP-RTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEprgvRRLVAY 3082
Cdd:PRK12316 875 RFVPSPfVAGERMYRTGDLARYRADGVIEYAGRIDHQVKLRGLRIELGEIEARLLEHPWVREAAVLAVDG----KQLVGY 950
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3083 AVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPEPQQTQGLAAQAAAADPLVERLAALVKEA 3162
Cdd:PRK12316 951 VVLESEGGDWREALKAHLAASLPEYMVPAQWLALERLPLTPNGKLDRKALPAPEASVAQQGYVAPRNALERTLAAIWQDV 1030
|
970 980 990 1000 1010 1020
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 53747904 3163 LRLERVEPQDSLLDLGADSVALIRLINRL-EAELQFRPRlaDIYENPTVQGL---ATLHQEKTKSQG 3225
Cdd:PRK12316 1031 LGVERVGLDDNFFELGGDSIVSIQVVSRArQAGIQLSPR--DLFQHQTIRSLalvAKAGQATAADQG 1095
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
2179-3255 |
1.37e-123 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 426.00 E-value: 1.37e-123
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2179 EPFPLTDVQEAYWVGRRSAFELGGVAAHGYFEIESPgLEVERFIQCWRQLLQRHDMLRM--VVLPDGRQQVL-EQVPEYT 2255
Cdd:PRK10252 6 QHLPLVAAQPGIWMAEKLSPLPSAWSVAHYVELTGE-LDAPLLARAVVAGLAEADTLRMrfTEDNGEVWQWVdPALTFPL 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2256 PEVVELRGLSPQEAESRRLQLRERMahQVLRSDRW-PLFELVLCR--------YEggvRIHMsmdaLMLDAWSSAVLRQD 2326
Cdd:PRK10252 85 PEIIDLRTQPDPHAAAQALMQADLQ--QDLRVDSGkPLVFHQLIQlgdnrwywYQ---RYHH----LLVDGFSFPAITRR 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2327 FAQLYHEPGRPLEPLAITFRDY--VLAE-RRLREGEAHERARAYWWARLdtlppppelPLVKEPSQLEHARFTHREARLE 2403
Cdd:PRK10252 156 IAAIYCAWLRGEPTPASPFTPFadVVEEyQRYRASEAWQRDAAFWAEQR---------RQLPPPASLSPAPLPGRSASAD 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2404 PHRWARL-------QERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRLplhpqvDELVGDFTSLVL----LE 2472
Cdd:PRK10252 227 ILRLKLEftdgafrQLAAQASGVQRPDLALALVALWLGRLCGRMDYAAGFIFMRRL------GSAALTATGPVLnvlpLR 300
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2473 VEAHAASTFAERASRLQAQLWRDLEHGSVSAVQLIRELVRTG--RRSPGAIMPV-VFTSILSLDarrGPQGSLsffegel 2549
Cdd:PRK10252 301 VHIAAQETLPELATRLAAQLKKMRRHQRYDAEQIVRDSGRAAgdEPLFGPVLNIkVFDYQLDFP---GVQAQT------- 370
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2550 vYSISQTPQVWLDHGVH-EEEGALVLAWDSVEALFPPGMVDDMFHAYQRLLGALAEEEQAWEGELPeLLPPAQRELLARY 2628
Cdd:PRK10252 371 -HTLATGPVNDLELALFpDEHGGLSIEILANPQRYDEATLIAHAERLKALIAQFAADPALLCGDVD-ILLPGEYAQLAQV 448
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2629 NATQAPRPSGRLEEGFFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGV 2708
Cdd:PRK10252 449 NATAVEIPETTLSALVAQQAAKTPDAPALADARYQFSYREMREQVVALANLLRERGVKPGDSVAVALPRSVFLTLALHAI 528
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2709 LQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSLLHTVPWPPGVQVIAVDELEPATEAPPLpPRGTPEHLAYVIYTS 2788
Cdd:PRK10252 529 VEAGAAWLPLDTGYPDDRLKMMLEDARPSLLITTADQLPRFADVPDLTSLCYNAPLAPQGAAPL-QLSQPHHTAYIIFTS 607
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2789 GSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAhWWERLVA 2868
Cdd:PRK10252 608 GSTGRPKGVMVGQTAIVNRLLWMQNHYPLTADDVVLQKTPCSFDVSVWEFFWPFIAGAKLVMAEPEAHRDPL-AMQQFFA 686
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2869 G-RVTVWNSTPALMLLLVEYAEQRGLKLP-AALRLVMLSGDWIPVALPDRIRALgRDVQVVSLGGATEASI---WSIAYP 2943
Cdd:PRK10252 687 EyGVTTTHFVPSMLAAFVASLTPEGARQScASLRQVFCSGEALPADLCREWQQL-TGAPLHNLYGPTEAAVdvsWYPAFG 765
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2944 IGQVAPQWKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHP-RTGERLYRTGDQG 3022
Cdd:PRK10252 766 EELAAVRGSSVPIGYPVWNTGLRILDARMRPVPPGVAGDLYLTGIQLAQGYLGRPDLTASRFIADPfAPGERMYRTGDVA 845
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3023 RMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVAR------GEPRGVRRLVAYAVPRSGQTPAAGEL 3096
Cdd:PRK10252 846 RWLDDGAVEYLGRSDDQLKIRGQRIELGEIDRAMQALPDVEQAVTHACvinqaaATGGDARQLVGYLVSQSGLPLDTSAL 925
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3097 RRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPEPQQTQGLAAQAAAAdPLVERLAALVKEALRLERVEPQDSLLD 3176
Cdd:PRK10252 926 QAQLRERLPPHMVPVVLLQLDQLPLSANGKLDRKALPLPELKAQVPGRAPKT-GTETIIAAAFSSLLGCDVVDADADFFA 1004
|
1050 1060 1070 1080 1090 1100 1110
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 53747904 3177 LGADSVALIRLINRLEAELQFRPRLADIYENPTVQGLATLHQEKTKSQGEGGAprltaprSTLLPAEEwgrfkANRPGL 3255
Cdd:PRK10252 1005 LGGHSLLAMKLAAQLSRQFARQVTPGQVMVASTVAKLATLLDAEEDESRRLGF-------GTILPLRE-----GDGPTL 1071
|
|
| mycolic_Pks13 |
NF040607 |
polyketide synthase Pks13; |
13-884 |
8.81e-123 |
|
polyketide synthase Pks13;
Pssm-ID: 468580 [Multi-domain] Cd Length: 1671 Bit Score: 430.88 E-value: 8.81e-123
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 13 IALVGMAGRFPGA-PDVESFWRNLVAGVESISFFSEEELRQAGVSEQIRRRPEYVPAKG-VLEDLELFDAGFFGYSPREA 90
Cdd:NF040607 102 IAIVGLATRFPGAgNTPEEMWEALIEGRDGITDLPEGRWSEFAADPRIAERVAKANTRGgYLDDIKGFDAEFFALSPLEA 181
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 91 SHLDPQQRLLLECSWEALEDAGLRPDQLPGW-VGVYVGAGDTSYrfQLLRGhGDPlsGSKDVAGFFGNYPDFLATRVAYK 169
Cdd:NF040607 182 ENVDPQQRLALELTWEALEHARIPASSLRGEpVGVFIGSSNNDY--QMLAV-ADP--AEAHPYALTGTSSSIIANRVSYF 256
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 170 LNLRGPALGIHTACSTSLVSINMACSALRGFECDMALAGGVSLRL-PARSGYLYEEGGVASKDGHCRPFDARATGTVTGD 248
Cdd:NF040607 257 FDFRGPSVAVDTACSSSLVAVHQAVRALRSGEADVAVAGGVNMLLtPAVTLGFDELGGVLAPDGRIKAFSSDADGMVRSE 336
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 249 GVGVVVLKRLEDALKARDPIHAVIRGWALNNDGASRaGFTAPSVEGQSEVIALAHAAAGISARDITYVEAHGTGTPLGDP 328
Cdd:NF040607 337 GGGVVVLKRLADARRDGDTILAVIAGSAVNSDGRSN-GLTAPNPDAQVDVLRRAYADAGIDPRTVDYVEAHGTGTILGDP 415
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 329 IEVAALTRAF-RAHTADTAfCTLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERPNP-----ALHLEqspff 402
Cdd:NF040607 416 IEADALGRVVgRGRDADKP-ALLGSAKTNFGHLESAAGAAGLAKVVLAMQHDKLPPSLNYAGPNPyidfdAEHLK----- 489
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 403 VNTQPLPWesPR--GPRLAGVSSFGIGGTNAHTLFEEAPPPPASGPTRPNQVLLLSARSTSALEhiAGRLAAHLRRHPDL 480
Cdd:NF040607 490 VVDEPTEW--PRysGHAVAGVSGFGFGGTNAHVVVREVLPADLVEPEAQPDEDTEAELAGLTAE--AKRLLAEAELAAEF 565
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 481 ELA---DVAFTLQVGrARFPYRRALTCRTLAEAMErleapeprppeplAHEGERPPL------------------VM--- 536
Cdd:NF040607 566 APAapeGPVVPLPVS-GFLPSRRRAAAADLADWLE-------------SEEGRATPLadvaralarrnhgrsravVLaht 631
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 537 ----------LFPGQGTPLVGTA-----------------------RALHESEPTFRQAVEQCARLLRQTLGLDVREVLF 583
Cdd:NF040607 632 heeaikglraVAEGKPGPGVFSAdapaangpvwvlsgfgsqhrkmaKQLYLENPVFAARIDEVDELVQDESGYSIVELIL 711
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 584 PSAEQEEqarrlaaqTRVAQPALFTLEYALAQTWLGWGLQPQALAGHSLGELVAACLAGVFSLEDALQLVAARGQLM--- 660
Cdd:NF040607 712 DDEQTYD--------IETAQVGIFAIQIALADLLRHHGAKPAAVVGHSMGEAAAAYAAGGLSLEDAVRVICHRSRLMgeg 783
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 661 ----QGCPPGAMLAVPLPEAELAALLGS----ELCIAAvnGPRACVASGPLPAVEALTAALESRGVSSRRLETSHAFHSA 732
Cdd:NF040607 784 eamlPGDDIRLMALVEYSAEEIETVLADfpdlEVCVYA--APTHTVIGGPREQVDAIVARAEAEGKFARKLQTKGASHTS 861
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 733 SMEACQGPLTTLLRRMRLQAPRLPCVS----GLTGRwlTGEEATEPT-YWARQLREPVRFSEALETLWSLKEPVLLEVGP 807
Cdd:NF040607 862 QMDPLLGELAAELAGIEPQPLTVGLYSsvdrGTFYR--PGHEPIHDVdYWVKGLRHSVWFTQAVRKAVDAGHTTFLELAP 939
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 808 ---------GTTLTA----------LARRHPtrpartqEVASLPvqpdtavpcieEAVGELWQAGLELDWSALhAAPRHR 868
Cdd:NF040607 940 npvalmsvaATTFAAglhdaqliptLKRKED-------ESESVL-----------NALAQLYVHGHDVDLRSL-FGAGDY 1000
|
970
....*....|....*.
gi 53747904 869 AHLPPYPFERQRYWIE 884
Cdd:NF040607 1001 ADIPRTRFKRKPYWLD 1016
|
|
| AA-adenyl-dom |
TIGR01733 |
amino acid adenylation domain; This model represents a domain responsible for the specific ... |
2685-3067 |
2.49e-122 |
|
amino acid adenylation domain; This model represents a domain responsible for the specific recognition of amino acids and activation as adenylyl amino acids. The reaction catalyzed is aa + ATP -> aa-AMP + PPi. These domains are usually found as components of multi-domain non-ribosomal peptide synthetases and are usually called "A-domains" in that context. A-domains are almost invariably followed by "T-domains" (thiolation domains, pfam00550) to which the amino acid adenylate is transferred as a thiol-ester to a bound pantetheine cofactor with the release of AMP (these are also called peptide carrier proteins, or PCPs. When the A-domain does not represent the first module (corresponding to the first amino acid in the product molecule) it is usually preceded by a "C-domain" (condensation domain, pfam00668) which catalyzes the ligation of two amino acid thiol-esters from neighboring modules. This domain is a subset of the AMP-binding domain found in Pfam (pfam00501) which also hits substrate--CoA ligases and luciferases. Sequences scoring in between trusted and noise for this model may be ambiguous as to whether they activate amino acids or other molecules lacking an alpha amino group.
Pssm-ID: 273779 [Multi-domain] Cd Length: 409 Bit Score: 393.55 E-value: 2.49e-122
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2685 VQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSLLHTVPW-PPGVQVIAVDEL 2763
Cdd:TIGR01733 22 VGPGDRVAVLLERSAELVVAILAVLKAGAAYVPLDPAYPAERLAFILEDAGARLLLTDSALASRLAGlVLPVILLDPLEL 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2764 EPATEAPPLPPRGT---PEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLG 2840
Cdd:TIGR01733 102 AALDDAPAPPPPDApsgPDDLAYVIYTSGSTGRPKGVVVTHRSLVNLLAWLARRYGLDPDDRVLQFASLSFDASVEEIFG 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2841 LLGAGGALVLPAAEAEKDPAHWWERLVA-GRVTVWNSTPALMLLLVEYAEQRglklPAALRLVMLSGDWIPVALPDRIRA 2919
Cdd:TIGR01733 182 ALLAGATLVVPPEDEERDDAALLAALIAeHPVTVLNLTPSLLALLAAALPPA----LASLRLVILGGEALTPALVDRWRA 257
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2920 LGRDVQVVSLGGATEASIWSIAYPI-GQVAPQWKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDE 2998
Cdd:TIGR01733 258 RGPGARLINLYGPTETTVWSTATLVdPDDAPRESPVPIGRPLANTRLYVLDDDLRPVPVGVVGELYIGGPGVARGYLNRP 337
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 53747904 2999 PLTATRFIRHP---RTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVV 3067
Cdd:TIGR01733 338 ELTAERFVPDPfagGDGARLYRTGDLVRYLPDGNLEFLGRIDDQVKIRGYRIELGEIEAALLRHPGVREAVV 409
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
2215-3214 |
4.51e-120 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 429.58 E-value: 4.51e-120
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2215 GLEVERFIQCWRQLLQRHDMLRMVVLPDGRQQVLEQV--PEYTPEVVEL----RGLSPQEAESrrLQLRERMAHQVLRSD 2288
Cdd:PRK12467 2679 GLDVERFRTAWQAVIDRHEILRSGFLWDGELEEPLQVvyKQARLPFSRLdwrdRADLEQALDA--LAAADRQQGFDLLSA 2756
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2289 rwPLFELVLCRYeGGVRIHM--SMDALMLDAWSSAVLRQDFAQLYHepGRPLEPLAITFRDYVLAERRlregEAHERARA 2366
Cdd:PRK12467 2757 --PLLRLTLVRT-GEDRHHLiyTNHHILMDGWSGSQLLGEVLQRYF--GQPPPAREGRYRDYIAWLQA----QDAEASEA 2827
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2367 YWWARLdtlppppelPLVKEPSQLEHArFTHREAR-----------LEPHRWARLQERARAHGLTPSAACMAAFAEVLAR 2435
Cdd:PRK12467 2828 FWKEQL---------AALEEPTRLARA-LYPAPAEavaghgahylhLDATQTRQLIEFARRHRVTLNTLVQGAWLLLLQR 2897
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2436 WSRHPRFTLNLTLFQRLPLHPQVDELVGDFTSLVLLEVEAHAASTFAERASRLQAQ--LWRDLEHGSVSAVQlirelvrt 2513
Cdd:PRK12467 2898 FTGQDTVCFGATVAGRPAQLRGAEQQLGLFINTLPVIASPRAEQTVSDWLQQVQAQnlALREFEHTPLADIQ-------- 2969
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2514 grRSPGAIMPVVFTSILSLD----ARRGPQGSLSFFEGELVYSISQTpQVWLDHGVHEEEgALVLAWDSVEALFPPGMVD 2589
Cdd:PRK12467 2970 --RWAGQGGEALFDSILVFEnypiSEALKQGAPSGLRFGAVSSREQT-NYPLTLAVGLGD-TLELEFSYDRQHFDAAAIE 3045
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2590 DMFHAYQRLLGALAEEEQAWEGELPELLPPAQRELLARYNATQAPRPSGRL-EEGFFTQARLHPELPALLAPERTLSYGE 2668
Cdd:PRK12467 3046 RLAESFDRLLQAMLNNPAARLGELPTLAAHERRQVLHAWNATAAAYPSERLvHQLIEAQVARTPEAPALVFGDQQLSYAE 3125
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2669 LARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSLLHT 2748
Cdd:PRK12467 3126 LNRRANRLAHRLIAIGVGPDVLVGVAVERSVEMIVALLAVLKAGGAYVPLDPEYPRERLAYMIEDSGVKLLLTQAHLLEQ 3205
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2749 VPWPPGVQVIAVDELEPATEAPPLP-PRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLS 2827
Cdd:PRK12467 3206 LPAPAGDTALTLDRLDLNGYSENNPsTRVMGENLAYVIYTSGSTGKPKGVGVRHGALANHLCWIAEAYELDANDRVLLFM 3285
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2828 ALTFDLSVYDVLGLLGAGGALVLpAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLklpAALRLVMLSGD 2907
Cdd:PRK12467 3286 SFSFDGAQERFLWTLICGGCLVV-RDNDLWDPEELWQAIHAHRISIACFPPAYLQQFAEDAGGADC---ASLDIYVFGGE 3361
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2908 WIPVALPDRIRALGRDVQVVSLGGATEASIWSIAYPIGQVA-PQWKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIG 2986
Cdd:PRK12467 3362 AVPPAAFEQVKRKLKPRGLTNGYGPTEAVVTVTLWKCGGDAvCEAPYAPIGRPVAGRSIYVLDGQLNPVPVGVAGELYIG 3441
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2987 GEGLAREYWRDEPLTATRFIRHP--RTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSA 3064
Cdd:PRK12467 3442 GVGLARGYHQRPSLTAERFVADPfsGSGGRLYRTGDLARYRADGVIEYLGRIDHQVKIRGFRIELGEIEARLLQHPSVRE 3521
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3065 SVVVARGEPRGvRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPEPQQTQGLAAQ 3144
Cdd:PRK12467 3522 AVVLARDGAGG-KQLVAYVVPADPQGDWRETLRDHLAASLPDYMVPAQLLVLAAMPLGPNGKVDRKALPDPDAKGSREYV 3600
|
970 980 990 1000 1010 1020 1030
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3145 AAAADpLVERLAALVKEALRLERVEPQDSLLDLGADSVALIRLINRLEAELQFRPRLADIYENPTVQGLA 3214
Cdd:PRK12467 3601 APRSE-VEQQLAAIWADVLGVEQVGVTDNFFELGGDSLLALQVLSRIRQSLGLKLSLRDLMSAPTIAELA 3669
|
|
| A_NRPS_AB3403-like |
cd17646 |
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or ... |
2642-3132 |
8.37e-120 |
|
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341301 [Multi-domain] Cd Length: 488 Bit Score: 389.33 E-value: 8.37e-120
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2642 EGFFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPE 2721
Cdd:cd17646 2 ALVAEQAARTPDAPAVVDEGRTLTYRELDERANRLAHLLRARGVGPEDRVAVLLPRSADLVVALLAVLKAGAAYLPLDPG 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2722 QPPLRLHQLLEEGPARVVLTQSSLlhtVPWPPGVQVIAVDELEPATEAPPLPPRGT--PEHLAYVIYTSGSTGKPKGVAI 2799
Cdd:cd17646 82 YPADRLAYMLADAGPAVVLTTADL---AARLPAGGDVALLGDEALAAPPATPPLVPprPDNLAYVIYTSGSTGRPKGVMV 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2800 EHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPA 2879
Cdd:cd17646 159 THAGIVNRLLWMQDEYPLGPGDRVLQKTPLSFDVSVWELFWPLVAGARLVVARPGGHRDPAYLAALIREHGVTTCHFVPS 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2880 LMLLLVEYAEQRGLklpAALRLVMLSGDWIPVALPDRIRALGrDVQVVSLGGATEASIWSIAYPIGQVAPQwKSIPYGMP 2959
Cdd:cd17646 239 MLRVFLAEPAAGSC---ASLRRVFCSGEALPPELAARFLALP-GAELHNLYGPTEAAIDVTHWPVRGPAET-PSVPIGRP 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2960 LANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHP-RTGERLYRTGDQGRMLPEGSIEFLGREDL 3038
Cdd:cd17646 314 VPNTRLYVLDDALRPVPVGVPGELYLGGVQLARGYLGRPALTAERFVPDPfGPGSRMYRTGDLARWRPDGALEFLGRSDD 393
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3039 QVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQT-PAAGELRRYLAERLPAYMVPSAFVLLE 3117
Cdd:cd17646 394 QVKIRGFRVEPGEIEAALAAHPAVTHAVVVARAAPAGAARLVGYVVPAAGAAgPDTAALRAHLAERLPEYMVPAAFVVLD 473
|
490
....*....|....*
gi 53747904 3118 SLPRSRNGKIARDQL 3132
Cdd:cd17646 474 ALPLTANGKLDRAAL 488
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
2215-3214 |
1.13e-118 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 425.53 E-value: 1.13e-118
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2215 GLEVERFIQCWRQLLQRHDMLRMVV-----LPDGRQQVLEQVpEYTPEVVELRGLSPQEAESRRLQLRERMAHQVLrsDR 2289
Cdd:PRK12316 1589 GLDPDRFRAAWQATVDRHEILRSGFlwqdgLEQPLQVIHKQV-ELPFAELDWRGREDLGQALDALAQAERQKGFDL--TR 1665
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2290 WPLFELVLCRyEGGVRIHM--SMDALMLDAWSSAVLRQDFAQLYhePGRPLEPLAITFRDYV--LAERRLREGEAherar 2365
Cdd:PRK12316 1666 APLLRLVLVR-TGEGRHHLiyTNHHILMDGWSNAQLLGEVLQRY--AGQPVAAPGGRYRDYIawLQRQDAAASEA----- 1737
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2366 aYWWARLdtlppppelPLVKEPSQLEHARFTHREAR--------LEPHRWARLQERARAHGLTPSAACMAAFAEVLARWS 2437
Cdd:PRK12316 1738 -FWKEQL---------AALEEPTRLAQAARTEDGQVgygdhqqlLDPAQTRALAEFARAQKVTLNTLVQAAWLLLLQRYT 1807
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2438 RHPRFTLNLTLFQRLPLHPQVDELVGDFTSLVLLEVEAHAASTFAERASRLQAQ--LWRDLEHGSVSAVQlirelvrtgr 2515
Cdd:PRK12316 1808 GQETVAFGATVAGRPAELPGIEQQIGLFINTLPVIAAPRPDQSVADWLQEVQALnlALREHEHTPLYDIQ---------- 1877
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2516 RSPGAIMPVVFTSILSLD-------ARRGPQGSLSFFEgelVYSISQTpQVWLDHGVHEEEgALVLAWDSVEALFPPGMV 2588
Cdd:PRK12316 1878 RWAGQGGEALFDSLLVFEnypvaeaLKQGAPAGLVFGR---VSNHEQT-NYPLTLAVTLGE-TLSLQYSYDRGHFDAAAI 1952
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2589 DDMFHAYQRLLGALAEEEQAWEGELPELLPPAQRELLARYNATQAPRPSG-RLEEGFFTQARLHPELPALLAPERTLSYG 2667
Cdd:PRK12316 1953 ERLDRHLLHLLEQMAEDAQAALGELALLDAGERQRILADWDRTPEAYPRGpGVHQRIAEQAARAPEAIAVVFGDQHLSYA 2032
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2668 ELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSLLH 2747
Cdd:PRK12316 2033 ELDSRANRLAHRLRARGVGPEVRVAIAAERSFELVVALLAVLKAGGAYVPLDPNYPAERLAYMLEDSGAALLLTQRHLLE 2112
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2748 TVPWPPGVQVIAVDELEPATEAPPLPP--RGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLG 2825
Cdd:PRK12316 2113 RLPLPAGVARLPLDRDAEWADYPDTAPavQLAGENLAYVIYTSGSTGLPKGVAVSHGALVAHCQAAGERYELSPADCELQ 2192
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2826 LSALTFDLSVYDVLGLLGAGGALVLPAAEaEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGlkLPAALRLVMLS 2905
Cdd:PRK12316 2193 FMSFSFDGAHEQWFHPLLNGARVLIRDDE-LWDPEQLYDEMERHGVTILDFPPVYLQQLAEHAERDG--RPPAVRVYCFG 2269
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2906 GDWIPVALPDRIRALGRDVQVVSLGGATEASIWSIAYPIG-QVAPQWKSIPYGMPLANQRFHVLDGRLEARPWWVPGELY 2984
Cdd:PRK12316 2270 GEAVPAASLRLAWEALRPVYLFNGYGPTEAVVTPLLWKCRpQDPCGAAYVPIGRALGNRRAYILDADLNLLAPGMAGELY 2349
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2985 IGGEGLAREYWRDEPLTATRFIRHP--RTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPAL 3062
Cdd:PRK12316 2350 LGGEGLARGYLNRPGLTAERFVPDPfsASGERLYRTGDLARYRADGVVEYLGRIDHQVKIRGFRIELGEIEARLQAHPAV 2429
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3063 SASVVVARGEPRGvRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPEPQQTQGLA 3142
Cdd:PRK12316 2430 REAVVVAQDGASG-KQLVAYVVPDDAAEDLLAELRAWLAARLPAYMVPAHWVVLERLPLNPNGKLDRKALPKPDVSQLRQ 2508
|
970 980 990 1000 1010 1020 1030
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 53747904 3143 AQAAAADPLVERLAALVKEALRLERVEPQDSLLDLGADSVALIRLINRLEAELQFRPRLADIYENPTVQGLA 3214
Cdd:PRK12316 2509 AYVAPQEGLEQRLAAIWQAVLKVEQVGLDDHFFELGGHSLLATQVVSRVRQDLGLEVPLRILFERPTLAAFA 2580
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
2072-3190 |
2.29e-118 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 424.20 E-value: 2.29e-118
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2072 GRAAAAEPQALPPSSLEQLIEQVWRKHLGVERVQPTDSFFQLGGDSLLGIQVAADLRRHLGVELPTATLFSHPTLAALAA 2151
Cdd:PRK05691 572 LQAVEAAQTAASGDELQARIAAIWCEQLKVEQVAADDHFFLLGGNSIAATQVVARLRDELGIDLNLRQLFEAPTLAAFSA 651
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2152 ALRARQGEAAAPTAPAPALvpdpaARFEPFPLTDVQEAYWV-----GRRSAFEL-GGVAAHGyfEIESPGLEverfiQCW 2225
Cdd:PRK05691 652 AVARQLAGGGAAQAAIARL-----PRGQALPQSLAQNRLWLlwqldPQSAAYNIpGGLHLRG--ELDEAALR-----ASF 719
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2226 RQLLQRHDMLRMVVLP-DGR--QQVLEQvPEYTPEVVELRGLSPQEAESRRLQLRERMAHQVLRSDRWPLFELVLCRY-E 2301
Cdd:PRK05691 720 QRLVERHESLRTRFYErDGValQRIDAQ-GEFALQRIDLSDLPEAEREARAAQIREEEARQPFDLEKGPLLRVTLVRLdD 798
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2302 GGVRIHMSMDALMLDAWSSAVLRQDFAQLYHEP--GRPLE--PLAITFRDYVLAERR-LREGEAhERARAYWWARL-DTL 2375
Cdd:PRK05691 799 EEHQLLVTLHHIVADGWSLNILLDEFSRLYAAAcqGQTAElaPLPLGYADYGAWQRQwLAQGEA-ARQLAYWKAQLgDEQ 877
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2376 PPPPELPLVKEPSQLEH--ARFThreARLEPHRWARLQERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRLP 2453
Cdd:PRK05691 878 PVLELATDHPRSARQAHsaARYS---LRVDASLSEALRGLAQAHQATLFMVLLAAFQALLHRYSGQGDIRIGVPNANRPR 954
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2454 LHPQvdELVGDFTSLVLLEVEAHAASTFAE-----RASRLQAQLWRDLEHGsvsavQLIRELVRTGRRSPGAIMpvvfts 2528
Cdd:PRK05691 955 LETQ--GLVGFFINTQVLRAQLDGRLPFTAllaqvRQATLGAQAHQDLPFE-----QLVEALPQAREQGLFQVM------ 1021
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2529 ilsLDARRGPQGSLSFFEGELVYSIS-QTPQVWLDHGVHEEE---GALVLAWDSVEALFPPGMVDDMFHAYQRLLGALAE 2604
Cdd:PRK05691 1022 ---FNHQQRDLSALRRLPGLLAEELPwHSREAKFDLQLHSEEdrnGRLTLSFDYAAELFDAATIERLAEHFLALLEQVCE 1098
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2605 EEQAWEGELpELLPPAQRELLARYNATQAPRPSGRLEEGFFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELE 2684
Cdd:PRK05691 1099 DPQRALGDV-QLLDAAERAQLAQWGQAPCAPAQAWLPELLNEQARQTPERIALVWDGGSLDYAELHAQANRLAHYLRDKG 1177
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2685 VQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSLLHTVPWPPGVQVIAVDELE 2764
Cdd:PRK05691 1178 VGPDVCVAIAAERSPQLLVGLLAILKAGGAYVPLDPDYPAERLAYMLADSGVELLLTQSHLLERLPQAEGVSAIALDSLH 1257
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2765 PA---TEAPPLPPRGtpEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGL 2841
Cdd:PRK05691 1258 LDswpSQAPGLHLHG--DNLAYVIYTSGSTGQPKGVGNTHAALAERLQWMQATYALDDSDVLMQKAPISFDVSVWECFWP 1335
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2842 LGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVeyaEQRGLKLPAALRLVMLSGDWIPVALPDRIRALG 2921
Cdd:PRK05691 1336 LITGCRLVLAGPGEHRDPQRIAELVQQYGVTTLHFVPPLLQLFI---DEPLAAACTSLRRLFSGGEALPAELRNRVLQRL 1412
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2922 RDVQVVSLGGATEASIwSIAYPIGQVAPQWKSiPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLT 3001
Cdd:PRK05691 1413 PQVQLHNRYGPTETAI-NVTHWQCQAEDGERS-PIGRPLGNVLCRVLDAELNLLPPGVAGELCIGGAGLARGYLGRPALT 1490
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3002 ATRFIRHP--RTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGvRRL 3079
Cdd:PRK05691 1491 AERFVPDPlgEDGARLYRTGDRARWNADGALEYLGRLDQQVKLRGFRVEPEEIQARLLAQPGVAQAAVLVREGAAG-AQL 1569
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3080 VAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPEPqqTQGLAAQAAAADPLVERLAALV 3159
Cdd:PRK05691 1570 VGYYTGEAGQEAEAERLKAALAAELPEYMVPAQLIRLDQMPLGPSGKLDRRALPEP--VWQQREHVEPRTELQQQIAAIW 1647
|
1130 1140 1150
....*....|....*....|....*....|.
gi 53747904 3160 KEALRLERVEPQDSLLDLGADSVALIRLINR 3190
Cdd:PRK05691 1648 REVLGLPRVGLRDDFFALGGHSLLATQIVSR 1678
|
|
| A_NRPS_Srf_like |
cd12117 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis ... |
2647-3132 |
9.93e-116 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis termination module Surfactin (SrfA-C); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the adenylation domain of the Bacillus subtilis termination module (Surfactin domain, SrfA-C) which recognizes a specific amino acid building block, which is then activated and transferred to the terminal thiol of the 4'-phosphopantetheine (Ppan) arm of the downstream peptidyl carrier protein (PCP) domain.
Pssm-ID: 341282 [Multi-domain] Cd Length: 483 Bit Score: 377.31 E-value: 9.93e-116
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2647 QARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLR 2726
Cdd:cd12117 6 QAARTPDAVAVVYGDRSLTYAELNERANRLARRLRAAGVGPGDVVGVLAERSPELVVALLAVLKAGAAYVPLDPELPAER 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2727 LHQLLEEGPARVVLTQSSLlhTVPWPPGVQVIAVDELEPATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALN 2806
Cdd:cd12117 86 LAFMLADAGAKVLLTDRSL--AGRAGGLEVAVVIDEALDAGPAGNPAVPVSPDDLAYVMYTSGSTGRPKGVAVTHRGVVR 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2807 TVvdLNTRFG-VGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLV 2885
Cdd:cd12117 164 LV--KNTNYVtLGPDDRVLQTSPLAFDASTFEIWGALLNGARLVLAPKGTLLDPDALGALIAEEGVTVLWLTAALFNQLA 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2886 EYAEQRglklPAALRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEASIWSIAYPIGQVAPQWKSIPYGMPLANQRF 2965
Cdd:cd12117 242 DEDPEC----FAGLRELLTGGEVVSPPHVRRVLAACPGLRLVNGYGPTENTTFTTSHVVTELDEVAGSIPIGRPIANTRV 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2966 HVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHPRT-GERLYRTGDQGRMLPEGSIEFLGREDLQVKVQG 3044
Cdd:cd12117 318 YVLDEDGRPVPPGVPGELYVGGDGLALGYLNRPALTAERFVADPFGpGERLYRTGDLARWLPDGRLEFLGRIDDQVKIRG 397
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3045 FRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRsgQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRN 3124
Cdd:cd12117 398 FRIELGEIEAALRAHPGVREAVVVVREDAGGDKRLVAYVVAE--GALDAAELRAFLRERLPAYMVPAAFVVLDELPLTAN 475
|
....*...
gi 53747904 3125 GKIARDQL 3132
Cdd:cd12117 476 GKVDRRAL 483
|
|
| A_NRPS_Ta1_like |
cd12116 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A ... |
2652-3132 |
7.21e-115 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A polyketide synthase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the myxovirescin (TA) antibiotic biosynthetic gene in Myxococcus xanthus; TA production plays a role in predation. It also includes the salinosporamide A polyketide synthase which is involved in the biosynthesis of salinosporamide A, a marine microbial metabolite whose chlorine atom is crucial for potent proteasome inhibition and anticancer activity.
Pssm-ID: 341281 [Multi-domain] Cd Length: 470 Bit Score: 374.32 E-value: 7.21e-115
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2652 PELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLL 2731
Cdd:cd12116 1 PDATAVRDDDRSLSYAELDERANRLAARLRARGVGPGDRVAVYLPRSARLVAAMLAVLKAGAAYVPLDPDYPADRLRYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2732 EEGPARVVLTQSSLLHTVPWPPGVqviaVDELEPATEAPPLPPRGT--PEHLAYVIYTSGSTGKPKGVAIEHRAALNTVV 2809
Cdd:cd12116 81 EDAEPALVLTDDALPDRLPAGLPV----LLLALAAAAAAPAAPRTPvsPDDLAYVIYTSGSTGRPKGVVVSHRNLVNFLH 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2810 DLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVeYAE 2889
Cdd:cd12116 157 SMRERLGLGPGDRLLAVTTYAFDISLLELLLPLLAGARVVIAPRETQRDPEALARLIEAHSITVMQATPATWRMLL-DAG 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2890 QRGLklpAALRLVmLSGDWIPVALPDRIRALGRdvQVVSLGGATEASIWSIAypiGQVAPQWKSIPYGMPLANQRFHVLD 2969
Cdd:cd12116 236 WQGR---AGLTAL-CGGEALPPDLAARLLSRVG--SLWNLYGPTETTIWSTA---ARVTAAAGPIPIGRPLANTQVYVLD 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2970 GRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHPRT--GERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRV 3047
Cdd:cd12116 307 AALRPVPPGVPGELYIGGDGVAQGYLGRPALTAERFVPDPFAgpGSRLYRTGDLVRRRADGRLEYLGRADGQVKIRGHRI 386
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3048 ELGEIEAALAQHPALSASVVVARGEpRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKI 3127
Cdd:cd12116 387 ELGEIEAALAAHPGVAQAAVVVRED-GGDRRLVAYVVLKAGAAPDAAALRAHLRATLPAYMVPSAFVRLDALPLTANGKL 465
|
....*
gi 53747904 3128 ARDQL 3132
Cdd:cd12116 466 DRKAL 470
|
|
| A_NRPS_VisG_like |
cd17651 |
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) ... |
2644-3133 |
1.64e-112 |
|
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes virginiamycin S synthetase (VisG) in Streptomyces virginiae; VisG is involved in virginiamycin S (VS) biosynthesis as the provider of an L-pheGly molecule, a highly specific substrate for the last condensation step by VisF. This family also includes linear gramicidin synthetase B (LgrB) in Brevibacillus brevis. Substrate specificity analysis using residues of the substrate-binding pockets of all 16 adenylation domains has shown good agreement of the substrate amino acids predicted with the sequence of linear gramicidin. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341306 [Multi-domain] Cd Length: 491 Bit Score: 368.59 E-value: 1.64e-112
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2644 FFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQP 2723
Cdd:cd17651 1 FERQAARTPDAPALVAEGRRLTYAELDRRANRLAHRLRARGVGPGDLVALCARRSAELVVALLAILKAGAAYVPLDPAYP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2724 PLRLHQLLEEGPARVVLTQSSLLHTVPWPPGVQVIAVDELEPATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRA 2803
Cdd:cd17651 81 AERLAFMLADAGPVLVLTHPALAGELAVELVAVTLLDQPGAAAGADAEPDPALDADDLAYVIYTSGSTGRPKGVVMPHRS 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2804 ALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLL 2883
Cdd:cd17651 161 LANLVAWQARASSLGPGARTLQFAGLGFDVSVQEIFSTLCAGATLVLPPEEVRTDPPALAAWLDEQRISRVFLPTVALRA 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2884 LVEYAeQRGLKLPAALRLVMLSGDwiPVALPDRIRALGRDV---QVVSLGGATEASIWSiAYPIGQVAPQWKSIP-YGMP 2959
Cdd:cd17651 241 LAEHG-RPLGVRLAALRYLLTGGE--QLVLTEDLREFCAGLpglRLHNHYGPTETHVVT-ALSLPGDPAAWPAPPpIGRP 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2960 LANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHP-RTGERLYRTGDQGRMLPEGSIEFLGREDL 3038
Cdd:cd17651 317 IDNTRVYVLDAALRPVPPGVPGELYIGGAGLARGYLNRPELTAERFVPDPfVPGARMYRTGDLARWLPDGELEFLGRADD 396
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3039 QVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLES 3118
Cdd:cd17651 397 QVKIRGFRIELGEIEAALARHPGVREAVVLAREDRPGEKRLVAYVVGDPEAPVDAAELRAALATHLPEYMVPSAFVLLDA 476
|
490
....*....|....*
gi 53747904 3119 LPRSRNGKIARDQLP 3133
Cdd:cd17651 477 LPLTPNGKLDRRALP 491
|
|
| A_NRPS_Bac |
cd17655 |
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of ... |
2644-3135 |
1.16e-110 |
|
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetases 1, 2, and 3 (BA1, also known as ATP-dependent cysteine adenylase or cysteine activase, BA2, also known as ATP-dependent lysine adenylase or lysine activase, and BA3, also known as ATP-dependent isoleucine adenylase or isoleucine activase) in Bacilli. Bacitracin is a mixture of related cyclic peptides used as a polypeptide antibiotic. This family also includes gramicidin synthetase 1 involved in synthesis of the cyclic peptide antibiotic gramicidin S via activation of phenylalanine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341310 [Multi-domain] Cd Length: 490 Bit Score: 363.19 E-value: 1.16e-110
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2644 FFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQP 2723
Cdd:cd17655 3 FEEQAEKTPDHTAVVFEDQTLTYRELNERANQLARTLREKGVGPDTIVGIMAERSLEMIVGILGILKAGGAYLPIDPDYP 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2724 PLRLHQLLEEGPARVVLTQSSLLHTVPWPPGVQVIAVDELEpATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRA 2803
Cdd:cd17655 83 EERIQYILEDSGADILLTQSHLQPPIAFIGLIDLLDEDTIY-HEESENLEPVSKSDDLAYVIYTSGSTGKPKGVMIEHRG 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2804 ALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLL 2883
Cdd:cd17655 162 VVNLVEWANKVIYQGEHLRVALFASISFDASVTEIFASLLSGNTLYIVRKETVLDGQALTQYIRQNRITIIDLTPAHLKL 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2884 LVEYAEQRGLKLpaalRLVMLSGDWIPVALPDRIRALGRD-VQVVSLGGATEASIWSIAYPIGQVAPQWKSIPYGMPLAN 2962
Cdd:cd17655 242 LDAADDSEGLSL----KHLIVGGEALSTELAKKIIELFGTnPTITNAYGPTETTVDASIYQYEPETDQQVSVPIGKPLGN 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2963 QRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHP-RTGERLYRTGDQGRMLPEGSIEFLGREDLQVK 3041
Cdd:cd17655 318 TRIYILDQYGRPQPVGVAGELYIGGEGVARGYLNRPELTAEKFVDDPfVPGERMYRTGDLARWLPDGNIEFLGRIDHQVK 397
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3042 VQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAagELRRYLAERLPAYMVPSAFVLLESLPR 3121
Cdd:cd17655 398 IRGYRIELGEIEARLLQHPDIKEAVVIARKDEQGQNYLCAYIVSEKELPVA--QLREFLARELPDYMIPSYFIKLDEIPL 475
|
490
....*....|....
gi 53747904 3122 SRNGKIARDQLPEP 3135
Cdd:cd17655 476 TPNGKVDRKALPEP 489
|
|
| A_NRPS_CmdD_like |
cd17652 |
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) ... |
2652-3133 |
4.62e-110 |
|
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes phosphinothricin tripeptide (PTT, phosphinothricylalanylalanine) synthetase, where PTT is a natural-product antibiotic and potent herbicide that is produced by Streptomyces hygroscopicus. This adenylation domain has been confirmed to directly activate beta-tyrosine, and fluorinated chondramides are produced through precursor-directed biosynthesis. Also included in this family is chondramide synthase D (also known as ATP-dependent phenylalanine adenylase or phenylalanine activase or tyrosine activase). Chondramides A-D are depsipeptide antitumor and antifungal antibiotics produced by C. crocatus, are a class of mixed peptide/polyketide depsipeptides comprised of three amino acids (alanine, N-methyltryptophan, plus the unusual amino acid beta-tyrosine or alpha-methoxy-beta-tyrosine) and a polyketide chain ([E]-7-hydroxy-2,4,6-trimethyloct-4-enoic acid).
Pssm-ID: 341307 [Multi-domain] Cd Length: 436 Bit Score: 359.26 E-value: 4.62e-110
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2652 PELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLL 2731
Cdd:cd17652 1 PDAPAVVFGDETLTYAELNARANRLARLLAARGVGPERLVALALPRSAELVVAILAVLKAGAAYLPLDPAYPAERIAYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2732 EEGPARVVLTQssllhtvpwppgvqviavdelepateapplpprgtPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDL 2811
Cdd:cd17652 81 ADARPALLLTT-----------------------------------PDNLAYVIYTSGSTGRPKGVVVTHRGLANLAAAQ 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2812 NTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAeqr 2891
Cdd:cd17652 126 IAAFDVGPGSRVLQFASPSFDASVWELLMALLAGATLVLAPAEELLPGEPLADLLREHRITHVTLPPAALAALPPDD--- 202
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2892 glkLPAaLRLVMLSGDWIPVALPDRIrALGRdvQVVSLGGATEASIWSIAYpigQVAPQWKSIPYGMPLANQRFHVLDGR 2971
Cdd:cd17652 203 ---LPD-LRTLVVAGEACPAELVDRW-APGR--RMINAYGPTETTVCATMA---GPLPGGGVPPIGRPVPGTRVYVLDAR 272
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2972 LEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHP--RTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVEL 3049
Cdd:cd17652 273 LRPVPPGVPGELYIAGAGLARGYLNRPGLTAERFVADPfgAPGSRMYRTGDLARWRADGQLEFLGRADDQVKIRGFRIEL 352
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3050 GEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIAR 3129
Cdd:cd17652 353 GEVEAALTEHPGVAEAVVVVRDDRPGDKRLVAYVVPAPGAAPTAAELRAHLAERLPGYMVPAAFVVLDALPLTPNGKLDR 432
|
....
gi 53747904 3130 DQLP 3133
Cdd:cd17652 433 RALP 436
|
|
| A_NRPS_ApnA-like |
cd17644 |
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the ... |
2644-3133 |
1.46e-109 |
|
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Planktothrix agardhii anabaenopeptin synthetase (ApnA A1), which is capable of activating two chemically distinct amino acids (Arg and Tyr). Structural studies show that the architecture of the active site forces Arg to adopt a Tyr-like conformation, thus explaining the bispecificity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341299 [Multi-domain] Cd Length: 465 Bit Score: 359.06 E-value: 1.46e-109
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2644 FFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQP 2723
Cdd:cd17644 6 FEEQVERTPDAVAVVFEDQQLTYEELNTKANQLAHYLQSLGVKSESLVGICVERSLEMIIGLLAILKAGGAYVPLDPNYP 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2724 PLRLHQLLEEGPARVVLTQssllhtvpwppgvqviavdelepateapplpprgtPEHLAYVIYTSGSTGKPKGVAIEHRA 2803
Cdd:cd17644 86 QERLTYILEDAQISVLLTQ-----------------------------------PENLAYVIYTSGSTGKPKGVMIEHQS 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2804 ALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLL 2883
Cdd:cd17644 131 LVNLSHGLIKEYGITSSDRVLQFASIAFDVAAEEIYVTLLSGATLVLRPEEMRSSLEDFVQYIQQWQLTVLSLPPAYWHL 210
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2884 LVEYAEQRGLKLPAALRLVMLSGDWIpvaLPDRIR----ALGRDVQVVSLGGATEASIWSIAYPIGQV-APQWKSIPYGM 2958
Cdd:cd17644 211 LVLELLLSTIDLPSSLRLVIVGGEAV---QPELVRqwqkNVGNFIQLINVYGPTEATIAATVCRLTQLtERNITSVPIGR 287
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2959 PLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHP---RTGERLYRTGDQGRMLPEGSIEFLGR 3035
Cdd:cd17644 288 PIANTQVYILDENLQPVPVGVPGELHIGGVGLARGYLNRPELTAEKFISHPfnsSESERLYKTGDLARYLPDGNIEYLGR 367
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3036 EDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVL 3115
Cdd:cd17644 368 IDNQVKIRGFRIELGEIEAVLSQHNDVKTAVVIVREDQPGNKRLVAYIVPHYEESPSTVELRQFLKAKLPDYMIPSAFVV 447
|
490
....*....|....*...
gi 53747904 3116 LESLPRSRNGKIARDQLP 3133
Cdd:cd17644 448 LEELPLTPNGKIDRRALP 465
|
|
| PKS_ER |
smart00829 |
Enoylreductase; Enoylreductase in Polyketide synthases. |
1703-1988 |
6.80e-106 |
|
Enoylreductase; Enoylreductase in Polyketide synthases.
Pssm-ID: 214840 [Multi-domain] Cd Length: 287 Bit Score: 340.90 E-value: 6.80e-106
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1703 IEVEAAGLNFLDVLGALGMMPaleaEESVLGRECSGRIAAVGEGVSGLRVGDEVLAVAPGCFRSYVLVDESQVVRRPASL 1782
Cdd:smart00829 1 IEVRAAGLNFRDVLIALGLYP----GEAVLGGECAGVVTRVGPGVTGLAVGDRVMGLAPGAFATRVVTDARLVVPIPDGW 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1783 GLAEGAAQMVPFATAYFALHTVGRLRRGERILIHAAAGGLGLAAVQLASRTGAEILATAGSEQKREYLRSLGI--AHVLD 1860
Cdd:smart00829 77 SFEEAATVPVVFLTAYYALVDLARLRPGESVLIHAAAGGVGQAAIQLARHLGAEVFATAGSPEKRDFLRALGIpdDHIFS 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1861 SRSTSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELGKRDLYADQQVGLRTLARGQTFAAIDFGP--HH 1938
Cdd:smart00829 157 SRDLSFADEILRATGGRGVDVVLNSLSGEFLDASLRCLAPGGRFVEIGKRDIRDNSQLAMAPFRPNVSYHAVDLDAleEG 236
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|.
gi 53747904 1939 PD-FRAVLEEVATQLTQGQLEPLPTRLFPARQVAEAFSFMARALHIGRVAV 1988
Cdd:smart00829 237 PDrIRELLAEVLELFAEGVLRPLPVTVFPISDAEDAFRYMQQGKHIGKVVL 287
|
|
| PKS_AT |
smart00827 |
Acyl transferase domain in polyketide synthase (PKS) enzymes; |
537-831 |
1.20e-104 |
|
Acyl transferase domain in polyketide synthase (PKS) enzymes;
Pssm-ID: 214838 [Multi-domain] Cd Length: 298 Bit Score: 337.84 E-value: 1.20e-104
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 537 LFPGQGTPLVGTARALHESEPTFRQAVEQCARLLRQTLGLDVREVLFPSAEQEEQARrlaaqTRVAQPALFTLEYALAQT 616
Cdd:smart00827 1 VFTGQGSQWAGMGRELYETEPVFREALDECDAALQPLLGWSLLDVLLGEDGAASLLD-----TEVAQPALFAVQVALARL 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 617 WLGWGLQPQALAGHSLGELVAACLAGVFSLEDALQLVAARGQLMQGCPP-GAMLAVPLPEAELAALL---GSELCIAAVN 692
Cdd:smart00827 76 LRSWGVRPDAVVGHSSGEIAAAYVAGVLSLEDAARLVAARGRLMQALPGgGAMLAVGLSEEEVEPLLagvPDRVSVAAVN 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 693 GPRACVASGPLPAVEALTAALESRGVSSRRLETSHAFHSASMEACQGPLTTLLRRMRLQAPRLPCVSGLTGRWLTGEEAT 772
Cdd:smart00827 156 SPSSVVLSGDEDAVDELAARLEAEGIFARRLKVDHAFHSPHMEPILDEFRAALAGLTPRPPRIPFVSTVTGTLIDGAELD 235
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 773 EPTYWARQLREPVRFSEALETLWSLKEP-VLLEVGPGTTLTALARRHPTRPARTQEVASL 831
Cdd:smart00827 236 DADYWVRNLREPVRFADAVRALLAEGGVtVFLEVGPHPVLTGPIKQTLAAAGSAVVLPSL 295
|
|
| A_NRPS_Sfm_like |
cd12115 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene ... |
2640-3132 |
5.33e-104 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene cluster from Streptomyces lavendulae; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the saframycin A gene cluster from Streptomyces lavendulae which implicates the NRPS system for assembling the unusual tetrapeptidyl skeleton in an iterative manner. It also includes saframycin Mx1 produced by Myxococcus xanthus NRPS.
Pssm-ID: 341280 [Multi-domain] Cd Length: 447 Bit Score: 342.37 E-value: 5.33e-104
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2640 LEEGFFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLD 2719
Cdd:cd12115 1 LHDLVEAQAARTPDAIALVCGDESLTYAELNRRANRLAARLRAAGVGPESRVGVCLERTPDLVVALLAVLKAGAAYVPLD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2720 PEQPPLRLHQLLEEGPARVVLTQssllhtvpwppgvqviavdelepateapplpprgtPEHLAYVIYTSGSTGKPKGVAI 2799
Cdd:cd12115 81 PAYPPERLRFILEDAQARLVLTD-----------------------------------PDDLAYVIYTSGSTGRPKGVAI 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2800 EHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDV-------LGLLGAGGALVLPAAEAEKDpahwwerlvagrVT 2872
Cdd:cd12115 126 EHRNAAAFLQWAAAAFSAEELAGVLASTSICFDLSVFELfgplatgGKVVLADNVLALPDLPAAAE------------VT 193
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2873 VWNSTPALMLLLVEYAeqrglKLPAALRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEASIWSIAYPIGQVAPQWK 2952
Cdd:cd12115 194 LINTVPSAAAELLRHD-----ALPASVRVVNLAGEPLPRDLVQRLYARLQVERVVNLYGPSEDTTYSTVAPVPPGASGEV 268
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2953 SIpyGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHPR-TGERLYRTGDQGRMLPEGSIE 3031
Cdd:cd12115 269 SI--GRPLANTQAYVLDRALQPVPLGVPGELYIGGAGVARGYLGRPGLTAERFLPDPFgPGARLYRTGDLVRWRPDGLLE 346
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3032 FLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPS 3111
Cdd:cd12115 347 FLGRADNQVKVRGFRIELGEIEAALRSIPGVREAVVVAIGDAAGERRLVAYIVAEPGAAGLVEDLRRHLGTRLPAYMVPS 426
|
490 500
....*....|....*....|.
gi 53747904 3112 AFVLLESLPRSRNGKIARDQL 3132
Cdd:cd12115 427 RFVRLDALPLTPNGKIDRSAL 447
|
|
| A_NRPS_Cytc1-like |
cd17643 |
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation ... |
2652-3132 |
9.01e-104 |
|
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Streptomyces sp. cytotrienin synthetase (CytC1), a relatively promiscuous adenylation enzyme that installs the aminoacyl moieties on the phosphopantetheinyl arm of the holo carrier protein CytC2. Also included are Streptomyces sp Thr1, involved in the biosynthesis of 4-chlorothreonine, Pseudomonas aeruginosa pyoverdine synthetase D (PvdD), involved in the biosynthesis of the siderophore pyoverdine and Pseudomonas syringae syringopeptin synthetase, where syringpeptin is a necrosis-inducing phytotoxin that functions as a virulence determinant in the plant-pathogen interaction. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341298 [Multi-domain] Cd Length: 450 Bit Score: 341.60 E-value: 9.01e-104
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2652 PELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLL 2731
Cdd:cd17643 1 PEAVAVVDEDRRLTYGELDARANRLARTLRAEGVGPGDRVALALPRSAELIVALLAILKAGGAYVPIDPAYPVERIAFIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2732 EEGPARVVLTQssllhtvpwppgvqviavdelepateapplpprgtPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDL 2811
Cdd:cd17643 81 ADSGPSLLLTD-----------------------------------PDDLAYVIYTSGSTGRPKGVVVSHANVLALFAAT 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2812 NTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEyAEQR 2891
Cdd:cd17643 126 QRWFGFNEDDVWTLFHSYAFDFSVWEIWGALLHGGRLVVVPYEVARSPEDFARLLRDEGVTVLNQTPSAFYQLVE-AADR 204
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2892 GLKLPAALRLVMLSGDWIPVAL--PDRIRALGRDVQVVSLGGATEASIWSIAYPI--GQVAPQWKSiPYGMPLANQRFHV 2967
Cdd:cd17643 205 DGRDPLALRYVIFGGEALEAAMlrPWAGRFGLDRPQLVNMYGITETTVHVTFRPLdaADLPAAAAS-PIGRPLPGLRVYV 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2968 LDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHPRT--GERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGF 3045
Cdd:cd17643 284 LDADGRPVPPGVVGELYVSGAGVARGYLGRPELTAERFVANPFGgpGSRMYRTGDLARRLPDGELEYLGRADEQVKIRGF 363
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3046 RVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNG 3125
Cdd:cd17643 364 RIELGEIEAALATHPSVRDAAVIVREDEPGDTRLVAYVVADDGAAADIAELRALLKELLPDYMVPARYVPLDALPLTVNG 443
|
....*..
gi 53747904 3126 KIARDQL 3132
Cdd:cd17643 444 KLDRAAL 450
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
2083-3245 |
1.45e-101 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 368.73 E-value: 1.45e-101
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2083 PPSSLEQLIEQVWRKHLGVERVQPTDSFFQLGGDSLLGIQVAADLRRHLGVELPTATLFSHPTLAALAAALRARQGEAAA 2162
Cdd:PRK05691 1635 PRTELQQQIAAIWREVLGLPRVGLRDDFFALGGHSLLATQIVSRTRQACDVELPLRALFEASELGAFAEQVARIQAAGER 1714
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2163 PTAPAPALVPdpaaRFEPFPLTDVQEAYWV-----GRRSAFELGGVAAHgyfeieSPGLEVERFIQCWRQLLQRHDMLRm 2237
Cdd:PRK05691 1715 NSQGAIARVD----RSQPVPLSYSQQRMWFlwqmePDSPAYNVGGMARL------SGVLDVDRFEAALQALILRHETLR- 1783
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2238 VVLPDGRQQVLEQVPEYTPEVVELRGLSPQEAESR--RLQ-LRERMAHQVLRSDRWPLfeLVLCRYEGGVRIH---MSMD 2311
Cdd:PRK05691 1784 TTFPSVDGVPVQQVAEDSGLRMDWQDFSALPADARqqRLQqLADSEAHQPFDLERGPL--LRACLVKAAEREHyfvLTLH 1861
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2312 ALMLDAWSSAVLRQDFAQLYH----EPGRPLEPLAITFRDYVLAERRLREGEAHERARAYWWARLDTLPPPPELPLVKEP 2387
Cdd:PRK05691 1862 HIVTEGWAMDIFARELGALYEafldDRESPLEPLPVQYLDYSVWQRQWLESGERQRQLDYWKAQLGNEHPLLELPADRPR 1941
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2388 SQLEHARFTHREARLEPHRWARLQERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRLplHPQVDELVGDFTS 2467
Cdd:PRK05691 1942 PPVQSHRGELYRFDLSPELAARVRAFNAQRGLTLFMTMTATLAALLYRYSGQRDLRIGAPVANRI--RPESEGLIGAFLN 2019
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2468 LVLLEVEAHAASTFAE-----RASRLQAQLWRDL--EHgSVSAVQLIRElvrtgrrspGAIMPV--VFTSILSLDARRGP 2538
Cdd:PRK05691 2020 TQVLRCQLDGQMSVSElleqvRQTVIEGQSHQDLpfDH-LVEALQPPRS---------AAYNPLfqVMCNVQRWEFQQSR 2089
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2539 QgsLSFFEGELVYSISQTPQVWLDHGVHEEEGALVLAWDSVEALFPPGMVDDMFHAYQRLLGALAEEEQAWEGELPELLP 2618
Cdd:PRK05691 2090 Q--LAGMTVEYLVNDARATKFDLNLEVTDLDGRLGCCLTYSRDLFDEPRIARMAEHWQNLLEALLGDPQQRLAELPLLAA 2167
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2619 PAQRELLARYNATQA-PRPSGRLEEGFFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHK 2697
Cdd:PRK05691 2168 AEQQQLLDSLAGEAGeARLDQTLHGLFAAQAARTPQAPALTFAGQTLSYAELDARANRLARALRERGVGPQVRVGLALER 2247
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2698 GWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSLLHTV-PWPPGVQVIAVDELEPATEA---PPLP 2773
Cdd:PRK05691 2248 SLEMVVGLLAILKAGGAYVPLDPEYPLERLHYMIEDSGIGLLLSDRALFEALgELPAGVARWCLEDDAAALAAysdAPLP 2327
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2774 PRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDlSVYDVLGLLGAGGALVLPAA 2853
Cdd:PRK05691 2328 FLSLPQHQAYLIYTSGSTGKPKGVVVSHGEIAMHCQAVIERFGMRADDCELHFYSINFD-AASERLLVPLLCGARVVLRA 2406
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2854 EAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPaaLRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGAT 2933
Cdd:PRK05691 2407 QGQWGAEEICQLIREQQVSILGFTPSYGSQLAQWLAGQGEQLP--VRMCITGGEALTGEHLQRIRQAFAPQLFFNAYGPT 2484
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2934 EASIWSIAYPIGQVAPQ-WKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHP--R 3010
Cdd:PRK05691 2485 ETVVMPLACLAPEQLEEgAASVPIGRVVGARVAYILDADLALVPQGATGELYVGGAGLAQGYHDRPGLTAERFVADPfaA 2564
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3011 TGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGvRRLVAYAV-PRSGQ 3089
Cdd:PRK05691 2565 DGGRLYRTGDLVRLRADGLVEYVGRIDHQVKIRGFRIELGEIESRLLEHPAVREAVVLALDTPSG-KQLAGYLVsAVAGQ 2643
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3090 TPAA-----GELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPEPQQTQGLAAQAAAADPLVERLAALVKEALR 3164
Cdd:PRK05691 2644 DDEAqaalrEALKAHLKQQLPDYMVPAHLILLDSLPLTANGKLDRRALPAPDPELNRQAYQAPRSELEQQLAQIWREVLN 2723
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3165 LERVEPQDSLLDLGADSVALIRLINRL-EAELQFRPRlaDIYENPTVQGLATLHQEKTKSQGEGGaprLTAPRSTLLPAE 3243
Cdd:PRK05691 2724 VERVGLGDNFFELGGDSILSIQVVSRArQLGIHFSPR--DLFQHQTVQTLAAVATHSEAAQAEQG---PLQGASGLTPIQ 2798
|
..
gi 53747904 3244 EW 3245
Cdd:PRK05691 2799 HW 2800
|
|
| enoyl_red |
cd05195 |
enoyl reductase of polyketide synthase; Putative enoyl reductase of polyketide synthase. ... |
1700-1988 |
7.50e-100 |
|
enoyl reductase of polyketide synthase; Putative enoyl reductase of polyketide synthase. Polyketide synthases produce polyketides in step by step mechanism that is similar to fatty acid synthesis. Enoyl reductase reduces a double to single bond. Erythromycin is one example of a polyketide generated by 3 complex enzymes (megasynthases). 2-enoyl thioester reductase (ETR) catalyzes the NADPH-dependent dependent conversion of trans-2-enoyl acyl carrier protein/coenzyme A (ACP/CoA) to acyl-(ACP/CoA) in fatty acid synthesis. 2-enoyl thioester reductase activity has been linked in Candida tropicalis as essential in maintaining mitiochondrial respiratory function. This ETR family is a part of the medium chain dehydrogenase/reductase family, but lack the zinc coordination sites characteristic of the alcohol dehydrogenases in this family. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site, and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains, at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding.
Pssm-ID: 176179 [Multi-domain] Cd Length: 293 Bit Score: 324.14 E-value: 7.50e-100
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1700 QVEIEVEAAGLNFLDVLGALGMMPAleaEESVLGRECSGRIAAVGEGVSGLRVGDEVLAVAPGCFRSYVLVDESQVVRRP 1779
Cdd:cd05195 2 EVEVEVKAAGLNFRDVLVALGLLPG---DETPLGLECSGIVTRVGSGVTGLKVGDRVMGLAPGAFATHVRVDARLVVKIP 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1780 ASLGLAEGAAQMVPFATAYFALHTVGRLRRGERILIHAAAGGLGLAAVQLASRTGAEILATAGSEQKREYLRSLG--IAH 1857
Cdd:cd05195 79 DSLSFEEAATLPVAYLTAYYALVDLARLQKGESVLIHAAAGGVGQAAIQLAQHLGAEVFATVGSEEKREFLRELGgpVDH 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1858 VLDSRSTSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELGKRDLYADQQVGLRTLARGQTFAAIDFGP- 1936
Cdd:cd05195 159 IFSSRDLSFADGILRATGGRGVDVVLNSLSGELLRASWRCLAPFGRFVEIGKRDILSNSKLGMRPFLRNVSFSSVDLDQl 238
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 1937 --HHPD-FRAVLEEVATQLTQGQLEPLPTRLFPARQVAEAFSFMARALHIGRVAV 1988
Cdd:cd05195 239 arERPElLRELLREVLELLEAGVLKPLPPTVVPSASEIDAFRLMQSGKHIGKVVL 293
|
|
| A_NRPS_PpsD_like |
cd17650 |
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation ... |
2652-3132 |
3.37e-99 |
|
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetase 1 (BacA) in Bacillus licheniformis, tyrocidine synthetase in Brevibacillus brevis, plipastatin synthase (PpsD, an important antifungal protein) in Bacillus subtilis and mannopeptimycin peptide synthetase (MppB) in Streptomyces hygroscopicus. Plipastatin has strong fungitoxic activity and is involved in inhibition of phospholipase A2 and biofilm formation. Bacitracin, a mixture of related cyclic peptides, is used as a polypeptide antibiotic while function of tyrocidine is thought to be regulation of sporulation. MppB is involved in biosynthetic pathway of mannopeptimycin, a novel class of mannosylated lipoglycopeptides. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341305 [Multi-domain] Cd Length: 447 Bit Score: 328.27 E-value: 3.37e-99
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2652 PELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLL 2731
Cdd:cd17650 1 PDAIAVSDATRQLTYRELNERANQLARTLRGLGVAPGSVVGVCADRSLDAIVGLLAVLKAGGAYVPIDPDYPAERLQYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2732 EEGPARVVLTQssllhtvpwppgvqviavdelepateapplpprgtPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDL 2811
Cdd:cd17650 81 EDSGAKLLLTQ-----------------------------------PEDLAYVIYTSGTTGKPKGVMVEHRNVAHAAHAW 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2812 NTRFGVGPED-RVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQ 2890
Cdd:cd17650 126 RREYELDSFPvRLLQMASFSFDVFAGDFARSLLNGGTLVICPDEVKLDPAALYDLILKSRITLMESTPALIRPVMAYVYR 205
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2891 RGLKLPAaLRLVMLSGDWIPVALP-DRIRALGRDVQVVSLGGATEASIWSIAYPIGQV-APQWKSIPYGMPLANQRFHVL 2968
Cdd:cd17650 206 NGLDLSA-MRLLIVGSDGCKAQDFkTLAARFGQGMRIINSYGVTEATIDSTYYEEGRDpLGDSANVPIGRPLPNTAMYVL 284
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2969 DGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHP-RTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRV 3047
Cdd:cd17650 285 DERLQPQPVGVAGELYIGGAGVARGYLNRPELTAERFVENPfAPGERMYRTGDLARWRADGNVELLGRVDHQVKIRGFRI 364
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3048 ELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSgqTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKI 3127
Cdd:cd17650 365 ELGEIESQLARHPAIDEAVVAVREDKGGEARLCAYVVAAA--TLNTAELRAFLAKELPSYMIPSYYVQLDALPLTPNGKV 442
|
....*
gi 53747904 3128 ARDQL 3132
Cdd:cd17650 443 DRRAL 447
|
|
| A_NRPS_PvdJ-like |
cd17649 |
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal ... |
2652-3133 |
3.48e-98 |
|
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes pyoverdine biosynthesis protein PvdJ involved in the synthesis of pyoverdine, which consists of a chromophore group attached to a variable peptide chain and comprises around 6-12 amino acids that are specific for each Pseudomonas species, and for which the peptide might be first synthesized before the chromophore assembly. Also included is ornibactin biosynthesis protein OrbI; ornibactin is a tetrapeptide siderophore with an l-ornithine-d-hydroxyaspartate-l-serine-l-ornithine backbone. The adenylation domain at the N-terminal of OrbI possibly initiates the ornibactin with the binding of N5-hydroxyornithine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341304 [Multi-domain] Cd Length: 450 Bit Score: 325.48 E-value: 3.48e-98
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2652 PELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLL 2731
Cdd:cd17649 1 PDAVALVFGDQSLSYAELDARANRLAHRLRALGVGPEVRVGIALERSLEMVVALLAILKAGGAYVPLDPEYPAERLRYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2732 EEGPARVVLTQssllhtvpwppgvqviavdelepateapplpprgTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDL 2811
Cdd:cd17649 81 EDSGAGLLLTH----------------------------------HPRQLAYVIYTSGSTGTPKGVAVSHGPLAAHCQAT 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2812 NTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQR 2891
Cdd:cd17649 127 AERYGLTPGDRELQFASFNFDGAHEQLLPPLICGACVVLRPDELWASADELAEMVRELGVTVLDLPPAYLQQLAEEADRT 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2892 GLKLPAALRLVMLSGDWIPvalPDRI-RALGRDVQVVSLGGATEASIWSIAYPI-GQVAPQWKSIPYGMPLANQRFHVLD 2969
Cdd:cd17649 207 GDGRPPSLRLYIFGGEALS---PELLrRWLKAPVRLFNAYGPTEATVTPLVWKCeAGAARAGASMPIGRPLGGRSAYILD 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2970 GRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHP--RTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRV 3047
Cdd:cd17649 284 ADLNPVPVGVTGELYIGGEGLARGYLGRPELTAERFVPDPfgAPGSRLYRTGDLARWRDDGVIEYLGRVDHQVKIRGFRI 363
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3048 ELGEIEAALAQHPALSASVVVARGEPrGVRRLVAYAVPRSGQTPAA--GELRRYLAERLPAYMVPSAFVLLESLPRSRNG 3125
Cdd:cd17649 364 ELGEIEAALLEHPGVREAAVVALDGA-GGKQLVAYVVLRAAAAQPElrAQLRTALRASLPDYMVPAHLVFLARLPLTPNG 442
|
....*...
gi 53747904 3126 KIARDQLP 3133
Cdd:cd17649 443 KLDRKALP 450
|
|
| omega_3_PfaA |
TIGR02813 |
polyketide-type polyunsaturated fatty acid synthase PfaA; Members of the seed for this ... |
13-914 |
1.50e-90 |
|
polyketide-type polyunsaturated fatty acid synthase PfaA; Members of the seed for this alignment are involved in omega-3 polyunsaturated fatty acid biosynthesis, such as the protein PfaA from the eicosapentaenoic acid biosynthesis operon in Photobacterium profundum strain SS9. PfaA is encoded together with PfaB, PfaC, and PfaD, and the functions of the individual polypeptides have not yet been described. More distant homologs of PfaA, also included with the reach of this model, appear to be involved in polyketide-like biosynthetic mechanisms of polyunsaturated fatty acid biosynthesis, an alternative to the more familiar iterated mechanism of chain extension and desaturation, and in most cases are encoded near genes for homologs of PfaB, PfaC, and/or PfaD.
Pssm-ID: 274311 [Multi-domain] Cd Length: 2582 Bit Score: 331.58 E-value: 1.50e-90
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 13 IALVGMAGRFPGAPDVESFWRNLVAGVESISFFSEEELRQAGVSEQIRRRPE--YVPAKGVLEDLElFDAGFFGYSPREA 90
Cdd:TIGR02813 9 IAIVGMASIFANSRYLNKFWDLIFEKIDAITDVPSDHWAKDDYYDSDKSEADksYCKRGGFLPEVD-FNPMEFGLPPNIL 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 91 SHLDPQQRLLLECSWEALEDAGLRPDQLPGWVGVYVGAGDTSYRFQLL--RGHGDPL------SGSKDV----------- 151
Cdd:TIGR02813 88 ELTDISQLLSLVVAKEVLNDAGLPDGYDRDKIGITLGVGGGQKQSSSLnaRLQYPVLkkvfkaSGVEDEdsemlikkfqd 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 152 -------AGFFGNYPDFLATRVAYKLNLRGPALGIHTACSTSLVSINMACSALRGFECDMALAGGVSLRlpaRSGYLY-- 222
Cdd:TIGR02813 168 qyihweeNSFPGSLGNVISGRIANRFDLGGMNCVVDAACAGSLAAIRMALSELLEGRSEMMITGGVCTD---NSPFMYms 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 223 -EEGGVASKDGHCRPFDARATGTVTGDGVGVVVLKRLEDALKARDPIHAVIRGWALNNDGASRAGFtAPSVEGQSEVIAL 301
Cdd:TIGR02813 245 fSKTPAFTTNEDIQPFDIDSKGMMIGEGIGMMALKRLEDAERDGDRIYAVIKGVGASSDGKFKSIY-APRPEGQAKALKR 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 302 AHAAAGISARDITYVEAHGTGTPLGDPIEVAALTRAFRAHTADTAFCTLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLI 381
Cdd:TIGR02813 324 AYDDAGFAPHTCGLIEAHGTGTAAGDVAEFGGLVSVFSQDNDQKQHIALGSVKSQIGHTKSTAGTAGMIKAVLALHHKVL 403
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 382 PPTLHFERPNPALHLEQSPFFVNTQPLPW--ESPRGPRLAGVSSFGIGGTNAHTLFEEAPPPPASGPT-RPNQV---LLL 455
Cdd:TIGR02813 404 PPTINVDQPNPKLDIENSPFYLNTETRPWmqREDGTPRRAGISSFGFGGTNFHMVLEEYSPKHQRDDQyRQRAVaqtLLF 483
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 456 SARSTSALehIAGRLAAHLRRHPDLELADVAF----------TLQVGRARFpyrrALTCRTLAEAMERLEAPEPRPPEPL 525
Cdd:TIGR02813 484 TAANEKAL--VSSLKDWKNKLSAKADDQPYAFnalaventlrTIAVALARL----GFVAKNADELITMLEQAITQLEAKS 557
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 526 AHEGERPP---------------LVMLFPGQGTPLVGTARALHESEPTFRQAVEQCARLLRQTLGLDVREVLFP------ 584
Cdd:TIGR02813 558 CEEWQLPSgisyrksalvvesgkVAALFAGQGSQYLNMGRELACNFPEVRQAAADMDSVFTQAGKGALSPVLYPipvfnd 637
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 585 -SAEQEEQARRLaaqTRVAQPALFTLEYALAQTWLGWGLQPQALAGHSLGELVAACLAGVFSLEDALQLVAARGQLMQGC 663
Cdd:TIGR02813 638 eSRKAQEEALTN---TQHAQSAIGTLSMGQYKLFTQAGFKADMTAGHSFGELSALCAAGVISDDDYMMLAFSRGQAMAAP 714
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 664 P----PGAMLAVPLPEAELAALLGSELC------IAAVNGPRACVASGPLPAVEALTAALESRGVSSRRLETSHAFHSAS 733
Cdd:TIGR02813 715 TgeadIGFMYAVILAVVGSPTVIANCIKdfegvsIANYNSPTQLVIAGVSTQIQIAAKALKEKGFKAIPLPVSGAFHTPL 794
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 734 MEACQGPLTTLLRRMRLQAPRLPCVSGLTGRWLTGEEATEPTYWARQLREPVRFSEALETLWSLKEPVLLEVGPGTTLTA 813
Cdd:TIGR02813 795 VAHAQKPFSAAIDKAKFNTPLVPLYSNGTGKLHSNDAAAIKKALKNHMLQSVHFSEQLEAMYAAGARVFVEFGPKNILQK 874
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 814 LARRhpTRPARTQEVASLPVQPD---TAVPCIEEAVGELWQAGLELDwsalhaaprhraHLPPYPFErqrywIEPEAAPQ 890
Cdd:TIGR02813 875 LVEN--TLKDKENELCAISINPNpkgDSDMQLRQAAVQLAVLGLELT------------EIDPYQAE-----KRPPAATS 935
|
970 980
....*....|....*....|....
gi 53747904 891 PRAQQPTPASLVPPEqpSREALED 914
Cdd:TIGR02813 936 PMNIKLNAANYISPA--TRKKMDD 957
|
|
| DltA |
cd05945 |
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes ... |
2648-3132 |
2.11e-86 |
|
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes D-alanyl carrier protein ligase DltA and aliphatic beta-amino acid adenylation enzymes IdnL1 and CmiS6. DltA incorporates D-ala in techoic acids in gram-positive bacteria via a two-step process, starting with adenylation of D-alanine that transfers D-alanine to the D-alanyl carrier protein. IdnL1, a short-chain aliphatic beta-amino acid adenylation enzyme, recognizes 3-aminobutanoic acid, and is involved in the synthesis of the macrolactam antibiotic incednine. CmiS6 is a medium-chain beta-amino acid adenylation enzyme that recognizes 3-aminononanoic acid, and is involved in the synthesis of cremimycin, also a macrolactam antibiotic. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341267 [Multi-domain] Cd Length: 449 Bit Score: 291.46 E-value: 2.11e-86
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRL 2727
Cdd:cd05945 1 AAANPDRPAVVEGGRTLTYRELKERADALAAALASLGLDAGDPVVVYGHKSPDAIAAFLAALKAGHAYVPLDASSPAERI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2728 HQLLEEGPARVVLTqssllhtvpwppgvqviavdelepateapplpprgTPEHLAYVIYTSGSTGKPKGVAIEHRAALNT 2807
Cdd:cd05945 81 REILDAAKPALLIA-----------------------------------DGDDNAYIIFTSGSTGRPKGVQISHDNLVSF 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2808 VVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEY 2887
Cdd:cd05945 126 TNWMLSDFPLGPGDVFLNQAPFSFDLSVMDLYPALASGATLVPVPRDATADPKQLFRFLAEHGITVWVSTPSFAAMCLLS 205
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2888 AEQRGLKLPaALRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEASIWSIAYPIGQ-VAPQWKSIPYGMPLANQRFH 2966
Cdd:cd05945 206 PTFTPESLP-SLRHFLFCGEVLPHKTARALQQRFPDARIYNTYGPTEATVAVTYIEVTPeVLDGYDRLPIGYAKPGAKLV 284
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2967 VLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHPrtGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFR 3046
Cdd:cd05945 285 ILDEDGRPVPPGEKGELVISGPSVSKGYLNNPEKTAAAFFPDE--GQRAYRTGDLVRLEADGLLFYRGRLDFQVKLNGYR 362
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3047 VELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAG-ELRRYLAERLPAYMVPSAFVLLESLPRSRNG 3125
Cdd:cd05945 363 IELEEIEAALRQVPGVKEAVVVPKYKGEKVTELIAFVVPKPGAEAGLTkAIKAELAERLPPYMIPRRFVYLDELPLNANG 442
|
....*..
gi 53747904 3126 KIARDQL 3132
Cdd:cd05945 443 KIDRKAL 449
|
|
| A_NRPS_LgrA-like |
cd17645 |
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This ... |
2644-3133 |
1.45e-85 |
|
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes linear gramicidin synthetase (LgrA) in Brevibacillus brevis. LgrA has a formylation domain fused to the N-terminal end that formylates its substrate for linear gramicidin synthesis to proceed. This formyl group is essential for the clinically important antibacterial activity of gramicidin by enabling head-to-head gramicidin dimers to make a beta-helical pore in gram-positive bacterial membranes, allowing free passage of monovalent cations, destroying the ion gradient and killing bacteria. This family also includes bacitracin synthetase 1 (known as ATP-dependent cysteine adenylase or BA1); it activates cysteine, incorporates two D-amino acids, releases and cyclizes the mature bacitracin, an antibiotic that is a mixture of related cyclic peptides that disrupt gram positive bacteria by interfering with cell wall and peptidoglycan synthesis. Also included is surfactin synthetase which activates and polymerizes the amino acids Leu, Glu, Asp, and Val to form the antibiotic surfactin.
Pssm-ID: 341300 [Multi-domain] Cd Length: 440 Bit Score: 288.68 E-value: 1.45e-85
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2644 FFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQP 2723
Cdd:cd17645 4 FEEQVERTPDHVAVVDRGQSLTYKQLNEKANQLARHLRGKGVKPDDQVGIMLDKSLDMIAAILGVLKAGGAYVPIDPDYP 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2724 PLRLHQLLEEGPARVVLTQssllhtvpwppgvqviavdelepateapplpprgtPEHLAYVIYTSGSTGKPKGVAIEHRA 2803
Cdd:cd17645 84 GERIAYMLADSSAKILLTN-----------------------------------PDDLAYVIYTSGSTGLPKGVMIEHHN 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2804 ALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLgllgaggalvlpaaeaekdpAHWwerLVAGRVTVWNSTPALMLL 2883
Cdd:cd17645 129 LVNLCEWHRPYFGVTPADKSLVYASFSFDASAWEIF--------------------PHL---TAGAALHVVPSERRLDLD 185
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2884 -LVEYAEQRGLK---LPA------------ALRLVMLSGDWIPvalpdriRALGRDVQVVSLGGATEASIWSIAYPIGqv 2947
Cdd:cd17645 186 aLNDYFNQEGITisfLPTgaaeqfmqldnqSLRVLLTGGDKLK-------KIERKGYKLVNNYGPTENTVVATSFEID-- 256
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2948 aPQWKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHPR-TGERLYRTGDQGRMLP 3026
Cdd:cd17645 257 -KPYANIPIGKPIDNTRVYILDEALQLQPIGVAGELCIAGEGLARGYLNRPELTAEKFIVHPFvPGERMYRTGDLAKFLP 335
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3027 EGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPaaGELRRYLAERLPA 3106
Cdd:cd17645 336 DGNIEFLGRLDQQVKIRGYRIEPGEIEPFLMNHPLIELAAVLAKEDADGRKYLVAYVTAPEEIPH--EELREWLKNDLPD 413
|
490 500
....*....|....*....|....*..
gi 53747904 3107 YMVPSAFVLLESLPRSRNGKIARDQLP 3133
Cdd:cd17645 414 YMIPTYFVHLKALPLTANGKVDRKALP 440
|
|
| A_NRPS_ProA |
cd17656 |
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the ... |
2652-3133 |
5.40e-84 |
|
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains gramicidin S synthase 2 (also known as ATP-dependent proline adenylase or proline activase or ProA). ProA is a multifunctional enzyme involved in synthesis of the cyclic peptide antibiotic gramicidin S and able to activate and polymerize the amino acids proline, valine, ornithine and leucine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341311 [Multi-domain] Cd Length: 479 Bit Score: 285.52 E-value: 5.40e-84
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2652 PELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLL 2731
Cdd:cd17656 2 PDAVAVVFENQKLTYRELNERSNQLARFLREKGVKKDSIVAIMMERSAEMIVGILGILKAGGAFVPIDPEYPEERRIYIM 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2732 EEGPARVVLTQSSllHTVPWP-PGVQVIAVDELEPATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVD 2810
Cdd:cd17656 82 LDSGVRVVLTQRH--LKSKLSfNKSTILLEDPSISQEDTSNIDYINNSDDLLYIIYTSGTTGKPKGVQLEHKNMVNLLHF 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2811 LNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLveyAEQ 2890
Cdd:cd17656 160 EREKTNINFSDKVLQFATCSFDVCYQEIFSTLLSGGTLYIIREETKRDVEQLFDLVKRHNIEVVFLPVAFLKFI---FSE 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2891 RGLK--LPAALRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEASIWSiAYPIGQVAPQWKSIPYGMPLANQRFHVL 2968
Cdd:cd17656 237 REFInrFPTCVKHIITAGEQLVITNEFKEMLHEHNVHLHNHYGPSETHVVT-TYTINPEAEIPELPPIGKPISNTWIYIL 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2969 DGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHP-RTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRV 3047
Cdd:cd17656 316 DQEQQLQPQGIVGELYISGASVARGYLNRQELTAEKFFPDPfDPNERMYRTGDLARYLPDGNIEFLGRADHQVKIRGYRI 395
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3048 ELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRsgQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKI 3127
Cdd:cd17656 396 ELGEIEAQLLNHPGVSEAVVLDKADDKGEKYLCAYFVME--QELNISQLREYLAKQLPEYMIPSFFVPLDQLPLTPNGKV 473
|
....*.
gi 53747904 3128 ARDQLP 3133
Cdd:cd17656 474 DRKALP 479
|
|
| A_NRPS_ACVS-like |
cd17648 |
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV ... |
2684-3133 |
9.44e-82 |
|
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV synthetase (ACVS, EC 6.3.2.26; also known as N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase or delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase) is involved in medically important antibiotic biosynthesis. ACV synthetase is active in an early step in the penicillin G biosynthesis pathway which involves the formation of the tripeptide 6-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine (ACV); each of the constituent amino acids of the tripeptide ACV are activated as aminoacyl-adenylates with peptide bonds formed through the participation of amino acid thioester intermediates. ACV is then cyclized by the action of isopenicillin N synthase.
Pssm-ID: 341303 [Multi-domain] Cd Length: 453 Bit Score: 278.13 E-value: 9.44e-82
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2684 EVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSllhtvpwppgvqviavdel 2763
Cdd:cd17648 34 EIRPDDLVGLVLDKSELMIIAILAVWKAGAAYVPIDPSYPDERIQFILEDTGARVVITNST------------------- 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2764 epateapplpprgtpeHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPED--RVLGLSALTFDLSVYDVLGL 2841
Cdd:cd17648 95 ----------------DLAYAIYTSGTTGKPKGVLVEHGSVVNLRTSLSERYFGRDNGdeAVLFFSNYVFDFFVEQMTLA 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2842 LGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALmLLLVEYAeqrglKLPAaLRLVMLSGDWIPVALPDRIRALG 2921
Cdd:cd17648 159 LLNGQKLVVPPDEMRFDPDRFYAYINREKVTYLSGTPSV-LQQYDLA-----RLPH-LKRVDAAGEEFTAPVFEKLRSRF 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2922 RDvQVVSLGGATEASIWSIAYPIGQVAPQWKSIpyGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLT 3001
Cdd:cd17648 232 AG-LIINAYGPTETTVTNHKRFFPGDQRFDKSL--GRPVRNTKCYVLNDAMKRVPVGAVGELYLGGDGVARGYLNRPELT 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3002 ATRFIRHPRTGE---------RLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGE 3072
Cdd:cd17648 309 AERFLPNPFQTEqerargrnaRLYKTGDLVRWLPSGELEYLGRNDFQVKIRGQRIEPGEVEAALASYPGVRECAVVAKED 388
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 53747904 3073 P-----RGVRRLVAYAVPRSGQTPAAgELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLP 3133
Cdd:cd17648 389 AsqaqsRIQKYLVGYYLPEPGHVPES-DLLSFLRAKLPRYMVPARLVRLEGIPVTINGKLDVRALP 453
|
|
| A_NRPS_SidN3_like |
cd05918 |
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); ... |
2644-3132 |
1.00e-80 |
|
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family of siderophore-synthesizing NRPS includes the third adenylation domain of SidN from the endophytic fungus Neotyphodium lolii, ferrichrome siderophore synthetase, HC-toxin synthetase, and enniatin synthase. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341242 [Multi-domain] Cd Length: 481 Bit Score: 276.35 E-value: 1.00e-80
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2644 FFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQP 2723
Cdd:cd05918 5 IEERARSQPDAPAVCAWDGSLTYAELDRLSSRLAHHLRSLGVGPGVFVPLCFEKSKWAVVAMLAVLKAGGAFVPLDPSHP 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2724 PLRLHQLLEEGPARVVLTqssllhtvpwppgvqviavdelepateapplpprGTPEHLAYVIYTSGSTGKPKGVAIEHRA 2803
Cdd:cd05918 85 LQRLQEILQDTGAKVVLT----------------------------------SSPSDAAYVIFTSGSTGKPKGVVIEHRA 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2804 ALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEK-DPAHWWERLvagRVTVWNSTPALML 2882
Cdd:cd05918 131 LSTSALAHGRALGLTSESRVLQFASYTFDVSILEIFTTLAAGGCLCIPSEEDRLnDLAGFINRL---RVTWAFLTPSVAR 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2883 LLveyaeqrGLKLPAALRLVMLSGDwiPVAlPDRIRALGRDVQVVSLGGATEASIWSIAypiGQVAPQWKSIPYGMPLAn 2962
Cdd:cd05918 208 LL-------DPEDVPSLRTLVLGGE--ALT-QSDVDTWADRVRLINAYGPAECTIAATV---SPVVPSTDPRNIGRPLG- 273
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2963 QRFHVLD----GRLeaRPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHP--------RTGERLYRTGDQGRMLPEGSI 3030
Cdd:cd05918 274 ATCWVVDpdnhDRL--VPIGAVGELLIEGPILARGYLNDPEKTAAAFIEDPawlkqegsGRGRRLYRTGDLVRYNPDGSL 351
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3031 EFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVA---RGEPRGVRRLVAYAVPRSGQT----------------- 3090
Cdd:cd05918 352 EYVGRKDTQVKIRGQRVELGEIEHHLRQSLPGAKEVVVEvvkPKDGSSSPQLVAFVVLDGSSSgsgdgdslflepsdefr 431
|
490 500 510 520
....*....|....*....|....*....|....*....|..
gi 53747904 3091 PAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd05918 432 ALVAELRSKLRQRLPSYMVPSVFLPLSHLPLTASGKIDRRAL 473
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
2171-3214 |
1.62e-77 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 289.38 E-value: 1.62e-77
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2171 VPDPAARFEP-FPLTDVQEAYWVGRRSAFELGGVAAHGYFEIESPgLEVERFIQCWRQLLQRHDMLRMVVLPDGRQQVLE 2249
Cdd:PRK05691 3247 LPVPAAEIEDvYPLTPMQEGLLLHTLLEPGTGLYYMQDRYRINSA-LDPERFAQAWQAVVARHEALRASFSWNAGETMLQ 3325
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2250 QV--PEYTP-EVVELRGLSP--QEAESRRLQLRERMAHQVLRsdRWPLFELVLCRY-EGGVRIHMSMDALMLDAWSSAVL 2323
Cdd:PRK05691 3326 VIhkPGRTPiDYLDWRGLPEdgQEQRLQALHKQEREAGFDLL--NQPPFHLRLIRVdEARYWFMMSNHHILIDAWCRSLL 3403
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2324 RQDFAQLYHE--PGRPLE-PLAITFRDYV--LAERRLREgeaherARAYWWARLDTLPPPPELPLvKEPSQLEHARFTH- 2397
Cdd:PRK05691 3404 MNDFFEIYTAlgEGREAQlPVPPRYRDYIgwLQRQDLAQ------ARQWWQDNLRGFERPTPIPS-DRPFLREHAGDSGg 3476
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2398 -----REARLEPHRWARLQERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRLPLHPQVDELVGDFTSLVLLE 2472
Cdd:PRK05691 3477 mvvgdCYTRLDAADGARLRELAQAHQLTVNTFAQAAWALVLRRYSGDRDVLFGVTVAGRPVSMPQMQRTVGLFINSIALR 3556
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2473 VEAHAASTFAERASRLQAQL-----WRDLEHGSVSAVQLIRELvrtgrrspgaimpvvftsilsldarrgPQGSlSFFEG 2547
Cdd:PRK05691 3557 VQLPAAGQRCSVRQWLQGLLdsnmeLREYEYLPLVAIQECSEL---------------------------PKGQ-PLFDS 3608
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2548 ELVYSISQTPQVWLDHGVH----------------------EEEGALVLAWDsvEALFPPGMVDDMFHAYQRLLGALAEE 2605
Cdd:PRK05691 3609 LFVFENAPVEVSVLDRAQSlnassdsgrthtnfpltavcypGDDLGLHLSYD--QRYFDAPTVERLLGEFKRLLLALVQG 3686
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2606 EQAWEGELPELLPPAQRELLARYNATQAPRPsgrLEEG----FFTQARLHPELPALLAPERTLSYGELARRAQALAARLR 2681
Cdd:PRK05691 3687 FHGDLSELPLLGEQERDFLLDGCNRSERDYP---LEQSyvrlFEAQVAAHPQRIAASCLDQQWSYAELNRAANRLGHALR 3763
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2682 ELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSS-------LLHTVPWPPG 2754
Cdd:PRK05691 3764 AAGVGVDQPVALLAERGLDLLGMIVGSFKAGAGYLPLDPGLPAQRLQRIIELSRTPVLVCSAAcreqaraLLDELGCANR 3843
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2755 VQVIAVDELEPATEAPPLPPR-GTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDL 2833
Cdd:PRK05691 3844 PRLLVWEEVQAGEVASHNPGIySGPDNLAYVIYTSGSTGLPKGVMVEQRGMLNNQLSKVPYLALSEADVIAQTASQSFDI 3923
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2834 SVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEyAEQRGLklpAALRLVMLSGDWIPVAL 2913
Cdd:PRK05691 3924 SVWQFLAAPLFGARVEIVPNAIAHDPQGLLAHVQAQGITVLESVPSLIQGMLA-EDRQAL---DGLRWMLPTGEAMPPEL 3999
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2914 PDRIRALGRDVQVVSLGGATEASIWSIAYPIGQVAPQWKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLARE 2993
Cdd:PRK05691 4000 ARQWLQRYPQIGLVNAYGPAECSDDVAFFRVDLASTRGSYLPIGSPTDNNRLYLLDEALELVPLGAVGELCVAGTGVGRG 4079
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2994 YWRDEPLTATRFIRHP--RTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARG 3071
Cdd:PRK05691 4080 YVGDPLRTALAFVPHPfgAPGERLYRTGDLARRRSDGVLEYVGRIDHQVKIRGYRIELGEIEARLHEQAEVREAAVAVQE 4159
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3072 EPRGvRRLVAYAVPRSG-QTPAA--GELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPEPQQTQGLAAQ-AAA 3147
Cdd:PRK05691 4160 GVNG-KHLVGYLVPHQTvLAQGAllERIKQRLRAELPDYMVPLHWLWLDRLPLNANGKLDRKALPALDIGQLQSQAyLAP 4238
|
1050 1060 1070 1080 1090 1100
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 53747904 3148 ADPLVERLAALVKEALRLERVEPQDSLLDLGADSVALIRLINRLEAELQFRPRLADIYENPTVQGLA 3214
Cdd:PRK05691 4239 RNELEQTLATIWADVLKVERVGVHDNFFELGGHSLLATQIASRVQKALQRNVPLRAMFECSTVEELA 4305
|
|
| Qor |
COG0604 |
NADPH:quinone reductase or related Zn-dependent oxidoreductase [Energy production and ... |
1675-1991 |
9.11e-76 |
|
NADPH:quinone reductase or related Zn-dependent oxidoreductase [Energy production and conversion, General function prediction only];
Pssm-ID: 440369 [Multi-domain] Cd Length: 322 Bit Score: 255.84 E-value: 9.11e-76
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1675 VAVGTPGLLESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGD 1754
Cdd:COG0604 4 IVITEFGGPEVLELEEVPVPEPGPGEVLVRVKAAGVNPADLLIRRGLYPLPPGLPFIPGSDAAGVVVAVGEGVTGFKVGD 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1755 EVLA-VAPGCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGERILIHaaagglglaaVQLASRT 1833
Cdd:COG0604 84 RVAGlGRGGGYAEYVVVPADQLVPLPDGLSFEEAAALPLAGLTAWQALFDRGRLKPGETVLVHgaaggvgsaaVQLAKAL 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1834 GAEILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELGKRDLY 1913
Cdd:COG0604 164 GARVIATASSPEKAELLRALGADHVIDYREEDFAERVRALTGGRGVDVVLDTVGGDTLARSLRALAPGGRLVSIGAASGA 243
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 53747904 1914 ADQQVGLRTLARGQTFAAIDFGPHHPD-FRAVLEEVATQLTQGQLEPLPTRLFPARQVAEAFSFMARALHIGRVAVSMQ 1991
Cdd:COG0604 244 PPPLDLAPLLLKGLTLTGFTLFARDPAeRRAALAELARLLAAGKLRPVIDRVFPLEEAAEAHRLLESGKHRGKVVLTVD 322
|
|
| MenE/FadK |
COG0318 |
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid ... |
2644-3134 |
2.11e-75 |
|
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) is part of the Pathway/BioSystem: Menaquinone biosynthesis
Pssm-ID: 440087 [Multi-domain] Cd Length: 452 Bit Score: 259.74 E-value: 2.11e-75
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2644 FFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQP 2723
Cdd:COG0318 5 LRRAAARHPDRPALVFGGRRLTYAELDARARRLAAALRALGVGPGDRVALLLPNSPEFVVAFLAALRAGAVVVPLNPRLT 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2724 PLRLHQLLEEGPARVVLTqssllhtvpwppgvqviavdelepateapplpprgtpehlAYVIYTSGSTGKPKGVAIEHRA 2803
Cdd:COG0318 85 AEELAYILEDSGARALVT----------------------------------------ALILYTSGTTGRPKGVMLTHRN 124
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2804 ALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAekDPAHWWERLVAGRVTVWNSTPALMLL 2883
Cdd:COG0318 125 LLANAAAIAAALGLTPGDVVLVALPLFHVFGLTVGLLAPLLAGATLVLLPRF--DPERVLELIERERVTVLFGVPTMLAR 202
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2884 LVEYAEQRGLKLPAaLRLVMLSGDWIPVALPDRIRALGrDVQVVSLGGATEASIWSIAYPIGQVAPQWKSIpyGMPLANQ 2963
Cdd:COG0318 203 LLRHPEFARYDLSS-LRLVVSGGAPLPPELLERFEERF-GVRIVEGYGLTETSPVVTVNPEDPGERRPGSV--GRPLPGV 278
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2964 RFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIrhprtgERLYRTGDQGRMLPEGSIEFLGREDLQVKVQ 3043
Cdd:COG0318 279 EVRIVDEDGRELPPGEVGEIVVRGPNVMKGYWNDPEATAEAFR------DGWLRTGDLGRLDEDGYLYIVGRKKDMIISG 352
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3044 GFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSR 3123
Cdd:COG0318 353 GENVYPAEVEEVLAAHPGVAEAAVVGVPDEKWGERVVAFVVLRPGAELDAEELRAFLRERLARYKVPRRVEFVDELPRTA 432
|
490
....*....|.
gi 53747904 3124 NGKIARDQLPE 3134
Cdd:COG0318 433 SGKIDRRALRE 443
|
|
| A_NRPS_GliP_like |
cd17653 |
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of ... |
2644-3132 |
3.29e-75 |
|
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of nonribosomal peptide synthases (NRPS) gliotoxin biosynthesis protein P (GliP), thioclapurine biosynthesis protein P (tcpP) and Sirodesmin biosynthesis protein P (SirP). In the filamentous fungus Aspergillus fumigatus, NRPS GliP is involved in the biosynthesis of gliotoxin, which is initiated by the condensation of serine and phenylalanine. Studies show that GliP is not required for invasive aspergillosis, suggesting that the principal targets of gliotoxin are neutrophils or other phagocytes. SirP is a phytotoxin produced by the fungus Leptosphaeria maculans, which causes blackleg disease of canola (Brassica napus). In the fungus Claviceps purpurea, NRPS tcpP catalyzes condensation of tyrosine and glycine, part of biosynthesis of an unusual class of epipolythiodioxopiperazines (ETPs) that lacks the reactive thiol group for toxicity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341308 [Multi-domain] Cd Length: 433 Bit Score: 258.39 E-value: 3.29e-75
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2644 FFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQP 2723
Cdd:cd17653 3 FERIAAAHPDAVAVESLGGSLTYGELDAASNALANRLLQLGVVPGDVVPLLSDRSLEMLVAILAILKAGAAYVPLDAKLP 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2724 PLRLHQLLEEGPARVVLTQSSllhtvpwppgvqviavdelepateapplpprgtPEHLAYVIYTSGSTGKPKGVAIEHRA 2803
Cdd:cd17653 83 SARIQAILRTSGATLLLTTDS---------------------------------PDDLAYIIFTSGSTGIPKGVMVPHRG 129
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2804 ALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGgalvlpAAEAEKDPAHWWERlVAGRVTVWNSTPAlmlL 2883
Cdd:cd17653 130 VLNYVSQPPARLDVGPGSRVAQVLSIAFDACIGEIFSTLCNG------GTLVLADPSDPFAH-VARTVDALMSTPS---I 199
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2884 LVEYAEQRglkLPaALRLVMLSGDWIPvalPDRIRALGRDVQVVSLGGATEASIwSIAYPigQVAPQwKSIPYGMPLANQ 2963
Cdd:cd17653 200 LSTLSPQD---FP-NLKTIFLGGEAVP---PSLLDRWSPGRRLYNAYGPTECTI-SSTMT--ELLPG-QPVTIGKPIPNS 268
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2964 RFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHPR-TGERLYRTGDQGRMLPEGSIEFLGREDLQVKV 3042
Cdd:cd17653 269 TCYILDADLQPVPEGVVGEICISGVQVARGYLGNPALTASKFVPDPFwPGSRMYRTGDYGRWTEDGGLEFLGREDNQVKV 348
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3043 QGFRVELGEIEAALAQHPAL--SASVVVARGeprgvrRLVAYAVPrsgQTPAAGELRRYLAERLPAYMVPSAFVLLESLP 3120
Cdd:cd17653 349 RGFRINLEEIEEVVLQSQPEvtQAAAIVVNG------RLVAFVTP---ETVDVDGLRSELAKHLPSYAVPDRIIALDSFP 419
|
490
....*....|..
gi 53747904 3121 RSRNGKIARDQL 3132
Cdd:cd17653 420 LTANGKVDRKAL 431
|
|
| AMP-binding |
pfam00501 |
AMP-binding enzyme; |
2644-3043 |
1.17e-74 |
|
AMP-binding enzyme;
Pssm-ID: 459834 [Multi-domain] Cd Length: 417 Bit Score: 256.47 E-value: 1.17e-74
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2644 FFTQARLHPELPALL-APERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQ 2722
Cdd:pfam00501 1 LERQAARTPDKTALEvGEGRRLTYRELDERANRLAAGLRALGVGKGDRVAILLPNSPEWVVAFLACLKAGAVYVPLNPRL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2723 PPLRLHQLLEEGPARVVLTQSSLL------HTVPWPPGVQVIAVD------------ELEPATEAPPLPPRGTPEHLAYV 2784
Cdd:pfam00501 81 PAEELAYILEDSGAKVLITDDALKleelleALGKLEVVKLVLVLDrdpvlkeeplpeEAKPADVPPPPPPPPDPDDLAYI 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2785 IYTSGSTGKPKGVAIEHRAALNTVVDL----NTRFGVGPEDRVLGLSALTFDLSV-YDVLGLLGAGGALVLPAAEAEKDP 2859
Cdd:pfam00501 161 IYTSGTTGKPKGVMLTHRNLVANVLSIkrvrPRGFGLGPDDRVLSTLPLFHDFGLsLGLLGPLLAGATVVLPPGFPALDP 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2860 AHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPaALRLVMLSGDWIPVALPDRIRALGRDvQVVSLGGATEASIWS 2939
Cdd:pfam00501 241 AALLELIERYKVTVLYGVPTLLNMLLEAGAPKRALLS-SLRLVLSGGAPLPPELARRFRELFGG-ALVNGYGLTETTGVV 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2940 IAYPIGQvaPQWKSIP-YGMPLANQRFHVLD-GRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRhprtgERLYR 3017
Cdd:pfam00501 319 TTPLPLD--EDLRSLGsVGRPLPGTEVKIVDdETGEPVPPGEPGELCVRGPGVMKGYLNDPELTAEAFDE-----DGWYR 391
|
410 420
....*....|....*....|....*.
gi 53747904 3018 TGDQGRMLPEGSIEFLGREDLQVKVQ 3043
Cdd:pfam00501 392 TGDLGRRDEDGYLEIVGRKKDQIKLG 417
|
|
| ketoacyl-synt |
pfam00109 |
Beta-ketoacyl synthase, N-terminal domain; The structure of beta-ketoacyl synthase is similar ... |
11-241 |
5.70e-68 |
|
Beta-ketoacyl synthase, N-terminal domain; The structure of beta-ketoacyl synthase is similar to that of the thiolase family (pfam00108) and also chalcone synthase. The active site of beta-ketoacyl synthase is located between the N and C-terminal domains. The N-terminal domain contains most of the structures involved in dimer formation and also the active site cysteine.
Pssm-ID: 425468 [Multi-domain] Cd Length: 251 Bit Score: 230.60 E-value: 5.70e-68
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 11 SSIALVGMAGRFPGAPDVESFWRNLVAGVESISFFSEEELRQAGVSEQIRRRPEYVPAK-GVLEDLELFDAGFFGYSPRE 89
Cdd:pfam00109 1 EPVAIVGMGCRFPGGNDPEEFWENLLEGRDGISEIPADRWDPDKLYDPPSRIAGKIYTKwGGLDDIFDFDPLFFGISPRE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 90 ASHLDPQQRLLLECSWEALEDAGLRPDQLPG-WVGVYVGAGDTSYR-FQLLRGHGDPLSGSkdvAGFFGNYPDFLATRVA 167
Cdd:pfam00109 81 AERMDPQQRLLLEAAWEALEDAGITPDSLDGsRTGVFIGSGIGDYAaLLLLDEDGGPRRGS---PFAVGTMPSVIAGRIS 157
|
170 180 190 200 210 220 230
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 53747904 168 YKLNLRGPALGIHTACSTSLVSINMACSALRGFECDMALAGGVSLRLPARSGYLYEEGGVASKDGHCRPFDARA 241
Cdd:pfam00109 158 YFLGLRGPSVTVDTACSSSLVAIHAAVQSIRSGEADVALAGGVNLLLTPLGFAGFSAAGMLSPDGPCKAFDPFA 231
|
|
| polyketide_synthase |
cd08251 |
polyketide synthase; Polyketide synthases produce polyketides in step by step mechanism that ... |
1694-1988 |
7.81e-64 |
|
polyketide synthase; Polyketide synthases produce polyketides in step by step mechanism that is similar to fatty acid synthesis. Enoyl reductase reduces a double to single bond. Erythromycin is one example of a polyketide generated by 3 complex enzymes (megasynthases). 2-enoyl thioester reductase (ETR) catalyzes the NADPH-dependent dependent conversion of trans-2-enoyl acyl carrier protein/coenzyme A (ACP/CoA) to acyl-(ACP/CoA) in fatty acid synthesis. 2-enoyl thioester reductase activity has been linked in Candida tropicalis as essential in maintaining mitiochondrial respiratory function. This ETR family is a part of the medium chain dehydrogenase/reductase family, but lack the zinc coordination sites characteristic of the alcohol dehydrogenases in this family. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which have a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site, and a structural zinc in a lobe of the catalytic domain. NAD(H)-binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding.
Pssm-ID: 176213 [Multi-domain] Cd Length: 303 Bit Score: 220.76 E-value: 7.81e-64
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGDEVLAVAP---GCFRSYVLV 1770
Cdd:cd08251 3 APPGPGEVRIQVRAFSLNFGDLLCVRGLYPTMPPYPFTPGFEASGVVRAVGPHVTRLAVGDEVIAGTGesmGGHATLVTV 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1771 DESQVVRRPASLGLAEGAAQMVPFATAYFALHTvGRLRRGERILIHAAAGGLGLAAVQLASRTGAEILATAGSEQKREYL 1850
Cdd:cd08251 83 PEDQVVRKPASLSFEEACALPVVFLTVIDAFAR-AGLAKGEHILIQTATGGTGLMAVQLARLKGAEIYATASSDDKLEYL 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1851 RSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELGKRDLYADQQVGLRTLARGQTFA 1930
Cdd:cd08251 162 KQLGVPHVINYVEEDFEEEIMRLTGGRGVDVVINTLSGEAIQKGLNCLAPGGRYVEIAMTALKSAPSVDLSVLSNNQSFH 241
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 53747904 1931 AIDF---GPHHPDFRA-VLEEVATQLTQGQLEPLPTRLFPARQVAEAFSFMARALHIGRVAV 1988
Cdd:cd08251 242 SVDLrklLLLDPEFIAdYQAEMVSLVEEGELRPTVSRIFPFDDIGEAYRYLSDRENIGKVVV 303
|
|
| AFD_class_I |
cd04433 |
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as ... |
2780-3127 |
1.93e-62 |
|
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as the ANL (acyl-CoA synthetases, the NRPS adenylation domains, and the Luciferase enzymes) superfamily. It includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases.The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341228 [Multi-domain] Cd Length: 336 Bit Score: 217.92 E-value: 1.93e-62
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2780 HLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEaekDP 2859
Cdd:cd04433 1 DPALILYTSGTTGKPKGVVLSHRNLLAAAAALAASGGLTEGDVFLSTLPLFHIGGLFGLLGALLAGGTVVLLPKF---DP 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2860 AHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPAaLRLVMLSGDWIPVALPDRIRALgRDVQVVSLGGATEASIWS 2939
Cdd:cd04433 78 EAALELIEREKVTILLGVPTLLARLLKAPESAGYDLSS-LRALVSGGAPLPPELLERFEEA-PGIKLVNGYGLTETGGTV 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2940 IAYPIGQVAPQWKSIpyGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTAtrfirhPRTGERLYRTG 3019
Cdd:cd04433 156 ATGPPDDDARKPGSV--GRPVPGVEVRIVDPDGGELPPGEIGELVVRGPSVMKGYWNNPEATA------AVDEDGWYRTG 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3020 DQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRY 3099
Cdd:cd04433 228 DLGRLDEDGYLYIVGRLKDMIKSGGENVYPAEVEAVLLGHPGVAEAAVVGVPDPEWGERVVAVVVLRPGADLDAEELRAH 307
|
330 340
....*....|....*....|....*...
gi 53747904 3100 LAERLPAYMVPSAFVLLESLPRSRNGKI 3127
Cdd:cd04433 308 VRERLAPYKVPRRVVFVDALPRTASGKI 335
|
|
| FabD |
COG0331 |
Malonyl CoA-acyl carrier protein transacylase [Lipid transport and metabolism]; Malonyl ... |
534-817 |
1.27e-61 |
|
Malonyl CoA-acyl carrier protein transacylase [Lipid transport and metabolism]; Malonyl CoA-acyl carrier protein transacylase is part of the Pathway/BioSystem: Fatty acid biosynthesis
Pssm-ID: 440100 [Multi-domain] Cd Length: 306 Bit Score: 214.61 E-value: 1.27e-61
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 534 LVMLFPGQGTPLVGTARALHESEPTFRQAVEQcarlLRQTLGLDVREVLFPSAEQEeqarrlAAQTRVAQPALFTLEYAL 613
Cdd:COG0331 3 LAFLFPGQGSQYVGMGKDLYENFPVAREVFEE----ASEALGYDLSALCFEGPEEE------LNLTENTQPAILAASVAA 72
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 614 AQTWLGWGLQPQALAGHSLGELVAACLAGVFSLEDALQLVAARGQLMQGCPP---GAMLAV-PLPEAELAALL-----GS 684
Cdd:COG0331 73 YRALEEEGIRPDAVAGHSLGEYSALVAAGALSFEDALRLVRLRGRLMQEAVPagpGGMAAVlGLDDEEVEALCaeaaqGE 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 685 ELCIAAVNGPRACVASGPLPAVEALTAALESRGVS-SRRLETSHAFHSASMEACQGPLTTLLRRMRLQAPRLPCVSGLTG 763
Cdd:COG0331 153 VVEIANYNSPGQIVISGEKEAVEAAAELAKEAGAKrAVPLPVSGPFHTPLMAPAAEKLAEALAAVTFADPKIPVVSNVDA 232
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....
gi 53747904 764 RWLTGEEATePTYWARQLREPVRFSEALETLWSLKEPVLLEVGPGTTLTALARR 817
Cdd:COG0331 233 APVTDPEEI-RELLVRQLTSPVRWDESVEALAEAGVTTFVELGPGKVLSGLVKR 285
|
|
| KAS_I_II |
cd00834 |
Beta-ketoacyl-acyl carrier protein (ACP) synthase (KAS), type I and II. KASs are responsible ... |
23-431 |
1.46e-58 |
|
Beta-ketoacyl-acyl carrier protein (ACP) synthase (KAS), type I and II. KASs are responsible for the elongation steps in fatty acid biosynthesis. KASIII catalyses the initial condensation and KAS I and II catalyze further elongation steps by Claisen condensation of malonyl-acyl carrier protein (ACP) with acyl-ACP.
Pssm-ID: 238430 [Multi-domain] Cd Length: 406 Bit Score: 209.32 E-value: 1.46e-58
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 23 PGAPDVESFWRNLVAG---VESISFFSEEELRqagvseqiRRRPEYVPAkgvledlelFDAGFFGySPREASHLDPQQRL 99
Cdd:cd00834 13 PLGNGVEEFWEALLAGrsgIRPITRFDASGFP--------SRIAGEVPD---------FDPEDYL-DRKELRRMDRFAQF 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 100 LLECSWEALEDAGLRPDQLPGW-VGVYVG---AGDTSYRFQLLRGHGDplsGSKDVAGFFGNY--PDFLATRVAYKLNLR 173
Cdd:cd00834 75 ALAAAEEALADAGLDPEELDPErIGVVIGsgiGGLATIEEAYRALLEK---GPRRVSPFFVPMalPNMAAGQVAIRLGLR 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 174 GPALGIHTACSTSLVSINMACSALRGFECDMALAGGV-SLRLP------ARSGYLYEEGGVASKdgHCRPFDAR------ 240
Cdd:cd00834 152 GPNYTVSTACASGAHAIGDAARLIRLGRADVVIAGGAeALITPltlagfAALRALSTRNDDPEK--ASRPFDKDrdgfvl 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 241 ----ATGTvtgdgvgvvvLKRLEDALKARDPIHAVIRGWALNNDGASragFTAPSV--EGQSEVIALAHAAAGISARDIT 314
Cdd:cd00834 230 gegaGVLV----------LESLEHAKARGAKIYAEILGYGASSDAYH---ITAPDPdgEGAARAMRAALADAGLSPEDID 296
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 315 YVEAHGTGTPLGDPIEVAALTRAFRAHTADTAFCtlgAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERPNPAL 394
Cdd:cd00834 297 YINAHGTSTPLNDAAESKAIKRVFGEHAKKVPVS---STKSMTGHLLGAAGAVEAIATLLALRDGVLPPTINLEEPDPEC 373
|
410 420 430
....*....|....*....|....*....|....*...
gi 53747904 395 HLEqspfFVNTQPLPWESPrgprlAGVS-SFGIGGTNA 431
Cdd:cd00834 374 DLD----YVPNEAREAPIR-----YALSnSFGFGGHNA 402
|
|
| decarbox_cond_enzymes |
cd00825 |
decarboxylating condensing enzymes; Family of enzymes that catalyze the formation of a new ... |
96-432 |
6.06e-56 |
|
decarboxylating condensing enzymes; Family of enzymes that catalyze the formation of a new carbon-carbon bond by a decarboxylating Claisen-like condensation reaction. Members are involved in the synthesis of fatty acids and polyketides, a diverse group of natural products. Both pathways are an iterative series of additions of small carbon units, usually acetate, to a nascent acyl group. There are 2 classes of decarboxylating condensing enzymes, which can be distinguished by sequence similarity, type of active site residues and type of primer units (acetyl CoA or acyl carrier protein (ACP) linked units).
Pssm-ID: 238421 [Multi-domain] Cd Length: 332 Bit Score: 199.40 E-value: 6.06e-56
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 96 QQRLLLECSWEALEDAGLRPDQLPGW-VGVYVGAGDTSYRFQLLRGHGDPLSGSKDVAGFFgnYPdFLATRVAYKLNLRG 174
Cdd:cd00825 11 VSILGFEAAERAIADAGLSREYQKNPiVGVVVGTGGGSPRFQVFGADAMRAVGPYVVTKAM--FP-GASGQIATPLGIHG 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 175 PALGIHTACSTSLVSINMACSALRGFECDMALAGGVSLRLPARSGYLYEEGGVASKDGHCRPFDARATGTVTGDGVGVVV 254
Cdd:cd00825 88 PAYDVSAACAGSLHALSLAADAVQNGKQDIVLAGGSEELAAPMDCEFDAMGALSTPEKASRTFDAAADGFVFGDGAGALV 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 255 LKRLEDALKARDPIHAVIRGWALNNDGASRaGFTAPSVEGQSEVIALAHAAAGISARDITYVEAHGTGTPLGDPIEVAAL 334
Cdd:cd00825 168 VEELEHALARGAHIYAEIVGTAATIDGAGM-GAFAPSAEGLARAAKEALAVAGLTVWDIDYLVAHGTGTPIGDVKELKLL 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 335 TRAFRAHTAdtafcTLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERPNPALHLEQSPffvntqplpwESPR 414
Cdd:cd00825 247 RSEFGDKSP-----AVSATKAMTGNLSSAAVVLAVDEAVLMLEHGFIPPSIHIEELDEAGLNIVTE----------TTPR 311
|
330
....*....|....*...
gi 53747904 415 GPRLAGVSSFGIGGTNAH 432
Cdd:cd00825 312 ELRTALLNGFGLGGTNAT 329
|
|
| p53_inducible_oxidoreductase |
cd05276 |
PIG3 p53-inducible quinone oxidoreductase; PIG3 p53-inducible quinone oxidoreductase, a medium ... |
1675-1986 |
1.24e-54 |
|
PIG3 p53-inducible quinone oxidoreductase; PIG3 p53-inducible quinone oxidoreductase, a medium chain dehydrogenase/reductase family member, acts in the apoptotic pathway. PIG3 reduces ortho-quinones, but its apoptotic activity has been attributed to oxidative stress generation, since overexpression of PIG3 accumulates reactive oxygen species. PIG3 resembles the MDR family member quinone reductases, which catalyze the reduction of quinone to hydroxyquinone. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site, and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176180 [Multi-domain] Cd Length: 323 Bit Score: 194.97 E-value: 1.24e-54
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1675 VAVGTPGLLESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGD 1754
Cdd:cd05276 4 IVIKEPGGPEVLELGEVPKPAPGPGEVLIRVAAAGVNRADLLQRQGLYPPPPGASDILGLEVAGVVVAVGPGVTGWKVGD 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1755 EVLAVAPGC-FRSYVLVDESQVVRRPASLGLAEGAAqmVP--FATAYFALHTVGRLRRGERILIHAAAGGLGLAAVQLAS 1831
Cdd:cd05276 84 RVCALLAGGgYAEYVVVPAGQLLPVPEGLSLVEAAA--LPevFFTAWQNLFQLGGLKAGETVLIHGGASGVGTAAIQLAK 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1832 RTGAEILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELG--- 1908
Cdd:cd05276 162 ALGARVIATAGSEEKLEACRALGADVAINYRTEDFAEEVKEATGGRGVDVILDMVGGDYLARNLRALAPDGRLVLIGllg 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1909 -------------KRdlyadqqvgLR----TLaRGQTF---AAIdfgphhpdFRAVLEEVATQLTQGQLEPLPTRLFPAR 1968
Cdd:cd05276 242 gakaeldlapllrKR---------LTltgsTL-RSRSLeekAAL--------AAAFREHVWPLFASGRIRPVIDKVFPLE 303
|
330
....*....|....*...
gi 53747904 1969 QVAEAFSFMARALHIGRV 1986
Cdd:cd05276 304 EAAEAHRRMESNEHIGKI 321
|
|
| FabB |
COG0304 |
3-oxoacyl-(acyl-carrier-protein) synthase [Lipid transport and metabolism, Secondary ... |
23-431 |
5.26e-54 |
|
3-oxoacyl-(acyl-carrier-protein) synthase [Lipid transport and metabolism, Secondary metabolites biosynthesis, transport and catabolism]; 3-oxoacyl-(acyl-carrier-protein) synthase is part of the Pathway/BioSystem: Fatty acid biosynthesis
Pssm-ID: 440073 [Multi-domain] Cd Length: 409 Bit Score: 196.08 E-value: 5.26e-54
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 23 PGAPDVESFWRNLVAG---VESISFFSEEELRqagvseqirrrpeyVPAKGVLEDLELFDAgffgYSPREASHLDPQQRL 99
Cdd:COG0304 13 PLGNGVEEFWEALLAGrsgIRPITRFDASGLP--------------VRIAGEVKDFDPEEY----LDRKELRRMDRFTQY 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 100 LLECSWEALEDAGLRPDQLPGW-VGVYVGAG----DTSYRF-QLLRGHGDPLSGSKDVAGFFGNYPdflATRVAYKLNLR 173
Cdd:COG0304 75 ALAAAREALADAGLDLDEVDPDrTGVIIGSGigglDTLEEAyRALLEKGPRRVSPFFVPMMMPNMA---AGHVSIRFGLK 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 174 GPALGIHTACSTSLVSINMACSALRGFECDMALAGGVSLRL-PARSGYLYEEGGVASKDGH----CRPFDARAtgtvtgd 248
Cdd:COG0304 152 GPNYTVSTACASGAHAIGEAYRLIRRGRADVMIAGGAEAAItPLGLAGFDALGALSTRNDDpekaSRPFDKDRdgfvlge 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 249 gvgvvvLKRLEDAlKARD-PIHAVIRGWALNNDGASRAGfTAPSVEGQSEVIALAHAAAGISARDITYVEAHGTGTPLGD 327
Cdd:COG0304 232 gagvlvLEELEHA-KARGaKIYAEVVGYGASSDAYHITA-PAPDGEGAARAMRAALKDAGLSPEDIDYINAHGTSTPLGD 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 328 PIEVAALTRAFRAHTADTAfctLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERPNPALHLEqspfFVNTQP 407
Cdd:COG0304 310 AAETKAIKRVFGDHAYKVP---VSSTKSMTGHLLGAAGAIEAIASVLALRDGVIPPTINLENPDPECDLD----YVPNEA 382
|
410 420
....*....|....*....|....
gi 53747904 408 LPWEsprgPRLAGVSSFGIGGTNA 431
Cdd:COG0304 383 REAK----IDYALSNSFGFGGHNA 402
|
|
| C_NRPS-like |
cd19066 |
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of ... |
2180-2605 |
6.83e-54 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long, with various activities such as antibiotic, antifungal, antitumor and immunosuppression. There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380453 [Multi-domain] Cd Length: 427 Bit Score: 196.48 E-value: 6.83e-54
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2180 PFPLTDVQEAYWVGR-----RSAFelggvaaHGYFEIESPG-LEVERFIQCWRQLLQRHDMLRMVVL---PDGRQQVLEQ 2250
Cdd:cd19066 1 KIPLSPMQRGMWFLKklatdPSAF-------NVAIEMFLTGsLDLARLKQALDAVMERHDVLRTRFCeeaGRYEQVVLDK 73
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2251 VPEYTPEVVELRGLSPQEAesRRLQLRERMAHQVLRSDRWPLFELVLCRY-EGGVRIHMSMDALMLDAWSSAVLRQDFAQ 2329
Cdd:cd19066 74 TVRFRIEIIDLRNLADPEA--RLLELIDQIQQTIYDLERGPLVRVALFRLaDERDVLVVAIHHIIVDGGSFQILFEDISS 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2330 LY--HEPGRP-LEPLAITFRDYVLAERRLREGEAHERARAYWWARLDTLPPPPELPLVKEPSQLEHARFTHREARLEPHR 2406
Cdd:cd19066 152 VYdaAERQKPtLPPPVGSYADYAAWLEKQLESEAAQADLAYWTSYLHGLPPPLPLPKAKRPSQVASYEVLTLEFFLRSEE 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2407 WARLQERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRLPlhPQVDELVGDFTSLVLLEVEAHAASTFAERAS 2486
Cdd:cd19066 232 TKRLREVARESGTTPTQLLLAAFALALKRLTASIDVVIGLTFLNRPD--EAVEDTIGLFLNLLPLRIDTSPDATFPELLK 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2487 RLQAQLWRDLEHGSVSAVQLIRELVRTGRRSPGAIMPVVFTSILsldarrGPQGSLS---FFEGELVYSISQTPQVWLDH 2563
Cdd:cd19066 310 RTKEQSREAIEHQRVPFIELVRHLGVVPEAPKHPLFEPVFTFKN------NQQQLGKtggFIFTTPVYTSSEGTVFDLDL 383
|
410 420 430 440
....*....|....*....|....*....|....*....|...
gi 53747904 2564 GVHEE-EGALVLAWDSVEALFPPGMVDDMFHAYQRLLGALAEE 2605
Cdd:cd19066 384 EASEDpDGDLLLRLEYSRGVYDERTIDRFAERYMTALRQLIEN 426
|
|
| McbC_SagB-like_oxidoreductase |
cd02142 |
oxidase similar to the microcin B17 processing protein McbC; This family is the oxidase domain ... |
3261-3462 |
1.32e-53 |
|
oxidase similar to the microcin B17 processing protein McbC; This family is the oxidase domain of NRPS (non-ribosomal peptide synthetase) and other systems that modify polypeptides by cyclizing a thioester to form a ring. These include EpoB, part of the epothilone biosynthesis pathway; TubD, part of the tubulysin biosynthesis pathway, MtsD, part of the myxothiozol biosynthesis pathway; IndC, part of the indigoidine biosynthesis pathway and TfxB, part of the trifitoxin processing pathway. All are FMN-dependent and oxidize the product of the cyclization of thioesters in short polypeptides.
Pssm-ID: 380318 Cd Length: 200 Bit Score: 187.24 E-value: 1.32e-53
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3261 GTPEVALPGSGLAPAPEELTALERRRSVRTYSLEPVSHEQLGRLLAplREWEVQGSRRYLYASAGGLYPVQLYLHLKPGR 3340
Cdd:cd02142 3 VPLPDPNLKPALLATLDLSEALLNRRSRRTFSSEPLTLRELSRLAA--RGIPGSGYGLRPYPSAGALYPIEVYVIVKNVE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3341 arGLEPGTWYYDPSTHRLVLLSAGAGLDRRIHdPHQNQAIFDSAAFSLFLIARMGAVEPVYAEHALHFATLEAGLMTQLL 3420
Cdd:cd02142 81 --GLPAGIYHYDPKRHRLVLIREGDFRLDLAH-AAGNQAAFGSAAFSLIIVARFERIAWKYGERAYRYILLEAGHLAQNL 157
|
170 180 190 200
....*....|....*....|....*....|....*....|...
gi 53747904 3421 DLGAAPSGLGLCHIGDLDFAQARGLFHLEE-EHVLLHSLVGGV 3462
Cdd:cd02142 158 YLAATALGLGLCAIGAFDDDALRELLGLDEvEEVVLYAFVVGG 200
|
|
| QOR1 |
cd08241 |
Quinone oxidoreductase (QOR); QOR catalyzes the conversion of a quinone + NAD(P)H to a ... |
1694-1988 |
1.56e-53 |
|
Quinone oxidoreductase (QOR); QOR catalyzes the conversion of a quinone + NAD(P)H to a hydroquinone + NAD(P)+. Quinones are cyclic diones derived from aromatic compounds. Membrane bound QOR acts in the respiratory chains of bacteria and mitochondria, while soluble QOR acts to protect from toxic quinones (e.g. DT-diaphorase) or as a soluble eye-lens protein in some vertebrates (e.g. zeta-crystalin). QOR reduces quinones through a semi-quinone intermediate via a NAD(P)H-dependent single electron transfer. QOR is a member of the medium chain dehydrogenase/reductase family, but lacks the zinc-binding sites of the prototypical alcohol dehydrogenases of this group. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site, and a structural zinc in a lobe of the catalytic domain. NAD(H)-binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176203 [Multi-domain] Cd Length: 323 Bit Score: 191.94 E-value: 1.56e-53
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPG-PRQVEIEVEAAGLNFLDVLGALG---MMPALEAeesVLGRECSGRIAAVGEGVSGLRVGDEVLAVAP-GCFRSYV 1768
Cdd:cd08241 22 PEPGaPGEVRIRVEAAGVNFPDLLMIQGkyqVKPPLPF---VPGSEVAGVVEAVGEGVTGFKVGDRVVALTGqGGFAEEV 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1769 LVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGERILIHAAAGGLGLAAVQLASRTGAEILATAGSEQKRE 1848
Cdd:cd08241 99 VVPAAAVFPLPDGLSFEEAAALPVTYGTAYHALVRRARLQPGETVLVLGAAGGVGLAAVQLAKALGARVIAAASSEEKLA 178
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1849 YLRSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELGkrdlYAD---QQVGL-RTLA 1924
Cdd:cd08241 179 LARALGADHVIDYRDPDLRERVKALTGGRGVDVVYDPVGGDVFEASLRSLAWGGRLLVIG----FASgeiPQIPAnLLLL 254
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 53747904 1925 RGQTFAAIDFGP---HHPD-FRAVLEEVATQLTQGQLEPLPTRLFPARQVAEAFSFMARALHIGRVAV 1988
Cdd:cd08241 255 KNISVVGVYWGAyarREPElLRANLAELFDLLAEGKIRPHVSAVFPLEQAAEALRALADRKATGKVVL 322
|
|
| MDR2 |
cd08268 |
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; ... |
1694-1988 |
1.76e-51 |
|
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; This group is a member of the medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, but lacks the zinc-binding sites of the zinc-dependent alcohol dehydrogenases. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P)-binding Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176229 [Multi-domain] Cd Length: 328 Bit Score: 186.27 E-value: 1.76e-51
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAGLNFLDVL---GALGMMPALEAeesVLGRECSGRIAAVGEGVSGLRVGDEVLAVAP------GCF 1764
Cdd:cd08268 23 PAPGAGEVLIRVEAIGLNRADAMfrrGAYIEPPPLPA---RLGYEAAGVVEAVGAGVTGFAVGDRVSVIPAadlgqyGTY 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1765 RSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGERILIHAAAGGLGLAAVQLASRTGAEILATAGSE 1844
Cdd:cd08268 100 AEYALVPAAAVVKLPDGLSFVEAAALWMQYLTAYGALVELAGLRPGDSVLITAASSSVGLAAIQIANAAGATVIATTRTS 179
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1845 QKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELGKRDLYADQQVGLRTLA 1924
Cdd:cd08268 180 EKRDALLALGAAHVIVTDEEDLVAEVLRITGGKGVDVVFDPVGGPQFAKLADALAPGGTLVVYGALSGEPTPFPLKAALK 259
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 53747904 1925 RGQTFAAIDFGPHHPD---FRAVLEEVATQLTQGQLEPLPTRLFPARQVAEAFSFMARALHIGRVAV 1988
Cdd:cd08268 260 KSLTFRGYSLDEITLDpeaRRRAIAFILDGLASGALKPVVDRVFPFDDIVEAHRYLESGQQIGKIVV 326
|
|
| Ketoacyl-synt_C |
pfam02801 |
Beta-ketoacyl synthase, C-terminal domain; The structure of beta-ketoacyl synthase is similar ... |
269-388 |
5.02e-51 |
|
Beta-ketoacyl synthase, C-terminal domain; The structure of beta-ketoacyl synthase is similar to that of the thiolase family (pfam00108) and also chalcone synthase. The active site of beta-ketoacyl synthase is located between the N and C-terminal domains.
Pssm-ID: 426989 Cd Length: 118 Bit Score: 176.60 E-value: 5.02e-51
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 269 HAVIRGWALNNDGASrAGFTAPSVEGQSEVIALAHAAAGISARDITYVEAHGTGTPLGDPIEVAALTRAFRAHtADTAFC 348
Cdd:pfam02801 1 YAVIKGSAVNHDGRH-NGLTAPNGEGQARAIRRALADAGVDPEDVDYVEAHGTGTPLGDPIEAEALKRVFGSG-ARKQPL 78
|
90 100 110 120
....*....|....*....|....*....|....*....|
gi 53747904 349 TLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFE 388
Cdd:pfam02801 79 AIGSVKSNIGHLEGAAGAAGLIKVVLALRHGVIPPTLNLE 118
|
|
| KR_2_SDR_x |
cd08953 |
ketoreductase (KR), subgroup 2, complex (x) SDRs; Ketoreductase, a module of the multidomain ... |
967-1373 |
1.02e-50 |
|
ketoreductase (KR), subgroup 2, complex (x) SDRs; Ketoreductase, a module of the multidomain polyketide synthase (PKS), has 2 subdomains, each corresponding to a SDR family monomer. The C-terminal subdomain catalyzes the NADPH-dependent reduction of the beta-carbonyl of a polyketide to a hydroxyl group, a step in the biosynthesis of polyketides, such as erythromycin. The N-terminal subdomain, an interdomain linker, is a truncated Rossmann fold which acts to stabilizes the catalytic subdomain. Unlike typical SDRs, the isolated domain does not oligomerize but is composed of 2 subdomains, each resembling an SDR monomer. The active site resembles that of typical SDRs, except that the usual positions of the catalytic Asn and Tyr are swapped, so that the canonical YXXXK motif changes to YXXXN. Modular PKSs are multifunctional structures in which the makeup recapitulates that found in (and may have evolved from) FAS. Polyketide synthesis also proceeds via the addition of 2-carbon units as in fatty acid synthesis. The complex SDR NADP-binding motif, GGXGXXG, is often present, but is not strictly conserved in each instance of the module. This subfamily includes both KR domains of the Bacillus subtilis Pks J,-L, and PksM, and all three KR domains of PksN, components of the megacomplex bacillaene synthase, which synthesizes the antibiotic bacillaene. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold (alpha/beta folding pattern with a central beta-sheet), an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Classical SDRs are typically about 250 residues long, while extended SDRs are approximately 350 residues. Sequence identity between different SDR enzymes are typically in the 15-30% range, but the enzymes share the Rossmann fold NAD-binding motif and characteristic NAD-binding and catalytic sequence patterns. These enzymes catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human prostaglandin dehydrogenase (PGDH) numbering). In addition to the Tyr and Lys, there is often an upstream Ser (Ser-138, PGDH numbering) and/or an Asn (Asn-107, PGDH numbering) contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Extended SDRs have additional elements in the C-terminal region, and typically have a TGXXGXXG cofactor binding motif. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type KRs have a TGXXXGX(1-2)G NAD(P)-binding motif. Some atypical SDRs have lost catalytic activity and/or have an unusual NAD(P)-binding motif and missing or unusual active site residues. Reactions catalyzed within the SDR family include isomerization, decarboxylation, epimerization, C=N bond reduction, dehydratase activity, dehalogenation, Enoyl-CoA reduction, and carbonyl-alcohol oxidoreduction.
Pssm-ID: 187656 [Multi-domain] Cd Length: 436 Bit Score: 187.57 E-value: 1.02e-50
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 967 VEPAGHYEQLSEHAFRLRPEseEDWDALFQALQSQGRLPRRILHAWALTAEPGPC---TPDGEAVL-------EQGFFSL 1036
Cdd:cd08953 10 VIDLAYTLQVGREAMEERRR--LEALASLQPVWAPAALASAFLALAYEAALLGLAaaeAALLDALSaldpaaaLQLLESL 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1037 LRLARALGRHApeRPVQLEVLSSFVHAVG--PREPLEPLKATLLGACAVLPLEYPHVQCRTIDVRPGSEPREVLVRSLAA 1114
Cdd:cd08953 88 QRLLKAGLLAA--RASGRALLQVVTGLPGalGLDALDPAGAGLAGLLRTLAQEYPGLTCRLIDLDAGEASAEALARELAA 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1115 ELAAPMGESpVAWRDGQRYVRRATRQRLEASRPLRS-LRERGVYLVAGGLGGIGLVLARALAQRARARLALLTHSPFPPR 1193
Cdd:cd08953 166 ELAAPGAAE-VRYRDGLRYVQTLEPLPLPAGAAASApLKPGGVYLVTGGAGGIGRALARALARRYGARLVLLGRSPLPPE 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1194 EQWEQWLeeapahpepawrseadpserrrtqhrircLLELEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGKIHGVLHA 1273
Cdd:cd08953 245 EEWKAQT-----------------------------LAALEALGARVLYISADVTDAAAVRRLLEKVRERYGAIDGVIHA 295
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1274 AATFDDGVIQLRTHEQSSRALRTKVRGSMVLHEVLASEGLDWFALCSSLASALGSFGQADYCAANAFQDAYAHHLRRQG- 1352
Cdd:cd08953 296 AGVLRDALLAQKTAEDFEAVLAPKVDGLLNLAQALADEPLDFFVLFSSVSAFFGGAGQADYAAANAFLDAFAAYLRQRGp 375
|
410 420
....*....|....*....|.
gi 53747904 1353 FTGALALDWGTWRDTGAAMRL 1373
Cdd:cd08953 376 QGRVLSINWPAWREGGMAADL 396
|
|
| PRK04813 |
PRK04813 |
D-alanine--poly(phosphoribitol) ligase subunit DltA; |
2648-3132 |
7.28e-48 |
|
D-alanine--poly(phosphoribitol) ligase subunit DltA;
Pssm-ID: 235313 [Multi-domain] Cd Length: 503 Bit Score: 180.86 E-value: 7.28e-48
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRL 2727
Cdd:PRK04813 12 AQTQPDFPAYDYLGEKLTYGQLKEDSDALAAFIDSLKLPDKSPIIVFGHMSPEMLATFLGAVKAGHAYIPVDVSSPAERI 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2728 HQLLEEGPARVVLTqssllhTVPWPP---GVQVIAVDELEPATEAPPLPPrgtPEHL------AYVIYTSGSTGKPKGVA 2798
Cdd:PRK04813 92 EMIIEVAKPSLIIA------TEELPLeilGIPVITLDELKDIFATGNPYD---FDHAvkgddnYYIIFTSGTTGKPKGVQ 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2799 IEHrAALNTVVD-LNTRFGVGPEDRVLGLSALTFDLSVYDvlgllgaggalVLPA-----------AEAEKDPAHWWERL 2866
Cdd:PRK04813 163 ISH-DNLVSFTNwMLEDFALPEGPQFLNQAPYSFDLSVMD-----------LYPTlasggtlvalpKDMTANFKQLFETL 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2867 VAGRVTVWNSTPALM---LLLVEYAEQrglKLPaALRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEASIWSIAYP 2943
Cdd:PRK04813 231 PQLPINVWVSTPSFAdmcLLDPSFNEE---HLP-NLTHFLFCGEELPHKTAKKLLERFPSATIYNTYGPTEATVAVTSIE 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2944 IGQ-VAPQWKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIrhPRTGERLYRTGDQG 3022
Cdd:PRK04813 307 ITDeMLDQYKRLPIGYAKPDSPLLIIDEEGTKLPDGEQGEIVISGPSVSKGYLNNPEKTAEAFF--TFDGQPAYHTGDAG 384
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3023 RMlPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGEL----RR 3098
Cdd:PRK04813 385 YL-EDGLLFYQGRIDFQIKLNGYRIELEEIEQNLRQSSYVESAVVVPYNKDHKVQYLIAYVVPKEEDFEREFELtkaiKK 463
|
490 500 510
....*....|....*....|....*....|....
gi 53747904 3099 YLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PRK04813 464 ELKERLMEYMIPRKFIYRDSLPLTPNGKIDRKAL 497
|
|
| elong_cond_enzymes |
cd00828 |
"elongating" condensing enzymes are a subclass of decarboxylating condensing enzymes, ... |
24-434 |
7.52e-47 |
|
"elongating" condensing enzymes are a subclass of decarboxylating condensing enzymes, including beta-ketoacyl [ACP] synthase, type I and II and polyketide synthases.They are characterized by the utlization of acyl carrier protein (ACP) thioesters as primer substrates, as well as the nature of their active site residues.
Pssm-ID: 238424 [Multi-domain] Cd Length: 407 Bit Score: 175.32 E-value: 7.52e-47
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 24 GAPDVESFWRNLVAGVESISFFSEEELRQA-GVSEQIRrrpeyvpakgvledlelfDAGFFGYSPREASHLDPQQRLLLE 102
Cdd:cd00828 17 GCDEVEEFWEALREGRSGIAPVARLKSRFDrGVAGQIP------------------TGDIPGWDAKRTGIVDRTTLLALV 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 103 CSWEALEDAGLRPDQL--PGWVGVYVGAGDTSYRFQLLRGHGDPLSGSKDVAGFFGNYPDFLATRVAYKLNL-RGPALGI 179
Cdd:cd00828 79 ATEEALADAGITDPYEvhPSEVGVVVGSGMGGLRFLRRGGKLDARAVNPYVSPKWMLSPNTVAGWVNILLLSsHGPIKTP 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 180 HTACSTSLVSINMACSALRGFECDMALAGGVSLRLP------ARSGYLYEEGGVASkdGHCRPFDARATGTVTGDGVGVV 253
Cdd:cd00828 159 VGACATALEALDLAVEAIRSGKADIVVVGGVEDPLEeglsgfANMGALSTAEEEPE--EMSRPFDETRDGFVEAEGAGVL 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 254 VLKRLEDALKARDPIHAVIRGWALNNDGASRAGftAPSVEGQSEVIALAHAAAGISARDITYVEAHGTGTPLGDPIEVAA 333
Cdd:cd00828 237 VLERAELALARGAPIYGRVAGTASTTDGAGRSV--PAGGKGIARAIRTALAKAGLSLDDLDVISAHGTSTPANDVAESRA 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 334 LTRAFRAHTADTAfctLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERPNPALhleqSPFFVNTQPLPWesP 413
Cdd:cd00828 315 IAEVAGALGAPLP---VTAQKALFGHSKGAAGALQLIGALQSLEHGLIPPTANLDDVDPDV----EHLSVVGLSRDL--N 385
|
410 420
....*....|....*....|.
gi 53747904 414 RGPRLAGVSSFGIGGTNAHTL 434
Cdd:cd00828 386 LKVRAALVNAFGFGGSNAALV 406
|
|
| zeta_crystallin |
cd08253 |
Zeta-crystallin with NADP-dependent quinone reductase activity (QOR); Zeta-crystallin is a eye ... |
1684-1973 |
7.97e-47 |
|
Zeta-crystallin with NADP-dependent quinone reductase activity (QOR); Zeta-crystallin is a eye lens protein with NADP-dependent quinone reductase activity (QOR). It has been cited as a structural component in mammalian eyes, but also has homology to quinone reductases in unrelated species. QOR catalyzes the conversion of a quinone and NAD(P)H to a hydroquinone and NAD(P+. Quinones are cyclic diones derived from aromatic compounds. Membrane bound QOR acts in the respiratory chains of bacteria and mitochondria, while soluble QOR acts to protect from toxic quinones (e.g. DT-diaphorase) or as a soluble eye-lens protein in some vertebrates (e.g. zeta-crystalin). QOR reduces quinones through a semi-quinone intermediate via a NAD(P)H-dependent single electron transfer. QOR is a member of the medium chain dehydrogenase/reductase family, but lacks the zinc-binding sites of the prototypical alcohol dehydrogenases of this group. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site, and a structural zinc in a lobe of the catalytic domain. NAD(H)-binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176215 [Multi-domain] Cd Length: 325 Bit Score: 172.38 E-value: 7.97e-47
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1684 ESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGDEV------L 1757
Cdd:cd08253 13 DVLRLGDLPVPTPGPGEVLVRVHASGVNPVDTYIRAGAYPGLPPLPYVPGSDGAGVVEAVGEGVDGLKVGDRVwltnlgW 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1758 AVAPGCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGERILIHAAAGGLGLAAVQLASRTGAEI 1837
Cdd:cd08253 93 GRRQGTAAEYVVVPADQLVPLPDGVSFEQGAALGIPALTAYRALFHRAGAKAGETVLVHGGSGAVGHAAVQLARWAGARV 172
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1838 LATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELGKRDLYADqq 1917
Cdd:cd08253 173 IATASSAEGAELVRQAGADAVFNYRAEDLADRILAATAGQGVDVIIEVLANVNLAKDLDVLAPGGRIVVYGSGGLRGT-- 250
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1918 VGLRTLARGQtfAAID----FGPHHPDFRAVLEEVATQLTQGQLEPLPTRLFPARQVAEA 1973
Cdd:cd08253 251 IPINPLMAKE--ASIRgvllYTATPEERAAAAEAIAAGLADGALRPVIAREYPLEEAAAA 308
|
|
| MDR_like_2 |
cd05289 |
alcohol dehydrogenase and quinone reductase-like medium chain degydrogenases/reductases; ... |
1693-1988 |
2.26e-46 |
|
alcohol dehydrogenase and quinone reductase-like medium chain degydrogenases/reductases; Members identified as zinc-dependent alcohol dehydrogenases and quinone oxidoreductase. QOR catalyzes the conversion of a quinone + NAD(P)H to a hydroquinone + NAD(P)+. Quinones are cyclic diones derived from aromatic compounds. Membrane bound QOR actin the respiratory chains of bacteria and mitochondria, while soluble QOR acts to protect from toxic quinones (e.g. DT-diaphorase) or as a soluble eye-lens protein in some vertebrates (e.g. zeta-crystalin). QOR reduces quinones through a semi-quinone intermediate via a NAD(P)H-dependent single electron transfer. QOR is a member of the medium chain dehydrogenase/reductase family, but lacks the zinc-binding sites of the prototypical alcohol dehydrogenases of this group. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176191 [Multi-domain] Cd Length: 309 Bit Score: 170.82 E-value: 2.26e-46
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1693 RPAPGPRQVEIEVEAAGLNFLDVL---GALGMMPALEaEESVLGRECSGRIAAVGEGVSGLRVGDEVLAVAP----GCFR 1765
Cdd:cd05289 22 TPEPGPGEVLVKVHAAGVNPVDLKireGLLKAAFPLT-LPLIPGHDVAGVVVAVGPGVTGFKVGDEVFGMTPftrgGAYA 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1766 SYVLVDESQVVRRPASLGLAEGAAqmVPFA--TAYFALHTVGRLRRGERILIHAAAGGLGLAAVQLASRTGAEILATAgS 1843
Cdd:cd05289 101 EYVVVPADELALKPANLSFEEAAA--LPLAglTAWQALFELGGLKAGQTVLIHGAAGGVGSFAVQLAKARGARVIATA-S 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1844 EQKREYLRSLGIAHVLDSRSTSFVsevrERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELgkrdlyADQQVGLRTL 1923
Cdd:cd05289 178 AANADFLRSLGADEVIDYTKGDFE----RAAAPGGVDAVLDTVGGETLARSLALVKPGGRLVSI------AGPPPAEQAA 247
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 1924 ARGQtfAAIDFGPHHPDfRAVLEEVATQLTQGQLEPLPTRLFPARQVAEAFSFMARALHIGRVAV 1988
Cdd:cd05289 248 KRRG--VRAGFVFVEPD-GEQLAELAELVEAGKLRPVVDRVFPLEDAAEAHERLESGHARGKVVL 309
|
|
| MDR3 |
cd08275 |
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; ... |
1675-1990 |
5.70e-46 |
|
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; This group is a member of the medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, but lacks the zinc-binding sites of the zinc-dependent alcohol dehydrogenases. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P)-binding Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176236 [Multi-domain] Cd Length: 337 Bit Score: 170.46 E-value: 5.70e-46
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1675 VAVGTPGLLESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGD 1754
Cdd:cd08275 3 VVLTGFGGLDKLKVEKEALPEPSSGEVRVRVEACGLNFADLMARQGLYDSAPKPPFVPGFECAGTVEAVGEGVKDFKVGD 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1755 EVLAVAP-GCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGERILIHAAAGGLGLAAVQLASR- 1832
Cdd:cd08275 83 RVMGLTRfGGYAEVVNVPADQVFPLPDGMSFEEAAAFPVNYLTAYYALFELGNLRPGQSVLVHSAAGGVGLAAGQLCKTv 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1833 TGAEILATAgSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTgGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELGKRDL 1912
Cdd:cd08275 163 PNVTVVGTA-SASKHEALKENGVTHVIDYRTQDYVEEVKKIS-PEGVDIVLDALGGEDTRKSYDLLKPMGRLVVYGAANL 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1913 YADQQVGLRTLARG--QTF--------------AAIDFG---PHHPDFRAVLEEVATQLTQGQLEPLPTRLFPARQVAEA 1973
Cdd:cd08275 241 VTGEKRSWFKLAKKwwNRPkvdpmklisenksvLGFNLGwlfEERELLTEVMDKLLKLYEEGKIKPKIDSVFPFEEVGEA 320
|
330
....*....|....*..
gi 53747904 1974 FSFMARALHIGRVAVSM 1990
Cdd:cd08275 321 MRRLQSRKNIGKVVLTP 337
|
|
| KR_2_FAS_SDR_x |
cd08955 |
beta-ketoacyl reductase (KR) domain of fatty acid synthase (FAS), subgroup 2, complex (x); ... |
1008-1378 |
6.40e-46 |
|
beta-ketoacyl reductase (KR) domain of fatty acid synthase (FAS), subgroup 2, complex (x); Ketoreductase, a module of the multidomain polyketide synthase, has 2 subdomains, each corresponding to a short-chain dehydrogenases/reductase (SDR) family monomer. The C-terminal subdomain catalyzes the NADPH-dependent reduction of the beta-carbonyl of a polyketide to a hydroxyl group, a step in the biosynthesis of polyketides, such as erythromycin. The N-terminal subdomain, an interdomain linker, is a truncated Rossmann fold which acts to stabilizes the catalytic subdomain. Unlike typical SDRs, the isolated domain does not oligomerizes but is composed of 2 subdomains, each resembling an SDR monomer. In some instances, as in porcine FAS, an enoyl reductase (a Rossman fold NAD binding domain of the MDR family) module is inserted between the sub-domains. The active site resembles that of typical SDRs, except that the usual positions of the catalytic asparagine and tyrosine are swapped, so that the canonical YXXXK motif changes to YXXXN. Modular polyketide synthases are multifunctional structures in which the makeup recapitulates that found in (and may have evolved from) fatty acid synthase. In some instances, such as porcine FAS , an enoyl reductase module is inserted between the sub-domains. Fatty acid synthesis occurs via the stepwise elongation of a chain (which is attached to acyl carrier protein, ACP) with 2-carbon units. Eukaryotic systems consists of large, multifunctional synthases (type I) while bacterial, type II systems, use single function proteins. Fungal fatty acid synthesis uses dodecamer of 6 alpha and 6 beta subunits. In mammalian type FAS cycles, ketoacyl synthase forms acetoacetyl-ACP which is reduced by the NADP-dependent beta-ketoacyl reductase (KR), forming beta-hydroxyacyl-ACP, which is in turn dehydrated by dehydratase to a beta-enoyl intermediate, which is reduced by NADP-dependent beta-enoyl reductase (ER). Polyketide syntheses also proceeds via the addition of 2-carbon units as in fatty acid synthesis. The complex SDR NADP binding motif, GGXGXXG, is often present, but is not strictly conserved in each instance of the module. This subfamily includes the KR domain of the Lyngbya majuscule Jam J, -K, and #L which are encoded on the jam gene cluster and are involved in the synthesis of the Jamaicamides (neurotoxins); Lyngbya majuscule Jam P belongs to a different KR_FAS_SDR_x subfamily. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold (alpha/beta folding pattern with a central beta-sheet), an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Classical SDRs are typically about 250 residues long, while extended SDRs are approximately 350 residues. Sequence identity between different SDR enzymes are typically in the 15-30% range, but the enzymes share the Rossmann fold NAD-binding motif and characteristic NAD-binding and catalytic sequence patterns. These enzymes catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human prostaglandin dehydrogenase (PGDH) numbering). In addition to the Tyr and Lys, there is often an upstream Ser (Ser-138, PGDH numbering) and/or an Asn (Asn-107, PGDH numbering) contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Extended SDRs have additional elements in the C-terminal region, and typically have a TGXXGXXG cofactor binding motif. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type KRs have a TGXXXGX(1-2)G NAD(P)-binding motif. Some atypical SDRs have lost catalytic activity and/or have an unusual NAD(P)-binding motif and missing or unusual active site residues. Reactions catalyzed within the SDR family include isomerization, decarboxylation, epimerization, C=N bond reduction, dehydratase activity, dehalogenation, Enoyl-CoA reduction, and carbonyl-alcohol oxidoreduction.
Pssm-ID: 187658 [Multi-domain] Cd Length: 376 Bit Score: 171.70 E-value: 6.40e-46
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1008 ILHAWALTAEPgpCTPDGEAVLEQGFFSLLRLARALGRHAPERPVQLEVLSSFVHAVGP-REPLEPLKATLLGACAVLPL 1086
Cdd:cd08955 11 VVHLWSLDAPR--EEPADAASQELGCASALHLVQALSKAGLRRAPRLWLVTRGAQSVLAdGEPVSPAQAPLWGLGRVIAL 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1087 EYPHVQCRTIDVRPgSEPREVLVRSLAAELAAPMGESPVAWRDGQRYVRRATRQRLEASRPLRSlrergvYLVAGGLGGI 1166
Cdd:cd08955 89 EHPELRCGLVDLDP-EATAAEEAEALLAELLAADAEDQVALRGGARYVARLVRAPARPLRPDAT------YLITGGLGGL 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1167 GLVLAralaqrararlallthspfppreqweQWLEEAPA-HPEPAWRSEADPSERRRtqhrircLLELEQLGAEVQVYTA 1245
Cdd:cd08955 162 GLLVA--------------------------EWLVERGArHLVLTGRRAPSAAARQA-------IAALEEAGAEVVVLAA 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1246 DVAEEAAVRSVVEQVHARWGKIHGVLHAAATFDDGVIQLRTHEQSSRALRTKVRGSMVLHEVLASEGLDWFALCSSLASA 1325
Cdd:cd08955 209 DVSDRDALAAALAQIRASLPPLRGVIHAAGVLDDGVLANQDWERFRKVLAPKVQGAWNLHQLTQDLPLDFFVLFSSVASL 288
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|...
gi 53747904 1326 LGSFGQADYCAANAFQDAYAHHLRRQGFTgALALDWGTWRDTGAAMRLVARTR 1378
Cdd:cd08955 289 LGSPGQANYAAANAFLDALAHYRRARGLP-ALSINWGPWAEVGMAASLARQAR 340
|
|
| PKS_KR |
smart00822 |
This enzymatic domain is part of bacterial polyketide synthases; It catalyses the first step ... |
1212-1366 |
2.81e-45 |
|
This enzymatic domain is part of bacterial polyketide synthases; It catalyses the first step in the reductive modification of the beta-carbonyl centres in the growing polyketide chain. It uses NADPH to reduce the keto group to a hydroxy group.
Pssm-ID: 214833 [Multi-domain] Cd Length: 180 Bit Score: 162.65 E-value: 2.81e-45
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1212 RSEADPSERRRTqhrircLLELEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAATFDDGVIQLRTHEQSS 1291
Cdd:smart00822 33 RSGPDAPGAAAL------LAELEAAGARVTVVACDVADRDALAAVLAAIPAVEGPLTGVIHAAGVLDDGVLASLTPERFA 106
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 1292 RALRTKVRGSMVLHEVLASEGLDWFALCSSLASALGSFGQADYCAANAFQDAYAHHLRRQGfTGALALDWGTWRD 1366
Cdd:smart00822 107 AVLAPKAAGAWNLHELTADLPLDFFVLFSSIAGVLGSPGQANYAAANAFLDALAEYRRARG-LPALSIAWGAWAE 180
|
|
| ligase_PEP_1 |
TIGR03098 |
acyl-CoA ligase (AMP-forming), exosortase A-associated; This group of proteins contains an ... |
2648-3132 |
8.08e-43 |
|
acyl-CoA ligase (AMP-forming), exosortase A-associated; This group of proteins contains an AMP-binding domain (pfam00501) associated with acyl CoA-ligases. These proteins are generally found in genomes containing the exosortase/PEP-CTERM protein expoert system, specifically the type 1 variant of this system described by the Genome Property GenProp0652. When found in this context they are invariably present next to a decarboxylase enzyme. A number of sequences from Burkholderia species also hit this model, but the genomic context is obviously different. The hypothesis of a constant substrate for this family is only strong where the exosortase context is present.
Pssm-ID: 211788 [Multi-domain] Cd Length: 517 Bit Score: 166.50 E-value: 8.08e-43
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDP----EQ- 2722
Cdd:TIGR03098 10 AARLPDATALVHHDRTLTYAALSERVLALASGLRGLGLARGERVAIYLDKRLETVTAMFGAALAGGVFVPINPllkaEQv 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2723 --------------PPLRLhQLLEEGPA-----RVVLTQSSLLHTVPWPPGVQVIAVDELEPATEAPPlPPRGTPEHLAY 2783
Cdd:TIGR03098 90 ahiladcnvrllvtSSERL-DLLHPALPgchdlRTLIIVGDPAHASEGHPGEEPASWPKLLALGDADP-PHPVIDSDMAA 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2784 VIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAhww 2863
Cdd:TIGR03098 168 ILYTSGSTGRPKGVVLSHRNLVAGAQSVATYLENRPDDRLLAVLPLSFDYGFNQLTTAFYVGATVVLHDYLLPRDVL--- 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2864 ERLVAGRVTVWNSTPALMLLLVEyaeqrgLKLP----AALRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEAsIWS 2939
Cdd:TIGR03098 245 KALEKHGITGLAAVPPLWAQLAQ------LDWPesaaPSLRYLTNSGGAMPRATLSRLRSFLPNARLFLMYGLTEA-FRS 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2940 IAYPIGQVAPQWKSIPYGMPlaNQRFHVL--DGRlEARPwWVPGELYIGGEGLAREYWRDEPLTATRFIRHPRTGERLYR 3017
Cdd:TIGR03098 318 TYLPPEEVDRRPDSIGKAIP--NAEVLVLreDGS-ECAP-GEEGELVHRGALVAMGYWNDPEKTAERFRPLPPFPGELHL 393
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3018 T------GDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTP 3091
Cdd:TIGR03098 394 PelavwsGDTVRRDEEGFLYFVGRRDEMIKTSGYRVSPTEVEEVAYATGLVAEAVAFGVPDPTLGQAIVLVVTPPGGEEL 473
|
490 500 510 520
....*....|....*....|....*....|....*....|.
gi 53747904 3092 AAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:TIGR03098 474 DRAALLAECRARLPNYMVPALIHVRQALPRNANGKIDRKAL 514
|
|
| QOR2 |
cd05286 |
Quinone oxidoreductase (QOR); Quinone oxidoreductase (QOR) and 2-haloacrylate reductase. QOR ... |
1675-1973 |
1.11e-42 |
|
Quinone oxidoreductase (QOR); Quinone oxidoreductase (QOR) and 2-haloacrylate reductase. QOR catalyzes the conversion of a quinone + NAD(P)H to a hydroquinone + NAD(P)+. Quinones are cyclic diones derived from aromatic compounds. Membrane bound QOR actin the respiratory chains of bacteria and mitochondria, while soluble QOR acts to protect from toxic quinones (e.g. DT-diaphorase) or as a soluble eye-lens protein in some vertebrates (e.g. zeta-crystalin). QOR reduces quinones through a semi-quinone intermediate via a NAD(P)H-dependent single electron transfer. QOR is a member of the medium chain dehydrogenase/reductase family, but lacks the zinc-binding sites of the prototypical alcohol dehydrogenases of this group. 2-haloacrylate reductase, a member of this subgroup, catalyzes the NADPH-dependent reduction of a carbon-carbon double bond in organohalogen compounds. Although similar to QOR, Burkholderia 2-haloacrylate reductase does not act on the quinones 1,4-benzoquinone and 1,4-naphthoquinone. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which have a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176189 [Multi-domain] Cd Length: 320 Bit Score: 160.30 E-value: 1.11e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1675 VAVGTPGLLESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPAleAEESVLGRECSGRIAAVGEGVSGLRVGD 1754
Cdd:cd05286 3 VRIHKTGGPEVLEYEDVPVPEPGPGEVLVRNTAIGVNFIDTYFRSGLYPL--PLPFVLGVEGAGVVEAVGPGVTGFKVGD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1755 EVL-AVAPGCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGERILIHAAAGGLGLAAVQLASRT 1833
Cdd:cd05286 81 RVAyAGPPGAYAEYRVVPASRLVKLPDGISDETAAALLLQGLTAHYLLRETYPVKPGDTVLVHAAAGGVGLLLTQWAKAL 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1834 GAEILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRF--------- 1904
Cdd:cd05286 161 GATVIGTVSSEEKAELARAAGADHVINYRDEDFVERVREITGGRGVDVVYDGVGKDTFEGSLDSLRPRGTLvsfgnasgp 240
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 53747904 1905 ------LELGKRDLYadqqvglrtLARGQTFaaidfgpHHPDFRAVLEEVATQL----TQGQLEPLPTRLFPARQVAEA 1973
Cdd:cd05286 241 vppfdlLRLSKGSLF---------LTRPSLF-------HYIATREELLARAAELfdavASGKLKVEIGKRYPLADAAQA 303
|
|
| Acyl_transf_1 |
pfam00698 |
Acyl transferase domain; |
535-817 |
1.37e-42 |
|
Acyl transferase domain;
Pssm-ID: 395567 Cd Length: 319 Bit Score: 159.95 E-value: 1.37e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 535 VMLFPGQGTPLVGTARALHESEPTFRQAVEQCARLLRQTLGLDVREVLfpsAEQEEQarrLAAQTRVAQPALFTLEYALA 614
Cdd:pfam00698 1 VFVFSGQGSQWAGMGMQLLKTSPAFAAVIDRADEAFKPQYGFSVSDVL---RNNPEG---TLDGTQFVQPALFAMQIALA 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 615 QTWLGWGLQPQALAGHSLGELVAACLAGVFSLEDALQLVAARGQLM-QGCPPGAMLAVPLPEAELAALLGSELCIAAVNG 693
Cdd:pfam00698 75 ALLQSYGVRPDAVVGHSLGEYAAAVVAGALSPEEALLAAVLRSRLMmQLAGPGGMAAVELSAEEVEQRWPDDVVGAVVNS 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 694 PRACVASGPLPAVEALTAALESRGVSSRRLETSHAFHSASMEACQGPLTTLLRRMRLQAPRLPCVSGLTGRWLTGEEATE 773
Cdd:pfam00698 155 PRSVVISGPQEAVRELVERVSKEGVGALVENVNYAVHSPQMDAIAPALLSALADIAPRTPRVPFISSTSIDPSDQRTLSA 234
|
250 260 270 280
....*....|....*....|....*....|....*....|....*..
gi 53747904 774 pTYWARQLREPVRFSEAletLWSLKEP---VLLEVGPGTTLTALARR 817
Cdd:pfam00698 235 -EYWVRNLRSPVRFAEA---ILSAAEPgplVFIEISPHPLLLAALID 277
|
|
| MDR6 |
cd08272 |
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; ... |
1675-1990 |
5.16e-42 |
|
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; This group is a member of the medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, but lacks the zinc-binding sites of the zinc-dependent alcohol dehydrogenases. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P)-binding Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176233 [Multi-domain] Cd Length: 326 Bit Score: 158.49 E-value: 5.16e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1675 VAVGTPGLLESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGD 1754
Cdd:cd08272 4 LVLESFGGPEVFELREVPRPQPGPGQVLVRVHASGVNPLDTKIRRGGAAARPPLPAILGCDVAGVVEAVGEGVTRFRVGD 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1755 EV------LAVAPGCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGERILIHAAAGGLGLAAVQ 1828
Cdd:cd08272 84 EVygcaggLGGLQGSLAEYAVVDARLLALKPANLSMREAAALPLVGITAWEGLVDRAAVQAGQTVLIHGGAGGVGHVAVQ 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1829 LASRTGAEILATAGSEqKREYLRSLGiAHVLDSRSTSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRF---L 1905
Cdd:cd08272 164 LAKAAGARVYATASSE-KAAFARSLG-ADPIIYYRETVVEYVAEHTGGRGFDVVFDTVGGETLDASFEAVALYGRVvsiL 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1906 ELGKRDLyadqqVGLRtlARGQTF------AAIDFGPHHPDFRAVLEEVATQLTQGQLEP-LPTRLFPARQVAEAFSFMA 1978
Cdd:cd08272 242 GGATHDL-----APLS--FRNATYsgvftlLPLLTGEGRAHHGEILREAARLVERGQLRPlLDPRTFPLEEAAAAHARLE 314
|
330
....*....|..
gi 53747904 1979 RALHIGRVAVSM 1990
Cdd:cd08272 315 SGSARGKIVIDV 326
|
|
| FACL_like_6 |
cd05922 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
2687-3132 |
5.25e-42 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341246 [Multi-domain] Cd Length: 457 Bit Score: 162.61 E-value: 5.25e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2687 PQELVAIAMHKGWEQATAVLGVLQAAAA----YLPLDPEQPPLRLHQLLEEGPARVVLTQSSL------LHTVPWPPGVq 2756
Cdd:cd05922 17 RGERVVLILPNRFTYIELSFAVAYAGGRlglvFVPLNPTLKESVLRYLVADAGGRIVLADAGAadrlrdALPASPDPGT- 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2757 VIAVDELEPA-TEAPPLPPrgTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFD--L 2833
Cdd:cd05922 96 VLDADGIRAArASAPAHEV--SHEDLALLLYTSGSTGSPKLVRLSHQNLLANARSIAEYLGITADDRALTVLPLSYDygL 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2834 SVYDVLGLLGAGGALvlpaAEAEKDPAHWWERLVAGRVTVWNSTPAL--MLLLVEYAEQrglKLPaALRLVMLSGDWIPV 2911
Cdd:cd05922 174 SVLNTHLLRGATLVL----TNDGVLDDAFWEDLREHGATGLAGVPSTyaMLTRLGFDPA---KLP-SLRYLTQAGGRLPQ 245
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2912 ALPDRIRALGRDVQVVSLGGATEASIWSIAYPIGQVAPQWKSIpyGMPLANQRFHVL--DGRLEarPWWVPGELYIGGEG 2989
Cdd:cd05922 246 ETIARLRELLPGAQVYVMYGQTEATRRMTYLPPERILEKPGSI--GLAIPGGEFEILddDGTPT--PPGEPGEIVHRGPN 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2990 LAREYWRDEPltatrFIRHPRTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVA 3069
Cdd:cd05922 322 VMKGYWNDPP-----YRRKEGRGGGVLHTGDLARRDEDGFLFIVGRRDRMIKLFGNRISPTEIEAAARSIGLIIEAAAVG 396
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 53747904 3070 RGEPRGvRRLVAYAVPRSGQTPAAgeLRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd05922 397 LPDPLG-EKLALFVTAPDKIDPKD--VLRSLAERLPPYKVPATVRVVDELPLTASGKVDYAAL 456
|
|
| fabD |
TIGR00128 |
malonyl CoA-acyl carrier protein transacylase; This enzyme of fatty acid biosynthesis ... |
536-817 |
9.72e-42 |
|
malonyl CoA-acyl carrier protein transacylase; This enzyme of fatty acid biosynthesis transfers the malonyl moeity from coenzyme A to acyl-carrier protein. The seed alignment for this family of proteins contains a single member each from a number of bacterial species but also an additional pair of closely related, uncharacterized proteins from B. subtilis, one of which has a long C-terminal extension. [Fatty acid and phospholipid metabolism, Biosynthesis]
Pssm-ID: 272922 [Multi-domain] Cd Length: 290 Bit Score: 156.86 E-value: 9.72e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 536 MLFPGQGTPLVGTARALHESEPTFRQAVEQCArllrQTLGLDVREVLFpsaEQEEQARRLAAQTrvaQPALFTLEYALAQ 615
Cdd:TIGR00128 5 YVFPGQGSQTVGMGKDLYEQYPIAKELFDQAS----EALGYDLKKLCQ---EGPAEELNKTQYT---QPALYVVSAILYL 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 616 TWL-GWGLQPQALAGHSLGELVAACLAGVFSLEDALQLVAARGQLMQGCPP---GAMLAV-PLPEAELAALLG----SEL 686
Cdd:TIGR00128 75 KLKeQGGLKPDFAAGHSLGEYSALVAAGALDFETALKLVKKRGELMQEAVPeggGAMAAViGLDEEQLAQACEeateNDV 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 687 CIAAVNGPRACVASGPLPAVEALTAALESRGVssRR---LETSHAFHSASMEACQGPLTTLLRRMRLQAPRLPCVSGLTG 763
Cdd:TIGR00128 155 DLANFNSPGQVVISGTKDGVEAAAALFKEMGA--KRavpLEVSGAFHSRFMKPAAEKFAETLEACQFNDPTVPVISNVDA 232
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....
gi 53747904 764 RWLTGEEATEPTYwARQLREPVRFSEALETLWSLKEPVLLEVGPGTTLTALARR 817
Cdd:TIGR00128 233 KPYTNGDRIKEKL-SEQLTSPVRWTDSVEKLMARGVTEFAEVGPGKVLTGLIKR 285
|
|
| alpha_am_amid |
TIGR03443 |
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are ... |
2615-3214 |
2.22e-41 |
|
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), product of the LYS2 gene. It is also called alpha-aminoadipate reductase. In fungi, lysine is synthesized via aminoadipate. Currently, all members of this family are fungal.
Pssm-ID: 274582 [Multi-domain] Cd Length: 1389 Bit Score: 169.09 E-value: 2.22e-41
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2615 ELLPPAQRELLarynatqaPRPS---------GRLEEGFFTQARLHP------ELPALLAPE---RTLSYGELARRAQAL 2676
Cdd:TIGR03443 212 SLITPSQKSLL--------PDPTkdldwsgfrGAIHDIFADNAEKHPdrtcvvETPSFLDPSsktRSFTYKQINEASNIL 283
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2677 AARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRlhQLLEEGPAR----VVLTQSSLLHtvpwp 2752
Cdd:TIGR03443 284 AHYLLKTGIKRGDVVMIYAYRGVDLVVAVMGVLKAGATFSVIDPAYPPAR--QTIYLSVAKpralIVIEKAGTLD----- 356
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2753 PGVQVIAVDELEPATEAPPL------------PPRGTPEHLA-YVIY-------------------TSGSTGKPKGVAIE 2800
Cdd:TIGR03443 357 QLVRDYIDKELELRTEIPALalqddgslvggsLEGGETDVLApYQALkdtptgvvvgpdsnptlsfTSGSEGIPKGVLGR 436
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2801 HRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPAL 2880
Cdd:TIGR03443 437 HFSLAYYFPWMAKRFGLSENDKFTMLSGIAHDPIQRDMFTPLFLGAQLLVPTADDIGTPGRLAEWMAKYGATVTHLTPAM 516
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2881 MLLLVEYAEQrglKLPAaLRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEA-------SIWSIAYPIGQVAPQWKS 2953
Cdd:TIGR03443 517 GQLLSAQATT---PIPS-LHHAFFVGDILTKRDCLRLQTLAENVCIVNMYGTTETqravsyfEIPSRSSDSTFLKNLKDV 592
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2954 IPYGMPLANQRFHVLDGRLEARPWWVP--GELYIGGEGLAREYwRDEP-LTATRFIRH---------------------- 3008
Cdd:TIGR03443 593 MPAGKGMKNVQLLVVNRNDRTQTCGVGevGEIYVRAGGLAEGY-LGLPeLNAEKFVNNwfvdpshwidldkennkperef 671
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3009 ---PRtgERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVP 3085
Cdd:TIGR03443 672 wlgPR--DRLYRTGDLGRYLPDGNVECCGRADDQVKIRGFRIELGEIDTHLSQHPLVRENVTLVRRDKDEEPTLVSYIVP 749
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3086 RSGQT----------------PAAGELRRY----------LAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPEPQQTQ 3139
Cdd:TIGR03443 750 QDKSDeleefksevddeessdPVVKGLIKYrklikdireyLKKKLPSYAIPTVIVPLKKLPLNPNGKVDKPALPFPDTAQ 829
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3140 GLAAQAAAADPLVERLAALVKEALR---LE-------RVEPQDSLLDLGADSVALIRLINRLEAELQFRPRLADIYENPT 3209
Cdd:TIGR03443 830 LAAVAKNRSASAADEEFTETEREIRdlwLEllpnrpaTISPDDSFFDLGGHSILATRMIFELRKKLNVELPLGLIFKSPT 909
|
....*
gi 53747904 3210 VQGLA 3214
Cdd:TIGR03443 910 IKGFA 914
|
|
| KR |
pfam08659 |
KR domain; This enzymatic domain is part of bacterial polyketide synthases and catalyzes the ... |
1220-1366 |
1.05e-40 |
|
KR domain; This enzymatic domain is part of bacterial polyketide synthases and catalyzes the first step in the reductive modification of the beta-carbonyl centres in the growing polyketide chain. It uses NADPH to reduce the keto group to a hydroxy group.
Pssm-ID: 430138 [Multi-domain] Cd Length: 180 Bit Score: 149.63 E-value: 1.05e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1220 RRRTQHRIRcllELEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAATFDDGVIQLRTHEQSSRALRTKVR 1299
Cdd:pfam08659 38 RPDAQALIA---ELEARGVEVVVVACDVSDPDAVAALLAEIKAEGPPIRGVIHAAGVLRDALLENMTDEDWRRVLAPKVT 114
|
90 100 110 120 130 140
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 53747904 1300 GSMVLHEVLASEGLDWFALCSSLASALGSFGQADYCAANAFQDAYAHHLRRQGfTGALALDWGTWRD 1366
Cdd:pfam08659 115 GTWNLHEATPDEPLDFFVLFSSIAGLLGSPGQANYAAANAFLDALAEYRRSQG-LPATSINWGPWAE 180
|
|
| PTZ00050 |
PTZ00050 |
3-oxoacyl-acyl carrier protein synthase; Provisional |
27-435 |
1.21e-39 |
|
3-oxoacyl-acyl carrier protein synthase; Provisional
Pssm-ID: 240245 [Multi-domain] Cd Length: 421 Bit Score: 154.47 E-value: 1.21e-39
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 27 DVESFWRNLVAGVESISFFSEEELRQAGVSEQIRRRPEYVPAK----GVLEDLELFDAGFFGYSPREashlDPQQRLLLE 102
Cdd:PTZ00050 8 GAESTWEALIAGKSGIRKLTEFPKFLPDCIPEQKALENLVAAMpcqiAAEVDQSEFDPSDFAPTKRE----SRATHFAMA 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 103 CSWEALEDAGLRP--DQLPGWVGVYVGAGDTSYRFQL-------LRGHgdplsgsKDVAGFFgnYPDFLATR----VAYK 169
Cdd:PTZ00050 84 AAREALADAKLDIlsEKDQERIGVNIGSGIGSLADLTdemktlyEKGH-------SRVSPYF--IPKILGNMaaglVAIK 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 170 LNLRGPALGIHTACSTSLVSINMACSALRGFECDMALAGGV-----------SLRLPARSGYLYEEGGVASkdghcRPFD 238
Cdd:PTZ00050 155 HKLKGPSGSAVTACATGAHCIGEAFRWIKYGEADIMICGGTeasitpvsfagFSRMRALCTKYNDDPQRAS-----RPFD 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 239 ARATGTVTGDGVGVVVLKRLEDALKARDPIHAVIRGWalnndGASRAGF--TAPSVEGQSEVIALAHA---AAGISARDI 313
Cdd:PTZ00050 230 KDRAGFVMGEGAGILVLEELEHALRRGAKIYAEIRGY-----GSSSDAHhiTAPHPDGRGARRCMENAlkdGANININDV 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 314 TYVEAHGTGTPLGDPIEVAALTRAFRAHTADTafCTLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERPNPA 393
Cdd:PTZ00050 305 DYVNAHATSTPIGDKIELKAIKKVFGDSGAPK--LYVSSTKGGLGHLLGAAGAVESIVTILSLYEQIIPPTINLENPDAE 382
|
410 420 430 440
....*....|....*....|....*....|....*....|..
gi 53747904 394 LHLEQSPffvNTQPLPwesPRGPRLAGVSSFGIGGTNAHTLF 435
Cdd:PTZ00050 383 CDLNLVQ---GKTAHP---LQSIDAVLSTSFGFGGVNTALLF 418
|
|
| BCL_4HBCL |
cd05959 |
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate ... |
2644-3132 |
1.47e-39 |
|
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate CoA ligase and 4-hydroxybenzoate-coenzyme A ligase catalyze the first activating step for benzoate and 4-hydroxybenzoate catabolic pathways, respectively. Although these two enzymes share very high sequence homology, they have their own substrate preference. The reaction proceeds via a two-step process; the first ATP-dependent step forms the substrate-AMP intermediate, while the second step forms the acyl-CoA ester, releasing the AMP. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Some bacteria can use benzoic acid or benzenoid compounds as the sole source of carbon and energy through degradation. Benzoate CoA ligase and 4-hydroxybenzoate-Coenzyme A ligase are key enzymes of this process.
Pssm-ID: 341269 [Multi-domain] Cd Length: 508 Bit Score: 156.37 E-value: 1.47e-39
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2644 FFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQP 2723
Cdd:cd05959 10 DLNLNEGRGDKTAFIDDAGSLTYAELEAEARRVAGALRALGVKREERVLLIMLDTVDFPTAFLGAIRAGIVPVPVNTLLT 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2724 PLRLHQLLEEGPARVVLTQSSLLHTV------PWPPGVQVIAVD-----------ELEPATEAPPLPPRGT-PEHLAYVI 2785
Cdd:cd05959 90 PDDYAYYLEDSRARVVVVSGELAPVLaaaltkSEHTLVVLIVSGgagpeagalllAELVAAEAEQLKPAAThADDPAFWL 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2786 YTSGSTGKPKGVAIEHrAALNTVVDLNTR--FGVGPEDRVL---------GL-SALTFDLSVydvlgLLGAGGALVLPAa 2853
Cdd:cd05959 170 YSSGSTGRPKGVVHLH-ADIYWTAELYARnvLGIREDDVCFsaaklffayGLgNSLTFPLSV-----GATTVLMPERPT- 242
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2854 eaekdPAHWWERLVAGRVTVWNSTPALM--LLLVEYAEQRGLKlpaALRLVMLSGDWIPVALPDRIRALgRDVQVVSLGG 2931
Cdd:cd05959 243 -----PAAVFKRIRRYRPTVFFGVPTLYaaMLAAPNLPSRDLS---SLRLCVSAGEALPAEVGERWKAR-FGLDILDGIG 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2932 ATEA-SIWSIAYPiGQVAPQWKSIP---YGMPLANQRFH-VLDGrlearpwwVPGELYIGGEGLAREYWRDEPLTATRFI 3006
Cdd:cd05959 314 STEMlHIFLSNRP-GRVRYGTTGKPvpgYEVELRDEDGGdVADG--------EPGELYVRGPSSATMYWNNRDKTRDTFQ 384
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3007 rhprtGErLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPR 3086
Cdd:cd05959 385 -----GE-WTRTGDKYVRDDDGFYTYAGRADDMLKVSGIWVSPFEVESALVQHPAVLEAAVVGVEDEDGLTKPKAFVVLR 458
|
490 500 510 520
....*....|....*....|....*....|....*....|....*....
gi 53747904 3087 SGQTP---AAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd05959 459 PGYEDseaLEEELKEFVKDRLAPYKYPRWIVFVDELPKTATGKIQRFKL 507
|
|
| MDR |
cd05188 |
Medium chain reductase/dehydrogenase (MDR)/zinc-dependent alcohol dehydrogenase-like family; ... |
1700-1948 |
1.09e-38 |
|
Medium chain reductase/dehydrogenase (MDR)/zinc-dependent alcohol dehydrogenase-like family; The medium chain reductase/dehydrogenases (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P) binding-Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH) , quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines. Other MDR members have only a catalytic zinc, and some contain no coordinated zinc.
Pssm-ID: 176178 [Multi-domain] Cd Length: 271 Bit Score: 147.08 E-value: 1.09e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1700 QVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGDEVLA--------------------- 1758
Cdd:cd05188 1 EVLVRVEAAGLCGTDLHIRRGGYPPPPKLPLILGHEGAGVVVEVGPGVTGVKVGDRVVVlpnlgcgtcelcrelcpgggi 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1759 ---VAPGCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGERILIHaaagglglaaVQLASRTGA 1835
Cdd:cd05188 81 lgeGLDGGFAEYVVVPADNLVPLPDGLSLEEAALLPEPLATAYHALRRAGVLKPGDTVLVLgaggv-gllaAQLAKAAGA 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1836 EILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRErTGGRGVDVVLNSL-AGELLLAGLSVLAPHGRFLELGKRDLYA 1914
Cdd:cd05188 160 RVIVTDRSDEKLELAKELGADHVIDYKEEDLEEELRL-TGGGGADVVIDAVgGPETLAQALRLLRPGGRIVVVGGTSGGP 238
|
250 260 270
....*....|....*....|....*....|....
gi 53747904 1915 DQQVGLRTLARGQTFAAIDFGPHHpDFRAVLEEV 1948
Cdd:cd05188 239 PLDDLRRLLFKELTIIGSTGGTRE-DFEEALDLL 271
|
|
| Zn_ADH_like1 |
cd08266 |
Alcohol dehydrogenases of the MDR family; This group contains proteins related to the ... |
1693-1988 |
3.01e-38 |
|
Alcohol dehydrogenases of the MDR family; This group contains proteins related to the zinc-dependent alcohol dehydrogenases. However, while the group has structural zinc site characteristic of these enzymes, it lacks the consensus site for a catalytic zinc. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site, and a structural zinc in a lobe of the catalytic domain. NAD(H)-binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176227 [Multi-domain] Cd Length: 342 Bit Score: 148.17 E-value: 3.01e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1693 RPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGDEVlAVAPG---------- 1762
Cdd:cd08266 22 EPEPGPDEVLVRVKAAALNHLDLWVRRGMPGIKLPLPHILGSDGAGVVEAVGPGVTNVKPGQRV-VIYPGiscgrceycl 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1763 ------CFRS-------------YVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGERILIHAAAGGLG 1823
Cdd:cd08266 101 agrenlCAQYgilgehvdggyaeYVAVPARNLLPIPDNLSFEEAAAAPLTFLTAWHMLVTRARLRPGETVLVHGAGSGVG 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1824 LAAVQLASRTGAEILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGR 1903
Cdd:cd08266 181 SAAIQIAKLFGATVIATAGSEDKLERAKELGADYVIDYRKEDFVREVRELTGKRGVDVVVEHVGAATWEKSLKSLARGGR 260
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1904 FLELGKRDLYaDQQVGLRTLARGQTFAAIDFGPHHPDFRAVLEEVAtqltQGQLEPLPTRLFPARQVAEAFSFMARALHI 1983
Cdd:cd08266 261 LVTCGATTGY-EAPIDLRHVFWRQLSILGSTMGTKAELDEALRLVF----RGKLKPVIDSVFPLEEAAEAHRRLESREQF 335
|
....*
gi 53747904 1984 GRVAV 1988
Cdd:cd08266 336 GKIVL 340
|
|
| A_NRPS_acs4 |
cd17654 |
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal ... |
2689-3132 |
1.11e-37 |
|
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains acyl-CoA synthethase family member 4, also known as 2-aminoadipic 6-semialdehyde dehydrogenase or aminoadipate-semialdehyde dehydrogenase, most of which are uncharacterized. Acyl-CoA synthetase catalyzes the initial reaction in fatty acid metabolism, by forming a thioester with CoA. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341309 [Multi-domain] Cd Length: 449 Bit Score: 149.54 E-value: 1.11e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2689 ELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLR-LHQLLEEGPARVVltQSSLLHTVPwppgvqviavDELEPAT 2767
Cdd:cd17654 42 RAIGLRCDRGTESPVAILAILFLGAAYAPIDPASPEQRsLTVMKKCHVSYLL--QNKELDNAP----------LSFTPEH 109
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2768 EAPPLPprgTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGA 2847
Cdd:cd17654 110 RHFNIR---TDECLAYVIHTSGTTGTPKIVAVPHKCILPNIQHFRSLFNITSEDILFLTSPLTFDPSVVEIFLSLSSGAT 186
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2848 LVLPAAEAEKDPAHWWERLVAG-RVTVWNSTPALM-LLLVEYAEQRGLKLPAALRLVMLSGDWIPVALPDRIRA-LGRDV 2924
Cdd:cd17654 187 LLIVPTSVKVLPSKLADILFKRhRITVLQATPTLFrRFGSQSIKSTVLSATSSLRVLALGGEPFPSLVILSSWRgKGNRT 266
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2925 QVVSLGGATEASIWSIAYpigQVAPQWKSIPYGMPLANQRFHVLDGRLEArpwwVPGELYIGgeGLAREYWRDEPLTatr 3004
Cdd:cd17654 267 RIFNIYGITEVSCWALAY---KVPEEDSPVQLGSPLLGTVIEVRDQNGSE----GTGQVFLG--GLNRVCILDDEVT--- 334
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3005 firhpRTGERLYRTGDQGRmLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEprgvRRLVAYAV 3084
Cdd:cd17654 335 -----VPKGTMRATGDFVT-VKDGELFFLGRKDSQIKRRGKRINLDLIQQVIESCLGVESCAVTLSDQ----QRLIAFIV 404
|
410 420 430 440
....*....|....*....|....*....|....*....|....*...
gi 53747904 3085 PRSGQTPAAGELRRYLaerLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd17654 405 GESSSSRIHKELQLTL---LSSHAIPDTFVQIDKLPLTSHGKVDKSEL 449
|
|
| fabF |
TIGR03150 |
beta-ketoacyl-acyl-carrier-protein synthase II; 3-oxoacyl-[acyl-carrier-protein] synthase 2 ... |
27-435 |
1.26e-37 |
|
beta-ketoacyl-acyl-carrier-protein synthase II; 3-oxoacyl-[acyl-carrier-protein] synthase 2 (KAS-II, FabF) is involved in the condensation step of fatty acid biosynthesis in which the malonyl donor group is decarboxylated and the resulting carbanion used to attack and extend the acyl group attached to the acyl carrier protein. Most genomes encoding fatty acid biosynthesis contain a number of condensing enzymes, often of all three types: 1, 2 and 3. Synthase 2 is mechanistically related to synthase 1 (KAS-I, FabB) containing a number of absolutely conserved catalytic residues in common. This model is based primarily on genes which are found in apparent operons with other essential genes of fatty acid biosynthesis (GenProp0681). The large gap between the trusted cutoff and the noise cutoff contains many genes which are not found adjacent to genes of the fatty acid pathway in genomes that often also contain a better hit to this model. These genes may be involved in other processes such as polyketide biosyntheses. Some genomes contain more than one above-trusted hit to this model which may result from recent paralogous expansions. Second hits to this model which are not next to other fatty acid biosynthesis genes may be involved in other processes. FabB sequences should fall well below the noise cutoff of this model. [Fatty acid and phospholipid metabolism, Biosynthesis]
Pssm-ID: 274452 [Multi-domain] Cd Length: 407 Bit Score: 148.40 E-value: 1.26e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 27 DVESFWRNLVA---GVESISFFSEEELrqagvseqirrrpeyvPAK--GVLEDlelFDAGFFgYSPREASHLDPQQRLLL 101
Cdd:TIGR03150 17 GVEEFWENLLAgksGIGPITRFDASDL----------------PVKiaGEVKD---FDPEDY-IDKKEARRMDRFIQYAL 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 102 ECSWEALEDAGLRPDQLPGW-VGVYVGAG--------DTSYRFQLlrghgdplSGSKDVAGFF--GNYPDFLATRVAYKL 170
Cdd:TIGR03150 77 AAAKEAVEDSGLDIEEEDAErVGVIIGSGiggletieEQHIVLLE--------KGPRRVSPFFipMSIINMAAGQISIRY 148
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 171 NLRGPALGIHTACSTSLVSINMACSALRGFECDMALAGGV-------------SLR-LPARSgylyEEGGVASkdghcRP 236
Cdd:TIGR03150 149 GAKGPNHAVVTACATGTHAIGDAFRLIQRGDADVMIAGGAeaaitplgiagfaAMKaLSTRN----DDPEKAS-----RP 219
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 237 FDARATGTVTGDGVGVVVLKRLEDALK--ARdpIHAVIRGWALNNDgasrAG-FTAPSVEG--QSEVIALAHAAAGISAR 311
Cdd:TIGR03150 220 FDKDRDGFVMGEGAGVLVLEELEHAKArgAK--IYAEIVGYGMSGD----AYhITAPAPEGegAARAMRAALKDAGINPE 293
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 312 DITYVEAHGTGTPLGDPIEVAALTRAFRAHTADTAfctLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERPN 391
Cdd:TIGR03150 294 DVDYINAHGTSTPLGDKAETKAIKKVFGDHAYKLA---VSSTKSMTGHLLGAAGAIEAIFTVLAIRDGIVPPTINLDNPD 370
|
410 420 430 440
....*....|....*....|....*....|....*....|....*
gi 53747904 392 PALHLEqspfFVntqplPWES-PRGPRLAGVSSFGIGGTNAHTLF 435
Cdd:TIGR03150 371 PECDLD----YV-----PNEArEAKIDYALSNSFGFGGTNASLVF 406
|
|
| FC-FACS_FadD_like |
cd05936 |
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This ... |
2647-3132 |
2.70e-37 |
|
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This subfamily of the AMP-forming adenylation family contains Escherichia coli FadD and similar prokaryotic fatty acid CoA synthetases. FadD was characterized as a long-chain fatty acid CoA synthetase. The gene fadD is regulated by the fatty acid regulatory protein FadR. Fatty acid CoA synthetase catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341259 [Multi-domain] Cd Length: 468 Bit Score: 148.87 E-value: 2.70e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2647 QARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLR 2726
Cdd:cd05936 8 AARRFPDKTALIFMGRKLTYRELDALAEAFAAGLQNLGVQPGDRVALMLPNCPQFPIAYFGALKAGAVVVPLNPLYTPRE 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2727 LHQLLEEGPARVVLTQSSLLHtvpwppgvqVIAvdelepATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALN 2806
Cdd:cd05936 88 LEHILNDSGAKALIVAVSFTD---------LLA------AGAPLGERVALTPEDVAVLQYTSGTTGVPKGAMLTHRNLVA 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2807 TVVDLNTRFGVG--PEDRVLGlsAL----TFDLSVydvlgllgagGALVLPAAEAEK------DPAHWWERLVAGRVTVW 2874
Cdd:cd05936 153 NALQIKAWLEDLleGDDVVLA--ALplfhVFGLTV----------ALLLPLALGATIvliprfRPIGVLKEIRKHRVTIF 220
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2875 NSTPALMLLLVEYAEQRGLkLPAALRLVMLSGDWIPVALPDRIRALGRdVQVVSLGGATEASiwsiayPIGQVAPQWK-- 2952
Cdd:cd05936 221 PGVPTMYIALLNAPEFKKR-DFSSLRLCISGGAPLPVEVAERFEELTG-VPIVEGYGLTETS------PVVAVNPLDGpr 292
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2953 ---SIpyGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFirhprTGERLyRTGDQGRMLPEGS 3029
Cdd:cd05936 293 kpgSI--GIPLPGTEVKIVDDDGEELPPGEVGELWVRGPQVMKGYWNRPEETAEAF-----VDGWL-RTGDIGYMDEDGY 364
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3030 IEFLGR-EDLqVKVQGFRVELGEIEAALAQHPALSASVVVarGEPRGVR--RLVAYAVPRSGQTPAAGELRRYLAERLPA 3106
Cdd:cd05936 365 FFIVDRkKDM-IIVGGFNVYPREVEEVLYEHPAVAEAAVV--GVPDPYSgeAVKAFVVLKEGASLTEEEIIAFCREQLAG 441
|
490 500
....*....|....*....|....*.
gi 53747904 3107 YMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd05936 442 YKVPRQVEFRDELPKSAVGKILRREL 467
|
|
| cond_enzymes |
cd00327 |
Condensing enzymes; Family of enzymes that catalyze a (decarboxylating or non-decarboxylating) ... |
96-432 |
7.23e-37 |
|
Condensing enzymes; Family of enzymes that catalyze a (decarboxylating or non-decarboxylating) Claisen-like condensation reaction. Members are share strong structural similarity, and are involved in the synthesis and degradation of fatty acids, and the production of polyketides, a diverse group of natural products.
Pssm-ID: 238201 [Multi-domain] Cd Length: 254 Bit Score: 141.43 E-value: 7.23e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 96 QQRLLLECSWEALEDAGLRPDQLpgwVGVYVGAGDTSYRFQllrghgdplsgskdvagffgnypdFLATRVAYKLNLR-G 174
Cdd:cd00327 7 ASELGFEAAEQAIADAGLSKGPI---VGVIVGTTGGSGEFS------------------------GAAGQLAYHLGISgG 59
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 175 PALGIHTACSTSLVSINMACSALRGFECDMALAGGVSLRLPArsgylyeEGGVAskdghcrpfdaratgtvtgdgvgvVV 254
Cdd:cd00327 60 PAYSVNQACATGLTALALAVQQVQNGKADIVLAGGSEEFVFG-------DGAAA------------------------AV 108
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 255 LKRLEDALKARDPIHAVIRGWALNNDGASRAgfTAPSVEGQSEVIALAHAAAGISARDITYVEAHGTGTPLGDPIEVAAL 334
Cdd:cd00327 109 VESEEHALRRGAHPQAEIVSTAATFDGASMV--PAVSGEGLARAARKALEGAGLTPSDIDYVEAHGTGTPIGDAVELALG 186
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 335 TRAFRAHTAdtafcTLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTlhferpnpalhleqspffvntqplpwesPR 414
Cdd:cd00327 187 LDPDGVRSP-----AVSATLIMTGHPLGAAGLAILDELLLMLEHEFIPPT----------------------------PR 233
|
330
....*....|....*...
gi 53747904 415 GPRLAGVSSFGIGGTNAH 432
Cdd:cd00327 234 EPRTVLLLGFGLGGTNAA 251
|
|
| A_NRPS_alphaAR |
cd17647 |
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as ... |
2659-3135 |
7.96e-37 |
|
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as alpha-aminoadipate reductase (EC 1.2.1.95) or alpha-AR or L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), which catalyzes the activation of alpha-aminoadipate by ATP-dependent adenylation and the reduction of activated alpha-aminoadipate by NADPH. The activated alpha-aminoadipate is bound to the phosphopantheinyl group of the enzyme itself before it is reduced to (S)-2-amino-6-oxohexanoate.
Pssm-ID: 341302 [Multi-domain] Cd Length: 520 Bit Score: 148.43 E-value: 7.96e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2659 APERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRlhQLLEEGPARv 2738
Cdd:cd17647 16 SKTRSFTYRDINEASNIVAHYLIKTGIKRGDVVMIYSYRGVDLMVAVMGVLKAGATFSVIDPAYPPAR--QNIYLGVAK- 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2739 vltqssllhtvpwPPGVQVIAVDELepateapPLPPRGTPEhlayVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVG 2818
Cdd:cd17647 93 -------------PRGLIVIRAAGV-------VVGPDSNPT----LSFTSGSEGIPKGVLGRHFSLAYYFPWMAKRFNLS 148
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2819 PEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPAA 2898
Cdd:cd17647 149 ENDKFTMLSGIAHDPIQRDMFTPLFLGAQLLVPTQDDIGTPGRLAEWMAKYGATVTHLTPAMGQLLTAQATTPFPKLHHA 228
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2899 LrlvmLSGDWIPVALPDRIRALGRDVQVVSLGGATEASiWSIAY---PIGQVAPQW----KS-IPYGMPLANQRFHVLDG 2970
Cdd:cd17647 229 F----FVGDILTKRDCLRLQTLAENVRIVNMYGTTETQ-RAVSYfevPSRSSDPTFlknlKDvMPAGRGMLNVQLLVVNR 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2971 RLEARPWWVP--GELYIGGEGLAREYWRDEPLTATRFIRH-------------------------PRtgERLYRTGDQGR 3023
Cdd:cd17647 304 NDRTQICGIGevGEIYVRAGGLAEGYRGLPELNKEKFVNNwfvepdhwnyldkdnnepwrqfwlgPR--DRLYRTGDLGR 381
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3024 MLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPR----------------- 3086
Cdd:cd17647 382 YLPNGDCECCGRADDQVKIRGFRIELGEIDTHISQHPLVRENITLVRRDKDEEPTLVSYIVPRfdkpddesfaqedvpke 461
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*....
gi 53747904 3087 SGQTPAAGELRRY----------LAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPEP 3135
Cdd:cd17647 462 VSTDPIVKGLIGYrklikdirefLKKRLASYAIPSLIVVLDKLPLNPNGKVDKPKLQFP 520
|
|
| KR_FAS_SDR_x |
cd05274 |
ketoreductase (KR) and fatty acid synthase (FAS), complex (x) SDRs; Ketoreductase, a module of ... |
1021-1381 |
2.59e-36 |
|
ketoreductase (KR) and fatty acid synthase (FAS), complex (x) SDRs; Ketoreductase, a module of the multidomain polyketide synthase (PKS), has 2 subdomains, each corresponding to a SDR family monomer. The C-terminal subdomain catalyzes the NADPH-dependent reduction of the beta-carbonyl of a polyketide to a hydroxyl group, a step in the biosynthesis of polyketides, such as erythromycin. The N-terminal subdomain, an interdomain linker, is a truncated Rossmann fold which acts to stabilizes the catalytic subdomain. Unlike typical SDRs, the isolated domain does not oligomerize but is composed of 2 subdomains, each resembling an SDR monomer. The active site resembles that of typical SDRs, except that the usual positions of the catalytic Asn and Tyr are swapped, so that the canonical YXXXK motif changes to YXXXN. Modular PKSs are multifunctional structures in which the makeup recapitulates that found in (and may have evolved from) FAS. In some instances, such as porcine FAS, an enoyl reductase (ER) module is inserted between the sub-domains. Fatty acid synthesis occurs via the stepwise elongation of a chain (which is attached to acyl carrier protein, ACP) with 2-carbon units. Eukaryotic systems consist of large, multifunctional synthases (type I) while bacterial, type II systems, use single function proteins. Fungal fatty acid synthase uses a dodecamer of 6 alpha and 6 beta subunits. In mammalian type FAS cycles, ketoacyl synthase forms acetoacetyl-ACP which is reduced by the NADP-dependent beta-KR, forming beta-hydroxyacyl-ACP, which is in turn dehydrated by dehydratase to a beta-enoyl intermediate, which is reduced by NADP-dependent beta-ER. Polyketide synthesis also proceeds via the addition of 2-carbon units as in fatty acid synthesis. The complex SDR NADP-binding motif, GGXGXXG, is often present, but is not strictly conserved in each instance of the module. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold (alpha/beta folding pattern with a central beta-sheet), an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Classical SDRs are typically about 250 residues long, while extended SDRs are approximately 350 residues. Sequence identity between different SDR enzymes are typically in the 15-30% range, but the enzymes share the Rossmann fold NAD-binding motif and characteristic NAD-binding and catalytic sequence patterns. These enzymes catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human prostaglandin dehydrogenase (PGDH) numbering). In addition to the Tyr and Lys, there is often an upstream Ser (Ser-138, PGDH numbering) and/or an Asn (Asn-107, PGDH numbering) contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Extended SDRs have additional elements in the C-terminal region, and typically have a TGXXGXXG cofactor binding motif. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type KRs have a TGXXXGX(1-2)G NAD(P)-binding motif. Some atypical SDRs have lost catalytic activity and/or have an unusual NAD(P)-binding motif and missing or unusual active site residues. Reactions catalyzed within the SDR family include isomerization, decarboxylation, epimerization, C=N bond reduction, dehydratase activity, dehalogenation, Enoyl-CoA reduction, and carbonyl-alcohol oxidoreduction.
Pssm-ID: 187582 [Multi-domain] Cd Length: 375 Bit Score: 143.68 E-value: 2.59e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1021 CTPDGEAVLEQGFFSLLRLARALGRHAPERPVQLEVLSSFVHAVGPREPLEPLKATLLGACAVLPLEYPHVQCRTIDVRP 1100
Cdd:cd05274 18 APACGAADAVLALAALLALVAALLAAYASTGPPLWLVTRGAEAVSADDVAALAQAALWGLLRVLALEHPELWGGLVDLDA 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1101 GSEPREVlvRSLAAELAAPMGESPVAWRDGQRYVRRATRQRLEASR-PLRSLRERGVYLVAGGLGGIGLVLAralaqrar 1179
Cdd:cd05274 98 ADAADEA--AALAALLAGAPGEDELALRGGQRLVPRLVRAPAAALElAAAPGGLDGTYLITGGLGGLGLLVA-------- 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1180 arlallthspfppreqweQWLEEAPAhpepawRSEADPSERRRTQHRIRCLLELEQLGAEVQVYTADVAEEAAVRSVVEQ 1259
Cdd:cd05274 168 ------------------RWLAARGA------RHLVLLSRRGPAPRAAARAALLRAGGARVSVVRCDVTDPAALAALLAE 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1260 vHARWGKIHGVLHAAATFDDGVIQLRTHEQSSRALRTKVRGSMVLHEVLASEGLDWFALCSSLASALGSFGQADYCAANA 1339
Cdd:cd05274 224 -LAAGGPLAGVIHAAGVLRDALLAELTPAAFAAVLAAKVAGALNLHELTPDLPLDFFVLFSSVAALLGGAGQAAYAAANA 302
|
330 340 350 360
....*....|....*....|....*....|....*....|....
gi 53747904 1340 FQDAYAHHLRRQGFTgALALDWGTWRDTGAAMR--LVARTRRGG 1381
Cdd:cd05274 303 FLDALAAQRRRRGLP-ATSVQWGAWAGGGMAAAaaLRARLARSG 345
|
|
| MDR1 |
cd08267 |
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; ... |
1693-1974 |
4.06e-36 |
|
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; This group is a member of the medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, but lacks the zinc-binding sites of the zinc-dependent alcohol dehydrogenases. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P)-binding Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176228 [Multi-domain] Cd Length: 319 Bit Score: 141.20 E-value: 4.06e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1693 RPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEES--VLGRECSGRIAAVGEGVSGLRVGDEVLAVAP----GCFRS 1766
Cdd:cd08267 21 IPTPKPGEVLVKVHAASVNPVDWKLRRGPPKLLLGRPFppIPGMDFAGEVVAVGSGVTRFKVGDEVFGRLPpkggGALAE 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1767 YVLVDESQVVRRPASLGLAEGAAqmVPFA--TAYFALHTVGRLRRGERILI--------HAaagglglaAVQLASRTGAE 1836
Cdd:cd08267 101 YVVAPESGLAKKPEGVSFEEAAA--LPVAglTALQALRDAGKVKPGQRVLIngasggvgTF--------AVQIAKALGAH 170
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1837 ILATAgSEQKREYLRSLGIAHVLDSRSTSFVSevrERTGGRGVDVVLN--SLAGELLLAGLSVLAPHGRFLELG---KRD 1911
Cdd:cd08267 171 VTGVC-STRNAELVRSLGADEVIDYTTEDFVA---LTAGGEKYDVIFDavGNSPFSLYRASLALKPGGRYVSVGggpSGL 246
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 53747904 1912 LYADQQVGLRTLARGQTFAAIDFGPHHPDfravLEEVATQLTQGQLEPLPTRLFPARQVAEAF 1974
Cdd:cd08267 247 LLVLLLLPLTLGGGGRRLKFFLAKPNAED----LEQLAELVEEGKLKPVIDSVYPLEDAPEAY 305
|
|
| MDR7 |
cd08276 |
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; ... |
1683-1990 |
4.37e-36 |
|
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; This group is a member of the medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, but lacks the zinc-binding sites of the zinc-dependent alcohol dehydrogenases. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P)-binding Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176237 [Multi-domain] Cd Length: 336 Bit Score: 141.90 E-value: 4.37e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1683 LESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGDEVLA---- 1758
Cdd:cd08276 12 LDNLKLVEEPVPEPGPGEVLVRVHAVSLNYRDLLILNGRYPPPVKDPLIPLSDGAGEVVAVGEGVTRFKVGDRVVPtffp 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1759 ------------------VAPGCFRSYVLVDESQVVRRPASLGLAEGAAqmVPFA--TAYFALHTVGRLRRGERILIHaa 1818
Cdd:cd08276 92 nwldgpptaedeasalggPIDGVLAEYVVLPEEGLVRAPDHLSFEEAAT--LPCAglTAWNALFGLGPLKPGDTVLVQgt 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1819 agglglaAVQLASRTGAEILATAGSEQKREYLRSLGIAHVLDSRSTS-FVSEVRERTGGRGVDVVLNSLAGELLLAGLSV 1897
Cdd:cd08276 170 gg-vslfALQFAKAAGARVIATSSSDEKLERAKALGADHVINYRTTPdWGEEVLKLTGGRGVDHVVEVGGPGTLAQSIKA 248
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1898 LAPHGR-----FLElgkrdlYADQQVGL-RTLARGQTFAAIDFGPhhpdfRAVLEEVATQLTQGQLEPLPTRLFPARQVA 1971
Cdd:cd08276 249 VAPGGVisligFLS------GFEAPVLLlPLLTKGATLRGIAVGS-----RAQFEAMNRAIEAHRIRPVIDRVFPFEEAK 317
|
330
....*....|....*....
gi 53747904 1972 EAFSFMARALHIGRVAVSM 1990
Cdd:cd08276 318 EAYRYLESGSHFGKVVIRV 336
|
|
| BCL_like |
cd05919 |
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate ... |
2655-3132 |
4.77e-36 |
|
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate CoA ligase (BCL) and related ligases that catalyze the acylation of benzoate derivatives, 2-aminobenzoate and 4-hydroxybenzoate. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Xenobiotic aromatic compounds are also a major class of man-made pollutants. Some bacteria use benzoate as the sole source of carbon and energy through benzoate degradation. Benzoate degradation starts with its activation to benzoyl-CoA by benzoate CoA ligase. The reaction catalyzed by benzoate CoA ligase proceeds via a two-step process; the first ATP-dependent step forms an acyl-AMP intermediate, and the second step forms the acyl-CoA ester with release of the AMP.
Pssm-ID: 341243 [Multi-domain] Cd Length: 436 Bit Score: 144.53 E-value: 4.77e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2655 PALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEG 2734
Cdd:cd05919 2 TAFYAADRSVTYGQLHDGANRLGSALRNLGVSSGDRVLLLMLDSPELVQLFLGCLARGAIAVVINPLLHPDDYAYIARDC 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2735 PARVVLTQSsllhtvpwppgvqviavdelepateapplpprgtpEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTR 2814
Cdd:cd05919 82 EARLVVTSA-----------------------------------DDIAYLLYSSGTTGPPKGVMHAHRDPLLFADAMARE 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2815 -FGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAeKDPAHWWERLVAGRVTVWNSTPALM--LLLVEYAEQR 2891
Cdd:cd05919 127 aLGLTPGDRVFSSAKMFFGYGLGNSLWFPLAVGASAVLNPGW-PTAERVLATLARFRPTVLYGVPTFYanLLDSCAGSPD 205
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2892 GLKlpaALRLVMLSGDWIPVALPDRIRALGrDVQVVSLGGATEASIWSIAYPIGQvapqWKSIPYGMPLANQRFHVLDGR 2971
Cdd:cd05919 206 ALR---SLRLCVSAGEALPRGLGERWMEHF-GGPILDGIGATEVGHIFLSNRPGA----WRLGSTGRPVPGYEIRLVDEE 277
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2972 LEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIrhprtgERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGE 3051
Cdd:cd05919 278 GHTIPPGEEGDLLVRGPSAAVGYWNNPEKSRATFN------GGWYRTGDKFCRDADGWYTHAGRADDMLKVGGQWVSPVE 351
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3052 IEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPA---AGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIA 3128
Cdd:cd05919 352 VESLIIQHPAVAEAAVVAVPESTGLSRLTAFVVLKSPAAPQeslARDIHRHLLERLSAHKVPRRIAFVDELPRTATGKLQ 431
|
....
gi 53747904 3129 RDQL 3132
Cdd:cd05919 432 RFKL 435
|
|
| FACL_FadD13-like |
cd17631 |
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, ... |
2648-3129 |
6.84e-36 |
|
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, including Mycobacterium tuberculosis acid-induced operon MymA encoding the fatty acyl-CoA synthetase FadD13 which is essential for virulence and intracellular growth of the pathogen. The fatty acyl-CoA synthetase activates lipids before entering into the metabolic pathways and is also involved in transmembrane lipid transport. However, unlike soluble fatty acyl-CoA synthetases, but like the mammalian integral-membrane very-long-chain acyl-CoA synthetases, FadD13 accepts lipid substrates up to the maximum length of C26, and this is facilitated by an extensive hydrophobic tunnel from the active site to a positively charged patch. Also included is feruloyl-CoA synthetase (Fcs) in Rhodococcus strains where it is involved in biotechnological vanillin production from eugenol and ferulic acid via a non-beta-oxidative pathway.
Pssm-ID: 341286 [Multi-domain] Cd Length: 435 Bit Score: 143.90 E-value: 6.84e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRL 2727
Cdd:cd17631 5 ARRHPDRTALVFGGRSLTYAELDERVNRLAHALRALGVAKGDRVAVLSKNSPEFLELLFAAARLGAVFVPLNFRLTPPEV 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2728 HQLLEEGPARVVLtqssllhtvpwppgvqviavdelepateapplpprgtpEHLAYVIYTSGSTGKPKGVAIEHRAALNT 2807
Cdd:cd17631 85 AYILADSGAKVLF--------------------------------------DDLALLMYTSGTTGRPKGAMLTHRNLLWN 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2808 VVDLNTRFGVGPEDRVLGLSAL--TFDLSVYDVLGLLGAGGALVLPAAeaekDPAHWWERLVAGRVTVWNSTPALMLLLV 2885
Cdd:cd17631 127 AVNALAALDLGPDDVLLVVAPLfhIGGLGVFTLPTLLRGGTVVILRKF----DPETVLDLIERHRVTSFFLVPTMIQALL 202
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2886 EYAEQRGLKLPAaLRLVMLSGDWIPVALPDRIRAlgRDVQVVSLGGATEAS-IWSIAYPIGQVApqwKSIPYGMPLANQR 2964
Cdd:cd17631 203 QHPRFATTDLSS-LRAVIYGGAPMPERLLRALQA--RGVKFVQGYGMTETSpGVTFLSPEDHRR---KLGSAGRPVFFVE 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2965 FHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFirhpRTGerLYRTGDQGRMLPEGSIEFLGREDLQVKVQG 3044
Cdd:cd17631 277 VRIVDPDGREVPPGEVGEIVVRGPHVMAGYWNRPEATAAAF----RDG--WFHTGDLGRLDEDGYLYIVDRKKDMIISGG 350
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3045 FRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRN 3124
Cdd:cd17631 351 ENVYPAEVEDVLYEHPAVAEVAVIGVPDEKWGEAVVAVVVPRPGAELDEDELIAHCRERLARYKIPKSVEFVDALPRNAT 430
|
....*
gi 53747904 3125 GKIAR 3129
Cdd:cd17631 431 GKILK 435
|
|
| PRK07314 |
PRK07314 |
beta-ketoacyl-ACP synthase II; |
23-435 |
1.07e-35 |
|
beta-ketoacyl-ACP synthase II;
Pssm-ID: 235987 [Multi-domain] Cd Length: 411 Bit Score: 142.62 E-value: 1.07e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 23 PGAPDVESFWRNLVAGVESISFFSEEElrqagvseqirrrPEYVPAK--GVLEDlelFDAGFFgYSPREASHLDPQQRLL 100
Cdd:PRK07314 14 PLGNDVESTWKNLLAGKSGIGPITHFD-------------TSDLAVKiaGEVKD---FNPDDY-MSRKEARRMDRFIQYG 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 101 LECSWEALEDAGLRPDQL-PGWVGVYVGAG--------DTSYRfqLLRGhgdplsGSKDVAGFF--GNYPDFLATRVAYK 169
Cdd:PRK07314 77 IAAAKQAVEDAGLEITEEnADRIGVIIGSGiggletieEQHIT--LLEK------GPRRVSPFFvpMAIINMAAGHVSIR 148
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 170 LNLRGPALGIHTACSTSLVSINMACSALRGFECDMALAGGV-------------SLRL-------PARSgylyeeggvas 229
Cdd:PRK07314 149 YGAKGPNHSIVTACATGAHAIGDAARLIAYGDADVMVAGGAeaaitplgiagfaAARAlstrnddPERA----------- 217
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 230 kdghCRPFDARATGTVTGDGVGVVVLKRLEDALK--ARdpIHAVIRGWALNNDGASragFTAPSVEGQSEV--IALAHAA 305
Cdd:PRK07314 218 ----SRPFDKDRDGFVMGEGAGILVLEELEHAKArgAK--IYAEVVGYGMTGDAYH---MTAPAPDGEGAAraMKLALKD 288
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 306 AGISARDITYVEAHGTGTPLGDPIEVAALTRAFRAHTADTAfctLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTL 385
Cdd:PRK07314 289 AGINPEDIDYINAHGTSTPAGDKAETQAIKRVFGEHAYKVA---VSSTKSMTGHLLGAAGAVEAIFSVLAIRDQVIPPTI 365
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|.
gi 53747904 386 HFERPNPALHLEqspfFVntqplPWES-PRGPRLAGVSSFGIGGTNAHTLF 435
Cdd:PRK07314 366 NLDNPDEECDLD----YV-----PNEArERKIDYALSNSFGFGGTNASLVF 407
|
|
| PRK07656 |
PRK07656 |
long-chain-fatty-acid--CoA ligase; Validated |
2648-3134 |
1.04e-34 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236072 [Multi-domain] Cd Length: 513 Bit Score: 141.97 E-value: 1.04e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRL 2727
Cdd:PRK07656 15 ARRFGDKEAYVFGDQRLTYAELNARVRRAAAALAALGIGKGDRVAIWAPNSPHWVIAALGALKAGAVVVPLNTRYTADEA 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2728 HQLLEEGPARVVLTQSSLLHT----VPWPPGVQVIAVDELEPATEAPPL----------------PPRGTPEHLAYVIYT 2787
Cdd:PRK07656 95 AYILARGDAKALFVLGLFLGVdysaTTRLPALEHVVICETEEDDPHTEKmktftdflaagdpaerAPEVDPDDVADILFT 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2788 SGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVL---------GLSA---------------LTFdlsvydvlgllg 2843
Cdd:PRK07656 175 SGTTGRPKGAMLTHRQLLSNAADWAEYLGLTEGDRYLaanpffhvfGYKAgvnaplmrgatilplPVF------------ 242
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2844 aggalvlpaaeaekDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLpAALRLVMLSGDWIPVALPDRIRALgRD 2923
Cdd:PRK07656 243 --------------DPDEVFRLIETERITVLPGPPTMYNSLLQHPDRSAEDL-SSLRLAVTGAASMPVALLERFESE-LG 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2924 VQVVSLG-GATEASIWSIAYPIGQVApqwKSIPY--GMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPL 3000
Cdd:PRK07656 307 VDIVLTGyGLSEASGVTTFNRLDDDR---KTVAGtiGTAIAGVENKIVNELGEEVPVGEVGELLVRGPNVMKGYYDDPEA 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3001 TAtrfirHPRTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLV 3080
Cdd:PRK07656 384 TA-----AAIDADGWLHTGDLGRLDEEGYLYIVDRKKDMFIVGGFNVYPAEVEEVLYEHPAVAEAAVIGVPDERLGEVGK 458
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....
gi 53747904 3081 AYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPE 3134
Cdd:PRK07656 459 AYVVLKPGAELTEEELIAYCREHLAKYKVPRSIEFLDELPKNATGKVLKRALRE 512
|
|
| CBAL |
cd05923 |
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) ... |
2652-3132 |
1.60e-34 |
|
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) to 4-chlorobenzoyl-coenzyme A (4-CB-CoA) by the two-step adenylation and thioester-forming reactions. 4-Chlorobenzoate (4-CBA) is an environmental pollutant derived from microbial breakdown of aromatic pollutants, such as polychlorinated biphenyls (PCBs), DDT, and certain herbicides. The 4-CBA degrading pathway converts 4-CBA to the metabolite 4-hydroxybezoate (4-HBA), allowing some soil-dwelling microbes to utilize 4-CBA as an alternate carbon source. This pathway consists of three chemical steps catalyzed by 4-CBA-CoA ligase, 4-CBA-CoA dehalogenase, and 4HBA-CoA thioesterase in sequential reactions.
Pssm-ID: 341247 [Multi-domain] Cd Length: 493 Bit Score: 141.11 E-value: 1.60e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2652 PELPALLAPERT--LSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQ 2729
Cdd:cd05923 15 PDACAIADPARGlrLTYSELRARIEAVAARLHARGLRPGQRVAVVLPNSVEAVIALLALHRLGAVPALINPRLKAAELAE 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2730 LLEEGPARVVltqsslLHTVPWPP-------GVQVIAVD------ELEPATEAPPLPPRGtPEHLAYVIYTSGSTGKPKG 2796
Cdd:cd05923 95 LIERGEMTAA------VIAVDAQVmdaifqsGVRVLALSdlvglgEPESAGPLIEDPPRE-PEQPAFVFYTSGTTGLPKG 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2797 VAIEHRAALNTVVDLNTRFGV--GPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAekDPAHWWERLVAGRVTVW 2874
Cdd:cd05923 168 AVIPQRAAESRVLFMSTQAGLrhGRHNVVLGLMPLYHVIGFFAVLVAALALDGTYVVVEEF--DPADALKLIEQERVTSL 245
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2875 NSTPALMLLLVEYAEQRGLKLpAALRLVMLSGDWIPVALPDRIRALgRDVQVVSLGGATEASIWSIaypigqvAPQWKSI 2954
Cdd:cd05923 246 FATPTHLDALAAAAEFAGLKL-SSLRHVTFAGATMPDAVLERVNQH-LPGEKVNIYGTTEAMNSLY-------MRDARTG 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2955 PYGMPLANQRFH---VLDGRLEARPWWVPGELYIGGEGLA--REYWRDEPLTATRFIrhprtgERLYRTGDQGRMLPEGS 3029
Cdd:cd05923 317 TEMRPGFFSEVRivrIGGSPDEALANGEEGELIVAAAADAafTGYLNQPEATAKKLQ------DGWYRTGDVGYVDPSGD 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3030 IEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGqTPAAGELRRY-LAERLPAYM 3108
Cdd:cd05923 391 VRILGRVDDMIISGGENIHPSEIERVLSRHPGVTEVVVIGVADERWGQSVTACVVPREG-TLSADELDQFcRASELADFK 469
|
490 500
....*....|....*....|....
gi 53747904 3109 VPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd05923 470 RPRRYFFLDELPKNAMNKVLRRQL 493
|
|
| MDR5 |
cd08271 |
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; ... |
1679-1973 |
3.07e-34 |
|
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; This group is a member of the medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, but lacks the zinc-binding sites of the zinc-dependent alcohol dehydrogenases. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P)-binding Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176232 [Multi-domain] Cd Length: 325 Bit Score: 135.87 E-value: 3.07e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1679 TPGLLESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEEsVLGRECSGRIAAVGEGVSGLRVGDEVLA 1758
Cdd:cd08271 8 KPGAALQLTLEEIEIPGPGAGEVLVKVHAAGLNPVDWKVIAWGPPAWSYPH-VPGVDGAGVVVAVGAKVTGWKVGDRVAY 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1759 VA----PGCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGERILIHAAAGGLGLAAVQLASRTG 1834
Cdd:cd08271 87 HAslarGGSFAEYTVVDARAVLPLPDSLSFEEAAALPCAGLTAYQALFKKLRIEAGRTILITGGAGGVGSFAVQLAKRAG 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1835 AEILATAgSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELGKRDLYA 1914
Cdd:cd08271 167 LRVITTC-SKRNFEYVKSLGADHVIDYNDEDVCERIKEITGGRGVDAVLDTVGGETAAALAPTLAFNGHLVCIQGRPDAS 245
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 53747904 1915 DQQVGLRTLARGQTF--AAIDFG--PHHPDFRAVLEEVATQLTQGQLEPLPTRLFPARQVAEA 1973
Cdd:cd08271 246 PDPPFTRALSVHEVAlgAAHDHGdpAAWQDLRYAGEELLELLAAGKLEPLVIEVLPFEQLPEA 308
|
|
| Acs |
COG0365 |
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism]; |
2766-3132 |
4.41e-34 |
|
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism];
Pssm-ID: 440134 [Multi-domain] Cd Length: 565 Bit Score: 141.02 E-value: 4.41e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2766 ATEAPPLPPRGTP-EHLAYVIYTSGSTGKPKGVAIEHRA-ALNTVVDLNTRFGVGPEDRVL---------GLS-ALTFDL 2833
Cdd:COG0365 170 AAASAEFEPEPTDaDDPLFILYTSGTTGKPKGVVHTHGGyLVHAATTAKYVLDLKPGDVFWctadigwatGHSyIVYGPL 249
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2834 S------VYDVLGLLGaggalvlpaaeaekDPAHWWERLVAGRVTVWNSTP----ALMLLLVEYAEQRGLKlpaALRLVM 2903
Cdd:COG0365 250 LngatvvLYEGRPDFP--------------DPGRLWELIEKYGVTVFFTAPtairALMKAGDEPLKKYDLS---SLRLLG 312
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2904 LSGDWIPVALPDRIR-ALGrdVQVVSLGGATEA-SIWSIAYPIGQVAPqwKSIpyGMPLANQRFHVLDGRLEARPWWVPG 2981
Cdd:COG0365 313 SAGEPLNPEVWEWWYeAVG--VPIVDGWGQTETgGIFISNLPGLPVKP--GSM--GKPVPGYDVAVVDEDGNPVPPGEEG 386
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2982 ELYIGGE--GLAREYWRDEPLTATRFIRhprTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQH 3059
Cdd:COG0365 387 ELVIKGPwpGMFRGYWNDPERYRETYFG---RFPGWYRTGDGARRDEDGYFWILGRSDDVINVSGHRIGTAEIESALVSH 463
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 53747904 3060 PALSASVVVarGEP---RGVRrLVAYAVPRSGQTPA---AGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:COG0365 464 PAVAEAAVV--GVPdeiRGQV-VKAFVVLKPGVEPSdelAKELQAHVREELGPYAYPREIEFVDELPKTRSGKIMRRLL 539
|
|
| menE |
TIGR01923 |
O-succinylbenzoate-CoA ligase; This model represents an enzyme, O-succinylbenzoate-CoA ligase, ... |
2685-3132 |
5.95e-34 |
|
O-succinylbenzoate-CoA ligase; This model represents an enzyme, O-succinylbenzoate-CoA ligase, which is involved in the fourth step of the menaquinone biosynthesis pathway. O-succinylbenzoate-CoA ligase, together with menB - naphtoate synthase, take 2-succinylbenzoate and convert it into 1,4-di-hydroxy-2- naphtoate. [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]
Pssm-ID: 162605 [Multi-domain] Cd Length: 436 Bit Score: 137.97 E-value: 5.95e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2685 VQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSLLHTvpwppGVQVIAVDELE 2764
Cdd:TIGR01923 21 IRSGSRVALVGQNSIEMVLLLHACLLLGAEIAMLNTRLTENERTNQLEDLDVQLLLTDSLLEEK-----DFQADSLDRIE 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2765 -PATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVL---------GLSAL----- 2829
Cdd:TIGR01923 96 aAGRYETSLSASFNMDQIATLMFTSGTTGKPKAVPHTFRNHYASAVGSKENLGFTEDDNWLlslplyhisGLSILfrwli 175
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2830 -TFDLSVYDVLgllgaggalvlpaaeaekdpAHWWERLVAGRVTVWNSTPALmllLVEYAEQRGLklPAALRLVMLSGDW 2908
Cdd:TIGR01923 176 eGATLRIVDKF--------------------NQLLEMIANERVTHISLVPTQ---LNRLLDEGGH--NENLRKILLGGSA 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2909 IPVALPDRIRALGRDVQvvsLG-GATEASIWSIAYPIGQVAPQWKSipyGMPLANQrfhvlDGRLEARPWWVPGELYIGG 2987
Cdd:TIGR01923 231 IPAPLIEEAQQYGLPIY---LSyGMTETCSQVTTATPEMLHARPDV---GRPLAGR-----EIKIKVDNKEGHGEIMVKG 299
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2988 EGLAREYWRDEPLTATRFirhprtGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVV 3067
Cdd:TIGR01923 300 ANLMKGYLYQGELTPAFE------QQGWFNTGDIGELDGEGFLYVLGRRDDLIISGGENIYPEEIETVLYQHPGIQEAVV 373
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 3068 VARGEPRGVRRLVAYAVPRSgqTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:TIGR01923 374 VPKPDAEWGQVPVAYIVSES--DISQAKLIAYLTEKLAKYKVPIAFEKLDELPYNASGKILRNQL 436
|
|
| PLN02836 |
PLN02836 |
3-oxoacyl-[acyl-carrier-protein] synthase |
28-439 |
1.65e-33 |
|
3-oxoacyl-[acyl-carrier-protein] synthase
Pssm-ID: 215449 [Multi-domain] Cd Length: 437 Bit Score: 136.85 E-value: 1.65e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 28 VESFWRNLVAGVESISFFSEEELRQAGVSEQIRRR-------------PEYVPAKGVLEDLELFD---AGFFGYSPREAS 91
Cdd:PLN02836 23 VETTWRRLIAGECGVRALTQDDLKMKSEDEETQLYtldqlpsrvaalvPRGTGPGDFDEELWLNSrssSRFIGYALCAAD 102
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 92 hldpqqrlllecswEALEDAGLRP--DQLPGWVGVYVGAG-----DTSYRFQLLRGhgdplSGSKDVAGFFgnYPDFL-- 162
Cdd:PLN02836 103 --------------EALSDARWLPseDEAKERTGVSIGGGigsitDILEAAQLICE-----KRLRRLSPFF--VPRILin 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 163 --ATRVAYKLNLRGPALGIHTACSTSLVSINMACSALRGFECDMALAGG-------VSL----RLPARSGYLYEEGGVAS 229
Cdd:PLN02836 162 maAGHVSIRYGFQGPNHAAVTACATGAHSIGDAFRMIQFGDADVMVAGGtessidaLSIagfsRSRALSTKFNSCPTEAS 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 230 kdghcRPFDARATGTVTGDGVGVVVLKRLEDALKARDPIHAVIRGWALNNDGASragFTAPSVEGQSEVIALAHA--AAG 307
Cdd:PLN02836 242 -----RPFDCDRDGFVIGEGAGVLVLEELEHAKRRGAKIYAEVRGYGMSGDAHH---ITQPHEDGRGAVLAMTRAlqQSG 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 308 ISARDITYVEAHGTGTPLGDPIEVAALTRAFRAHtADTAFCTLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHF 387
Cdd:PLN02836 314 LHPNQVDYVNAHATSTPLGDAVEARAIKTVFSEH-ATSGGLAFSSTKGATGHLLGAAGAVEAIFSVLAIHHGIAPPTLNL 392
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|...
gi 53747904 388 ERPNPALHleqsPFFVntqPLPwESPRGPRLAGVS-SFGIGGTNAHTLFEEAP 439
Cdd:PLN02836 393 ERPDPIFD----DGFV---PLT-ASKAMLIRAALSnSFGFGGTNASLLFTSPP 437
|
|
| PRK06333 |
PRK06333 |
beta-ketoacyl-ACP synthase; |
13-435 |
5.40e-33 |
|
beta-ketoacyl-ACP synthase;
Pssm-ID: 235781 [Multi-domain] Cd Length: 424 Bit Score: 135.13 E-value: 5.40e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 13 IALVGMAGRFPGAPDVESFWRNLVAGVESISFFSEE--ELRQAGVSEQIRRRPEYVPAKgvledlelFDAGFFgYSPREA 90
Cdd:PRK06333 6 IVVTGMGAVSPLGCGVETFWQRLLAGQSGIRTLTDFpvGDLATKIGGQVPDLAEDAEAG--------FDPDRY-LDPKDQ 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 91 SHLDPQQRLLLECSWEALEDAGLRPDQLPGWV--GVYVGAG-------DTSYRFQLLRGHgdplsgsKDVAGFFgnYPDF 161
Cdd:PRK06333 77 RKMDRFILFAMAAAKEALAQAGWDPDTLEDRErtATIIGSGvggfpaiAEAVRTLDSRGP-------RRLSPFT--IPSF 147
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 162 L----ATRVAYKLNLRGPALGIHTACSTSLVSINMACSALRGFECDMALAGG-------VSLR--LPARSgylYEEGGVA 228
Cdd:PRK06333 148 LtnmaAGHVSIRYGFKGPLGAPVTACAAGVQAIGDAARLIRSGEADVAVCGGteaaidrVSLAgfAAARA---LSTRFND 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 229 SKDGHCRPFDARATGTVTGDGVGVVVLKRLEDALKARDPIHAVIRGWALNNDGASragFTAPSV--EGQSEVIALAHAAA 306
Cdd:PRK06333 225 APEQASRPFDRDRDGFVMGEGAGILVIETLEHALARGAPPLAELVGYGTSADAYH---MTAGPEdgEGARRAMLIALRQA 301
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 307 GISARDITYVEAHGTGTPLGDPIEVAALTRAFrAHTADTAfctLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLH 386
Cdd:PRK06333 302 GIPPEEVQHLNAHATSTPVGDLGEVAAIKKVF-GHVSGLA---VSSTKSATGHLLGAAGGVEAIFTILALRDQIAPPTLN 377
|
410 420 430 440
....*....|....*....|....*....|....*....|....*....
gi 53747904 387 FERPNPALhleQSPFFVNTQPLPWESprgpRLAGVSSFGIGGTNAHTLF 435
Cdd:PRK06333 378 LENPDPAA---EGLDVVANKARPMDM----DYALSNGFGFGGVNASILF 419
|
|
| PTZ00354 |
PTZ00354 |
alcohol dehydrogenase; Provisional |
1680-1996 |
6.07e-33 |
|
alcohol dehydrogenase; Provisional
Pssm-ID: 173547 [Multi-domain] Cd Length: 334 Bit Score: 132.46 E-value: 6.07e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1680 PGLLESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGDEVLAV 1759
Cdd:PTZ00354 10 FGGVDVLKIGESPKPAPKRNDVLIKVSAAGVNRADTLQRQGKYPPPPGSSEILGLEVAGYVEDVGSDVKRFKEGDRVMAL 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1760 APG-CFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGERILIHAAAGGLGLAAVQLASRTGAEIL 1838
Cdd:PTZ00354 90 LPGgGYAEYAVAHKGHVMHIPQGYTFEEAAAIPEAFLTAWQLLKKHGDVKKGQSVLIHAGASGVGTAAAQLAEKYGAATI 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1839 ATAGSEQKREYLRSLGIAHVLDSRS-TSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELGKRDLYADQQ 1917
Cdd:PTZ00354 170 ITTSSEEKVDFCKKLAAIILIRYPDeEGFAPKVKKLTGEKGVNLVLDCVGGSYLSETAEVLAVDGKWIVYGFMGGAKVEK 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1918 VGLRTLARGQtfAAIDFGPHHP---DFRAVL-----EEVATQLTQGQLEPLPTRLFPARQVAEAFSFMARALHIGRVAVS 1989
Cdd:PTZ00354 250 FNLLPLLRKR--ASIIFSTLRSrsdEYKADLvasfeREVLPYMEEGEIKPIVDRTYPLEEVAEAHTFLEQNKNIGKVVLT 327
|
....*..
gi 53747904 1990 MQGATAL 1996
Cdd:PTZ00354 328 VNEPLSL 334
|
|
| malonate_mdcH |
TIGR03131 |
malonate decarboxylase, epsilon subunit; Members of this protein family are the epsilon ... |
534-824 |
8.62e-33 |
|
malonate decarboxylase, epsilon subunit; Members of this protein family are the epsilon subunit of malonate decarboxylase. This subunit has malonyl-CoA/dephospho-CoA acyltransferase activity. Malonate decarboxylase may be a soluble enzyme, or linked to membrane subunits and active as a sodium pump. The epsilon subunit is closely related to the malonyl CoA-acyl carrier protein (ACP) transacylase family described by TIGR00128, but acts on an ACP subunit of malonate decarboxylase that has an unusual coenzyme A derivative as its prothetic group.
Pssm-ID: 132175 Cd Length: 295 Bit Score: 130.90 E-value: 8.62e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 534 LVMLFPGQGTPlvgTARALHE--SEPTFRQAVEQCARLlrqtLGLDVREVlfpsaeQEEQARrlaAQTRVAQPALFTLEY 611
Cdd:TIGR03131 1 IALLFPGQGSQ---RAGMLAElpDHPAVAAVLAEASDV----LGIDPREL------DDAEAL---ASTRSAQLCILAAGV 64
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 612 ALAQTWLGWGLQPQALAGHSLGELVAACLAGVFSLEDALQLVAARGQLMQGCPPG--AMLAVP-LPEAELAALL-GSELC 687
Cdd:TIGR03131 65 AAWRALLALLPRPSAVAGYSVGEYAAAVVAGVLTFDDALRLVALRAALMDQAVPGgyGMLAVLgLDLAAVEALIaKHGVY 144
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 688 IAAVNGPRACVASGPLPAVEALTAALESRGVS-SRRLETSHAFHSASMEACQGPLTTLLRRMRLQAPRLPCVSGLTGRwL 766
Cdd:TIGR03131 145 LAIINAPDQVVIAGSRAALRAVAELARAAGASrAKRLAVRVPSHTPLLAKAAEQFAEALAEIPLAAPRLPYLSGIDAR-L 223
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*....
gi 53747904 767 TGEEATEPTYWARQLREPVRFSEALETLWSLKEPVLLEVGPGTTLTALAR-RHPTRPAR 824
Cdd:TIGR03131 224 VRDAAQIRDDLARQIATPVDWHDCMQAAYERGARLVIELGPGDVLTKLANeAFPELPAR 282
|
|
| Condensation |
pfam00668 |
Condensation domain; This domain is found in many multi-domain enzymes which synthesize ... |
2182-2625 |
2.19e-32 |
|
Condensation domain; This domain is found in many multi-domain enzymes which synthesize peptide antibiotics. This domain catalyzes a condensation reaction to form peptide bonds in non- ribosomal peptide biosynthesis. It is usually found to the carboxy side of a phosphopantetheine binding domain (pfam00550). It has been shown that mutations in the HHXXXDG motif abolish activity suggesting this is part of the active site.
Pssm-ID: 395541 [Multi-domain] Cd Length: 454 Bit Score: 134.00 E-value: 2.19e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2182 PLTDVQEAYWVgrrsaFELGGVAAHGY-----FEIEsPGLEVERFIQCWRQLLQRHDMLRMVVLPDG----RQQVLEQVP 2252
Cdd:pfam00668 6 PLSPAQKRMWF-----LEKLEPHSSAYnmpavLKLT-GELDPERLEKALQELINRHDALRTVFIRQEngepVQVILEERP 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2253 eYTPEVVELRGLSPQEAESRRLQLRERMAHQVLRSDRWPLFELVLCRY-EGGVRIHMSMDALMLDAWSSAVLRQDFAQLY 2331
Cdd:pfam00668 80 -FELEIIDISDLSESEEEEAIEAFIQRDLQSPFDLEKGPLFRAGLFRIaENRHHLLLSMHHIIVDGVSLGILLRDLADLY 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2332 H--EPGRPLEPLAIT-FRDYVLAERRLREGEAHERARAYWWARLDTLPPPPELPLVKEPSQLEHARFTHREARLEPHRWA 2408
Cdd:pfam00668 159 QqlLKGEPLPLPPKTpYKDYAEWLQQYLQSEDYQKDAAYWLEQLEGELPVLQLPKDYARPADRSFKGDRLSFTLDEDTEE 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2409 RLQERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRlpLHPQVDELVGDFTSLVLLEVEAHAASTFAERASRL 2488
Cdd:pfam00668 239 LLRKLAKAHGTTLNDVLLAAYGLLLSRYTGQDDIVVGTPGSGR--PSPDIERMVGMFVNTLPLRIDPKGGKTFSELIKRV 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2489 QAQLWRDLEHGSVSAVQLIR--ELVRTGRRSPgaimpvVFTSILSLDARRGPQGSLSFF---EGELVYSISQTPQVWLDH 2563
Cdd:pfam00668 317 QEDLLSAEPHQGYPFGDLVNdlRLPRDLSRHP------LFDPMFSFQNYLGQDSQEEEFqlsELDLSVSSVIEEEAKYDL 390
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 53747904 2564 GVH--EEEGALVLAWDSVEALFPPGMVDDMFHAYQRLLGALAEEEQAWEGELpELLPPAQRELL 2625
Cdd:pfam00668 391 SLTasERGGGLTIKIDYNTSLFDEETIERFAEHFKELLEQAIAHPSQPLSEL-DLLSDAEKQKL 453
|
|
| LC_FACS_like |
cd05935 |
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain ... |
2664-3132 |
3.25e-32 |
|
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain fatty acyl-CoA synthetases, which catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters.
Pssm-ID: 341258 [Multi-domain] Cd Length: 430 Bit Score: 132.99 E-value: 3.25e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2664 LSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQS 2743
Cdd:cd05935 2 LTYLELLEVVKKLASFLSNKGVRKGDRVGICLQNSPQYVIAYFAIWRANAVVVPINPMLKERELEYILNDSGAKVAVVGS 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2744 SLlhtvpwppgvqviavdelepateapplpprgtpEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRV 2823
Cdd:cd05935 82 EL---------------------------------DDLALIPYTSGTTGLPKGCMHTHFSAAANALQSAVWTGLTPSDVI 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2824 LGLSAL--------TFDLSVYDVLGLLGAGGALVLPAAEAEKDPahwwerlvagRVTVWNSTPALMLLLVEYAEQRGLKL 2895
Cdd:cd05935 129 LACLPLfhvtgfvgSLNTAVYVGGTYVLMARWDRETALELIEKY----------KVTFWTNIPTMLVDLLATPEFKTRDL 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2896 pAALRLVMLSGDWIPVALPDRIRALGrDVQVVSLGGATEASIWSIAYPIGQVapqwKSIPYGMPLANQRFHVLDGR-LEA 2974
Cdd:cd05935 199 -SSLKVLTGGGAPMPPAVAEKLLKLT-GLRFVEGYGLTETMSQTHTNPPLRP----KLQCLGIP*FGVDARVIDIEtGRE 272
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2975 RPWWVPGELYIGGEGLAREYWRDEPLTATRFIRhpRTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEA 3054
Cdd:cd05935 273 LPPNEVGEIVVRGPQIFKGYWNRPEETEESFIE--IKGRRFFRTGDLGYMDEEGYFFFVDRVKRMINVSGFKVWPAEVEA 350
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3055 ALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQ--TPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd05935 351 KLYKHPAI*EVCVISVPDERVGEEVKAFIVLRPEYrgKVTEEDIIEWAREQMAAYKYPREVEFVDELPRSASGKILWRLL 430
|
|
| MCS |
cd05941 |
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step ... |
2655-3132 |
2.22e-31 |
|
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step reaction consisting of the adenylation of malonate with ATP, followed by malonyl transfer from malonyl-AMP to CoA. Malonic acid and its derivatives are the building blocks of polyketides and malonyl-CoA serves as the substrate of polyketide synthases. Malonyl-CoA synthetase has broad substrate tolerance and can activate a variety of malonyl acid derivatives. MCS may play an important role in biosynthesis of polyketides, the important secondary metabolites with therapeutic and agrochemical utility.
Pssm-ID: 341264 [Multi-domain] Cd Length: 442 Bit Score: 130.49 E-value: 2.22e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2655 PALLAPERTLSYGELARRAQALAARLRELE-VQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPlrlHQLlee 2733
Cdd:cd05941 3 IAIVDDGDSITYADLVARAARLANRLLALGkDLRGDRVAFLAPPSAEYVVAQLAIWRAGGVAVPLNPSYPL---AEL--- 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2734 gpaRVVLTQSsllhtvpwppGVQVIavdeLEPATeapplpprgtpehlayVIYTSGSTGKPKGVAIEHRAALNTVVDLNT 2813
Cdd:cd05941 77 ---EYVITDS----------EPSLV----LDPAL----------------ILYTSGTTGRPKGVVLTHANLAANVRALVD 123
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2814 RFGVGPEDRVL---------GL-SALTFDLSVydvlgllgaggalvlpAAEAEK----DPAHWWERLVAGRVTVWNSTPA 2879
Cdd:cd05941 124 AWRWTEDDVLLhvlplhhvhGLvNALLCPLFA----------------GASVEFlpkfDPKEVAISRLMPSITVFMGVPT 187
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2880 LMLLLVEYAEQRGLKL-------PAALRLvMLSGDW-IPVALPDRIRALGRDVqVVSLGGATEASIwSIAYPI-GQVAPQ 2950
Cdd:cd05941 188 IYTRLLQYYEAHFTDPqfaraaaAERLRL-MVSGSAaLPVPTLEEWEAITGHT-LLERYGMTEIGM-ALSNPLdGERRPG 264
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2951 WksipYGMPLANQRFHVLD-GRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFirhprTGERLYRTGDQGRMLPEGS 3029
Cdd:cd05941 265 T----VGMPLPGVQARIVDeETGEPLPRGEVGEIQVRGPSVFKEYWNKPEATKEEF-----TDDGWFKTGDLGVVDEDGY 335
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3030 IEFLGRE-DLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSG-QTPAAGELRRYLAERLPAY 3107
Cdd:cd05941 336 YWILGRSsVDIIKSGGYKVSALEIERVLLAHPGVSECAVIGVPDPDWGERVVAVVVLRAGaAALSLEELKEWAKQRLAPY 415
|
490 500
....*....|....*....|....*
gi 53747904 3108 MVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd05941 416 KRPRRLILVDELPRNAMGKVNKKEL 440
|
|
| MDR8 |
cd08273 |
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; ... |
1672-1987 |
7.77e-31 |
|
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; This group is a member of the medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, but lacks the zinc-binding sites of the zinc-dependent alcohol dehydrogenases. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P)-binding Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176234 [Multi-domain] Cd Length: 331 Bit Score: 126.22 E-value: 7.77e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1672 NVEVAVGTPGLLESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLR 1751
Cdd:cd08273 1 NREVVVTRRGGPEVLKVVEADLPEPAAGEVVVKVEASGVSFADVQMRRGLYPDQPPLPFTPGYDLVGRVDALGSGVTGFE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1752 VGDEVLAVAP-GCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGERILIHAAAGGLGLAAVQLA 1830
Cdd:cd08273 81 VGDRVAALTRvGGNAEYINLDAKYLVPVPEGVDAAEAVCLVLNYVTAYQMLHRAAKVLTGQRVLIHGASGGVGQALLELA 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1831 SRTGAEILATAgSEQKREYLRSLGiAHVLDsRSTSFVSEVRERTGgrGVDVVLNSLAGELLLAGLSVLAPHGRFLELGKR 1910
Cdd:cd08273 161 LLAGAEVYGTA-SERNHAALRELG-ATPID-YRTKDWLPAMLTPG--GVDVVFDGVGGESYEESYAALAPGGTLVCYGGN 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1911 DLYADQQVGLRTLA---------------RGQTFAAI--DFGPHHPDFRAVLEEVATQLTQGQLEPLPTRLFPARQVAEA 1973
Cdd:cd08273 236 SSLLQGRRSLAALGsllarlaklkllptgRRATFYYVwrDRAEDPKLFRQDLTELLDLLAKGKIRPKIAKRLPLSEVAEA 315
|
330
....*....|....
gi 53747904 1974 FsfmaRALHIGRVA 1987
Cdd:cd08273 316 H----RLLESGKVV 325
|
|
| FACL_fum10p_like |
cd05926 |
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL ... |
2652-3129 |
8.31e-31 |
|
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Fum10p is a fatty acid CoA ligase involved in the synthesis of fumonisin, a polyketide mycotoxin, in Gibberella moniliformis.
Pssm-ID: 341249 [Multi-domain] Cd Length: 493 Bit Score: 129.74 E-value: 8.31e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2652 PELPALLAPERT--LSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQ 2729
Cdd:cd05926 1 PDAPALVVPGSTpaLTYADLAELVDDLARQLAALGIKKGDRVAIALPNGLEFVVAFLAAARAGAVVAPLNPAYKKAEFEF 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2730 LLEEGPARVVLTQS--------SLLHTVP------WPPGVQVIAVDE-----LEPATEAPPLPPRGTPEHLAYVIYTSGS 2790
Cdd:cd05926 81 YLADLGSKLVLTPKgelgpasrAASKLGLailelaLDVGVLIRAPSAeslsnLLADKKNAKSEGVPLPDDLALILHTSGT 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2791 TGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLG--------------LSALTFDLSVydvlgllgaggalVLPAAeae 2856
Cdd:cd05926 161 TGRPKGVPLTHRNLAASATNITNTYKLTPDDRTLVvmplfhvhglvaslLSTLAAGGSV-------------VLPPR--- 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2857 KDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPAALRLVMLSGDWIPVALPDRIRALGRdVQVVSLGGATEAS 2936
Cdd:cd05926 225 FSASTFWPDVRDYNATWYTAVPTIHQILLNRPEPNPESPPPKLRFIRSCSASLPPAVLEALEATFG-APVLEAYGMTEAA 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2937 IWSIAYPIGQVAPQWKSipYGMPlANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFirhprTGERLY 3016
Cdd:cd05926 304 HQMTSNPLPPGPRKPGS--VGKP-VGVEVRILDEDGEILPPGVVGEICLRGPNVTRGYLNNPEANAEAA-----FKDGWF 375
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3017 RTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGEL 3096
Cdd:cd05926 376 RTGDLGYLDADGYLFLTGRIKELINRGGEKISPLEVDGVLLSHPAVLEAVAFGVPDEKYGEEVAAAVVLREGASVTEEEL 455
|
490 500 510
....*....|....*....|....*....|...
gi 53747904 3097 RRYLAERLPAYMVPSAFVLLESLPRSRNGKIAR 3129
Cdd:cd05926 456 RAFCRKHLAAFKVPKKVYFVDELPKTATGKIQR 488
|
|
| PRK06187 |
PRK06187 |
long-chain-fatty-acid--CoA ligase; Validated |
2644-3135 |
8.52e-31 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235730 [Multi-domain] Cd Length: 521 Bit Score: 130.31 E-value: 8.52e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2644 FFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLP----LD 2719
Cdd:PRK06187 12 LRHGARKHPDKEAVYFDGRRTTYAELDERVNRLANALRALGVKKGDRVAVFDWNSHEYLEAYFAVPKIGAVLHPinirLK 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2720 PEQpplrLHQLLEEGPARVVLTQSSLL-------------HTVPW-------PPGVQVIAVDELEPATEAPPLPPRGTPE 2779
Cdd:PRK06187 92 PEE----IAYILNDAEDRVVLVDSEFVpllaailpqlptvRTVIVegdgpaaPLAPEVGEYEELLAAASDTFDFPDIDEN 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2780 HLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVL-----------GLSALTFDL---SVYdvlgllgag 2845
Cdd:PRK06187 168 DAAAMLYTSGTTGHPKGVVLSHRNLFLHSLAVCAWLKLSRDDVYLvivpmfhvhawGLPYLALMAgakQVI--------- 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2846 galvlpaaEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLpAALRLVMLSGDWIPVALPDRIRALGRdVQ 2925
Cdd:PRK06187 239 --------PRRFDPENLLDLIETERVTFFFAVPTIWQMLLKAPRAYFVDF-SSLRLVIYGGAALPPALLREFKEKFG-ID 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2926 VVSLGGATEAS-IWSIAYPIGQVAPQW-KSIPYGMPLANQRFHVLDGRLEARPWWV--PGELYIGGEGLAREYWRDEPLT 3001
Cdd:PRK06187 309 LVQGYGMTETSpVVSVLPPEDQLPGQWtKRRSAGRPLPGVEARIVDDDGDELPPDGgeVGEIIVRGPWLMQGYWNRPEAT 388
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3002 AtRFIRHprtGerLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVA 3081
Cdd:PRK06187 389 A-ETIDG---G--WLHTGDVGYIDEDGYLYITDRIKDVIISGGENIYPRELEDALYGHPAVAEVAVIGVPDEKWGERPVA 462
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....
gi 53747904 3082 YAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPEP 3135
Cdd:PRK06187 463 VVVLKPGATLDAKELRAFLRGRLAKFKLPKRIAFVDELPRTSVGKILKRVLREQ 516
|
|
| CT_NRPS-like |
cd19542 |
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike ... |
2181-2605 |
1.25e-30 |
|
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike bacterial NRPS, which typically have specialized terminal thioesterase (TE) domains to cyclize peptide products, many fungal NRPSs employ a terminal condensation-like (CT) domain to produce macrocyclic peptidyl products (e.g. cyclosporine and echinocandin). Domains in this subfamily (which includes both terminal and non-terminal domains) typically have a non-canonical conserved [SN]HxxxDx(14)Y motif at their active site compared to the standard Condensation (C) domain active site motif (HHxxxD). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380464 [Multi-domain] Cd Length: 401 Bit Score: 127.42 E-value: 1.25e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2181 FPLTDVQEAYWvgRRSAFELGGVAAHGYFEIESPgLEVERFIQCWRQLLQRHDMLRMVVLPDGRQQVLEQV--PEYTPEV 2258
Cdd:cd19542 2 YPCTPMQEGML--LSQLRSPGLYFNHFVFDLDSS-VDVERLRNAWRQLVQRHDILRTVFVESSAEGTFLQVvlKSLDPPI 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2259 VELRGLSPQEAESRR--LQLRERMAHqvlrsdrwPLFELVLCRYEGG---VRIHMSmDALMlDAWSSAVLRQDFAQLYHe 2333
Cdd:cd19542 79 EEVETDEDSLDALTRdlLDDPTLFGQ--------PPHRLTLLETSSGevyLVLRIS-HALY-DGVSLPIILRDLAAAYN- 147
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2334 pGRPLEPlAITFRDYVlaerRLREGEAHERARAYWWARLDTlppppeLPLVKEPSqLEHARFTHREARLEPHRWARLQER 2413
Cdd:cd19542 148 -GQLLPP-APPFSDYI----SYLQSQSQEESLQYWRKYLQG------ASPCAFPS-LSPKRPAERSLSSTRRSLAKLEAF 214
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2414 ARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRLPLHPQVDELVGDFTSLVLLEVEAHAASTFAERASRLQAQLW 2493
Cdd:cd19542 215 CASLGVTLASLFQAAWALVLARYTGSRDVVFGYVVSGRDLPVPGIDDIVGPCINTLPVRVKLDPDWTVLDLLRQLQQQYL 294
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2494 RDLEHGSVSAVQLIRELVRTGRRSPgaimpvvFTSILSLDaRRGPQGSLSFFEGELVYSISQTPQ----VWLDHGVHEEE 2569
Cdd:cd19542 295 RSLPHQHLSLREIQRALGLWPSGTL-------FNTLVSYQ-NFEASPESELSGSSVFELSAAEDPteypVAVEVEPSGDS 366
|
410 420 430
....*....|....*....|....*....|....*.
gi 53747904 2570 GALVLAWDsvEALFPPGMVDDMFHAYQRLLGALAEE 2605
Cdd:cd19542 367 LKVSLAYS--TSVLSEEQAEELLEQFDDILEALLAN 400
|
|
| Firefly_Luc_like |
cd05911 |
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family ... |
2682-3127 |
4.02e-30 |
|
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341237 [Multi-domain] Cd Length: 486 Bit Score: 127.71 E-value: 4.02e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2682 ELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSLLHTV-----PWPPGVQ 2756
Cdd:cd05911 29 KLGLKKGDVVGIISPNSTYYPPVFLGCLFAGGIFSAANPIYTADELAHQLKISKPKVIFTDPDGLEKVkeaakELGPKDK 108
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2757 VIAVDELEP---------------ATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFG--VGP 2819
Cdd:cd05911 109 IIVLDDKPDgvlsiedllsptlgeEDEDLPPPLKDGKDDTAAILYSSGTTGLPKGVCLSHRNLIANLSQVQTFLYgnDGS 188
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2820 EDRVLGlsALTFDlSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPAaL 2899
Cdd:cd05911 189 NDVILG--FLPLY-HIYGLFTTLASLLNGATVIIMPKFDSELFLDLIEKYKITFLYLVPPIAAALAKSPLLDKYDLSS-L 264
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2900 RLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEASIWSIAYPIGQVAPQwkSIpyGMPLANQRFHVLD--GRLEARPW 2977
Cdd:cd05911 265 RVILSGGAPLSKELQELLAKRFPNATIKQGYGMTETGGILTVNPDGDDKPG--SV--GRLLPNVEAKIVDddGKDSLGPN 340
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2978 wVPGELYIGGEGLAREYWRDEPLTATRFirhprTGERLYRTGDQGRMLPEGSIEFLGR-EDLqVKVQGFRVELGEIEAAL 3056
Cdd:cd05911 341 -EPGEICVRGPQVMKGYYNNPEATKETF-----DEDGWLHTGDIGYFDEDGYLYIVDRkKEL-IKYKGFQVAPAELEAVL 413
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 53747904 3057 AQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYM-----VpsafVLLESLPRSRNGKI 3127
Cdd:cd05911 414 LEHPGVADAAVIGIPDEVSGELPRAYVVRKPGEKLTEKEVKDYVAKKVASYKqlrggV----VFVDEIPKSASGKI 485
|
|
| MACS_like_4 |
cd05969 |
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most ... |
2685-3132 |
7.44e-30 |
|
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most similar to acetyl-CoA synthetase. Acetyl-CoA synthetase (ACS) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is only present in bacteria.
Pssm-ID: 341273 [Multi-domain] Cd Length: 442 Bit Score: 126.08 E-value: 7.44e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2685 VQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSLLHtvpwppgvqviavdele 2764
Cdd:cd05969 22 VGKGDRVFVLSPRSPELYFSMLGIGKIGAVICPLFSAFGPEAIRDRLENSEAKVLITTEELYE----------------- 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2765 pateapplppRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDR---------VLGLSALTF---- 2831
Cdd:cd05969 85 ----------RTDPEDPTLLHYTSGTTGTPKGVLHVHDAMIFYYFTGKYVLDLHPDDIywctadpgwVTGTVYGIWapwl 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2832 -DLSVYdvlgllgaggalvlpAAEAEKDPAHWWERLVAGRVTVWNSTPA----LMLLLVEYAEQRGLklpAALRLVMLSG 2906
Cdd:cd05969 155 nGVTNV---------------VYEGRFDAESWYGIIERVKVTVWYTAPTairmLMKEGDELARKYDL---SSLRFIHSVG 216
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2907 DwiPVAlPDRIR----ALGrdVQVVSLGGATEASIWSIA-YPIGQVAPQwksiPYGMPLANQRFHVLDGRLEARPWWVPG 2981
Cdd:cd05969 217 E--PLN-PEAIRwgmeVFG--VPIHDTWWQTETGSIMIAnYPCMPIKPG----SMGKPLPGVKAAVVDENGNELPPGTKG 287
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2982 ELYI--GGEGLAREYWRDEPLTATRFIrhprTGerLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQH 3059
Cdd:cd05969 288 ILALkpGWPSMFRGIWNDEERYKNSFI----DG--WYLTGDLAYRDEDGYFWFVGRADDIIKTSGHRVGPFEVESALMEH 361
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 53747904 3060 PALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAG---ELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd05969 362 PAVAEAGVIGKPDPLRGEIIKAFISLKEGFEPSDElkeEIINFVRQKLGAHVAPREIEFVDNLPKTRSGKIMRRVL 437
|
|
| ETR_like |
cd05282 |
2-enoyl thioester reductase-like; 2-enoyl thioester reductase (ETR) catalyzes the ... |
1680-1986 |
5.95e-29 |
|
2-enoyl thioester reductase-like; 2-enoyl thioester reductase (ETR) catalyzes the NADPH-dependent conversion of trans-2-enoyl acyl carrier protein/coenzyme A (ACP/CoA) to acyl-(ACP/CoA) in fatty acid synthesis. 2-enoyl thioester reductase activity has been linked in Candida tropicalis as essential in maintaining mitiochondrial respiratory function. This ETR family is a part of the medium chain dehydrogenase/reductase family, but lack the zinc coordination sites characteristic of the alcohol dehydrogenases in this family. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. Candida tropicalis enoyl thioester reductase (Etr1p) catalyzes the NADPH-dependent reduction of trans-2-enoyl thioesters in mitochondrial fatty acid synthesis. Etr1p forms homodimers with each subunit containing a nucleotide-binding Rossmann fold domain and a catalytic domain.
Pssm-ID: 176645 [Multi-domain] Cd Length: 323 Bit Score: 120.46 E-value: 5.95e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1680 PGLLESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVL---GALGMMPALEAeesVLGRECSGRIAAVGEGVSGLRVGDEV 1756
Cdd:cd05282 8 EPLPLVLELVSLPIPPPGPGEVLVRMLAAPINPSDLItisGAYGSRPPLPA---VPGNEGVGVVVEVGSGVSGLLVGQRV 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1757 LAVAP-GCFRSYVLVDESQVVRRPASLGLAEgAAQMV--PFaTAYFALHTVGRLRRGERILIHAAAGGLGLAAVQLASRT 1833
Cdd:cd05282 85 LPLGGeGTWQEYVVAPADDLIPVPDSISDEQ-AAMLYinPL-TAWLMLTEYLKLPPGDWVIQNAANSAVGRMLIQLAKLL 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1834 GAEILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELG----- 1908
Cdd:cd05282 163 GFKTINVVRRDEQVEELKALGADEVIDSSPEDLAQRVKEATGGAGARLALDAVGGESATRLARSLRPGGTLVNYGllsge 242
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1909 ----KRDLYADQQVGLRTLARGQTFAAIdfgpHHPDFRAVLEEVATQLTQGQLEPLPTRLFPARQVAEAFSFMARALHIG 1984
Cdd:cd05282 243 pvpfPRSVFIFKDITVRGFWLRQWLHSA----TKEAKQETFAEVIKLVEAGVLTTPVGAKFPLEDFEEAVAAAEQPGRGG 318
|
..
gi 53747904 1985 RV 1986
Cdd:cd05282 319 KV 320
|
|
| FACL_DitJ_like |
cd05934 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
2781-3133 |
6.51e-29 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Members of this family include DitJ from Pseudomonas and similar proteins.
Pssm-ID: 341257 [Multi-domain] Cd Length: 422 Bit Score: 122.79 E-value: 6.51e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2781 LAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDrVLGLSALTFDL-----SVYdvlgllgAGGALVLPAAEA 2855
Cdd:cd05934 83 PASILYTSGTTGPPKGVVITHANLTFAGYYSARRFGLGEDD-VYLTVLPLFHInaqavSVL-------AALSVGATLVLL 154
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2856 EK-DPAHWWERLVAGRVTVWNSTPALMLLLveyaeqrgLKLPAA-------LRLVMLSGdwipvALPDRIRALGR--DVQ 2925
Cdd:cd05934 155 PRfSASRFWSDVRRYGATVTNYLGAMLSYL--------LAQPPSpddrahrLRAAYGAP-----NPPELHEEFEErfGVR 221
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2926 VVSLGGATEASIWSIAyPIGQVAPqWKSIPYGMPLANQRfhVLDGRLEARPWWVPGELYIGGE---GLAREYWRDEPLTA 3002
Cdd:cd05934 222 LLEGYGMTETIVGVIG-PRDEPRR-PGSIGRPAPGYEVR--IVDDDGQELPAGEPGELVIRGLrgwGFFKGYYNMPEATA 297
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3003 TRFirhpRTGerLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAY 3082
Cdd:cd05934 298 EAM----RNG--WFHTGDLGYRDADGFFYFVDRKKDMIRRRGENISSAEVERAILRHPAVREAAVVAVPDEVGEDEVKAV 371
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|.
gi 53747904 3083 AVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLP 3133
Cdd:cd05934 372 VVLRPGETLDPEELFAFCEGQLAYFKVPRYIRFVDDLPKTPTEKVAKAQLR 422
|
|
| RTN4I1 |
cd08248 |
Human Reticulon 4 Interacting Protein 1; Human Reticulon 4 Interacting Protein 1 is a member ... |
1698-1977 |
1.67e-28 |
|
Human Reticulon 4 Interacting Protein 1; Human Reticulon 4 Interacting Protein 1 is a member of the medium chain dehydrogenase/ reductase (MDR) family. Riticulons are endoplasmic reticulum associated proteins involved in membrane trafficking and neuroendocrine secretion. The MDR/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P) binding-Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES.
Pssm-ID: 176210 [Multi-domain] Cd Length: 350 Bit Score: 120.02 E-value: 1.67e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1698 PRQVEIEVEAAGLNFLDVLGALG--------MMPALEAEES------VLGRECSGRIAAVGEGVSGLRVGDEVLAVAP-- 1761
Cdd:cd08248 29 PNQVLIKVHAASVNPIDVLMRSGygrtllnkKRKPQSCKYSgiefplTLGRDCSGVVVDIGSGVKSFEIGDEVWGAVPpw 108
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1762 --GCFRSYVLVDESQVVRRPASLGLAEGAAqmVPFA--TAYFALHTVGRLR----RGERILIHAAAGGLGLAAVQLASRT 1833
Cdd:cd08248 109 sqGTHAEYVVVPENEVSKKPKNLSHEEAAS--LPYAglTAWSALVNVGGLNpknaAGKRVLILGGSGGVGTFAIQLLKAW 186
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1834 GAEILATAgSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTggrGVDVVLNSLAGELLLAGLSVLAPHGRFLELGKRDLY 1913
Cdd:cd08248 187 GAHVTTTC-STDAIPLVKSLGADDVIDYNNEDFEEELTERG---KFDVILDTVGGDTEKWALKLLKKGGTYVTLVSPLLK 262
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1914 ADQQVGlrtLARGQTFAAIDFGPH----------------HPDfRAVLEEVATQLTQGQLEPLPTRLFPARQVAEAFSFM 1977
Cdd:cd08248 263 NTDKLG---LVGGMLKSAVDLLKKnvksllkgshyrwgffSPS-GSALDELAKLVEDGKIKPVIDKVFPFEEVPEAYEKV 338
|
|
| PS-DH |
pfam14765 |
Polyketide synthase dehydratase; This is the dehydratase domain of polyketide synthases. ... |
1410-1659 |
2.58e-28 |
|
Polyketide synthase dehydratase; This is the dehydratase domain of polyketide synthases. Structural analysis shows these DH domains are double hotdogs in which the active site contains a histidine from the N-terminal hotdog and an aspartate from the C-terminal hotdog. Studies have uncovered that a substrate tunnel formed between the DH domains may be essential for loading substrates and unloading products.
Pssm-ID: 434191 Cd Length: 296 Bit Score: 117.86 E-value: 2.58e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1410 TLRGGEDWVVDEHRLQGVPTLPGVAYLELARAACAQALGAEAVELAELLL-LEPLTVPRGESRQVRVVLQPEGQAHALRV 1488
Cdd:pfam14765 21 RLRLADLPWLRDHRVGGTVVLPGAGYLEMALEAARQLFGGSGAVALRDVSiLKALVLPEDDPVEVQTSLTPEEDGADSWW 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1489 E----SRSEEARGWNEHARGRVRAVPRL-AERIQPELLRAACehEQPVPGEPQEQGPVHAGARWHGL-----FQWVR--- 1555
Cdd:pfam14765 101 EfeifSRAGGGWEWTLHATGTVRLAPGEpAAPVDLESLPARC--AQPADPRSVSSAEFYERLAARGLfygpaFQGLRriw 178
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1556 RGPRQALAQLALPEPFHGDLERFELHPALMDMA--------TSFAIPGGVPWLAFGYERVLIHGPLPPQ--VLSHVSLPE 1625
Cdd:pfam14765 179 RGDGEALAEARLPEAAAGGESPYLLHPALLDAAlqllgaalPAEAEHADQAYLPVGIERLRIYRSLPPGepLWVHARLER 258
|
250 260 270
....*....|....*....|....*....|....
gi 53747904 1626 EsqaGAQQLRLQVRLLDLEGWERVRIDGYLLRPL 1659
Cdd:pfam14765 259 R---GGRTIVGDLTLVDEDGRVVARIEGLRLRRV 289
|
|
| Tdh |
COG1063 |
Threonine dehydrogenase or related Zn-dependent dehydrogenase [Amino acid transport and ... |
1693-1991 |
4.92e-28 |
|
Threonine dehydrogenase or related Zn-dependent dehydrogenase [Amino acid transport and metabolism, General function prediction only]; Threonine dehydrogenase or related Zn-dependent dehydrogenase is part of the Pathway/BioSystem: Non-phosphorylated Entner-Doudoroff pathway
Pssm-ID: 440683 [Multi-domain] Cd Length: 341 Bit Score: 118.32 E-value: 4.92e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1693 RPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEeSVLGRECSGRIAAVGEGVSGLRVGDEVlAVAP----------- 1761
Cdd:COG1063 19 DPEPGPGEVLVRVTAVGICGSDLHIYRGGYPFVRPP-LVLGHEFVGEVVEVGEGVTGLKVGDRV-VVEPnipcgecrycr 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1762 -------------------GCFRSYVLVDESQVVRRPASLGLAEGAaqMV-PFATAYFALHtVGRLRRGERILI------ 1815
Cdd:COG1063 97 rgrynlcenlqflgiagrdGGFAEYVRVPAANLVKVPDGLSDEAAA--LVePLAVALHAVE-RAGVKPGDTVLVigagpi 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1816 ---HaaagglglaaVQLASRTGA-EILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVLN-SLAGEL 1890
Cdd:COG1063 174 gllA----------ALAARLAGAaRVIVVDRNPERLELARELGADAVVNPREEDLVEAVRELTGGRGADVVIEaVGAPAA 243
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1891 LLAGLSVLAPHGRFLELGkrdLYADQ-QVGLRTL-ARGQTFAAIdFGPHHPDFRAVLEEVAtqltQGQL--EPLPTRLFP 1966
Cdd:COG1063 244 LEQALDLVRPGGTVVLVG---VPGGPvPIDLNALvRKELTLRGS-RNYTREDFPEALELLA----SGRIdlEPLITHRFP 315
|
330 340
....*....|....*....|....*.
gi 53747904 1967 ARQVAEAF-SFMARALHIGRVAVSMQ 1991
Cdd:COG1063 316 LDDAPEAFeAAADRADGAIKVVLDPD 341
|
|
| KR_1_SDR_x |
cd08952 |
ketoreductase (KR), subgroup 1, complex (x) SDRs; Ketoreductase, a module of the multidomain ... |
903-1380 |
8.16e-27 |
|
ketoreductase (KR), subgroup 1, complex (x) SDRs; Ketoreductase, a module of the multidomain polyketide synthase (PKS), has 2 subdomains, each corresponding to a SDR family monomer. The C-terminal subdomain catalyzes the NADPH-dependent reduction of the beta-carbonyl of a polyketide to a hydroxyl group, a step in the biosynthesis of polyketides, such as erythromycin. The N-terminal subdomain, an interdomain linker, is a truncated Rossmann fold which acts to stabilizes the catalytic subdomain. Unlike typical SDRs, the isolated domain does not oligomerize but is composed of 2 subdomains, each resembling an SDR monomer. The active site resembles that of typical SDRs, except that the usual positions of the catalytic Asn and Tyr are swapped, so that the canonical YXXXK motif changes to YXXXN. Modular PKSs are multifunctional structures in which the makeup recapitulates that found in (and may have evolved from) FAS. Polyketide synthesis also proceeds via the addition of 2-carbon units as in fatty acid synthesis. The complex SDR NADP-binding motif, GGXGXXG, is often present, but is not strictly conserved in each instance of the module. This subfamily includes KR domains found in many multidomain PKSs, including six of seven Sorangium cellulosum PKSs (encoded by spiDEFGHIJ) which participate in the synthesis of the polyketide scaffold of the cytotoxic spiroketal polyketide spirangien. These seven PKSs have either a single PKS module (SpiF), two PKR modules (SpiD,-E,-I,-J), or three PKS modules (SpiG,-H). This subfamily includes the single KR domain of SpiF, the first KR domains of SpiE,-G,H,-I,and #J, the third KR domain of SpiG, and the second KR domain of SpiH. The second KR domains of SpiE,-G, I, and #J, and the KR domains of SpiD, belong to a different KR_FAS_SDR subfamily. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold (alpha/beta folding pattern with a central beta-sheet), an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Classical SDRs are typically about 250 residues long, while extended SDRs are approximately 350 residues. Sequence identity between different SDR enzymes are typically in the 15-30% range, but the enzymes share the Rossmann fold NAD-binding motif and characteristic NAD-binding and catalytic sequence patterns. These enzymes catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human prostaglandin dehydrogenase (PGDH) numbering). In addition to the Tyr and Lys, there is often an upstream Ser (Ser-138, PGDH numbering) and/or an Asn (Asn-107, PGDH numbering) contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Extended SDRs have additional elements in the C-terminal region, and typically have a TGXXGXXG cofactor binding motif. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type KRs have a TGXXXGX(1-2)G NAD(P)-binding motif. Some atypical SDRs have lost catalytic activity and/or have an unusual NAD(P)-binding motif and missing or unusual active site residues. Reactions catalyzed within the SDR family include isomerization, decarboxylation, epimerization, C=N bond reduction, dehydratase activity, dehalogenation, Enoyl-CoA reduction, and carbonyl-alcohol oxidoreduction.
Pssm-ID: 187655 [Multi-domain] Cd Length: 480 Bit Score: 117.66 E-value: 8.16e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 903 PPEQPSREALEDWFYVPTWEQAPATSGGgqPLAGP---VLAFMDSSGLAEQVLAALwpADSGALLTRVEPAGHYEQLSEH 979
Cdd:cd08952 2 RRRRRERAAVDSWRYRVTWRPLPDPPAA--RLTGTwlvVVPAGADDALAAAVARAL--AAAGAEVVVLEVDAADADAAAA 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 980 AFRLRPESEEDWDAlfqalqsqgrlprrILHAWALTAEPGPCTPDGEAVLEqgffSLLRLARALGRHAPERPvqLEVLSS 1059
Cdd:cd08952 78 AALAAAAAGGPVAG--------------VLSLLALDERPHPDHPAVPAGLA----ATLALVQALGDAGVDAP--LWCVTR 137
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1060 FVHAVGPREPL-EPLKATLLGACAVLPLEYPHVQCRTIDVRPGSEPRevLVRSLAAELAAPMGESPVAWRDGQRYVRRAT 1138
Cdd:cd08952 138 GAVAVGPDDPLpDPAQAAVWGLGRVAALEHPDRWGGLVDLPADLDAR--ALRRLAAVLAGAGGEDQVAVRASGVFARRLV 215
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1139 RQRLEASRP----------------------LRSLRERGVylvagglggiglvlaralaqrararlallthspfppreqw 1196
Cdd:cd08952 216 RAPAPAPAArpwrprgtvlvtggtgalgahvARWLARRGA---------------------------------------- 255
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1197 EQWL------EEAPAHPEPAwrseadpserrrtqhrirclLELEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGkIHGV 1270
Cdd:cd08952 256 EHLVltsrrgPDAPGAAELV--------------------AELTALGARVTVAACDVADRDALAALLAALPAGHP-LTAV 314
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1271 LHAAATFDDGVIQLRTHEQSSRALRTKVRGSMVLHEVLASEGLDWFALCSSLASALGSFGQADYCAANAFQDAYAHHLRR 1350
Cdd:cd08952 315 VHAAGVLDDGPLDDLTPERLAEVLRAKVAGARHLDELTRDRDLDAFVLFSSIAGVWGSGGQGAYAAANAYLDALAERRRA 394
|
490 500 510
....*....|....*....|....*....|..
gi 53747904 1351 QGFTgALALDWGTWRDTGAAMRLVAR--TRRG 1380
Cdd:cd08952 395 RGLP-ATSVAWGPWAGGGMAAGAAAErlRRRG 425
|
|
| PLN02752 |
PLN02752 |
[acyl-carrier protein] S-malonyltransferase |
531-817 |
8.58e-27 |
|
[acyl-carrier protein] S-malonyltransferase
Pssm-ID: 215401 [Multi-domain] Cd Length: 343 Bit Score: 114.86 E-value: 8.58e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 531 RPPLVMLFPGQGTPLVGTARALHE---SEPTFRQAveqcarllRQTLGLDVREVLFpsaeqEEQARRLAAqTRVAQPALF 607
Cdd:PLN02752 37 KPTTAFLFPGQGAQAVGMGKEAAEvpaAKALFDKA--------SEILGYDLLDVCV-----NGPKEKLDS-TVVSQPAIY 102
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 608 TLEYALAQTWLGWGLQPQAL------AGHSLGELVAACLAGVFSLEDALQLVAARGQLMQGC---PPGAMLAV------- 671
Cdd:PLN02752 103 VASLAAVEKLRARDGGQAVIdsvdvcAGLSLGEYTALVFAGALSFEDGLKLVKLRGEAMQAAadaGPSGMVSVigldsdk 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 672 --PLPEAELAALLGSELC-IAAVNGPRACVASGPLPAVEALTAALESRGV-SSRRLETSHAFHSASMEACQGPLTTLLRR 747
Cdd:PLN02752 183 vqELCAAANEEVGEDDVVqIANYLCPGNYAVSGGKKGIDAVEAKAKSFKArMTVRLAVAGAFHTSFMEPAVDALEAALAA 262
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 748 MRLQAPRLPCVSGLTGRwLTGEEATEPTYWARQLREPVRFSEALETLWSLKEPVLLEVGPGTTLTALARR 817
Cdd:PLN02752 263 VEIRTPRIPVISNVDAQ-PHSDPATIKKILARQVTSPVQWETTVKTLLEKGLEKSYELGPGKVIAGIVKR 331
|
|
| AdhP |
COG1064 |
D-arabinose 1-dehydrogenase, Zn-dependent alcohol dehydrogenase family [Carbohydrate transport ... |
1693-1986 |
1.07e-26 |
|
D-arabinose 1-dehydrogenase, Zn-dependent alcohol dehydrogenase family [Carbohydrate transport and metabolism];
Pssm-ID: 440684 [Multi-domain] Cd Length: 332 Bit Score: 114.05 E-value: 1.07e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1693 RPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALeAEESVLGRECSGRIAAVGEGVSGLRVGDEVlAVAP--GC------- 1763
Cdd:COG1064 20 RPEPGPGEVLVKVEACGVCHSDLHVAEGEWPVP-KLPLVPGHEIVGRVVAVGPGVTGFKVGDRV-GVGWvdSCgtceycr 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1764 --------------------FRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGrLRRGERILI-------H 1816
Cdd:COG1064 98 sgrenlcengrftgyttdggYAEYVVVPARFLVKLPDGLDPAEAAPLLCAGITAYRALRRAG-VGPGDRVAVigagglgH 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1817 AaagglglaAVQLASRTGAEILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTggrGVDVVLN-SLAGELLLAGL 1895
Cdd:COG1064 177 L--------AVQIAKALGAEVIAVDRSPEKLELARELGADHVVNSSDEDPVEAVRELT---GADVVIDtVGAPATVNAAL 245
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1896 SVLAPHGRFLelgkrdlyadqQVGL----------RTLARGQTFAaidfGPHH---PDFRAVLEEVAtqltQGQLEPLpT 1962
Cdd:COG1064 246 ALLRRGGRLV-----------LVGLpggpiplppfDLILKERSIR----GSLIgtrADLQEMLDLAA----EGKIKPE-V 305
|
330 340
....*....|....*....|....
gi 53747904 1963 RLFPARQVAEAFSFMARALHIGRV 1986
Cdd:COG1064 306 ETIPLEEANEALERLRAGKVRGRA 329
|
|
| PRK13295 |
PRK13295 |
cyclohexanecarboxylate-CoA ligase; Reviewed |
2652-3134 |
2.11e-26 |
|
cyclohexanecarboxylate-CoA ligase; Reviewed
Pssm-ID: 171961 [Multi-domain] Cd Length: 547 Bit Score: 117.08 E-value: 2.11e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2652 PELPALLAPE------RTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAylpLDPEQPPL 2725
Cdd:PRK13295 38 PDKTAVTAVRlgtgapRRFTYRELAALVDRVAVGLARLGVGRGDVVSCQLPNWWEFTVLYLACSRIGAV---LNPLMPIF 114
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2726 RLHQL---LEEGPARVVLTQSSL-----------LHTvPWPPGVQVIAVD----------------ELEPATEAPPLPPR 2775
Cdd:PRK13295 115 RERELsfmLKHAESKVLVVPKTFrgfdhaamarrLRP-ELPALRHVVVVGgdgadsfeallitpawEQEPDAPAILARLR 193
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2776 GTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALtfdlsvydvLGLLGAGGALVLPAAEA 2855
Cdd:PRK13295 194 PGPDDVTQLIYTSGTTGEPKGVMHTANTLMANIVPYAERLGLGADDVILMASPM---------AHQTGFMYGLMMPVMLG 264
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2856 EK-------DPAHWWERLVAGRVT-VWNSTPALMlLLVEYAEQRGLKLPaALRLVMLSGDWIPVALPDRIRA-LGrdVQV 2926
Cdd:PRK13295 265 ATavlqdiwDPARAAELIRTEGVTfTMASTPFLT-DLTRAVKESGRPVS-SLRTFLCAGAPIPGALVERARAaLG--AKI 340
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2927 VSLGGATEASIWSIAYPigQVAPQWKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFi 3006
Cdd:PRK13295 341 VSAWGMTENGAVTLTKL--DDPDERASTTDGCPLPGVEVRVVDADGAPLPAGQIGRLQVRGCSNFGGYLKRPQLNGTDA- 417
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3007 rhprtgERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPR 3086
Cdd:PRK13295 418 ------DGWFDTGDLARIDADGYIRISGRSKDVIIRGGENIPVVEIEALLYRHPAIAQVAIVAYPDERLGERACAFVVPR 491
|
490 500 510 520
....*....|....*....|....*....|....*....|....*....
gi 53747904 3087 SGQTPAAGELRRYL-AERLPAYMVPSAFVLLESLPRSRNGKIARDQLPE 3134
Cdd:PRK13295 492 PGQSLDFEEMVEFLkAQKVAKQYIPERLVVRDALPRTPSGKIQKFRLRE 540
|
|
| enoyl_reductase_like |
cd08249 |
enoyl_reductase_like; Member identified as possible enoyl reductase of the MDR family. 2-enoyl ... |
1694-1966 |
3.53e-26 |
|
enoyl_reductase_like; Member identified as possible enoyl reductase of the MDR family. 2-enoyl thioester reductase (ETR) catalyzes the NADPH-dependent dependent conversion of trans-2-enoyl acyl carrier protein/coenzyme A (ACP/CoA) to acyl-(ACP/CoA) in fatty acid synthesis. 2-enoyl thioester reductase activity has been linked in Candida tropicalis as essential in maintaining mitiochondrial respiratory function. This ETR family is a part of the medium chain dehydrogenase/reductase family, but lack the zinc coordination sites characteristic of the alcohol dehydrogenases in this family. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site, and a structural zinc in a lobe of the catalytic domain. NAD(H)-binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. Candida tropicalis enoyl thioester reductase (Etr1p) catalyzes the NADPH-dependent reduction of trans-2-enoyl thioesters in mitochondrial fatty acid synthesis. Etr1p forms homodimers with each subunit containing a nucleotide-binding Rossmann fold domain and a catalytic domain.
Pssm-ID: 176211 [Multi-domain] Cd Length: 339 Bit Score: 112.68 E-value: 3.53e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAGLNFLDV----LGALGMMPAleaeesVLGRECSGRIAAVGEGVSGLRVGDEVLAVAPGC------ 1763
Cdd:cd08249 22 PKPGPDEVLVKVKAVALNPVDWkhqdYGFIPSYPA------ILGCDFAGTVVEVGSGVTRFKVGDRVAGFVHGGnpndpr 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1764 ---FRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLR----------RGERILIHAAAGGLGLAAVQLA 1830
Cdd:cd08249 96 ngaFQEYVVADADLTAKIPDNISFEEAATLPVGLVTAALALFQKLGLPlpppkpspasKGKPVLIWGGSSSVGTLAIQLA 175
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1831 SRTGAEILATAgSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGR---GVDVVlnsLAGELLLAGLSVLAPH--GRFL 1905
Cdd:cd08249 176 KLAGYKVITTA-SPKNFDLVKSLGADAVFDYHDPDVVEDIRAATGGKlryALDCI---STPESAQLCAEALGRSggGKLV 251
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 53747904 1906 ELGKRDLYADQQVGLRTlarGQTFAAIDFG--PHHPDFRAVLEEVATQ-LTQGQLEPLPTRLFP 1966
Cdd:cd08249 252 SLLPVPEETEPRKGVKV---KFVLGYTVFGeiPEDREFGEVFWKYLPElLEEGKLKPHPVRVVE 312
|
|
| KR_3_FAS_SDR_x |
cd08956 |
beta-ketoacyl reductase (KR) domain of fatty acid synthase (FAS), subgroup 3, complex (x); ... |
1232-1381 |
4.72e-26 |
|
beta-ketoacyl reductase (KR) domain of fatty acid synthase (FAS), subgroup 3, complex (x); Ketoreductase, a module of the multidomain polyketide synthase (PKS), has 2 subdomains, each corresponding to a SDR family monomer. The C-terminal subdomain catalyzes the NADPH-dependent reduction of the beta-carbonyl of a polyketide to a hydroxyl group, a step in the biosynthesis of polyketides, such as erythromycin. The N-terminal subdomain, an interdomain linker, is a truncated Rossmann fold which acts to stabilizes the catalytic subdomain. Unlike typical SDRs, the isolated domain does not oligomerize but is composed of 2 subdomains, each resembling an SDR monomer. The active site resembles that of typical SDRs, except that the usual positions of the catalytic Asn and Tyr are swapped, so that the canonical YXXXK motif changes to YXXXN. Modular PKSs are multifunctional structures in which the makeup recapitulates that found in (and may have evolved from) FAS. In some instances, such as porcine FAS, an enoyl reductase (ER) module is inserted between the sub-domains. Fatty acid synthesis occurs via the stepwise elongation of a chain (which is attached to acyl carrier protein, ACP) with 2-carbon units. Eukaryotic systems consists of large, multifunctional synthases (type I) while bacterial, type II systems, use single function proteins. Fungal fatty acid synthesis uses a dodecamer of 6 alpha and 6 beta subunits. In mammalian type FAS cycles, ketoacyl synthase forms acetoacetyl-ACP which is reduced by the NADP-dependent beta-KR, forming beta-hydroxyacyl-ACP, which is in turn dehydrated by dehydratase to a beta-enoyl intermediate, which is reduced by NADP-dependent beta- ER. Polyketide synthesis also proceeds via the addition of 2-carbon units as in fatty acid synthesis. The complex SDR NADP-binding motif, GGXGXXG, is often present, but is not strictly conserved in each instance of the module. This subfamily includes KR domains found in many multidomain PKSs, including six of seven Sorangium cellulosum PKSs (encoded by spiDEFGHIJ) which participate in the synthesis of the polyketide scaffold of the cytotoxic spiroketal polyketide spirangien. These seven PKSs have either a single PKS module (SpiF), two PKR modules (SpiD,-E,-I,-J), or three PKS modules (SpiG,-H). This subfamily includes the second KR domains of SpiE,-G, I, and -J, both KR domains of SpiD, and the third KR domain of SpiH. The single KR domain of SpiF, the first and second KR domains of SpiH, the first KR domains of SpiE,-G,- I, and -J, and the third KR domain of SpiG, belong to a different KR_FAS_SDR subfamily. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold (alpha/beta folding pattern with a central beta-sheet), an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Classical SDRs are typically about 250 residues long, while extended SDRs are approximately 350 residues. Sequence identity between different SDR enzymes are typically in the 15-30% range, but the enzymes share the Rossmann fold NAD-binding motif and characteristic NAD-binding and catalytic sequence patterns. These enzymes catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human prostaglandin dehydrogenase (PGDH) numbering). In addition to the Tyr and Lys, there is often an upstream Ser (Ser-138, PGDH numbering) and/or an Asn (Asn-107, PGDH numbering) contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Extended SDRs have additional elements in the C-terminal region, and typically have a TGXXGXXG cofactor binding motif. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type KRs have a TGXXXGX(1-2)G NAD(P)-binding motif. Some atypical SDRs have lost catalytic activity and/or have an unusual NAD(P)-binding motif and missing or unusual active site residues. Reactions catalyzed within the SDR family include isomerization, decarboxylation, epimerization, C=N bond reduction, dehydratase activity, dehalogenation, Enoyl-CoA reduction, and carbonyl-alcohol oxidoreduction.
Pssm-ID: 187659 [Multi-domain] Cd Length: 448 Bit Score: 114.67 E-value: 4.72e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1232 ELEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGkIHGVLHAAATFDDGVIQLRTHEQSSRALRTKVRGSMVLHEVLASE 1311
Cdd:cd08956 241 ELAALGAEVTVAACDVADRAALAALLAAVPADHP-LTAVVHAAGVLDDGVLTSLTPERLDAVLRPKVDAAWHLHELTRDL 319
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 1312 GLDWFALCSSLASALGSFGQADYCAANAFQDAYAHHLRRQGFTgALALDWGTWRDTGAAMRL-----VARTRRGG 1381
Cdd:cd08956 320 DLAAFVLFSSAAGVLGSPGQANYAAANAFLDALAQHRRARGLP-ATSLAWGLWAQASGMTAHlsdadLARLARGG 393
|
|
| MDR_enoyl_red |
cd08244 |
Possible enoyl reductase; Member identified as possible enoyl reductase of the MDR family. ... |
1684-1973 |
4.73e-26 |
|
Possible enoyl reductase; Member identified as possible enoyl reductase of the MDR family. 2-enoyl thioester reductase (ETR) catalyzes the NADPH-dependent dependent conversion of trans-2-enoyl acyl carrier protein/coenzyme A (ACP/CoA) to acyl-(ACP/CoA) in fatty acid synthesis. 2-enoyl thioester reductase activity has been linked in Candida tropicalis as essential in maintaining mitiochondrial respiratory function. This ETR family is a part of the medium chain dehydrogenase/reductase family, but lack the zinc coordination sites characteristic of the alcohol dehydrogenases in this family. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site, and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. Candida tropicalis enoyl thioester reductase (Etr1p) catalyzes the NADPH-dependent reduction of trans-2-enoyl thioesters in mitochondrial fatty acid synthesis. Etr1p forms homodimers, with each subunit containing a nucleotide-binding Rossmann fold domain and a catalytic domain.
Pssm-ID: 176206 [Multi-domain] Cd Length: 324 Bit Score: 112.08 E-value: 4.73e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1684 ESLGLRRCTRPAPGPRQVEIEVEAAGLNFLD--VLGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGDEV---LA 1758
Cdd:cd08244 13 EVLVPEDVPDPVPGPGQVRIAVAAAGVHFVDtqLRSGWGPGPFPPELPYVPGGEVAGVVDAVGPGVDPAWLGRRVvahTG 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1759 VAPGCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAyFALHTVGRLRRGERILIHAAAGGLGLAAVQLASRTGAEIL 1838
Cdd:cd08244 93 RAGGGYAELAVADVDSLHPVPDGLDLEAAVAVVHDGRTA-LGLLDLATLTPGDVVLVTAAAGGLGSLLVQLAKAAGATVV 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1839 ATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELGKRDLYADQQV 1918
Cdd:cd08244 172 GAAGGPAKTALVRALGADVAVDYTRPDWPDQVREALGGGGVTVVLDGVGGAIGRAALALLAPGGRFLTYGWASGEWTALD 251
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*.
gi 53747904 1919 GLRTLARGQT-FAAIDFGPHHPDFRAVLEEVATQLTQGQLEPLPTRLFPARQVAEA 1973
Cdd:cd08244 252 EDDARRRGVTvVGLLGVQAERGGLRALEARALAEAAAGRLVPVVGQTFPLERAAEA 307
|
|
| PRK08722 |
PRK08722 |
beta-ketoacyl-ACP synthase II; |
13-437 |
4.86e-26 |
|
beta-ketoacyl-ACP synthase II;
Pssm-ID: 181539 [Multi-domain] Cd Length: 414 Bit Score: 113.94 E-value: 4.86e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 13 IALVGMAGRFPGAPDVESFWRNLVAGVESISffSEEELRQAGVSEQIrrrpeyvpaKGVLEDlelFDAGFFgYSPREASH 92
Cdd:PRK08722 6 VVVTGMGMLSPVGNTVESSWKALLAGQSGIV--NIEHFDTTNFSTRF---------AGLVKD---FNCEEY-MSKKDARK 70
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 93 LDPQQRLLLECSWEALEDAGLR-PDQLPGWVGVYVGAGDTSYRFqLLRGHGDPLS-GSKDVAGFFgnYPDFLATRVAYKL 170
Cdd:PRK08722 71 MDLFIQYGIAAGIQALDDSGLEvTEENAHRIGVAIGSGIGGLGL-IEAGHQALVEkGPRKVSPFF--VPSTIVNMIAGNL 147
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 171 N----LRGPALGIHTACSTSLVSINMACSALRGFECDMALAGGVS-LRLPARSGYLYEEGGVASKDGH----CRPFDARA 241
Cdd:PRK08722 148 SimrgLRGPNIAISTACTTGLHNIGHAARMIAYGDADAMVAGGAEkASTPLGMAGFGAAKALSTRNDEpqkaSRPWDKDR 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 242 TGTVTGDGVGVVVLKRLEDAlKARDP-IHAVIRGWALNNDGASragFTAPSVEGQSEVIALAHAA--AGISARDITYVEA 318
Cdd:PRK08722 228 DGFVLGDGAGMMVLEEYEHA-KARGAkIYAELVGFGMSGDAYH---MTSPSEDGSGGALAMEAAMrdAGVTGEQIGYVNA 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 319 HGTGTPLGDPIEVAALTRAFRAHTADTAFCTlgAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERPNPALHLEQ 398
Cdd:PRK08722 304 HGTSTPAGDVAEIKGIKRALGEAGSKQVLVS--STKSMTGHLLGAAGSVEAIITVMSLVDQIVPPTINLDDPEEGLDIDL 381
|
410 420 430
....*....|....*....|....*....|....*....
gi 53747904 399 SPFFVntqplpwESPRGPRLAGVSSFGIGGTNAHTLFEE 437
Cdd:PRK08722 382 VPHTA-------RKVESMEYAICNSFGFGGTNGSLIFKK 413
|
|
| PRK08314 |
PRK08314 |
long-chain-fatty-acid--CoA ligase; Validated |
2648-3134 |
5.00e-26 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236235 [Multi-domain] Cd Length: 546 Bit Score: 116.21 E-value: 5.00e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPALLAPERTLSYGELARRAQALAA-RLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLR 2726
Cdd:PRK08314 20 ARRYPDKTAIVFYGRAISYRELLEEAERLAGyLQQECGVRKGDRVLLYMQNSPQFVIAYYAILRANAVVVPVNPMNREEE 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2727 LHQLLEEGPARVVLTQSSLL-------------H--------TVPWPPGVQVIAVDELEPATEA---------------- 2769
Cdd:PRK08314 100 LAHYVTDSGARVAIVGSELApkvapavgnlrlrHvivaqysdYLPAEPEIAVPAWLRAEPPLQAlapggvvawkealaag 179
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2770 -PPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALtFDL---------SVYDVL 2839
Cdd:PRK08314 180 lAPPPHTAGPDDLAVLPYTSGTTGVPKGCMHTHRTVMANAVGSVLWSNSTPESVVLAVLPL-FHVtgmvhsmnaPIYAGA 258
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2840 GLLGAGGalvlpaaeaekdpahwWERLVAG------RVTVWNSTPALM--LLLVEYAEQRGLklpAALRLVMLSGDWIPV 2911
Cdd:PRK08314 259 TVVLMPR----------------WDREAAArlieryRVTHWTNIPTMVvdFLASPGLAERDL---SSLRYIGGGGAAMPE 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2912 ALPDRIRAL-GrdVQVVSLGGATEASIWSIAYPIGQVAPQWKSIPYgmplanqrFHVlDGR------LEARPWWVPGELY 2984
Cdd:PRK08314 320 AVAERLKELtG--LDYVEGYGLTETMAQTHSNPPDRPKLQCLGIPT--------FGV-DARvidpetLEELPPGEVGEIV 388
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2985 IGGEGLAREYWRDEPLTATRFIRhpRTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSA 3064
Cdd:PRK08314 389 VHGPQVFKGYWNRPEATAEAFIE--IDGKRFFRTGDLGRMDEEGYFFITDRLKRMINASGFKVWPAEVENLLYKHPAIQE 466
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 53747904 3065 SVVVARGEPRGVRRLVAYAVPRSGQ--TPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPE 3134
Cdd:PRK08314 467 ACVIATPDPRRGETVKAVVVLRPEArgKTTEEEIIAWAREHMAAYKYPRIVEFVDSLPKSGSGKILWRQLQE 538
|
|
| COG4908 |
COG4908 |
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General ... |
2206-2421 |
6.05e-26 |
|
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General function prediction only];
Pssm-ID: 443936 [Multi-domain] Cd Length: 243 Bit Score: 109.36 E-value: 6.05e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2206 HGYFEIESPgLEVERFIQCWRQLLQRHDMLRMV-VLPDGR-QQVLEQVPEYTPEVVELRGLSPQEAESRRLQLRERMAHQ 2283
Cdd:COG4908 21 PAVLRLEGP-LDVEALERALRELVRRHPALRTRfVEEDGEpVQRIDPDADLPLEVVDLSALPEPEREAELEELVAEEASR 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2284 VLRSDRWPLFELVL-CRYEGGVRIHMSMDALMLDAWSSAVLRQDFAQLYHEPGR----PLEPLAITFRDYVLAERRLREG 2358
Cdd:COG4908 100 PFDLARGPLLRAALiRLGEDEHVLLLTIHHIISDGWSLGILLRELAALYAALLEgeppPLPELPIQYADYAAWQRAWLQS 179
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 53747904 2359 EAHERARAYWWARLDTLPPPPELPLVKEPSQLEHARFTHREARLEPHRWARLQERARAHGLTP 2421
Cdd:COG4908 180 EALEKQLEYWRQQLAGAPPVLELPTDRPRPAVQTFRGATLSFTLPAELTEALKALAKAHGATV 242
|
|
| CHC_CoA_lg |
cd05903 |
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); ... |
2663-3134 |
7.53e-26 |
|
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); Cyclohexanecarboxylate-CoA ligase activates the aliphatic ring compound, cyclohexanecarboxylate, for degradation. It catalyzes the synthesis of cyclohexanecarboxylate-CoA thioesters in a two-step reaction involving the formation of cyclohexanecarboxylate-AMP anhydride, followed by the nucleophilic substitution of AMP by CoA.
Pssm-ID: 341229 [Multi-domain] Cd Length: 437 Bit Score: 114.01 E-value: 7.53e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2663 TLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLdpeQPPLRLHQL---LEEGPARVV 2739
Cdd:cd05903 1 RLTYSELDTRADRLAAGLAALGVGPGDVVAFQLPNWWEFAVLYLACLRIGAVTNPI---LPFFREHELafiLRRAKAKVF 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2740 LTQSSLLHTVPWPpgvqviavdelepateapplpprgTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGP 2819
Cdd:cd05903 78 VVPERFRQFDPAA------------------------MPDAVALLLFTSGTTGEPKGVMHSHNTLSASIRQYAERLGLGP 133
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2820 EDRVLGLSALT-FDLSVYdvlgLLGAGGALVLPAAEAEK-DPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPa 2897
Cdd:cd05903 134 GDVFLVASPMAhQTGFVY----GFTLPLLLGAPVVLQDIwDPDKALALMREHGVTFMMGATPFLTDLLNAVEEAGEPLS- 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2898 ALRLVMLSGDWIPVALPDRIRALGRDVqVVSLGGATEASIWSIAYPIGQVAPQWKSipYGMPLANQRFHVLDGRLEARPW 2977
Cdd:cd05903 209 RLRTFVCGGATVPRSLARRAAELLGAK-VCSAYGSTECPGAVTSITPAPEDRRLYT--DGRPLPGVEIKVVDDTGATLAP 285
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2978 WVPGELYIGGEGLAREYWRDEPLTATRFirhprtGERLYRTGDQGRMLPEGSIEFLGR-EDLQVKvQGFRVELGEIEAAL 3056
Cdd:cd05903 286 GVEGELLSRGPSVFLGYLDRPDLTADAA------PEGWFRTGDLARLDEDGYLRITGRsKDIIIR-GGENIPVLEVEDLL 358
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 53747904 3057 AQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYL-AERLPAYMVPSAFVLLESLPRSRNGKIARDQLPE 3134
Cdd:cd05903 359 LGHPGVIEAAVVALPDERLGERACAVVVTKSGALLTFDELVAYLdRQGVAKQYWPERLVHVDDLPRTPSGKVQKFRLRE 437
|
|
| PRK07103 |
PRK07103 |
polyketide beta-ketoacyl:acyl carrier protein synthase; Validated |
98-431 |
9.38e-26 |
|
polyketide beta-ketoacyl:acyl carrier protein synthase; Validated
Pssm-ID: 180839 [Multi-domain] Cd Length: 410 Bit Score: 113.20 E-value: 9.38e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 98 RLLLECSWEALEDAGLRPDQlPGWVGVYVGAGDTSYRFQLLrghgdplsgskdVAGFFGNYPDFLATR------------ 165
Cdd:PRK07103 82 QAALAAAREAWRDAALGPVD-PDRIGLVVGGSNLQQREQAL------------VHETYRDRPAFLRPSyglsfmdtdlvg 148
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 166 -VAYKLNLRGPALGIHTACSTSLVSINMACSALRGFECDMALAGGVSLRLP-------ARSGYLYEEGGVASKDGHCRPF 237
Cdd:PRK07103 149 lCSEQFGIRGEGFTVGGASASGQLAVIQAARLVQSGSVDACIAVGALMDLSywecqalRSLGAMGSDRFADEPEAACRPF 228
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 238 DARATGTVTGDGVGVVVLKRLEDALKARDPIHAVIRGWALNNDGASRagfTAPSVEGQSEVIALAHAAAGISARDITYVE 317
Cdd:PRK07103 229 DQDRDGFIYGEACGAVVLESAESARRRGARPYAKLLGWSMRLDANRG---PDPSLEGEMRVIRAALRRAGLGPEDIDYVN 305
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 318 AHGTGTPLGDPIEVAALTRAFRAHtadtafCTLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERP-NPALHl 396
Cdd:PRK07103 306 PHGTGSPLGDETELAALFASGLAH------AWINATKSLTGHGLSAAGIVELIATLLQMRAGFLHPSRNLDEPiDERFR- 378
|
330 340 350
....*....|....*....|....*....|....*
gi 53747904 397 eqspfFVNTQPLPWESprgpRLAGVSSFGIGGTNA 431
Cdd:PRK07103 379 -----WVGSTAESARI----RYALSLSFGFGGINT 404
|
|
| MACS_like_2 |
cd05973 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
2664-3129 |
8.67e-25 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341277 [Multi-domain] Cd Length: 437 Bit Score: 110.69 E-value: 8.67e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2664 LSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQS 2743
Cdd:cd05973 1 LTFGELRALSARFANALQELGVGPGDVVAGLLPRTPELVVTILGIWRLGAVYQPLFTAFGPKAIEHRLRTSGARLVVTDA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2744 SLLHTVPWPPGVQviavdelepateapplpprgtpehlayvIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRV 2823
Cdd:cd05973 81 ANRHKLDSDPFVM----------------------------MFTSGTTGLPKGVPVPLRALAAFGAYLRDAVDLRPEDSF 132
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2824 LGLSALTFDLSVYdvlgllgaggalvlpaaEAEKDPahwwerLVAGRVTVWN----STPALMLLLVEYAEQRGLKLPAAL 2899
Cdd:cd05973 133 WNAADPGWAYGLY-----------------YAITGP------LALGHPTILLeggfSVESTWRVIERLGVTNLAGSPTAY 189
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2900 RLVMLSGDWIPVALPDRIRalgrdvqVVSLGG---ATEASIWSIAYPIGQVAPQWKSIPYGMPLANQ------------- 2963
Cdd:cd05973 190 RLLMAAGAEVPARPKGRLR-------RVSSAGeplTPEVIRWFDAALGVPIHDHYGQTELGMVLANHhalehpvhagsag 262
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2964 ------RFHVLDGRLEARPWWVPGELYIGGeglareywRDEPLTATRFIRHPRTGE---RLYRTGDQGRMLPEGSIEFLG 3034
Cdd:cd05973 263 rampgwRVAVLDDDGDELGPGEPGRLAIDI--------ANSPLMWFRGYQLPDTPAidgGYYLTGDTVEFDPDGSFSFIG 334
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3035 REDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQ--TPA-AGELRRYLAERLPAYMVPS 3111
Cdd:cd05973 335 RADDVITMSGYRIGPFDVESALIEHPAVAEAAVIGVPDPERTEVVKAFVVLRGGHegTPAlADELQLHVKKRLSAHAYPR 414
|
490
....*....|....*...
gi 53747904 3112 AFVLLESLPRSRNGKIAR 3129
Cdd:cd05973 415 TIHFVDELPKTPSGKIQR 432
|
|
| ArgR-Cyc_NRPS-like |
cd20480 |
Cyc (heterocyclization)-like domain of Vibrio anguillarum AngR and similar proteins; belongs ... |
2208-2606 |
9.44e-25 |
|
Cyc (heterocyclization)-like domain of Vibrio anguillarum AngR and similar proteins; belongs to the Condensation-domain family; Vibrio anguillarum AngR plays a role in regulating the expression of iron transport genes as well as in the production of the siderophore anguibactin. Cyc-domains are a type of Condensation (C) domain. Cyc-domains catalyze two separate reactions in the creation of heterocyclized peptide products in nonribosomal peptide synthesis: amide bond formation followed by intramolecular cyclodehydration between a Cys, Ser, or Thr side chain and a carbonyl carbon on the peptide backbone to form a thiazoline, oxazoline, or methyloxazoline ring. C-domains typically have a conserved HHxxxD motif at the active site; Cyc-domains have a alternative, conserved DxxxxD active site motif, mutation of the aspartate residues in this motif can abolish or diminish condensation activity. Members of this subfamily have an SxxxD motif at the active site. C-domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to Cyc-domains there are various other subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380470 [Multi-domain] Cd Length: 406 Bit Score: 109.90 E-value: 9.44e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2208 YFEIESPGLEVERFIQCWRQLLQRHDMLRMVVLPDGRQQVLEQVPEYTPEVVELRGLSPQEAEsrrlqlrERMAH---QV 2284
Cdd:cd20480 29 YQEFDYENISVDTLERCLTVLINHHPMLHALLSDDFYLHINSKNQIDAFAVNDLSSASEQEAA-------EQLARtraTL 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2285 LRSDRWPLFELVLCRYEGG-VRIHMSMDALMLDAWSSAVLRQDFAQLYHepGRPLEPLAITfrDYVLAERRLREGEAHE- 2362
Cdd:cd20480 102 TKSRSKATISVVLSLLPANkIRLHVRFNSVVVDHPSVNLFFEQLCQLLR--GSLLSFLAQE--QVILAHNQLVISELQSt 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2363 -RARAYWWARLDTLPPPPELPLVKEPSQLEHARFTHREARLEPHRWARLQERARAHGLTPSAACMAAFAEVLARWSRHPR 2441
Cdd:cd20480 178 gLSSAFWNEQILQLPSSANLPTVCEPEKLRETGITRRTLTLSSDKWQQLVTISKQHNVTPELTLASIFSAVLSLWGNQKD 257
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2442 FTLnltlfqRLPLHPQVD--ELVGDFTSLVLLEVEAHAAStFAERASRLQAQLWRDLEHGSVSAVQLIRELVRT--GRRS 2517
Cdd:cd20480 258 MML------RFDLNKKNDvaGVIGQFTQPLLVGLSGFGQS-FLSLVKENQKHFEQAYPFRQIPIFDLVRQLAKLseSHRY 330
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2518 PGAImpvVFTSILSldarrGPQGSlsffeGELVYSISQTPQVWLD-HGVHEEEGaLVLAWDSVEALFPPGMVDDMFHAYQ 2596
Cdd:cd20480 331 PANI---AFSSQLS-----GNNTL-----GRSGWGCRQSANTWLSlHAFISQGG-LILQWDSQDALFPKDMIQDMLTSYS 396
|
410
....*....|
gi 53747904 2597 RLLGALAEEE 2606
Cdd:cd20480 397 KLLESLSQSD 406
|
|
| ACS-like |
cd17634 |
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the ... |
2662-3127 |
1.63e-24 |
|
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases. The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341289 [Multi-domain] Cd Length: 587 Bit Score: 111.90 E-value: 1.63e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2662 RTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLT 2741
Cdd:cd17634 83 RTISYRELHREVCRFAGTLLDLGVKKGDRVAIYMPMIPEAAVAMLACARIGAVHSVIFGGFAPEAVAGRIIDSSSRLLIT 162
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2742 QSSLLH---TVPWPPGV------------QVIAVDELEPATEAPP------------LPPRGTPEHLA-----YVIYTSG 2789
Cdd:cd17634 163 ADGGVRagrSVPLKKNVddalnpnvtsveHVIVLKRTGSDIDWQEgrdlwwrdliakASPEHQPEAMNaedplFILYTSG 242
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2790 STGKPKGVAIEHRA-ALNTVVDLNTRFGVGPEDRVLGLSALTFDLS----VYDVLGLLGAGGALVlpAAEAEKDPAHWWE 2864
Cdd:cd17634 243 TTGKPKGVLHTTGGyLVYAATTMKYVFDYGPGDIYWCTADVGWVTGhsylLYGPLACGATTLLYE--GVPNWPTPARMWQ 320
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2865 RLVAGRVTVWNSTP----ALMLLLVEYAEQRGLklpAALRLVMLSGD-WIPVALPDRIRALGRD-VQVVSLGGATEASiW 2938
Cdd:cd17634 321 VVDKHGVNILYTAPtairALMAAGDDAIEGTDR---SSLRILGSVGEpINPEAYEWYWKKIGKEkCPVVDTWWQTETG-G 396
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2939 SIAYPIGQVAPQWKSIPYgMPLANQRFHVLDGRLEARPWWVPGELYIGGE--GLAREYWRDEPltaTRFIRHPRTGERLY 3016
Cdd:cd17634 397 FMITPLPGAIELKAGSAT-RPVFGVQPAVVDNEGHPQPGGTEGNLVITDPwpGQTRTLFGDHE---RFEQTYFSTFKGMY 472
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3017 RTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAG-- 3094
Cdd:cd17634 473 FSGDGARRDEDGYYWITGRSDDVINVAGHRLGTAEIESVLVAHPKVAEAAVVGIPHAIKGQAPYAYVVLNHGVEPSPEly 552
|
490 500 510
....*....|....*....|....*....|....
gi 53747904 3095 -ELRRYLAERLPAYMVPSAFVLLESLPRSRNGKI 3127
Cdd:cd17634 553 aELRNWVRKEIGPLATPDVVHWVDSLPKTRSGKI 586
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
2083-2642 |
2.45e-24 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 113.51 E-value: 2.45e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2083 PPSSLEQLIEQVWRKHLGVERVQPTDSFFQLGGDSLLGIQVAADLRRhLGVELPTATLFSHPTLAALAAALRARQGEAAA 2162
Cdd:PRK12316 3553 PVNELERRLAAIWADVLKLEQVGLTDNFFELGGDSIISLQVVSRARQ-AGIRFTPKDLFQHQTIQGLARVARVGGGVAVD 3631
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2163 PTAPAPALVPDPAARfEPFPLtDVQEAYWVGRRSAFELGGVaahgyfeiespgLEVERFIQCWRQLLQRHDMLRMVVLPD 2242
Cdd:PRK12316 3632 QGPVSGETLLLPIQQ-QFFEE-PVPERHHWNQSLLLKPREA------------LDAAALEAALQALVEHHDALRLRFVED 3697
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2243 GRQQVLEQVPeytpevVELRGLSPQEAESRRLQLRERMAHQVLRS---DRWPLFELVLCRY-EGGVRIHMSMDALMLDAW 2318
Cdd:PRK12316 3698 AGGWTAEHLP------VELGGALLWRAELDDAEELERLGEEAQRSldlADGPLLRALLATLaDGSQRLLLVIHHLVVDGV 3771
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2319 SSAVLRQDFAQLYH--EPGRP--LEPLAITFRDYVLAERRLREGEAHERARAYWWARLDTLPPPPELPLVKEPSQLEHAR 2394
Cdd:PRK12316 3772 SWRILLEDLQQAYQqlLQGEAprLPAKTSSFKAWAERLQEHARGEALKAELAYWQEQLQGVSSELPCDHPQGALQNRHAA 3851
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2395 ftHREARLEpHRWAR--LQERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRLPLHPQVD--ELVGDFTSLVL 2470
Cdd:PRK12316 3852 --SVQTRLD-RELTRrlLQQAPAAYRTQVNDLLLTALARVVCRWTGEASALVQLEGHGREDLFADIDlsRTVGWFTSLFP 3928
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2471 LEVEAHAASTFAERASRLQAQLWRDLEHGsvsaVQLIRELVRTGRRSPGAIMPV---VFTSILSLDARRGPQGSLSFFEG 2547
Cdd:PRK12316 3929 VRLSPVEDLGASIKAIKEQLRAIPNKGIG----FGLLRYLGDEESRRTLAGLPVpriTFNYLGQFDGSFDEEMALFVPAG 4004
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2548 ELVYSiSQTPQV----WLDHGVHEEEGALVLAWDSVEALFPPGMVDDMFHAYQRLLGALAEE--EQAWEGELPELLPPAQ 2621
Cdd:PRK12316 4005 ESAGA-EQSPDApldnWLSLNGRVYGGELSLDWTFSREMFEEATIQRLADDYAAELTALVEHccDAERHGVTPSDFPLAG 4083
|
570 580
....*....|....*....|.
gi 53747904 2622 relLARYNATQAPRPSGRLEE 2642
Cdd:PRK12316 4084 ---LDQARLDALPLPLGEIED 4101
|
|
| PRK05952 |
PRK05952 |
beta-ketoacyl-ACP synthase; |
106-431 |
3.13e-24 |
|
beta-ketoacyl-ACP synthase;
Pssm-ID: 235653 [Multi-domain] Cd Length: 381 Bit Score: 107.83 E-value: 3.13e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 106 EALEDAGLRPdQLPGWvGVYVGAgDTSYRFQLLRGHGDPLSG--SKDVAGFFGN----YPDFLATRVAYKLNLRGPALGI 179
Cdd:PRK05952 66 AALKDAGLTP-PLTDC-GVVIGS-SRGCQGQWEKLARQMYQGddSPDEELDLENwldtLPHQAAIAAARQIGTQGPVLAP 142
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 180 HTACSTSLVSINMACSALRGFECDMALAGGVSLRLPARSGYLYEEGGVASKDGhCRPFDARATGTVTGDGVGVVVLKRLE 259
Cdd:PRK05952 143 MAACATGLWAIAQGVELIQTGQCQRVIAGAVEAPITPLTLAGFQQMGALAKTG-AYPFDRQREGLVLGEGGAILVLESAE 221
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 260 DALKARDPIHAVIRGWALNNDGASRagfTAPSVEGQSEVIALAH--AAAGISARDITYVEAHGTGTPLGDPIEVAALTRA 337
Cdd:PRK05952 222 LAQKRGAKIYGQILGFGLTCDAYHM---SAPEPDGKSAIAAIQQclARSGLTPEDIDYIHAHGTATRLNDQREANLIQAL 298
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 338 FRAHTADTAfcTLGAVksniGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERPNPALHLEQSPffvNTQPLpwesprgpR 417
Cdd:PRK05952 299 FPHRVAVSS--TKGAT----GHTLGASGALGVAFSLLALRHQQLPPCVGLQEPEFDLNFVRQA---QQSPL--------Q 361
|
330
....*....|....
gi 53747904 418 LAGVSSFGIGGTNA 431
Cdd:PRK05952 362 NVLCLSFGFGGQNA 375
|
|
| SgcC5_NRPS-like |
cd19539 |
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- ... |
2182-2604 |
1.34e-23 |
|
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- bond forming activity and similar C-domains of modular NRPSs; SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. This subfamily also includes similar C-domains of modular NRPSs such as Penicillium chrysogenum N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase PCBAB. Condensation (C) domains of NRPSs normally catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380462 [Multi-domain] Cd Length: 427 Bit Score: 107.08 E-value: 1.34e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2182 PLTDVQEAYWVGRrsAFELGGVAAH--GYFEIEsPGLEVERFIQCWRQLLQRHDMLRMVVLPDG----RQQVLEQVPEYT 2255
Cdd:cd19539 3 PLSFAQERLWFID--QGEDGGPAYNipGAWRLT-GPLDVEALREALRDVVARHEALRTLLVRDDggvpRQEILPPGPAPL 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2256 PEVVELRGLSPQEAESRRLqLRERmAHQVLRSDRWPLFELVLCRYEGGvRIHMSMDA--LMLDAWSSAVLRQDFAQLY-- 2331
Cdd:cd19539 80 EVRDLSDPDSDRERRLEEL-LRER-ESRGFDLDEEPPIRAVLGRFDPD-DHVLVLVAhhTAFDAWSLDVFARDLAALYaa 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2332 --HEPGRPLEPLAITFRDYVLAERRLREGEAHERARAYWWARLDTLPPPPELPLVKEPSQLEhARFTHREARLEPHRWAR 2409
Cdd:cd19539 157 rrKGPAAPLPELRQQYKEYAAWQREALAAPRAAELLDFWRRRLRGAEPTALPTDRPRPAGFP-YPGADLRFELDAELVAA 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2410 LQERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRlpLHPQVDELVGDFTSLVLLEVEAHAASTFAERASRLQ 2489
Cdd:cd19539 236 LRELAKRARSSLFMVLLAAYCVLLRRYTGQTDIVVGTPVAGR--NHPRFESTVGFFVNLLPLRVDVSDCATFRDLIARVR 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2490 AQLWRDLEHGSVSAVQLIREL--VRTGRRSPGAIMPVVFTSilSLDARRGPQGSLSFFEGELvysISQTPQVWLDHGVHE 2567
Cdd:cd19539 314 KALVDAQRHQELPFQQLVAELpvDRDAGRHPLVQIVFQVTN--APAGELELAGGLSYTEGSD---IPDGAKFDLNLTVTE 388
|
410 420 430
....*....|....*....|....*....|....*..
gi 53747904 2568 EEGALVLAWDSVEALFPPGMVDDMFHAYQRLLGALAE 2604
Cdd:cd19539 389 EGTGLRGSLGYATSLFDEETIQGFLADYLQVLRQLLA 425
|
|
| PRK09088 |
PRK09088 |
acyl-CoA synthetase; Validated |
2647-3134 |
1.44e-23 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181644 [Multi-domain] Cd Length: 488 Bit Score: 107.59 E-value: 1.44e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2647 QARLHPELPAL--LAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPP 2724
Cdd:PRK09088 4 HARLQPQRLAAvdLALGRRWTYAELDALVGRLAAVLRRRGCVDGERLAVLARNSVWLVALHFACARVGAIYVPLNWRLSA 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2725 LRLHQLLEEGPARVVLTQSSLLHTVPWPPGVQVI--AVDELEPAtEAPPLPPrgtpEHLAYVIYTSGSTGKPKGVAIEHR 2802
Cdd:PRK09088 84 SELDALLQDAEPRLLLGDDAVAAGRTDVEDLAAFiaSADALEPA-DTPSIPP----ERVSLILFTSGTSGQPKGVMLSER 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2803 AALNTVVDLNTRFGVGPEDRVLGLSAL--TFDLSVYDVLGLLGAGGALVLPAAEAEKDPAhWWERLVAGrVTVWNSTPAL 2880
Cdd:PRK09088 159 NLQQTAHNFGVLGRVDAHSSFLCDAPMfhIIGLITSVRPVLAVGGSILVSNGFEPKRTLG-RLGDPALG-ITHYFCVPQM 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2881 MLLLveyAEQRGLKlPAALR-LVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEA-SIWSIAYPIGQVAPQWKSIPYGM 2958
Cdd:PRK09088 237 AQAF---RAQPGFD-AAALRhLTALFTGGAPHAAEDILGWLDDGIPMVDGFGMSEAgTVFGMSVDCDVIRAKAGAAGIPT 312
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2959 PLANQRfhVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFirhprTGERLYRTGDQGRMLPEGSIEFLGREDL 3038
Cdd:PRK09088 313 PTVQTR--VVDDQGNDCPAGVPGELLLRGPNLSPGYWRRPQATARAF-----TGDGWFRTGDIARRDADGFFWVVDRKKD 385
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3039 QVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLES 3118
Cdd:PRK09088 386 MFISGGENVYPAEIEAVLADHPGIRECAVVGMADAQWGEVGYLAIVPADGAPLDLERIRSHLSTRLAKYKVPKHLRLVDA 465
|
490
....*....|....*.
gi 53747904 3119 LPRSRNGKIARDQLPE 3134
Cdd:PRK09088 466 LPRTASGKLQKARLRD 481
|
|
| OSB_MenE-like |
cd17630 |
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) ... |
2781-3132 |
1.58e-23 |
|
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) synthetase (also known as O-succinylbenzoic acid CoA ligase) that belongs to the ANL superfamily and catalyzes the ligation of CoA to o-succinylbenzoate (OSB). It includes MenE in the bacterial menaquinone biosynthesis pathway which is a promising target for the development of novel antibacterial agents. MenE catalyzes CoA ligation via an acyl-adenylate intermediate; tight-binding inhibitors of MenE based on stable acyl-sulfonyladenosine analogs of this intermediate provide a pathway toward the development of optimized MenE inhibitors.
Pssm-ID: 341285 [Multi-domain] Cd Length: 325 Bit Score: 104.72 E-value: 1.58e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2781 LAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLglsaLTFDLSVYDVLGLLGAGGALVLPAAEAEKDPA 2860
Cdd:cd17630 2 LATVILTSGSTGTPKAVVHTAANLLASAAGLHSRLGFGGGDSWL----LSLPLYHVGGLAILVRSLLAGAELVLLERNQA 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2861 HWwERLVAGRVTVWNSTPA-LMLLLVEYAEQRGLKlpaALRLVMLSGDWIPVALpdRIRALGRDVQVVSLGGATEASiws 2939
Cdd:cd17630 78 LA-EDLAPPGVTHVSLVPTqLQRLLDSGQGPAALK---SLRAVLLGGAPIPPEL--LERAADRGIPLYTTYGMTETA--- 148
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2940 iaypiGQVAPQwksiPYGMPLANQRFHVLDGRLEARPwwVPGELYIGGEGLAREYWRDEpltatrfIRHPRTGERLYRTG 3019
Cdd:cd17630 149 -----SQVATK----RPDGFGRGGVGVLLPGRELRIV--EDGEIWVGGASLAMGYLRGQ-------LVPEFNEDGWFTTK 210
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3020 DQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAagELRRY 3099
Cdd:cd17630 211 DLGELHADGRLTVLGRADNMIISGGENIQPEEIEAALAAHPAVRDAFVVGVPDEELGQRPVAVIVGRGPADPA--ELRAW 288
|
330 340 350
....*....|....*....|....*....|...
gi 53747904 3100 LAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd17630 289 LKDKLARFKLPKRIYPVPELPRTGGGKVDRRAL 321
|
|
| PRK07910 |
PRK07910 |
beta-ketoacyl-ACP synthase; |
12-435 |
2.54e-23 |
|
beta-ketoacyl-ACP synthase;
Pssm-ID: 236129 [Multi-domain] Cd Length: 418 Bit Score: 105.97 E-value: 2.54e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 12 SIALVGMAGRFPGAPDVESFWRNLVAGVESI-----SFFSEEELrqagvseqirrrPeyVPAKGVLedLELFDAGFFGYS 86
Cdd:PRK07910 13 NVVVTGIAMTTALATDAETTWKLLLDGQSGIrtlddPFVEEFDL------------P--VRIGGHL--LEEFDHQLTRVE 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 87 PREASHLdpqQRLLLECSWEALEDAG---LRPDQLPGWVGVYVGAGDT-SYRFQLLRGHG----DPLSgskdVAGFFGNY 158
Cdd:PRK07910 77 LRRMSYL---QRMSTVLGRRVWENAGspeVDTNRLMVSIGTGLGSAEElVFAYDDMRARGlravSPLA----VQMYMPNG 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 159 PdflATRVAYKLNLRGPALGIHTACSTSLVSINMACSALRGFECDMALAGGVSLRLPARS-GYLYEEGGVASKD-----G 232
Cdd:PRK07910 150 P---AAAVGLERHAKAGVITPVSACASGSEAIAQAWRQIVLGEADIAICGGVETRIEAVPiAGFAQMRIVMSTNnddpaG 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 233 HCRPFDaRATGTVTGDGVGVVVLKRLEDALKARD-PIHAVIRGWALNNDGASragFTAPSVEGQSEVIALAHAA--AGIS 309
Cdd:PRK07910 227 ACRPFD-KDRDGFVFGEGGALMVIETEEHAKARGaNILARIMGASITSDGFH---MVAPDPNGERAGHAMTRAIelAGLT 302
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 310 ARDITYVEAHGTGTPLGDPIEVAALTRAFRAHTAdtafcTLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFER 389
Cdd:PRK07910 303 PGDIDHVNAHATGTSVGDVAEGKAINNALGGHRP-----AVYAPKSALGHSVGAVGAVESILTVLALRDGVIPPTLNLEN 377
|
410 420 430 440
....*....|....*....|....*....|....*....|....*.
gi 53747904 390 PNPALHLEqspfFVNTQPLPWESprgpRLAGVSSFGIGGTNAHTLF 435
Cdd:PRK07910 378 LDPEIDLD----VVAGEPRPGNY----RYAINNSFGFGGHNVALAF 415
|
|
| antibiot_sagB |
TIGR03605 |
SagB-type dehydrogenase domain; SagB of Sterptococcus pyogenes participates in the maturation ... |
3299-3460 |
5.53e-23 |
|
SagB-type dehydrogenase domain; SagB of Sterptococcus pyogenes participates in the maturation of streptolysin S from a ribosomally produced precursor polypeptide. Chemically similar systems operate on highly diverse sets of bacteriocin precursors in numerous other bacteria. This model describes a domain within SgaB and homologous regions from other proteins, many of which appear to be involved in biosynthesis of secondary metabolites. While some substrates may be intermediates in non-ribosomal peptide syntheses, others are involved in heterocycle-containing bacteriocin biosynthesis, and can be found near SgaC-like (see TIGR03603, cyclodehydratase) and SgaD-like (see TIGR03604, "docking") proteins. Members of this domain family are heterogeneous in length, as many have a partial second copy of the domain represented here. The incomplete second domain scores below the cutoffs to this model in most cases.
Pssm-ID: 188352 Cd Length: 173 Bit Score: 98.53 E-value: 5.53e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3299 EQLGRLL---APLREWEV----QGSRRYLYASAGGLYPVQLYLHLKpgRARGLEPGTWYYDPSTHRLVLLSAGAG-LDRR 3370
Cdd:TIGR03605 3 EELSQLLwysAGVRSIKLpyndGILFRRPYPSGGGLYPLEIYLYVK--NIEGLPDGVYHYDPEEHRLILIRAGEEnVDAF 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3371 IHDPHQNQAIFDSAAFSLFLIARMGAVEPVYAEHALHFATLEAGLMTQLLDLGAAPSGLGLCHIGDLDFAQARGLFHLE- 3449
Cdd:TIGR03605 81 LVNALLNAENANPPPVIIFITARFWKNFWKYGNRAYRLALLDVGIIIQNFYLVATALGLGSCAIGGFDDDYIAELLGLDg 160
|
170
....*....|..
gi 53747904 3450 -EEHVLLHSLVG 3460
Cdd:TIGR03605 161 iEEHVVGVFPVG 172
|
|
| Zn_ADH5 |
cd08259 |
Alcohol dehydrogenases of the MDR family; NAD(P)(H)-dependent oxidoreductases are the major ... |
1676-1989 |
8.48e-23 |
|
Alcohol dehydrogenases of the MDR family; NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. This group contains proteins that share the characteristic catalytic and structural zinc-binding sites of the zinc-dependent alcohol dehydrogenase family. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which have a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H)-binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine (His-51), the ribose of NAD, a serine (Ser-48), then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176220 [Multi-domain] Cd Length: 332 Bit Score: 102.78 E-value: 8.48e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1676 AVGTPGLLESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEeSVLGRECSGRIAAVGEGVSGLRVGDE 1755
Cdd:cd08259 3 AAILHKPNKPLQIEEVPDPEPGPGEVLIKVKAAGVCYRDLLFWKGFFPRGKYP-LILGHEIVGTVEEVGEGVERFKPGDR 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1756 VLAVA----------------------------PGCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHtVGRL 1807
Cdd:cd08259 82 VILYYyipcgkceyclsgeenlcrnraeygeevDGGFAEYVKVPERSLVKLPDNVSDESAALAACVVGTAVHALK-RAGV 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1808 RRGERILIHAAAGGLGLAAVQLASRTGAEILATAGSEQKREYLRSLGIAHVLDSRstSFVSEVRERTggrGVDVVLNSLA 1887
Cdd:cd08259 161 KKGDTVLVTGAGGGVGIHAIQLAKALGARVIAVTRSPEKLKILKELGADYVIDGS--KFSEDVKKLG---GADVVIELVG 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1888 GELLLAGLSVLAPHGRFLELGKRDlyaDQQVGLR---TLARGQTFAAidfgpHHPDFRAVLEEVATQLTQGQLEPLPTRL 1964
Cdd:cd08259 236 SPTIEESLRSLNKGGRLVLIGNVT---PDPAPLRpglLILKEIRIIG-----SISATKADVEEALKLVKEGKIKPVIDRV 307
|
330 340
....*....|....*....|....*
gi 53747904 1965 FPARQVAEAFSFMARALHIGRVAVS 1989
Cdd:cd08259 308 VSLEDINEALEDLKSGKVVGRIVLK 332
|
|
| Mgc45594_like |
cd08250 |
Mgc45594 gene product and other MDR family members; Includes Human Mgc45594 gene product of ... |
1684-1988 |
1.13e-22 |
|
Mgc45594 gene product and other MDR family members; Includes Human Mgc45594 gene product of undetermined function. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P) binding-Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES.
Pssm-ID: 176212 [Multi-domain] Cd Length: 329 Bit Score: 102.34 E-value: 1.13e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1684 ESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGDEVLAVAPGC 1763
Cdd:cd08250 16 EATSIVDVPVPLPGPGEVLVKNRFVGINASDINFTAGRYDPGVKPPFDCGFEGVGEVVAVGEGVTDFKVGDAVATMSFGA 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1764 FRSYVLVDESQVVRRPASLglAEGAAQMVPFATAYFALHTVGRLRRGERILIHAAAGGLGLAAVQLASRTGAEILATAGS 1843
Cdd:cd08250 96 FAEYQVVPARHAVPVPELK--PEVLPLLVSGLTASIALEEVGEMKSGETVLVTAAAGGTGQFAVQLAKLAGCHVIGTCSS 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1844 EQKREYLRSLGIAHVLDSRSTSfVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELGKRDLYADQ------- 1916
Cdd:cd08250 174 DEKAEFLKSLGCDRPINYKTED-LGEVLKKEYPKGVDVVYESVGGEMFDTCVDNLALKGRLIVIGFISGYQSGtgpspvk 252
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 53747904 1917 --QVGLRTLARGQTFAAIdFGPHH-PDFRAVLEEVATQLTQGQLEPL--PTRLFPARQVAEAFSFMARALHIGRVAV 1988
Cdd:cd08250 253 gaTLPPKLLAKSASVRGF-FLPHYaKLIPQHLDRLLQLYQRGKLVCEvdPTRFRGLESVADAVDYLYSGKNIGKVVV 328
|
|
| ttLC_FACS_AlkK_like |
cd12119 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes ... |
2752-3127 |
1.61e-22 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes fatty acyl-CoA synthetases that can activate medium-chain to long-chain fatty acids. They catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family catalyzes the long-chain fatty acid, myristoyl acid, while another member in this family, the AlkK protein identified from Pseudomonas oleovorans, targets medium chain fatty acids. This family also includes uncharacterized FACS proteins.
Pssm-ID: 341284 [Multi-domain] Cd Length: 518 Bit Score: 105.02 E-value: 1.61e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2752 PPGVQVIAVDEL----EPATEAPPLPprgtpEHLAYVI-YTSGSTGKPKGVAIEHRAA-LNTVVDLNTR-FGVGPEDRVL 2824
Cdd:cd12119 136 PAGVGVLAYEELlaaeSPEYDWPDFD-----ENTAAAIcYTSGTTGNPKGVVYSHRSLvLHAMAALLTDgLGLSESDVVL 210
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2825 -----------GL---SALTFDLSVYdvlgllgaggalvlPAAEAekDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQ 2890
Cdd:cd12119 211 pvvpmfhvnawGLpyaAAMVGAKLVL--------------PGPYL--DPASLAELIEREGVTFAAGVPTVWQGLLDHLEA 274
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2891 RGLKLPaALRLVMLSGDWIPVALPDRIRALGrdVQVVSLGGATEASiwsiayPIGQVA---PQWKSIPY----------G 2957
Cdd:cd12119 275 NGRDLS-SLRRVVIGGSAVPRSLIEAFEERG--VRVIHAWGMTETS------PLGTVArppSEHSNLSEdeqlalrakqG 345
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2958 MPLANQRFHVLD-------------GRLEARPWWVPGElYIGGEGLAREYWRDEPLtatrfirhprtgerlyRTGDQGRM 3024
Cdd:cd12119 346 RPVPGVELRIVDddgrelpwdgkavGELQVRGPWVTKS-YYKNDEESEALTEDGWL----------------RTGDVATI 408
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3025 LPEGSIEFLGR-EDLqVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAER 3103
Cdd:cd12119 409 DEDGYLTITDRsKDV-IKSGGEWISSVELENAIMAHPAVAEAAVIGVPHPKWGERPLAVVVLKEGATVTAEELLEFLADK 487
|
410 420
....*....|....*....|....
gi 53747904 3104 LPAYMVPSAFVLLESLPRSRNGKI 3127
Cdd:cd12119 488 VAKWWLPDDVVFVDEIPKTSTGKI 511
|
|
| KAsynt_C_assoc |
pfam16197 |
Ketoacyl-synthetase C-terminal extension; KAsynt_C_assoc represents the very C-terminus of a ... |
390-499 |
2.45e-22 |
|
Ketoacyl-synthetase C-terminal extension; KAsynt_C_assoc represents the very C-terminus of a subset of proteins from the keto-acyl-synthetase 2 family. It is found in proteins ranging from bacteria to human.
Pssm-ID: 465059 [Multi-domain] Cd Length: 111 Bit Score: 94.53 E-value: 2.45e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 390 PNPALH-LEQSPFFVNTQPLPWesPRGprLAGVSSFGIGGTNAHTLFEEAPPPPASGPTRPN--QVLLLSARSTSALEHI 466
Cdd:pfam16197 1 PNPDIPaLLDGRLKVVTEPTPW--PGG--IVGVNSFGFGGANAHVILKSNPKPKIPPESPDNlpRLVLLSGRTEEAVKAL 76
|
90 100 110
....*....|....*....|....*....|...
gi 53747904 467 AGRLAAHLRRHPDLELADVAFTLQvgRARFPYR 499
Cdd:pfam16197 77 LEKLENHLDDAEFLSLLNDIHSLP--ISGHPYR 107
|
|
| hydroxyacyl_CoA_DH |
cd08254 |
6-hydroxycyclohex-1-ene-1-carboxyl-CoA dehydrogenase, N-benzyl-3-pyrrolidinol dehydrogenase, ... |
1694-1988 |
3.21e-22 |
|
6-hydroxycyclohex-1-ene-1-carboxyl-CoA dehydrogenase, N-benzyl-3-pyrrolidinol dehydrogenase, and other MDR family members; This group contains enzymes of the zinc-dependent alcohol dehydrogenase family, including members (aka MDR) identified as 6-hydroxycyclohex-1-ene-1-carboxyl-CoA dehydrogenase and N-benzyl-3-pyrrolidinol dehydrogenase. 6-hydroxycyclohex-1-ene-1-carboxyl-CoA dehydrogenase catalyzes the conversion of 6-Hydroxycyclohex-1-enecarbonyl-CoA and NAD+ to 6-Ketoxycyclohex-1-ene-1-carboxyl-CoA,NADH, and H+. This group displays the characteristic catalytic and structural zinc sites of the zinc-dependent alcohol dehydrogenases. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which have a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H)-binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176216 [Multi-domain] Cd Length: 338 Bit Score: 101.17 E-value: 3.21e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAG-----LNFLDVLGalgmmPALEAEESVLGRECSGRIAAVGEGVSGLRVGDEVLAVAP------- 1761
Cdd:cd08254 22 PEPGPGEVLVKVKAAGvchsdLHILDGGV-----PTLTKLPLTLGHEIAGTVVEVGAGVTNFKVGDRVAVPAVipcgaca 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1762 ---------------------GCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGERILI----- 1815
Cdd:cd08254 97 lcrrgrgnlclnqgmpglgidGGFAEYIVVPARALVPVPDGVPFAQAAVATDAVLTPYHAVVRAGEVKPGETVLViglgg 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1816 ---HaaagglglaAVQLASRTGAEILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVrERTGGRGVDVVLN-SLAGELL 1891
Cdd:cd08254 177 lglN---------AVQIAKAMGAAVIAVDIKEEKLELAKELGADEVLNSLDDSPKDKK-AAGLGGGFDVIFDfVGTQPTF 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1892 LAGLSVLAPHGRFLELGkrdlYADQQVGLRT--LARGQTFAAIDFGPHHPDFRAVLEEVAtqltQGQLEPLPTRLfPARQ 1969
Cdd:cd08254 247 EDAQKAVKPGGRIVVVG----LGRDKLTVDLsdLIARELRIIGSFGGTPEDLPEVLDLIA----KGKLDPQVETR-PLDE 317
|
330
....*....|....*....
gi 53747904 1970 VAEAFSFMARALHIGRVAV 1988
Cdd:cd08254 318 IPEVLERLHKGKVKGRVVL 336
|
|
| MACS_like_3 |
cd05971 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
2682-3132 |
4.35e-22 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341275 [Multi-domain] Cd Length: 439 Bit Score: 102.51 E-value: 4.35e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2682 ELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSllhtvpwppgvqviavD 2761
Cdd:cd05971 25 EIGLEKGDRVGVFLSQGPECAIAHIAILRSGAIAVPLFALFGPEALEYRLSNSGASALVTDGS----------------D 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2762 ELepateapplpprgtpehlAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVL-----------GLsalt 2830
Cdd:cd05971 89 DP------------------ALIIYTSGTTGPPKGALHAHRVLLGHLPGVQFPFNLFPRDGDLywtpadwawigGL---- 146
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2831 FDLSVydvlgllgaggalvlPAaeaekdpAHWWERLVAGRVTVWnSTPALMLLLVEYAEQRGLKLPAALRLVMLSGDwiP 2910
Cdd:cd05971 147 LDVLL---------------PS-------LYFGVPVLAHRMTKF-DPKAALDLMSRYGVTTAFLPPTALKMMRQQGE--Q 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2911 VALPD-RIRAL---GRDVQVVSLGGATEASIWSIAYPIGQV--------APQWKSI---PYGMPLANQRFHVLDGRLEAR 2975
Cdd:cd05971 202 LKHAQvKLRAIatgGESLGEELLGWAREQFGVEVNEFYGQTecnlvignCSALFPIkpgSMGKPIPGHRVAIVDDNGTPL 281
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2976 PwwvPGElyIGGEGLAR-------EYWRDEPLTATRFIrhprtGERLyRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVE 3048
Cdd:cd05971 282 P---PGE--VGEIAVELpdpvaflGYWNNPSATEKKMA-----GDWL-LTGDLGRKDSDGYFWYVGRDDDVITSSGYRIG 350
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3049 LGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPA---AGELRRYLAERLPAYMVPSAFVLLESLPRSRNG 3125
Cdd:cd05971 351 PAEIEECLLKHPAVLMAAVVGIPDPIRGEIVKAFVVLNPGETPSdalAREIQELVKTRLAAHEYPREIEFVNELPRTATG 430
|
....*..
gi 53747904 3126 KIARDQL 3132
Cdd:cd05971 431 KIRRREL 437
|
|
| MACS_like |
cd05972 |
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of ... |
2779-3132 |
1.28e-21 |
|
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes.
Pssm-ID: 341276 [Multi-domain] Cd Length: 428 Bit Score: 100.87 E-value: 1.28e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2779 EHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKD 2858
Cdd:cd05972 81 EDPALIYFTSGTTGLPKGVLHTHSYPLGHIPTAAYWLGLRPDDIHWNIADPGWAKGAWSSFFGPWLLGATVFVYEGPRFD 160
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2859 PAHWWERLVAGRVTVWNSTP-ALMLLLVEYAEQRGLKlpaALRLVMLSGDWI-PVALPDRIRALGRDVQvvSLGGATEAS 2936
Cdd:cd05972 161 AERILELLERYGVTSFCGPPtAYRMLIKQDLSSYKFS---HLRLVVSAGEPLnPEVIEWWRAATGLPIR--DGYGQTETG 235
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2937 IWSIAYPIGQVAPqwKSIpyGMPLANQRFHVLDGRLEARPWWVPGELYI--GGEGLAREYWRDEPLTATRFirhprtGER 3014
Cdd:cd05972 236 LTVGNFPDMPVKP--GSM--GRPTPGYDVAIIDDDGRELPPGEEGDIAIklPPPGLFLGYVGDPEKTEASI------RGD 305
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3015 LYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPrgVRRLV--AYAVPRSGQTPA 3092
Cdd:cd05972 306 YYLTGDRAYRDEDGYFWFVGRADDIIKSSGYRIGPFEVESALLEHPAVAEAAVVGSPDP--VRGEVvkAFVVLTSGYEPS 383
|
330 340 350 360
....*....|....*....|....*....|....*....|...
gi 53747904 3093 ---AGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd05972 384 eelAEELQGHVKKVLAPYKYPREIEFVEELPKTISGKIRRVEL 426
|
|
| LCL_NRPS-like |
cd19531 |
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar ... |
2216-2605 |
2.32e-21 |
|
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar domains including the C-domain of SgcC5, a free-standing NRPS with both ester- and amide- bond forming activity; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. Streptomyces globisporus SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380454 [Multi-domain] Cd Length: 427 Bit Score: 100.12 E-value: 2.32e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2216 LEVERFIQCWRQLLQRHDMLRMV-VLPDG--RQQVLEQVPeYTPEVVELRGLSPQEAESRrlqLRERMAHQVLRS---DR 2289
Cdd:cd19531 36 LDVAALERALNELVARHEALRTTfVEVDGepVQVILPPLP-LPLPVVDLSGLPEAEREAE---AQRLAREEARRPfdlAR 111
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2290 WPLFELVLcryeggVRI----HmsmdALML-------DAWSSAVLRQDFAQLY----HEPGRPLEPLAITFRDYVLAERR 2354
Cdd:cd19531 112 GPLLRATL------LRLgedeH----VLLLtmhhivsDGWSMGVLLRELAALYaaflAGRPSPLPPLPIQYADYAVWQRE 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2355 LREGEAHERARAYWWARLDTlppppelplvkEPSQLE-------HARFTHREAR----LEPHRWARLQERARAHGLTPSA 2423
Cdd:cd19531 182 WLQGEVLERQLAYWREQLAG-----------APPVLElptdrprPAVQSFRGARvrftLPAELTAALRALARREGATLFM 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2424 ACMAAFAEVLARWS-------------RHprftlnltlfqrlplHPQVDELVGDFTSLVLLEVEAHAASTFAE-----RA 2485
Cdd:cd19531 251 TLLAAFQVLLHRYSgqddivvgtpvagRN---------------RAELEGLIGFFVNTLVLRTDLSGDPTFREllarvRE 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2486 SRLQAQlwrdlEHGSVSAVQLIREL--VRTGRRSPgaimpvVFTSILSLDARRGPQGSLSFFEGELVYSISQTPQVWLDH 2563
Cdd:cd19531 316 TALEAY-----AHQDLPFEKLVEALqpERDLSRSP------LFQVMFVLQNAPAAALELPGLTVEPLEVDSGTAKFDLTL 384
|
410 420 430 440
....*....|....*....|....*....|....*....|..
gi 53747904 2564 GVHEEEGALVLAWDSVEALFPPGMVDDMFHAYQRLLGALAEE 2605
Cdd:cd19531 385 SLTETDGGLRGSLEYNTDLFDAATIERMAGHFQTLLEAIVAD 426
|
|
| FACL_like_1 |
cd05910 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
2782-3132 |
2.45e-21 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341236 [Multi-domain] Cd Length: 457 Bit Score: 100.61 E-value: 2.45e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2782 AYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGlsalTFDL-SVYDVLGLLGAGGALVLPAAEAEKDPA 2860
Cdd:cd05910 88 AAILFTSGSTGTPKGVVYRHGTFAAQIDALRQLYGIRPGEVDLA----TFPLfALFGPALGLTSVIPDMDPTRPARADPQ 163
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2861 HWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPaALRLVMLSGDWIPVALPDRIR-ALGRDVQVVSLGGATEA-SIW 2938
Cdd:cd05910 164 KLVGAIRQYGVSIVFGSPALLERVARYCAQHGITLP-SLRRVLSAGAPVPIALAARLRkMLSDEAEILTPYGATEAlPVS 242
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2939 SIA-----YPIGQVAPQWKSIPYGMPLANQRFHVL----------DGRLEArPWWVPGELYIGGEGLAREYWRDEplTAT 3003
Cdd:cd05910 243 SIGsrellATTTAATSGGAGTCVGRPIPGVRVRIIeiddepiaewDDTLEL-PRGEIGEITVTGPTVTPTYVNRP--VAT 319
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3004 RFIRHPRTGER-LYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAY 3082
Cdd:cd05910 320 ALAKIDDNSEGfWHRMGDLGYLDDEGRLWFCGRKAHRVITTGGTLYTEPVERVFNTHPGVRRSALVGVGKPGCQLPVLCV 399
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....
gi 53747904 3083 AVPRSGQTPAAGELR--RYLAERLPAYMVPSAFVLLESLPRS--RNGKIARDQL 3132
Cdd:cd05910 400 EPLPGTITPRARLEQelRALAKDYPHTQRIGRFLIHPSFPVDirHNAKIFREKL 453
|
|
| PRK07787 |
PRK07787 |
acyl-CoA synthetase; Validated |
2655-3132 |
3.16e-21 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236096 [Multi-domain] Cd Length: 471 Bit Score: 100.45 E-value: 3.16e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2655 PALLAPERTLSYGELARRAQALAArlrelEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEG 2734
Cdd:PRK07787 17 DAVRIGGRVLSRSDLAGAATAVAE-----RVAGARRVAVLATPTLATVLAVVGALIAGVPVVPVPPDSGVAERRHILADS 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2735 PARVVLTQssllhtVPW-PPGVQVIAVDELEPATEAPPLPPrgtPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNT 2813
Cdd:PRK07787 92 GAQAWLGP------APDdPAGLPHVPVRLHARSWHRYPEPD---PDAPALIVYTSGTTGPPKGVVLSRRAIAADLDALAE 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2814 RFGVGPEDR-------------VLG-LSALTFDLSVydvlgllgAGGALVLPAAEAEKDPAHwwERLVAGRVTVWNSTPA 2879
Cdd:PRK07787 163 AWQWTADDVlvhglplfhvhglVLGvLGPLRIGNRF--------VHTGRPTPEAYAQALSEG--GTLYFGVPTVWSRIAA 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2880 lmlllvEYAEQRGLKlPAALrLVMLSGDwIPVALPDRIRAL-GRdvQVVSLGGATEASIWSIAYPIGQVAPQWksipYGM 2958
Cdd:PRK07787 233 ------DPEAARALR-GARL-LVSGSAA-LPVPVFDRLAALtGH--RPVERYGMTETLITLSTRADGERRPGW----VGL 297
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2959 PLANQRFHVLDGRLEARPWWVP--GELYIGGEGLAREYWRDEPLTATRFirhprTGERLYRTGDQGRMLPEGSIEFLGRE 3036
Cdd:PRK07787 298 PLAGVETRLVDEDGGPVPHDGEtvGELQVRGPTLFDGYLNRPDATAAAF-----TADGWFRTGDVAVVDPDGMHRIVGRE 372
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3037 --DLqVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGqtPAAGELRRYLAERLPAYMVPSAFV 3114
Cdd:PRK07787 373 stDL-IKSGGYRIGAGEIETALLGHPGVREAAVVGVPDDDLGQRIVAYVVGADD--VAADELIDFVAQQLSVHKRPREVR 449
|
490
....*....|....*...
gi 53747904 3115 LLESLPRSRNGKIARDQL 3132
Cdd:PRK07787 450 FVDALPRNAMGKVLKKQL 467
|
|
| MDR9 |
cd08274 |
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; ... |
1692-1988 |
4.97e-21 |
|
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; This group is a member of the medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, but lacks the zinc-binding sites of the zinc-dependent alcohol dehydrogenases. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P)-binding Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176235 [Multi-domain] Cd Length: 350 Bit Score: 97.75 E-value: 4.97e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1692 TRPAPGPRQVEIEVEAAGLNFLDV---LGALG--MMPALEAEESVL--------------GRECSGRIAAVGEGVSGLRV 1752
Cdd:cd08274 22 PVPTPAPGEVLIRVGACGVNNTDIntrEGWYSteVDGATDSTGAGEagwwggtlsfpriqGADIVGRVVAVGEGVDTARI 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1753 GDEVLaVAP---------------------GCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTvGRLRRGE 1811
Cdd:cd08274 102 GERVL-VDPsirdppeddpadidyigserdGGFAEYTVVPAENAYPVNSPLSDVELATFPCSYSTAENMLER-AGVGAGE 179
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1812 RILIHAAAGGLGLAAVQLASRTGAEILATAGSEqKREYLRSLGiAHVLDSRSTSFVSEVRErTGGRGVDVVLNSLAGELL 1891
Cdd:cd08274 180 TVLVTGASGGVGSALVQLAKRRGAIVIAVAGAA-KEEAVRALG-ADTVILRDAPLLADAKA-LGGEPVDVVADVVGGPLF 256
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1892 LAGLSVLAPHGRF----------LELGKRDLYadqqvgLRTLargqTFAAIDFGPhhpdfRAVLEEVATQLTQGQLEPLP 1961
Cdd:cd08274 257 PDLLRLLRPGGRYvtagaiagpvVELDLRTLY------LKDL----TLFGSTLGT-----REVFRRLVRYIEEGEIRPVV 321
|
330 340
....*....|....*....|....*..
gi 53747904 1962 TRLFPARQVAEAFSFMARALHIGRVAV 1988
Cdd:cd08274 322 AKTFPLSEIREAQAEFLEKRHVGKLVL 348
|
|
| PRK13383 |
PRK13383 |
acyl-CoA synthetase; Provisional |
2652-3133 |
5.09e-21 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139531 [Multi-domain] Cd Length: 516 Bit Score: 100.07 E-value: 5.09e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2652 PELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLL 2731
Cdd:PRK13383 49 PGRTAIIDDDGALSYRELQRATESLARRLTRDGVAPGRAVGVMCRNGRGFVTAVFAVGLLGADVVPISTEFRSDALAAAL 128
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2732 EEGPARVVLTQSSLLHtvpwppgvQVIAVDE----LEPAT----EAPPLPPRGTPEHLayVIYTSGSTGKPKGV--AIEH 2801
Cdd:PRK13383 129 RAHHISTVVADNEFAE--------RIAGADDavavIDPATagaeESGGRPAVAAPGRI--VLLTSGTTGKPKGVprAPQL 198
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2802 RAALNTVVDL--NTRFGVG-------PEDRVLGLSALTFDLSVydvlGLLGAGGALVLPAAEAEKDPAHwwerlvagRVT 2872
Cdd:PRK13383 199 RSAVGVWVTIldRTRLRTGsrisvamPMFHGLGLGMLMLTIAL----GGTVLTHRHFDAEAALAQASLH--------RAD 266
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2873 VWNSTPALMLLLVEYAEQRGLKLP-AALRLVMLSGDWIPVALPDRIRALGRDVqVVSLGGATEASIWSIAYPIG-QVAPQ 2950
Cdd:PRK13383 267 AFTAVPVVLARILELPPRVRARNPlPQLRVVMSSGDRLDPTLGQRFMDTYGDI-LYNGYGSTEVGIGALATPADlRDAPE 345
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2951 wksiPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEgLAREYWRDEPLTATRfirhprtgERLYRTGDQGRMLPEGSI 3030
Cdd:PRK13383 346 ----TVGKPVAGCPVRILDRNNRPVGPRVTGRIFVGGE-LAGTRYTDGGGKAVV--------DGMTSTGDMGYLDNAGRL 412
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3031 EFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVP 3110
Cdd:PRK13383 413 FIVGREDDMIISGGENVYPRAVENALAAHPAVADNAVIGVPDERFGHRLAAFVVLHPGSGVDAAQLRDYLKDRVSRFEQP 492
|
490 500
....*....|....*....|...
gi 53747904 3111 SAFVLLESLPRSRNGKIARDQLP 3133
Cdd:PRK13383 493 RDINIVSSIPRNPTGKVLRKELP 515
|
|
| Zn_ADH9 |
cd08269 |
Alcohol dehydrogenases of the MDR family; The medium chain dehydrogenases/reductase (MDR) ... |
1679-1980 |
5.30e-21 |
|
Alcohol dehydrogenases of the MDR family; The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P)-binding Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability.
Pssm-ID: 176230 [Multi-domain] Cd Length: 312 Bit Score: 96.66 E-value: 5.30e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1679 TPGLLEslgLRRCTRPAPGPRQVEIEVEAAGL--NFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGDEV 1756
Cdd:cd08269 3 GPGRFE---VEEHPRPTPGPGQVLVRVEGCGVcgSDLPAFNQGRPWFVYPAEPGGPGHEGWGRVVALGPGVRGLAVGDRV 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1757 LAVAPGCFRSYVLVDESQVVRRPASLGLAEGAAQmvPFATAYFALHtVGRLRRGERILIhAAAGGLGLAAVQLASRTGAE 1836
Cdd:cd08269 80 AGLSGGAFAEYDLADADHAVPLPSLLDGQAFPGE--PLGCALNVFR-RGWIRAGKTVAV-IGAGFIGLLFLQLAAAAGAR 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1837 ILATAGSEQKREYL-RSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVL-APHGRFLELG-KRDLY 1913
Cdd:cd08269 156 RVIAIDRRPARLALaRELGATEVVTDDSEAIVERVRELTGGAGADVVIEAVGHQWPLDLAGELvAERGRLVIFGyHQDGP 235
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1914 AdqQVGLRTL-ARGQTFAAIDFGPHHPDFRAVLEEVATqLTQGQLEP--LPTRLFPARQVAEAFSFMARA 1980
Cdd:cd08269 236 R--PVPFQTWnWKGIDLINAVERDPRIGLEGMREAVKL-IADGRLDLgsLLTHEFPLEELGDAFEAARRR 302
|
|
| quinone_oxidoreductase_like_1 |
cd08243 |
Quinone oxidoreductase (QOR); NAD(P)(H)-dependent oxidoreductases are the major enzymes in the ... |
1675-1977 |
9.64e-21 |
|
Quinone oxidoreductase (QOR); NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. The medium chain alcohol dehydrogenase family (MDR) have a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The N-terminal region typically has an all-beta catalytic domain. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit.
Pssm-ID: 176205 [Multi-domain] Cd Length: 320 Bit Score: 96.14 E-value: 9.64e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1675 VAVGTPGLLESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEEsVLGRECSGRIAAVGEGvsGLRVGD 1754
Cdd:cd08243 4 IVIEQPGGPEVLKLREIPIPEPKPGWVLIRVKAFGLNRSEIFTRQGHSPSVKFPR-VLGIEAVGEVEEAPGG--TFTPGQ 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1755 EVLAVAPGCFRS-------YVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGERILIHAAAGGLGLAAV 1827
Cdd:cd08243 81 RVATAMGGMGRTfdgsyaeYTLVPNEQVYAIDSDLSWAELAALPETYYTAWGSLFRSLGLQPGDTLLIRGGTSSVGLAAL 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1828 QLASRTGAEILATAGSEQKREYLRSLGIAHV-LDSRSTSfvSEVRERTGgrGVDVVLNSLAGELLLAGLSVLAPHGRFL- 1905
Cdd:cd08243 161 KLAKALGATVTATTRSPERAALLKELGADEVvIDDGAIA--EQLRAAPG--GFDKVLELVGTATLKDSLRHLRPGGIVCm 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1906 --ELGkrdlyadqqvGLRTLARGQTFAAID-------FGPHHPDFRA-VLEEVATQLTQGQLEPLPTRLFPARQVAEAFS 1975
Cdd:cd08243 237 tgLLG----------GQWTLEDFNPMDDIPsgvnltlTGSSSGDVPQtPLQELFDFVAAGHLDIPPSKVFTFDEIVEAHA 306
|
..
gi 53747904 1976 FM 1977
Cdd:cd08243 307 YM 308
|
|
| Zn_ADH6 |
cd08260 |
Alcohol dehydrogenases of the MDR family; NAD(P)(H)-dependent oxidoreductases are the major ... |
1684-1988 |
2.14e-20 |
|
Alcohol dehydrogenases of the MDR family; NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. This group has the characteristic catalytic and structural zinc sites of the zinc-dependent alcohol dehydrogenases. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H)-binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176221 [Multi-domain] Cd Length: 345 Bit Score: 95.75 E-value: 2.14e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1684 ESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMmPALEAEESVLGRECSGRIAAVGEGVSGLRVGDEVLA----- 1758
Cdd:cd08260 11 EPLEIREVPDPEPPPDGVVVEVEACGVCRSDWHGWQGH-DPDVTLPHVPGHEFAGVVVEVGEDVSRWRVGDRVTVpfvlg 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1759 -----------------------VAPGCFRSYVLVDESQV--VRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGERI 1813
Cdd:cd08260 90 cgtcpycragdsnvcehqvqpgfTHPGSFAEYVAVPRADVnlVRLPDDVDFVTAAGLGCRFATAFRALVHQARVKPGEWV 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1814 LIHaAAGGLGLAAVQLASRTGAEILATAGSEQKREYLRSLGIAHVLDSR-STSFVSEVRERTGGrGVDVVLNSlAGELLL 1892
Cdd:cd08260 170 AVH-GCGGVGLSAVMIASALGARVIAVDIDDDKLELARELGAVATVNASeVEDVAAAVRDLTGG-GAHVSVDA-LGIPET 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1893 AGLSV--LAPHGRFLelgkrdlyadqQVGLRTLARGQTFAAIDF---------GPH---HPDFRAVLEEVATqlTQGQLE 1958
Cdd:cd08260 247 CRNSVasLRKRGRHV-----------QVGLTLGEEAGVALPMDRvvareleivGSHgmpAHRYDAMLALIAS--GKLDPE 313
|
330 340 350
....*....|....*....|....*....|
gi 53747904 1959 PLPTRLFPARQVAEAFSFMARALHIGRVAV 1988
Cdd:cd08260 314 PLVGRTISLDEAPDALAAMDDYATAGITVI 343
|
|
| PRK04319 |
PRK04319 |
acetyl-CoA synthetase; Provisional |
2660-3129 |
2.45e-20 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 235279 [Multi-domain] Cd Length: 570 Bit Score: 98.43 E-value: 2.45e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2660 PERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVV 2739
Cdd:PRK04319 70 RKEKYTYKELKELSNKFANVLKELGVEKGDRVFIFMPRIPELYFALLGALKNGAIVGPLFEAFMEEAVRDRLEDSEAKVL 149
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2740 LTQSSLLHTVPWP--PGVQ-VIAVDE--------------LEPATEAPPLPPrGTPEHLAYVIYTSGSTGKPKGV----- 2797
Cdd:PRK04319 150 ITTPALLERKPADdlPSLKhVLLVGEdveegpgtldfnalMEQASDEFDIEW-TDREDGAILHYTSGSTGKPKGVlhvhn 228
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2798 -AIEHRAALNTVVDLNtrfgvgPEDR---------VLGLSALTFD------LSVYDvlgllgaggalvlpaaEAEKDPAH 2861
Cdd:PRK04319 229 aMLQHYQTGKYVLDLH------EDDVywctadpgwVTGTSYGIFApwlngaTNVID----------------GGRFSPER 286
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2862 WWERLVAGRVTVWNSTPA----LMLLLVEYAEQRGLklpAALRLVMLSGDwiPVAlPDRIRaLGRDVqvvsLG------- 2930
Cdd:PRK04319 287 WYRILEDYKVTVWYTAPTairmLMGAGDDLVKKYDL---SSLRHILSVGE--PLN-PEVVR-WGMKV----FGlpihdnw 355
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2931 GATEASIWSIA-YPIGQVAPqwKSIpyGMPLANQRFHVLDGRLEARPWWVPGELYI--GGEGLAREYWRDEPltatRFIR 3007
Cdd:PRK04319 356 WMTETGGIMIAnYPAMDIKP--GSM--GKPLPGIEAAIVDDQGNELPPNRMGNLAIkkGWPSMMRGIWNNPE----KYES 427
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3008 HPRTGerLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVarGEPRGVR--RLVAYAVP 3085
Cdd:PRK04319 428 YFAGD--WYVSGDSAYMDEDGYFWFQGRVDDVIKTSGERVGPFEVESKLMEHPAVAEAGVI--GKPDPVRgeIIKAFVAL 503
|
490 500 510 520
....*....|....*....|....*....|....*....|....*..
gi 53747904 3086 RSGQTPA---AGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIAR 3129
Cdd:PRK04319 504 RPGYEPSeelKEEIRGFVKKGLGAHAAPREIEFKDKLPKTRSGKIMR 550
|
|
| PRK06178 |
PRK06178 |
acyl-CoA synthetase; Validated |
2648-3132 |
3.02e-20 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235724 [Multi-domain] Cd Length: 567 Bit Score: 98.19 E-value: 3.02e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRL 2727
Cdd:PRK06178 43 ARERPQRPAIIFYGHVITYAELDELSDRFAALLRQRGVGAGDRVAVFLPNCPQFHIVFFGILKLGAVHVPVSPLFREHEL 122
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2728 HQLLEEGPARVVLTQSSLLH---------------------------TVPWPPGVQ--------VIAVDELEPATEAPPL 2772
Cdd:PRK06178 123 SYELNDAGAEVLLALDQLAPvveqvraetslrhvivtsladvlpaepTLPLPDSLRaprlaaagAIDLLPALRACTAPVP 202
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2773 PPRGTPEHLAYVIYTSGSTGKPKGVAIEHR-----AALNTVVDLntrfgVGPEDRV--------------LGL-----SA 2828
Cdd:PRK06178 203 LPPPALDALAALNYTGGTTGMPKGCEHTQRdmvytAAAAYAVAV-----VGGEDSVflsflpefwiagenFGLlfplfSG 277
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2829 LTFDLSvydvlgllgaggalvlpaaeaekdpAHWWERLVAGRVTVWNSTPALMLL--LVEYAEQRGLKLP--AALRLVML 2904
Cdd:PRK06178 278 ATLVLL-------------------------ARWDAVAFMAAVERYRVTRTVMLVdnAVELMDHPRFAEYdlSSLRQVRV 332
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2905 SgDWIPVALPD---RIRALGRDVQVVSLGGATE---ASIWSIAYPIGQVAPQWKSIPYGMPLANQRFHVLD---GRLeaR 2975
Cdd:PRK06178 333 V-SFVKKLNPDyrqRWRALTGSVLAEAAWGMTEthtCDTFTAGFQDDDFDLLSQPVFVGLPVPGTEFKICDfetGEL--L 409
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2976 PWWVPGELYIGGEGLAREYWRDEPLTATRFirhpRTGerLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAA 3055
Cdd:PRK06178 410 PLGAEGEIVVRTPSLLKGYWNKPEATAEAL----RDG--WLHTGDIGKIDEQGFLHYLGRRKEMLKVNGMSVFPSEVEAL 483
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 53747904 3056 LAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVlLESLPRSRNGKIARDQL 3132
Cdd:PRK06178 484 LGQHPAVLGSAVVGRPDPDKGQVPVAFVQLKPGADLTAAALQAWCRENMAVYKVPEIRI-VDALPMTATGKVRKQDL 559
|
|
| PRK07798 |
PRK07798 |
acyl-CoA synthetase; Validated |
2652-3126 |
3.42e-20 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236100 [Multi-domain] Cd Length: 533 Bit Score: 97.65 E-value: 3.42e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2652 PELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLL 2731
Cdd:PRK07798 17 PDRVALVCGDRRLTYAELEERANRLAHYLIAQGLGPGDHVGIYARNRIEYVEAMLGAFKARAVPVNVNYRYVEDELRYLL 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2732 EEGPARVVLTQSSLLHTV----PWPPGVQVI--------------AVDELEPATEAPPLPPRGT--PEHLaYVIYTSGST 2791
Cdd:PRK07798 97 DDSDAVALVYEREFAPRVaevlPRLPKLRTLvvvedgsgndllpgAVDYEDALAAGSPERDFGErsPDDL-YLLYTGGTT 175
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2792 GKPKGVAIEH----RAALN-----------TVVDLNTRFGVGPEDRVL-------------GLSALTFDLSV--YDvlgl 2841
Cdd:PRK07798 176 GMPKGVMWRQedifRVLLGgrdfatgepieDEEELAKRAAAGPGMRRFpapplmhgagqwaAFAALFSGQTVvlLP---- 251
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2842 lgaggalvlpaaEAEKDPAHWWERLVAGRVTVWNSTPALML--LLVEYAEQRGLKLPAaLRLVMLSGDWIPVALPDRIRA 2919
Cdd:PRK07798 252 ------------DVRFDADEVWRTIEREKVNVITIVGDAMArpLLDALEARGPYDLSS-LFAIASGGALFSPSVKEALLE 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2920 LGRDVQVVSLGGATEASIWSIAYpigqVAPqwKSIPYGMPL--ANQRFHVLDgrlEARPWWVPGElyiGGEG-LARE--- 2993
Cdd:PRK07798 319 LLPNVVLTDSIGSSETGFGGSGT----VAK--GAVHTGGPRftIGPRTVVLD---EDGNPVEPGS---GEIGwIARRghi 386
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2994 ---YWRDEPLTATRFIRHprTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVAR 3070
Cdd:PRK07798 387 plgYYKDPEKTAETFPTI--DGVRYAIPGDRARVEADGTITLLGRGSVCINTGGEKVFPEEVEEALKAHPDVADALVVGV 464
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*.
gi 53747904 3071 GEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGK 3126
Cdd:PRK07798 465 PDERWGQEVVAVVQLREGARPDLAELRAHCRSSLAGYKVPRAIWFVDEVQRSPAGK 520
|
|
| DCL_NRPS |
cd19543 |
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the ... |
2209-2438 |
4.10e-20 |
|
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor; The DCL-type Condensation (C) domain catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. This domain is D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains in addition to the LCL- and DCL-types such as starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380465 [Multi-domain] Cd Length: 423 Bit Score: 96.12 E-value: 4.10e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2209 FEIESPgLEVERFIQCWRQLLQRHDMLRMVVLPDGRQQ----VLEQVPeyTP-EVVELRGLSPQEAESRRLQLRERMAHQ 2283
Cdd:cd19543 30 ITLEGP-LDPDRFRAAWQAVVDRHPILRTSFVWEGLGEplqvVLKDRK--LPwRELDLSHLSEAEQEAELEALAEEDRER 106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2284 VLRSDRWPLFELVLCRYEGG-VRIHMSMDALMLDAWSSAVLRQDFAQLYHEP--GRPLE-PLAITFRDYV--LAERRlre 2357
Cdd:cd19543 107 GFDLARAPLMRLTLIRLGDDrYRLVWSFHHILLDGWSLPILLKELFAIYAALgeGQPPSlPPVRPYRDYIawLQRQD--- 183
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2358 geaHERARAYWWARLDTLPPPPELPLVKEPSQLEHARFTHREARLEPHRWARLQERARAHGLTPSAACMAAFAEVLARWS 2437
Cdd:cd19543 184 ---KEAAEAYWREYLAGFEEPTPLPKELPADADGSYEPGEVSFELSAELTARLQELARQHGVTLNTVVQGAWALLLSRYS 260
|
.
gi 53747904 2438 R 2438
Cdd:cd19543 261 G 261
|
|
| PRK03640 |
PRK03640 |
o-succinylbenzoate--CoA ligase; |
2647-3132 |
4.37e-20 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 235146 [Multi-domain] Cd Length: 483 Bit Score: 96.96 E-value: 4.37e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2647 QARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLR 2726
Cdd:PRK03640 11 RAFLTPDRTAIEFEEKKVTFMELHEAVVSVAGKLAALGVKKGDRVALLMKNGMEMILVIHALQQLGAVAVLLNTRLSREE 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2727 LHQLLEEGPARVVLTQSSLLHTVpwpPGVQVIAVDELEPATEAPPLPPrgTPEHL---AYVIYTSGSTGKPKGV------ 2797
Cdd:PRK03640 91 LLWQLDDAEVKCLITDDDFEAKL---IPGISVKFAELMNGPKEEAEIQ--EEFDLdevATIMYTSGTTGKPKGViqtygn 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2798 ----AIEhrAALNtvvdlntrFGVGPEDRVL---------GLSAL----TFDLSVYdvlgllgaggalVLPAAEAEKdpA 2860
Cdd:PRK03640 166 hwwsAVG--SALN--------LGLTEDDCWLaavpifhisGLSILmrsvIYGMRVV------------LVEKFDAEK--I 221
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2861 HWWerLVAGRVTVWnSTPALML--LLVEYAEQRglkLPAALRLVMLSGDWIPVALPDRIRAlgRDVQVVSLGGATEASIW 2938
Cdd:PRK03640 222 NKL--LQTGGVTII-SVVSTMLqrLLERLGEGT---YPSSFRCMLLGGGPAPKPLLEQCKE--KGIPVYQSYGMTETASQ 293
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2939 SIAYP-------IGQVapqwksipyGMPLANQRFHVLDGRLEARPwWVPGELYIGGEGLAREYWRDEPLTATRFirhpRT 3011
Cdd:PRK03640 294 IVTLSpedaltkLGSA---------GKPLFPCELKIEKDGVVVPP-FEEGEIVVKGPNVTKGYLNREDATRETF----QD 359
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3012 GerLYRTGDQGRMLPEGSIEFLGRE-DLQVKvQGFRVELGEIEAALAQHPALSASVVVarGEPRGVRRLVAYAVPRSGQT 3090
Cdd:PRK03640 360 G--WFKTGDIGYLDEEGFLYVLDRRsDLIIS-GGENIYPAEIEEVLLSHPGVAEAGVV--GVPDDKWGQVPVAFVVKSGE 434
|
490 500 510 520
....*....|....*....|....*....|....*....|..
gi 53747904 3091 PAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PRK03640 435 VTEEELRHFCEEKLAKYKVPKRFYFVEELPRNASGKLLRHEL 476
|
|
| sugar_DH |
cd08236 |
NAD(P)-dependent sugar dehydrogenases; This group contains proteins identified as sorbitol ... |
1693-1979 |
6.39e-20 |
|
NAD(P)-dependent sugar dehydrogenases; This group contains proteins identified as sorbitol dehydrogenases and other sugar dehydrogenases of the medium-chain dehydrogenase/reductase family (MDR), which includes zinc-dependent alcohol dehydrogenase and related proteins. Sorbitol and aldose reductase are NAD(+) binding proteins of the polyol pathway, which interconverts glucose and fructose. Sorbitol dehydrogenase is tetrameric and has a single catalytic zinc per subunit. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Related proteins include threonine dehydrogenase, formaldehyde dehydrogenase, and butanediol dehydrogenase. The medium chain alcohol dehydrogenase family (MDR) has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The N-terminal region typically has an all-beta catalytic domain. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit. Horse liver alcohol dehydrogenase is a dimeric enzyme and each subunit has two domains. The NAD binding domain is in a Rossmann fold and the catalytic domain contains a zinc ion to which substrates bind. There is a cleft between the domains that closes upon formation of the ternary complex.
Pssm-ID: 176198 [Multi-domain] Cd Length: 343 Bit Score: 94.22 E-value: 6.39e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1693 RPAPGPRQVEIEVEAAGLNFLDVLGALG----MMPAleaeesVLGRECSGRIAAVGEGVSGLRVGDEVlAVAP------- 1761
Cdd:cd08236 19 KPEPGPGEVLVKVKACGICGSDIPRYLGtgayHPPL------VLGHEFSGTVEEVGSGVDDLAVGDRV-AVNPllpcgkc 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1762 ----------------------GCFRSYVLVDESQVVRRPASLGLAEGAaqMV-PFATayfALHTVGR--LRRGERILI- 1815
Cdd:cd08236 92 eyckkgeyslcsnydyigsrrdGAFAEYVSVPARNLIKIPDHVDYEEAA--MIePAAV---ALHAVRLagITLGDTVVVi 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1816 ------HaaagglglAAVQLASRTGAE-ILATAGSEQKREYLRSLGIAHVLDSRSTSfVSEVRERTGGRGVDVVLNSL-A 1887
Cdd:cd08236 167 gagtigL--------LAIQWLKILGAKrVIAVDIDDEKLAVARELGADDTINPKEED-VEKVRELTEGRGADLVIEAAgS 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1888 GELLLAGLSVLAPHGRFLELGkrDLYADQ---QVGLRTLARGQ-----TFAAIDFGPHHPDFRAVLEEVATQLTqgQLEP 1959
Cdd:cd08236 238 PATIEQALALARPGGKVVLVG--IPYGDVtlsEEAFEKILRKEltiqgSWNSYSAPFPGDEWRTALDLLASGKI--KVEP 313
|
330 340
....*....|....*....|
gi 53747904 1960 LPTRLFPARQVAEAFSFMAR 1979
Cdd:cd08236 314 LITHRLPLEDGPAAFERLAD 333
|
|
| ttLC_FACS_AEE21_like |
cd12118 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This ... |
2648-3127 |
8.26e-20 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This family includes fatty acyl-CoA synthetases that can activate medium to long-chain fatty acids. These enzymes catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family has been shown to catalyze the long-chain fatty acid, myristoyl acid. Also included in this family are acyl activating enzymes from Arabidopsis, which contains a large number of proteins from this family with up to 63 different genes, many of which are uncharacterized.
Pssm-ID: 341283 [Multi-domain] Cd Length: 486 Bit Score: 96.21 E-value: 8.26e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAI------AM---HKGWEQATAVLGVLQAAaaylpL 2718
Cdd:cd12118 14 AAVYPDRTSIVYGDRRYTWRQTYDRCRRLASALAALGISRGDTVAVlapntpAMyelHFGVPMAGAVLNALNTR-----L 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2719 DPEQpplrLHQLLEEGPARVVLTQSSLLHTV------PWPPGVQviAVDELEPATeapplpprgtpehlayVIYTSGSTG 2792
Cdd:cd12118 89 DAEE----IAFILRHSEAKVLFVDREFEYEDllaegdPDFEWIP--PADEWDPIA----------------LNYTSGTTG 146
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2793 KPKGVAIEHRAA-LNTVVDLnTRFGVGPEDRVLGL------SALTFDLSVydvlgllgaggalvlpAAEA-------EKD 2858
Cdd:cd12118 147 RPKGVVYHHRGAyLNALANI-LEWEMKQHPVYLWTlpmfhcNGWCFPWTV----------------AAVGgtnvclrKVD 209
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2859 PAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPAALRlVMLSGDWIPVALPDRIRALGRDVQVVSlgGATEAsiw 2938
Cdd:cd12118 210 AKAIYDLIEKHKVTHFCGAPTVLNMLANAPPSDARPLPHRVH-VMTAGAPPPAAVLAKMEELGFDVTHVY--GLTET--- 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2939 siaYPIGQVA---PQWKSIP----YGMpLANQ--RFHVLDGRLEARPWW---VP------GELYIGGEGLAREYWRDEPL 3000
Cdd:cd12118 284 ---YGPATVCawkPEWDELPteerARL-KARQgvRYVGLEEVDVLDPETmkpVPrdgktiGEIVFRGNIVMKGYLKNPEA 359
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3001 TATRFirhpRTGerLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLV 3080
Cdd:cd12118 360 TAEAF----RGG--WFHSGDLAVIHPDGYIEIKDRSKDIIISGGENISSVEVEGVLYKHPAVLEAAVVARPDEKWGEVPC 433
|
490 500 510 520
....*....|....*....|....*....|....*....|....*..
gi 53747904 3081 AYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLEsLPRSRNGKI 3127
Cdd:cd12118 434 AFVELKEGAKVTEEEIIAFCREHLAGFMVPKTVVFGE-LPKTSTGKI 479
|
|
| CAD3 |
cd08297 |
Cinnamyl alcohol dehydrogenases (CAD); These alcohol dehydrogenases are related to the ... |
1694-1903 |
1.16e-19 |
|
Cinnamyl alcohol dehydrogenases (CAD); These alcohol dehydrogenases are related to the cinnamyl alcohol dehydrogenases (CAD), members of the medium chain dehydrogenase/reductase family. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Cinnamyl alcohol dehydrogenases (CAD) reduce cinnamaldehydes to cinnamyl alcohols in the last step of monolignal metabolism in plant cells walls. CAD binds 2 zinc ions and is NADPH- dependent. CAD family members are also found in non-plant species, e.g. in yeast where they have an aldehyde reductase activity. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P) binding-Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176257 [Multi-domain] Cd Length: 341 Bit Score: 93.37 E-value: 1.16e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGDEVlAVA------------- 1760
Cdd:cd08297 22 PEPGPGEVLVKLEASGVCHTDLHAALGDWPVKPKLPLIGGHEGAGVVVAVGPGVSGLKVGDRV-GVKwlydacgkceycr 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1761 -----------------PGCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALhTVGRLRRGERILI-------- 1815
Cdd:cd08297 101 tgdetlcpnqknsgytvDGTFAEYAIADARYVTPIPDGLSFEQAAPLLCAGVTVYKAL-KKAGLKPGDWVVIsgaggglg 179
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1816 HAaagglglaAVQLASRTGAEILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVD-VVLNSLAGELLLAG 1894
Cdd:cd08297 180 HL--------GVQYAKAMGLRVIAIDVGDEKLELAKELGADAFVDFKKSDDVEAVKELTGGGGAHaVVVTAVSAAAYEQA 251
|
....*....
gi 53747904 1895 LSVLAPHGR 1903
Cdd:cd08297 252 LDYLRPGGT 260
|
|
| AFD_YhfT-like |
cd17633 |
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, ... |
2780-3129 |
1.71e-19 |
|
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, as well as long-chain fatty acid-CoA ligase VraA, all of which are as yet to be characterized. These proteins belong to the adenylate-forming enzymes which catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain
Pssm-ID: 341288 [Multi-domain] Cd Length: 320 Bit Score: 92.47 E-value: 1.71e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2780 HLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLpaaEAEKDP 2859
Cdd:cd17633 1 NPFYIGFTSGTTGLPKAYYRSERSWIESFVCNEDLFNISGEDAILAPGPLSHSLFLYGAISALYLGGTFIG---QRKFNP 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2860 AHWWERLVAGRVTVWNSTPALMLLLVeyaeqRGLKLPAALRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEASIws 2939
Cdd:cd17633 78 KSWIRKINQYNATVIYLVPTMLQALA-----RTLEPESKIKSIFSSGQKLFESTKKKLKNIFPKANLIEFYGTSELSF-- 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2940 IAYPIGQVAPQWKSIpyGMPLANQRFHVLD------GRLearpwWVPGELYIGGEGLAREYWRDEPLTatrfirhprtge 3013
Cdd:cd17633 151 ITYNFNQESRPPNSV--GRPFPNVEIEIRNadggeiGKI-----FVKSEMVFSGYVRGGFSNPDGWMS------------ 211
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3014 rlyrTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVarGEPRGVRRLVAYAVpRSGQTPAA 3093
Cdd:cd17633 212 ----VGDIGYVDEEGYLYLVGRESDMIIIGGINIFPTEIESVLKAIPGIEEAIVV--GIPDARFGEIAVAL-YSGDKLTY 284
|
330 340 350
....*....|....*....|....*....|....*.
gi 53747904 3094 GELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIAR 3129
Cdd:cd17633 285 KQLKRFLKQKLSRYEIPKKIIFVDSLPYTSSGKIAR 320
|
|
| FACL_like_5 |
cd05924 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
2915-3126 |
4.66e-19 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341248 [Multi-domain] Cd Length: 364 Bit Score: 92.06 E-value: 4.66e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2915 DRIRALGRDVQVVSLGGATEASIWSIAYPIGQVAPQWKSIpygmpLANQRFHVLDGRLEARPWWVPGELYIGGEGL-ARE 2993
Cdd:cd05924 152 QGLLELVPNITLVDAFGSSETGFTGSGHSAGSGPETGPFT-----RANPDTVVLDDDGRVVPPGSGGVGWIARRGHiPLG 226
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2994 YWRDEPLTATRFIRhpRTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEP 3073
Cdd:cd05924 227 YYGDEAKTAETFPE--VDGVRYAVPGDRATVEADGTVTLLGRGSVCINTGGEKVFPEEVEEALKSHPAVYDVLVVGRPDE 304
|
170 180 190 200 210
....*....|....*....|....*....|....*....|....*....|...
gi 53747904 3074 RGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGK 3126
Cdd:cd05924 305 RWGQEVVAVVQLREGAGVDLEELREHCRTRIARYKLPKQVVFVDEIERSPAGK 357
|
|
| iditol_2_DH_like |
cd08235 |
L-iditol 2-dehydrogenase; Putative L-iditol 2-dehydrogenase based on annotation of some ... |
1693-1974 |
4.86e-19 |
|
L-iditol 2-dehydrogenase; Putative L-iditol 2-dehydrogenase based on annotation of some members in this subgroup. L-iditol 2-dehydrogenase catalyzes the NAD+-dependent conversion of L-iditol to L-sorbose in fructose and mannose metabolism. This enzyme is related to sorbitol dehydrogenase, alcohol dehydrogenase, and other medium chain dehydrogenase/reductases. The zinc-dependent alcohol dehydrogenase (ADH-Zn)-like family of proteins is a diverse group of proteins related to the first identified member, class I mammalian ADH. This group is also called the medium chain dehydrogenases/reductase family (MDR) to highlight its broad range of activities and to distinguish from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P) binding-Rossmann fold domain of a beta-alpha form and an N-terminal GroES-like catalytic domain. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176197 [Multi-domain] Cd Length: 343 Bit Score: 91.50 E-value: 4.86e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1693 RPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEeSVLGRECSGRIAAVGEGVSGLRVGDEVlAVAPGC--------- 1763
Cdd:cd08235 19 VPEPGPGEVLVKVRACGICGTDVKKIRGGHTDLKPP-RILGHEIAGEIVEVGDGVTGFKVGDRV-FVAPHVpcgechycl 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1764 --------------------FRSYVLVDESQVVRR-----PASLGLAEGAaqMV-PFATAYFALHTVGrLRRGERILI-- 1815
Cdd:cd08235 97 rgnenmcpnykkfgnlydggFAEYVRVPAWAVKRGgvlklPDNVSFEEAA--LVePLACCINAQRKAG-IKPGDTVLVig 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1816 -------HaaagglglaaVQLASRTGAE-ILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVDVV-LNSL 1886
Cdd:cd08235 174 agpigllH----------AMLAKASGARkVIVSDLNEFRLEFAKKLGADYTIDAAEEDLVEKVRELTDGRGADVViVATG 243
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1887 AGELLLAGLSVLAPHGRFLELGKrdLYADQQVGL--RTLARGQ-----TFAAIDfgphhPDFRAVLEEVATqltqGQ--L 1957
Cdd:cd08235 244 SPEAQAQALELVRKGGRILFFGG--LPKGSTVNIdpNLIHYREititgSYAASP-----EDYKEALELIAS----GKidV 312
|
330
....*....|....*..
gi 53747904 1958 EPLPTRLFPARQVAEAF 1974
Cdd:cd08235 313 KDLITHRFPLEDIEEAF 329
|
|
| crotonyl_coA_red |
cd08246 |
crotonyl-CoA reductase; Crotonyl-CoA reductase, a member of the medium chain dehydrogenase ... |
1694-1988 |
5.02e-19 |
|
crotonyl-CoA reductase; Crotonyl-CoA reductase, a member of the medium chain dehydrogenase/reductase family, catalyzes the NADPH-dependent conversion of crotonyl-CoA to butyryl-CoA, a step in (2S)-methylmalonyl-CoA production for straight-chain fatty acid biosynthesis. Like enoyl reductase, another enzyme in fatty acid synthesis, crotonyl-CoA reductase is a member of the zinc-dependent alcohol dehydrogenase-like medium chain dehydrogenase/reductase family. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P) binding-Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES.
Pssm-ID: 176208 [Multi-domain] Cd Length: 393 Bit Score: 92.48 E-value: 5.02e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAGLNFLDVLGALG--------MMPALEAEE-SVLGRECSGRIAAVGEGVSGLRVGDEVLA------ 1758
Cdd:cd08246 38 PELGPGEVLVAVMAAGVNYNNVWAALGepvstfaaRQRRGRDEPyHIGGSDASGIVWAVGEGVKNWKVGDEVVVhcsvwd 117
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1759 ------------VAP-----------GCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFAL-----HTVgrlRRG 1810
Cdd:cd08246 118 gndperaggdpmFDPsqriwgyetnyGSFAQFALVQATQLMPKPKHLSWEEAAAYMLVGATAYRMLfgwnpNTV---KPG 194
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1811 ERILIHAAAGGLGLAAVQLASRTGAEILATAGSEQKREYLRSLGIAHVLD----------------------SRSTSFVS 1868
Cdd:cd08246 195 DNVLIWGASGGLGSMAIQLARAAGANPVAVVSSEEKAEYCRALGAEGVINrrdfdhwgvlpdvnseaytawtKEARRFGK 274
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1869 EVRERTGGR-GVDVVLNSLAGELLLAGLSVLAPHGRFLELGKRDLYaDQQVGLRTL----ARGQtfaaidfGPHHPDFRA 1943
Cdd:cd08246 275 AIWDILGGReDPDIVFEHPGRATFPTSVFVCDRGGMVVICAGTTGY-NHTYDNRYLwmrqKRIQ-------GSHFANDRE 346
|
330 340 350 360
....*....|....*....|....*....|....*....|....*..
gi 53747904 1944 VLEevATQLT-QGQLEPLPTRLFPARQVAEAFSFMAR-ALHIGRVAV 1988
Cdd:cd08246 347 AAE--ANRLVmKGRIDPCLSKVFSLDETPDAHQLMHRnQHHVGNMAV 391
|
|
| PRK09185 |
PRK09185 |
beta-ketoacyl-ACP synthase; |
156-439 |
5.81e-19 |
|
beta-ketoacyl-ACP synthase;
Pssm-ID: 236398 [Multi-domain] Cd Length: 392 Bit Score: 92.21 E-value: 5.81e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 156 GNYPDFLAtrvAYkLNLRGPALGIHTACSTSLVSINMACSALRGFECDMALAGGV-SL-RLParsgyLYeegGVAS---- 229
Cdd:PRK09185 137 GSLADFLR---AY-LGLSGPAYTISTACSSSAKVFASARRLLEAGLCDAAIVGGVdSLcRLT-----LN---GFNSlesl 204
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 230 KDGHCRPFDAR---------ATGtvtgdgvgvvvlkrledALKARDPIHAVirgwALNNDGASRAGF--TAPSVEGQSEV 298
Cdd:PRK09185 205 SPQPCRPFSANrdginigeaAAF-----------------FLLEREDDAAV----ALLGVGESSDAHhmSAPHPEGLGAI 263
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 299 IAL--AHAAAGISARDITYVEAHGTGTPLGDPIEVAALTRAFRAHTAdtafCTlgAVKSNIGHLDAAAGVAGVIKTVQAL 376
Cdd:PRK09185 264 LAMqqALADAGLAPADIGYINLHGTATPLNDAMESRAVAAVFGDGVP----CS--STKGLTGHTLGAAGAVEAAICWLAL 337
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 53747904 377 RHRLIPPTLHFERPNPALHLEqsPFFVNTQPLPwesprgPRLAGVSSFGIGGTNAHTLFEEAP 439
Cdd:PRK09185 338 RHGLPPHGWNTGQPDPALPPL--YLVENAQALA------IRYVLSNSFAFGGNNCSLIFGRAD 392
|
|
| FAAL |
cd05931 |
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and ... |
2686-3129 |
7.01e-19 |
|
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and is homologous to fatty acyl-coenzyme A (CoA) ligases (FACLs). However, FAALs produce only the acyl adenylate and are unable to perform the thioester-forming reaction, while FACLs perform a two-step catalytic reaction; AMP ligation followed by CoA ligation using ATP and CoA as cofactors. FAALs have insertion motifs between the N-terminal and C-terminal subdomains that distinguish them from the FACLs. This insertion motif precludes the binding of CoA, thus preventing CoA ligation. It has been suggested that the acyl adenylates serve as substrates for multifunctional polyketide synthases to permit synthesis of complex lipids such as phthiocerol dimycocerosate, sulfolipids, mycolic acids, and mycobactin.
Pssm-ID: 341254 [Multi-domain] Cd Length: 547 Bit Score: 93.84 E-value: 7.01e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2686 QPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPL---RLHQLLEEGPARVVLTQSSLL-------HTVPWPPGV 2755
Cdd:cd05931 46 KPGDRVLLLAPPGLDFVAAFLGCLYAGAIAVPLPPPTPGRhaeRLAAILADAGPRVVLTTAAALaavrafaASRPAAGTP 125
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2756 QVIAVDELEPATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLG---------- 2825
Cdd:cd05931 126 RLLVVDLLPDTSAADWPPPSPDPDDIAYLQYTSGSTGTPKGVVVTHRNLLANVRQIRRAYGLDPGDVVVSwlplyhdmgl 205
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2826 ----LSALTFDLSVYdvlgllgaggaLVLPAAEAeKDPAHWWERLVAGRVTVwnsTPA------LMLLLVEYAEQRGLKL 2895
Cdd:cd05931 206 igglLTPLYSGGPSV-----------LMSPAAFL-RRPLRWLRLISRYRATI---SAApnfaydLCVRRVRDEDLEGLDL 270
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2896 pAALRLVMLSGDwiPV------ALPDRIRALGRDVQV-------------VSLGGATE---------ASIWSIAYPIGQV 2947
Cdd:cd05931 271 -SSWRVALNGAE--PVrpatlrRFAEAFAPFGFRPEAfrpsyglaeatlfVSGGPPGTgpvvlrvdrDALAGRAVAVAAD 347
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2948 APQWKSIP-YGMPLANQRFHVLD--GRLEARPWWVpGELYIGGEGLAREYWRDEPLTATRFIRHPRTGERLY-RTGDQGR 3023
Cdd:cd05931 348 DPAARELVsCGRPLPDQEVRIVDpeTGRELPDGEV-GEIWVRGPSVASGYWGRPEATAETFGALAATDEGGWlRTGDLGF 426
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3024 MLpEGSIEFLGR-EDLQVkVQGFRVELGEIEAALAQ-HPALSASVVVARG-EPRGVRRLVAYAVPRSGQTPA-----AGE 3095
Cdd:cd05931 427 LH-DGELYITGRlKDLII-VRGRNHYPQDIEATAEEaHPALRPGCVAAFSvPDDGEERLVVVAEVERGADPAdlaaiAAA 504
|
490 500 510
....*....|....*....|....*....|....*.
gi 53747904 3096 LRRYLAERLPayMVPSAFVLLE--SLPRSRNGKIAR 3129
Cdd:cd05931 505 IRAAVAREHG--VAPADVVLVRpgSIPRTSSGKIQR 538
|
|
| OSB_CoA_lg |
cd05912 |
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA ... |
2779-3132 |
7.51e-19 |
|
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA synthetase, or MenE); O-succinylbenzoic acid-CoA synthase catalyzes the coenzyme A (CoA)- and ATP-dependent conversion of o-succinylbenzoic acid to o-succinylbenzoyl-CoA. The reaction is the fourth step of the biosynthesis pathway of menaquinone (vitamin K2). In certain bacteria, menaquinone is used during fumarate reduction in anaerobic respiration. In cyanobacteria, the product of the menaquinone pathway is phylloquinone (2-methyl-3-phytyl-1,4-naphthoquinone), a molecule used exclusively as an electron transfer cofactor in Photosystem 1. In green sulfur bacteria and heliobacteria, menaquinones are used as loosely bound secondary electron acceptors in the photosynthetic reaction center.
Pssm-ID: 341238 [Multi-domain] Cd Length: 411 Bit Score: 92.02 E-value: 7.51e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2779 EHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVL---------GLS----ALTFDLSVYdvlgllgag 2845
Cdd:cd05912 77 DDIATIMYTSGTTGKPKGVQQTFGNHWWSAIGSALNLGLTEDDNWLcalplfhisGLSilmrSVIYGMTVY--------- 147
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2846 galVLPAAEAEKdpAHwwERLVAGRVTVWNSTPALmllLVEYAEQRGLKLPAALRLVMLSGDWIPVALPDRirALGRDVQ 2925
Cdd:cd05912 148 ---LVDKFDAEQ--VL--HLINSGKVTIISVVPTM---LQRLLEILGEGYPNNLRCILLGGGPAPKPLLEQ--CKEKGIP 215
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2926 VVSLGGATEASIWSIAYPIGQVAPQWKSIpyGMPLANQRFHVLDgrlEARPWWVPGELYIGGEGLAREYWRDEPLTATRF 3005
Cdd:cd05912 216 VYQSYGMTETCSQIVTLSPEDALNKIGSA--GKPLFPVELKIED---DGQPPYEVGEILLKGPNVTKGYLNRPDATEESF 290
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3006 irhpRTGerLYRTGDQGRMLPEGSIEFLGR-EDLQVKvQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAV 3084
Cdd:cd05912 291 ----ENG--WFKTGDIGYLDEEGFLYVLDRrSDLIIS-GGENIYPAEIEEVLLSHPAIKEAGVVGIPDDKWGQVPVAFVV 363
|
330 340 350 360
....*....|....*....|....*....|....*....|....*...
gi 53747904 3085 prSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd05912 364 --SERPISEEELIAYCSEKLAKYKVPKKIYFVDELPRTASGKLLRHEL 409
|
|
| PRK05605 |
PRK05605 |
long-chain-fatty-acid--CoA ligase; Validated |
2748-3134 |
1.27e-18 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235531 [Multi-domain] Cd Length: 573 Bit Score: 93.14 E-value: 1.27e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2748 TVPWPpgvqvIAVDELEPATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHR----------AALNTVVDLNTRF-G 2816
Cdd:PRK05605 193 TVPWE-----TLVDAAIGGDGSDVSHPRPTPDDVALILYTSGTTGKPKGAQLTHRnlfanaaqgkAWVPGLGDGPERVlA 267
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2817 VGPEDRVLGLS-ALTFDLSVydvlgllgAGGALVLPAAEAE-------KDPAHWwerlVAGrvtvwnsTPALMLLLVEYA 2888
Cdd:PRK05605 268 ALPMFHAYGLTlCLTLAVSI--------GGELVLLPAPDIDlildamkKHPPTW----LPG-------VPPLYEKIAEAA 328
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2889 EQRGLKLpAALRlVMLSGdwiPVALPDRIRALGRDVQ---VVSLGGATEASIWSIAYPIGQVA-PQWKSIPYgmPLANQR 2964
Cdd:PRK05605 329 EERGVDL-SGVR-NAFSG---AMALPVSTVELWEKLTgglLVEGYGLTETSPIIVGNPMSDDRrPGYVGVPF--PDTEVR 401
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2965 FHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIrhprtgERLYRTGDQGRMLPEGSIEFLGREDLQVKVQG 3044
Cdd:PRK05605 402 IVDPEDPDETMPDGEEGELLVRGPQVFKGYWNRPEETAKSFL------DGWFRTGDVVVMEEDGFIRIVDRIKELIITGG 475
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3045 FRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRN 3124
Cdd:PRK05605 476 FNVYPAEVEEVLREHPGVEDAAVVGLPREDGSEEVVAAVVLEPGAALDPEGLRAYCREHLTRYKVPRRFYHVDELPRDQL 555
|
410
....*....|
gi 53747904 3125 GKIARDQLPE 3134
Cdd:PRK05605 556 GKVRRREVRE 565
|
|
| AL_MDR |
cd08252 |
Arginate lyase and other MDR family members; This group contains a structure identified as an ... |
1693-1904 |
1.38e-18 |
|
Arginate lyase and other MDR family members; This group contains a structure identified as an arginate lyase. Other members are identified quinone reductases, alginate lyases, and other proteins related to the zinc-dependent dehydrogenases/reductases. QOR catalyzes the conversion of a quinone and NAD(P)H to a hydroquinone and NAD(P+. Quinones are cyclic diones derived from aromatic compounds. Membrane bound QOR acts in the respiratory chains of bacteria and mitochondria, while soluble QOR acts to protect from toxic quinones (e.g. DT-diaphorase) or as a soluble eye-lens protein in some vertebrates (e.g. zeta-crystalin). QOR reduces quinones through a semi-quinone intermediate via a NAD(P)H-dependent single electron transfer. QOR is a member of the medium chain dehydrogenase/reductase family, but lacks the zinc-binding sites of the prototypical alcohol dehydrogenases of this group. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176214 [Multi-domain] Cd Length: 336 Bit Score: 90.28 E-value: 1.38e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1693 RPAPGPRQVEIEVEAAGLNFLDVlGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGDEVL---AVA-PGCFRSYV 1768
Cdd:cd08252 25 KPVPGGRDLLVRVEAVSVNPVDT-KVRAGGAPVPGQPKILGWDASGVVEAVGSEVTLFKVGDEVYyagDITrPGSNAEYQ 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1769 LVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGER-----ILIHAAAGGLGLAAVQLASR-TGAEILATAG 1842
Cdd:cd08252 104 LVDERIVGHKPKSLSFAEAAALPLTSLTAWEALFDRLGISEDAEnegktLLIIGGAGGVGSIAIQLAKQlTGLTVIATAS 183
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 53747904 1843 SEQKREYLRSLGIAHVLDSRStSFVSEVRERtGGRGVDVVLN-SLAGELLLAGLSVLAPHGRF 1904
Cdd:cd08252 184 RPESIAWVKELGADHVINHHQ-DLAEQLEAL-GIEPVDYIFClTDTDQHWDAMAELIAPQGHI 244
|
|
| ABCL |
cd05958 |
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate ... |
2655-3132 |
1.51e-18 |
|
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate aerobic degradation pathway by activating 2-aminobenzoate to 2-aminobenzoyl-CoA. The reaction is carried out via a two-step process; the first step is ATP-dependent and forms a 2-aminobenzoyl-AMP intermediate, and the second step forms the 2-aminobenzoyl-CoA ester and releases the AMP. 2-Aminobenzoyl-CoA is further converted to 2-amino-5-oxo-cyclohex-1-ene-1-carbonyl-CoA catalyzed by 2-aminobenzoyl-CoA monooxygenase/reductase. ABCL has been purified from cells aerobically grown with 2-aminobenzoate as sole carbon, energy, and nitrogen source, and has been characterized as a monomer.
Pssm-ID: 341268 [Multi-domain] Cd Length: 439 Bit Score: 91.77 E-value: 1.51e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2655 PALLAPERTLSYGELARRA-QALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEE 2733
Cdd:cd05958 2 TCLRSPEREWTYRDLLALAnRIANVLVGELGIVPGNRVLLRGSNSPELVACWFGIQKAGAIAVATMPLLRPKELAYILDK 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2734 GPARVVLTQSSLLHTvpwppgvqviavdelepateapplpprgtpEHLAYVIYTSGSTGKPKGVAIEHRAALnTVVDLNT 2813
Cdd:cd05958 82 ARITVALCAHALTAS------------------------------DDICILAFTSGTTGAPKATMHFHRDPL-ASADRYA 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2814 R--FGVGPEDRVLGLSAL--TFDLSVYDVLGLLGAGGALVLPAAEAEKdpahwwerlVAG-----RVTVWNSTPALMLLL 2884
Cdd:cd05958 131 VnvLRLREDDRFVGSPPLafTFGLGGVLLFPFGVGASGVLLEEATPDL---------LLSaiaryKPTVLFTAPTAYRAM 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2885 VEYAEQRGLKLpAALRLVMLSGDWIPVALPDRIR-ALGrdVQVVSLGGATEASIWSIAYPIGQVAPQwksiPYGMPLANQ 2963
Cdd:cd05958 202 LAHPDAAGPDL-SSLRKCVSAGEALPAALHRAWKeATG--IPIIDGIGSTEMFHIFISARPGDARPG----ATGKPVPGY 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2964 RFHVLDGRLEARPWWVPGELYIGGEGLAReyWRDEPLTATRFirhprTGERLYrTGDQGRMLPEGSIEFLGREDLQVKVQ 3043
Cdd:cd05958 275 EAKVVDDEGNPVPDGTIGRLAVRGPTGCR--YLADKRQRTYV-----QGGWNI-TGDTYSRDPDGYFRHQGRSDDMIVSG 346
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3044 GFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPA---AGELRRYLAERLPAYMVPSAFVLLESLP 3120
Cdd:cd05958 347 GYNIAPPEVEDVLLQHPAVAECAVVGHPDESRGVVVKAFVVLRPGVIPGpvlARELQDHAKAHIAPYKYPRAIEFVTELP 426
|
490
....*....|..
gi 53747904 3121 RSRNGKIARDQL 3132
Cdd:cd05958 427 RTATGKLQRFAL 438
|
|
| ACLS-CaiC |
cd17637 |
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ... |
2784-3129 |
1.64e-18 |
|
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized, but may be similar to Carnitine-CoA ligase (CaiC) which catalyzes the transfer of CoA to carnitine. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341292 [Multi-domain] Cd Length: 333 Bit Score: 90.02 E-value: 1.64e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2784 VIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGL------SALTFDLSVYDVLGLLGAggalvlpaaeAEK 2857
Cdd:cd17637 5 IIHTAAVAGRPRGAVLSHGNLIAANLQLIHAMGLTEADVYLNMlplfhiAGLNLALATFHAGGANVV----------MEK 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2858 -DPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLpAALRLVmlSGdwipVALPDRIRALGRDV--QVVSLGGATE 2934
Cdd:cd17637 75 fDPAEALELIEEEKVTLMGSFPPILSNLLDAAEKSGVDL-SSLRHV--LG----LDAPETIQRFEETTgaTFWSLYGQTE 147
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2935 ASIWSIAYPIGQvapqwKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFirhpRTGer 3014
Cdd:cd17637 148 TSGLVTLSPYRE-----RPGSAGRPGPLVRVRIVDDNDRPVPAGETGEIVVRGPLVFQGYWNLPELTAYTF----RNG-- 216
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3015 LYRTGDQGRMLPEGSIEFLGR--EDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPR---GVRrlvAYAVPRSGQ 3089
Cdd:cd17637 217 WHHTGDLGRFDEDGYLWYAGRkpEKELIKPGGENVYPAEVEKVILEHPAIAEVCVIGVPDPKwgeGIK---AVCVLKPGA 293
|
330 340 350 360
....*....|....*....|....*....|....*....|
gi 53747904 3090 TPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIAR 3129
Cdd:cd17637 294 TLTADELIEFVGSRIARYKKPRYVVFVEALPKTADGSIDR 333
|
|
| PRK08439 |
PRK08439 |
3-oxoacyl-(acyl carrier protein) synthase II; Reviewed |
86-435 |
1.65e-18 |
|
3-oxoacyl-(acyl carrier protein) synthase II; Reviewed
Pssm-ID: 236265 [Multi-domain] Cd Length: 406 Bit Score: 90.95 E-value: 1.65e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 86 SPREASHLDPQQRLLLECSWEALEDAGLRPDQL-PGWVGVYVGAG---------DTSYRFQllrghgdplSGSKDVAGFF 155
Cdd:PRK08439 62 DPKEVKKADRFIQLGLKAAREAMKDAGFLPEELdAERFGVSSASGigglpniekNSIICFE---------KGPRKISPFF 132
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 156 --GNYPDFLATRVAYKLNLRGPALGIHTACSTSLVSINMA--CSALRGFE-----------CDMALAGGVSLR-LPARSg 219
Cdd:PRK08439 133 ipSALVNMLGGFISIEHGLKGPNLSSVTACAAGTHAIIEAvkTIMLGGADkmlvvgaesaiCPVGIGGFAAMKaLSTRN- 211
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 220 ylyEEGGVASkdghcRPFDARATGTVTGDGVGVVVLKRLEDALKARDPIHAVIRGWALNNDGASragFTAPSVEGQSEVI 299
Cdd:PRK08439 212 ---DDPKKAS-----RPFDKDRDGFVMGEGAGALVLEEYESAKKRGAKIYAEIIGFGESGDANH---ITSPAPEGPLRAM 280
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 300 ALAHAAAGISarDITYVEAHGTGTPLGDPIEVAALTRAFrahtADTAFCTL-GAVKSNIGH-LDAAAGVAGVIkTVQALR 377
Cdd:PRK08439 281 KAALEMAGNP--KIDYINAHGTSTPYNDKNETAALKELF----GSKEKVPPvSSTKGQIGHcLGAAGAIEAVI-SIMAMR 353
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 378 HRLIPPTLHFERPNPALHLEQSPffvNTqplpwesPRGPRLAGV--SSFGIGGTNAHTLF 435
Cdd:PRK08439 354 DGILPPTINQETPDPECDLDYIP---NV-------ARKAELNVVmsNSFGFGGTNGVVIF 403
|
|
| FACL_like_2 |
cd05917 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
2786-3132 |
1.76e-18 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341241 [Multi-domain] Cd Length: 349 Bit Score: 90.03 E-value: 1.76e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2786 YTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDR-------------VLG-LSALTFDLS-VYdvlgllgaggalvl 2850
Cdd:cd05917 9 FTSGTTGSPKGATLTHHNIVNNGYFIGERLGLTEQDRlcipvplfhcfgsVLGvLACLTHGATmVF-------------- 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2851 paAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLpAALRLVMLSGDWIPVALPDRIRALGRDVQVVSLG 2930
Cdd:cd05917 75 --PSPSFDPLAVLEAIEKEKCTALHGVPTMFIAELEHPDFDKFDL-SSLRTGIMAGAPCPPELMKRVIEVMNMKDVTIAY 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2931 GATEASIWSIAYPIGQVAPQwKSIPYGMPLANQRFHVLD--GRLEArPWWVPGELYIGGEGLAREYWRDEPLTATRFirh 3008
Cdd:cd05917 152 GMTETSPVSTQTRTDDSIEK-RVNTVGRIMPHTEAKIVDpeGGIVP-PVGVPGELCIRGYSVMKGYWNDPEKTAEAI--- 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3009 prTGERLYRTGDQGRMLPEGSIEFLGR-EDLQVKvQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRS 3087
Cdd:cd05917 227 --DGDGWLHTGDLAVMDEDGYCRIVGRiKDMIIR-GGENIYPREIEEFLHTHPKVSDVQVVGVPDERYGEEVCAWIRLKE 303
|
330 340 350 360
....*....|....*....|....*....|....*....|....*
gi 53747904 3088 GQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd05917 304 GAELTEEDIKAYCKGKIAHYKVPRYVFFVDEFPLTVSGKIQKFKL 348
|
|
| PRK10754 |
PRK10754 |
NADPH:quinone reductase; |
1678-1885 |
1.83e-18 |
|
NADPH:quinone reductase;
Pssm-ID: 182701 [Multi-domain] Cd Length: 327 Bit Score: 89.79 E-value: 1.83e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1678 GTPGLLESLGLrrcTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPAlEAEESVLGRECSGRIAAVGEGVSGLRVGDEVL 1757
Cdd:PRK10754 11 GGPEVLQAVEF---TPADPAENEVQVENKAIGINYIDTYIRSGLYPP-PSLPSGLGTEAAGVVSKVGSGVKHIKVGDRVV 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1758 -AVAP-GCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGERILIHAAAGGLGLAAVQLASRTGA 1835
Cdd:PRK10754 87 yAQSAlGAYSSVHNVPADKAAILPDAISFEQAAASFLKGLTVYYLLRKTYEIKPDEQFLFHAAAGGVGLIACQWAKALGA 166
|
170 180 190 200 210
....*....|....*....|....*....|....*....|....*....|
gi 53747904 1836 EILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVLNS 1885
Cdd:PRK10754 167 KLIGTVGSAQKAQRAKKAGAWQVINYREENIVERVKEITGGKKVRVVYDS 216
|
|
| PRK06145 |
PRK06145 |
acyl-CoA synthetase; Validated |
2648-3127 |
1.92e-18 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 102207 [Multi-domain] Cd Length: 497 Bit Score: 91.87 E-value: 1.92e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRL 2727
Cdd:PRK06145 12 ARRTPDRAALVYRDQEISYAEFHQRILQAAGMLHARGIGQGDVVALLMKNSAAFLELAFAASYLGAVFLPINYRLAADEV 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2728 HQLLEEGPARVVLTQSSLlhTVPWPPGVQVIAVDEL---------EPATEAPPLPPRgTPEHLAYVIYTSGSTGKPKGVA 2798
Cdd:PRK06145 92 AYILGDAGAKLLLVDEEF--DAIVALETPKIVIDAAaqadsrrlaQGGLEIPPQAAV-APTDLVRLMYTSGTTDRPKGVM 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2799 IEHRAALNTVVDLNTRFGVGPEDRVLGLSALtFDLSVYDVLGLLGAGGALVLpAAEAEKDPAHWWERLVAGRVTVWNSTP 2878
Cdd:PRK06145 169 HSYGNLHWKSIDHVIALGLTASERLLVVGPL-YHVGAFDLPGIAVLWVGGTL-RIHREFDPEAVLAAIERHRLTCAWMAP 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2879 ALMLLLVEYAEQRGLKLpAALRLVMLSGDWIPvalPDRIRALGR---DVQVVSLGGATEASIWSIAYPIGQVAPQWKSIp 2955
Cdd:PRK06145 247 VMLSRVLTVPDRDRFDL-DSLAWCIGGGEKTP---ESRIRDFTRvftRARYIDAYGLTETCSGDTLMEAGREIEKIGST- 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2956 yGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIrhprtgERLYRTGDQGRMLPEGSIEFLGR 3035
Cdd:PRK06145 322 -GRALAHVEIRIADGAGRWLPPNMKGEICMRGPKVTKGYWKDPEKTAEAFY------GDWFRSGDVGYLDEEGFLYLTDR 394
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3036 EDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVL 3115
Cdd:PRK06145 395 KKDMIISGGENIASSEVERVIYELPEVAEAAVIGVHDDRWGERITAVVVLNPGATLTLEALDRHCRQRLASFKVPRQLKV 474
|
490
....*....|..
gi 53747904 3116 LESLPRSRNGKI 3127
Cdd:PRK06145 475 RDELPRNPSGKV 486
|
|
| PRK08316 |
PRK08316 |
acyl-CoA synthetase; Validated |
2648-3132 |
3.91e-18 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181381 [Multi-domain] Cd Length: 523 Bit Score: 91.15 E-value: 3.91e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRL 2727
Cdd:PRK08316 21 ARRYPDKTALVFGDRSWTYAELDAAVNRVAAALLDLGLKKGDRVAALGHNSDAYALLWLACARAGAVHVPVNFMLTGEEL 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2728 HQLLEEGPARVVLTQSSLL------------HTVPWPPGV-------QVIAVDELEPATEAPPLPPRGTPEHLAYVIYTS 2788
Cdd:PRK08316 101 AYILDHSGARAFLVDPALAptaeaalallpvDTLILSLVLggreapgGWLDFADWAEAGSVAEPDVELADDDLAQILYTS 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2789 GSTGKPKGVAIEHRAAL----NTVVDLntrfGVGPEDRVlgLSAL----TFDLSVYDVLGLLGAGGALVLPAAeaekDPA 2860
Cdd:PRK08316 181 GTESLPKGAMLTHRALIaeyvSCIVAG----DMSADDIP--LHALplyhCAQLDVFLGPYLYVGATNVILDAP----DPE 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2861 HWWERLVAGRV-------TVWNStpalmLLLVEYAEQRGLklpAALRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGAT 2933
Cdd:PRK08316 251 LILRTIEAERItsffappTVWIS-----LLRHPDFDTRDL---SSLRKGYYGASIMPVEVLKELRERLPGLRFYNCYGQT 322
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2934 E-ASIWSIAYPIGQVApqwKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFirhpRTG 3012
Cdd:PRK08316 323 EiAPLATVLGPEEHLR---RPGSAGRPVLNVETRVVDDDGNDVAPGEVGEIVHRSPQLMLGYWDDPEKTAEAF----RGG 395
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3013 erLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPA 3092
Cdd:PRK08316 396 --WFHSGDLGVMDEEGYITVVDRKKDMIKTGGENVASREVEEALYTHPAVAEVAVIGLPDPKWIEAVTAVVVPKAGATVT 473
|
490 500 510 520
....*....|....*....|....*....|....*....|
gi 53747904 3093 AGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PRK08316 474 EDELIAHCRARLAGFKVPKRVIFVDELPRNPSGKILKREL 513
|
|
| PRK06060 |
PRK06060 |
p-hydroxybenzoic acid--AMP ligase FadD22; |
2736-3323 |
8.29e-18 |
|
p-hydroxybenzoic acid--AMP ligase FadD22;
Pssm-ID: 180374 [Multi-domain] Cd Length: 705 Bit Score: 90.86 E-value: 8.29e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2736 ARVVLTQSSLLHTvpWPPGVQVIAVDELEPATEAPPL---PPRGtpEHLAYVIYTSGSTGKPKGvAIEHRAALNTVVDLN 2812
Cdd:PRK06060 103 PALVVTSDALRDR--FQPSRVAEAAELMSEAARVAPGgyePMGG--DALAYATYTSGTTGPPKA-AIHRHADPLTFVDAM 177
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2813 TR--FGVGPEDrvLGLSA----LTFDL--SVYDVLGLLGAGGALVLP-AAEAEKDPAHWWERlvagrvTVWNSTPALMLL 2883
Cdd:PRK06060 178 CRkaLRLTPED--TGLCSarmyFAYGLgnSVWFPLATGGSAVINSAPvTPEAAAILSARFGP------SVLYGVPNFFAR 249
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2884 LVEYAEQRGLKlpaALRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEasiwsiaypIGQV-----APQWKSIPYGM 2958
Cdd:PRK06060 250 VIDSCSPDSFR---SLRCVVSAGEALELGLAERLMEFFGGIPILDGIGSTE---------VGQTfvsnrVDEWRLGTLGR 317
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2959 PLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYW-RDEPLTatrfirhprTGERLYRTGDQGRMLPEGSIEFLGRED 3037
Cdd:PRK06060 318 VLPPYEIRVVAPDGTTAGPGVEGDLWVRGPAIAKGYWnRPDSPV---------ANEGWLDTRDRVCIDSDGWVTYRCRAD 388
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3038 LQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELR---RYLAERLPAYMVPSAFV 3114
Cdd:PRK06060 389 DTEVIGGVNVDPREVERLIIEDEAVAEAAVVAVRESTGASTLQAFLVATSGATIDGSVMRdlhRGLLNRLSAFKVPHRFA 468
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3115 LLESLPRSRNGKIARD----QLP----------------------EPQQTQGLAAQAAAADPLVERLAALVKEALRL--E 3166
Cdd:PRK06060 469 VVDRLPRTPNGKLVRGalrkQSPtkpiwelsltepgsgvraqrddLSASNMTIAGGNDGGATLRERLVALRQERQRLvvD 548
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3167 RV---------EPQDSLL-------DLGADSVALIRLINRLEAELQFRPRLADIYENPTVQGLATLhqektksqgeggap 3230
Cdd:PRK06060 549 AVcaeaakmlgEPDPWSVdqdlafsELGFDSQMTVTLCKRLAAVTGLRLPETVGWDYGSISGLAQY-------------- 614
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3231 rltaprstllpaeewgrFKANRPGLRRFPDgTPEVALPGS-GLAPAPEELTALERRRSVRTYSLEPVSHEQLGRLLAPLR 3309
Cdd:PRK06060 615 -----------------LEAELAGGHGRLK-SAGPVNSGAtGLWAIEEQLNKVEELVAVIADGEKQRVADRLRALLGTIA 676
|
650
....*....|....
gi 53747904 3310 EWEVQGSRRYLYAS 3323
Cdd:PRK06060 677 GSEAGLGKLIQAAS 690
|
|
| PRK14691 |
PRK14691 |
3-oxoacyl-(acyl carrier protein) synthase II; Provisional |
147-436 |
1.04e-17 |
|
3-oxoacyl-(acyl carrier protein) synthase II; Provisional
Pssm-ID: 173154 [Multi-domain] Cd Length: 342 Bit Score: 87.86 E-value: 1.04e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 147 GSKDVAGFfgNYPDFL----ATRVAYKLNLRGPALGIHTACSTSLVSINMACSALRGFECDMALAGG-------VSLRLP 215
Cdd:PRK14691 53 GPKRLSPF--TVPSFLvnlaAGHVSIKHHFKGPIGAPVTACAAGVQAIGDAVRMIRNNEADVALCGGaeavidtVSLAGF 130
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 216 ARSGYLYEEGGvASKDGHCRPFDARATGTVTGDGVGVVVLKRLEDALKARDPIHAVIRGWALNNDgASRAGFTAPSVEGQ 295
Cdd:PRK14691 131 AAARALSTHFN-STPEKASRPFDTARDGFVMGEGAGLLIIEELEHALARGAKPLAEIVGYGTSAD-AYHMTSGAEDGDGA 208
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 296 SEVIALAHAAAGISARDITYVEAHGTGTPLGDPIEVAALTRAFRAHTAdtafCTLGAVKSNIGHLDAAAGVAGVIKTVQA 375
Cdd:PRK14691 209 YRAMKIALRQAGITPEQVQHLNAHATSTPVGDLGEINAIKHLFGESNA----LAITSTKSATGHLLGAAGGLETIFTVLA 284
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 53747904 376 LRHRLIPPTLHFERPNPA---LHLEQSpffvNTQplpwesPRGPRLAGVSSFGIGGTNAHTLFE 436
Cdd:PRK14691 285 LRDQIVPATLNLENPDPAakgLNIIAG----NAQ------PHDMTYALSNGFGFAGVNASILLK 338
|
|
| Zn_ADH_like2 |
cd08264 |
Alcohol dehydrogenases of the MDR family; This group resembles the zinc-dependent alcohol ... |
1683-1916 |
1.14e-17 |
|
Alcohol dehydrogenases of the MDR family; This group resembles the zinc-dependent alcohol dehydrogenases of the medium chain dehydrogenase family. However, this subgroup does not contain the characteristic catalytic zinc site. Also, it contains an atypical structural zinc-binding pattern: DxxCxxCxxxxxxxC. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H)-binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176225 [Multi-domain] Cd Length: 325 Bit Score: 87.02 E-value: 1.14e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1683 LESLGLRRCTRPAPGPRQVEIEVEAAGLNFLD--VLGALGM--MPaleaeeSVLGRECSGRIAAVGEGVSGLRVGDEVLA 1758
Cdd:cd08264 11 IENLKVEDVKDPKPGPGEVLIRVKMAGVNPVDynVINAVKVkpMP------HIPGAEFAGVVEEVGDHVKGVKKGDRVVV 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1759 ----------------------------VAPGCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGrLRRG 1810
Cdd:cd08264 85 ynrvfdgtcdmclsgnemlcrnggiigvVSNGGYAEYIVVPEKNLFKIPDSISDELAASLPVAALTAYHALKTAG-LGPG 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1811 ERILIHAAAGGLGLAAVQLASRTGAEILATAGseqkREYLRSLGIAHVLDsrSTSFVSEVRERTggRGVDVVLNSLAGEL 1890
Cdd:cd08264 164 ETVVVFGASGNTGIFAVQLAKMMGAEVIAVSR----KDWLKEFGADEVVD--YDEVEEKVKEIT--KMADVVINSLGSSF 235
|
250 260 270
....*....|....*....|....*....|....*.
gi 53747904 1891 LLAGLSVLAPHGRFLELGK----------RDLYADQ 1916
Cdd:cd08264 236 WDLSLSVLGRGGRLVTFGTltggevkldlSDLYSKQ 271
|
|
| butanediol_DH_like |
cd08233 |
(2R,3R)-2,3-butanediol dehydrogenase; (2R,3R)-2,3-butanediol dehydrogenase, a zinc-dependent ... |
1694-1883 |
2.86e-17 |
|
(2R,3R)-2,3-butanediol dehydrogenase; (2R,3R)-2,3-butanediol dehydrogenase, a zinc-dependent medium chain alcohol dehydrogenase, catalyzes the NAD(+)-dependent oxidation of (2R,3R)-2,3-butanediol and meso-butanediol to acetoin. BDH functions as a homodimer. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. The medium chain alcohol dehydrogenase family (MDR) have a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The N-terminal region typically has an all-beta catalytic domain. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit. Sorbitol and aldose reductase are NAD(+) binding proteins of the polyol pathway, which interconverts glucose and fructose. Sorbitol dehydrogenase is tetrameric and has a single catalytic zinc per subunit.
Pssm-ID: 176195 [Multi-domain] Cd Length: 351 Bit Score: 86.44 E-value: 2.86e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAGL------------NFLDVLGAlgmmPALEAEES--VLGRECSGRIAAVGEGVSGLRVGDEVlAV 1759
Cdd:cd08233 20 PPVKPGEVKIKVAWCGIcgsdlheyldgpIFIPTEGH----PHLTGETApvTLGHEFSGVVVEVGSGVTGFKVGDRV-VV 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1760 AP------------------------------GCFRSYVLVDESQVVRRPASLGLAEGAaqMV-PFATAYFALhTVGRLR 1808
Cdd:cd08233 95 EPtikcgtcgackrglynlcdslgfiglggggGGFAEYVVVPAYHVHKLPDNVPLEEAA--LVePLAVAWHAV-RRSGFK 171
|
170 180 190 200 210 220 230
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 53747904 1809 RGERILIhAAAGGLGLAAVQLASRTGA-EILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVL 1883
Cdd:cd08233 172 PGDTALV-LGAGPIGLLTILALKAAGAsKIIVSEPSEARRELAEELGATIVLDPTEVDVVAEVRKLTGGGGVDVSF 246
|
|
| ADH_zinc_N |
pfam00107 |
Zinc-binding dehydrogenase; |
1827-1950 |
2.93e-17 |
|
Zinc-binding dehydrogenase;
Pssm-ID: 395057 [Multi-domain] Cd Length: 129 Bit Score: 80.73 E-value: 2.93e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1827 VQLASRTGAEILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVLN-SLAGELLLAGLSVLAPHGRFL 1905
Cdd:pfam00107 7 IQLAKAAGAKVIAVDGSEEKLELAKELGADHVINPKETDLVEEIKELTGGKGVDVVFDcVGSPATLEQALKLLRPGGRVV 86
|
90 100 110 120
....*....|....*....|....*....|....*....|....*.
gi 53747904 1906 ELGKrdLYADQQVGLRTLA-RGQTFAAIDFGpHHPDFRAVLEEVAT 1950
Cdd:pfam00107 87 VVGL--PGGPLPLPLAPLLlKELTILGSFLG-SPEEFPEALDLLAS 129
|
|
| PLN02787 |
PLN02787 |
3-oxoacyl-[acyl-carrier-protein] synthase II |
166-439 |
3.27e-17 |
|
3-oxoacyl-[acyl-carrier-protein] synthase II
Pssm-ID: 215421 [Multi-domain] Cd Length: 540 Bit Score: 88.50 E-value: 3.27e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 166 VAYKLNLRGPALGIHTACSTSLVSI-NMACSALRGfECDMALAGGV-SLRLPARSGYLYEEGGVASKDGH----CRPFDA 239
Cdd:PLN02787 274 LAMDLGWMGPNYSISTACATSNFCIlNAANHIIRG-EADVMLCGGSdAAIIPIGLGGFVACRALSQRNDDptkaSRPWDM 352
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 240 RATGTVTGDGVGVVVLKRLEDALKARDPIHAVIRGWALNNDGASragFTAPSVEGQSEVIAL--AHAAAGISARDITYVE 317
Cdd:PLN02787 353 NRDGFVMGEGAGVLLLEELEHAKKRGANIYAEFLGGSFTCDAYH---MTEPHPEGAGVILCIekALAQSGVSKEDVNYIN 429
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 318 AHGTGTPLGDPIEVAALTRAFRAHTAdtafCTLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERPNPAlhle 397
Cdd:PLN02787 430 AHATSTKAGDLKEYQALMRCFGQNPE----LRVNSTKSMIGHLLGAAGAVEAIATVQAIRTGWVHPNINLENPESG---- 501
|
250 260 270 280
....*....|....*....|....*....|....*....|....*.
gi 53747904 398 qspffVNTQPLPweSPRGPRL----AGVSSFGIGGTNAHTLFeeAP 439
Cdd:PLN02787 502 -----VDTKVLV--GPKKERLdikvALSNSFGFGGHNSSILF--AP 538
|
|
| AMP-binding_C |
pfam13193 |
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to ... |
3051-3126 |
4.07e-17 |
|
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to pfam00501. It has a central beta sheet core that is flanked by alpha helices.
Pssm-ID: 463804 [Multi-domain] Cd Length: 76 Bit Score: 78.36 E-value: 4.07e-17
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 53747904 3051 EIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGK 3126
Cdd:pfam13193 1 EVESALVSHPAVAEAAVVGVPDELKGEAPVAFVVLKPGVELLEEELVAHVREELGPYAVPKEVVFVDELPKTRSGK 76
|
|
| PRK06087 |
PRK06087 |
medium-chain fatty-acid--CoA ligase; |
2685-3132 |
5.85e-17 |
|
medium-chain fatty-acid--CoA ligase;
Pssm-ID: 180393 [Multi-domain] Cd Length: 547 Bit Score: 87.50 E-value: 5.85e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2685 VQPQELVAIAMhKGWEQATAV-LGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQS------------SLLHTVPW 2751
Cdd:PRK06087 71 IEPGDRVAFQL-PGWCEFTIIyLACLKVGAVSVPLLPSWREAELVWVLNKCQAKMFFAPTlfkqtrpvdlilPLQNQLPQ 149
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2752 PPgvQVIAVDELEPATEAPPL------------PPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGP 2819
Cdd:PRK06087 150 LQ--QIVGVDKLAPATSSLSLsqiiadyeplttAITTHGDELAAVLFTSGTEGLPKGVMLTHNNILASERAYCARLNLTW 227
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2820 EDRVLGLSALTFDLSVYDVLGLLGAGGALVlpAAEAEKDPAHWWERLVAGRVT-VWNSTPALMLLLVEyAEQRGLKLPAa 2898
Cdd:PRK06087 228 QDVFMMPAPLGHATGFLHGVTAPFLIGARS--VLLDIFTPDACLALLEQQRCTcMLGATPFIYDLLNL-LEKQPADLSA- 303
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2899 LRLVMLSGDWIPVALPDRirALGRDVQVVSLGGATEASiwsiayPIGQVAP----QWKSIPYGMPLANQRFHVLDgrlEA 2974
Cdd:PRK06087 304 LRFFLCGGTTIPKKVARE--CQQRGIKLLSVYGSTESS------PHAVVNLddplSRFMHTDGYAAAGVEIKVVD---EA 372
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2975 RPWWVPGELyigGEGLARE------YWRDEPLTATRFirhprTGERLYRTGDQGRMLPEGSIEFLGRE-DLQVKvQGFRV 3047
Cdd:PRK06087 373 RKTLPPGCE---GEEASRGpnvfmgYLDEPELTARAL-----DEEGWYYSGDLCRMDEAGYIKITGRKkDIIVR-GGENI 443
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3048 ELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSG-QTPAAGELRRYLAE-RLPAYMVPSAFVLLESLPRSRNG 3125
Cdd:PRK06087 444 SSREVEDILLQHPKIHDACVVAMPDERLGERSCAYVVLKAPhHSLTLEEVVAFFSRkRVAKYKYPEHIVVIDKLPRTASG 523
|
....*..
gi 53747904 3126 KIARDQL 3132
Cdd:PRK06087 524 KIQKFLL 530
|
|
| PRK13771 |
PRK13771 |
putative alcohol dehydrogenase; Provisional |
1676-1990 |
6.73e-17 |
|
putative alcohol dehydrogenase; Provisional
Pssm-ID: 184316 [Multi-domain] Cd Length: 334 Bit Score: 85.09 E-value: 6.73e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1676 AVGTPGLLESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEeSVLGRECSGRIAAVGEGVSGLRVGDE 1755
Cdd:PRK13771 3 AVILPGFKQGYRIEEVPDPKPGKDEVVIKVNYAGLCYRDLLQLQGFYPRMKYP-VILGHEVVGTVEEVGENVKGFKPGDR 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1756 VLAV----------------------------APGCFRSYVLVDESQVVRRPAslGLAEGAAQMVPFATA--YFALHTVG 1805
Cdd:PRK13771 82 VASLlyapdgtceycrsgeeaycknrlgygeeLDGFFAEYAKVKVTSLVKVPP--NVSDEGAVIVPCVTGmvYRGLRRAG 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1806 rLRRGERILIHAAAGGLGLAAVQLASRTGAEILATAGSEQKREYLRSlgIA-HVLDSRstSFVSEVReRTGgrGVDVVLN 1884
Cdd:PRK13771 160 -VKKGETVLVTGAGGGVGIHAIQVAKALGAKVIAVTSSESKAKIVSK--YAdYVIVGS--KFSEEVK-KIG--GADIVIE 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1885 SLAGELLLAGLSVLAPHGRFLELGKRDlyADQQVGLR---TLARGqtfaaIDFGPHHPDFRAVLEEVATQLTQGQLEPLP 1961
Cdd:PRK13771 232 TVGTPTLEESLRSLNMGGKIIQIGNVD--PSPTYSLRlgyIILKD-----IEIIGHISATKRDVEEALKLVAEGKIKPVI 304
|
330 340
....*....|....*....|....*....
gi 53747904 1962 TRLFPARQVAEAFSFMARALHIGRVAVSM 1990
Cdd:PRK13771 305 GAEVSLSEIDKALEELKDKSRIGKILVKP 333
|
|
| PRK06501 |
PRK06501 |
beta-ketoacyl-ACP synthase; |
82-431 |
7.47e-17 |
|
beta-ketoacyl-ACP synthase;
Pssm-ID: 235817 [Multi-domain] Cd Length: 425 Bit Score: 86.22 E-value: 7.47e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 82 FFGYSPREASHLdpQQRLLLECSWEALEDAGLRPDQLPGwvGVYVGAG----DTSYRFQLlrGHGDPLSGSKDVAGFF-- 155
Cdd:PRK06501 63 FLPESPFGASAL--SEALARLAAEEALAQAGIGKGDFPG--PLFLAAPpvelEWPARFAL--AAAVGDNDAPSYDRLLra 136
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 156 ---GNYPDF--------LATRVAYKLNLRGPALGIHTACSTSLVSINMACSALRGFECDMALA----GGVSLRLPARSGY 220
Cdd:PRK06501 137 argGRFDALherfqfgsIADRLADRFGTRGLPISLSTACASGATAIQLGVEAIRRGETDRALCiatdGSVSAEALIRFSL 216
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 221 LY------EEGGVASKdghcrPFDARATGTVTGDGVGVVVLKRLEDALKARDPIHAVIRGWALNNDGASRagfTAPSVEG 294
Cdd:PRK06501 217 LSalstqnDPPEKASK-----PFSKDRDGFVMAEGAGALVLESLESAVARGAKILGIVAGCGEKADSFHR---TRSSPDG 288
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 295 qSEVIALAHAA---AGISARDITYVEAHGTGTPLGDPIEVAALTRAFRAHTADTAfctLGAVKSNIGHLDAAAGVAGVIK 371
Cdd:PRK06501 289 -SPAIGAIRAAladAGLTPEQIDYINAHGTSTPENDKMEYLGLSAVFGERLASIP---VSSNKSMIGHTLTAAGAVEAVF 364
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 53747904 372 TVQALRHRLIPPTLHFERPNPALHLEQSPffvNTQplpwespRGPRLAGV--SSFGIGGTNA 431
Cdd:PRK06501 365 SLLTIQTGRLPPTINYDNPDPAIPLDVVP---NVA-------RDARVTAVlsNSFGFGGQNA 416
|
|
| FadD3 |
cd17638 |
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ... |
2784-3129 |
7.96e-17 |
|
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ligases, including FadD3 which is an acyl-CoA synthetase that initiates catabolism of cholesterol rings C and D in actinobacteria. The cholesterol catabolic pathway occurs in most mycolic acid-containing actinobacteria, such as Rhodococcus jostii RHA1, and is critical for Mycobacterium tuberculosis (Mtb) during infection. FadD3 catalyzes the ATP-dependent CoA thioesterification of 3a-alpha-H-4alpha(3'-propanoate)-7a-beta-methylhexahydro-1,5-indanedione (HIP) to yield HIP-CoA. Hydroxylated analogs of HIP, 5alpha-OH HIP and 1beta-OH HIP, can also be used.
Pssm-ID: 341293 [Multi-domain] Cd Length: 330 Bit Score: 84.86 E-value: 7.96e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2784 VIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPaaEAEKDPAHWW 2863
Cdd:cd17638 5 IMFTSGTTGRSKGVMCAHRQTLRAAAAWADCADLTEDDRYLIINPFFHTFGYKAGIVACLLTGATVVP--VAVFDVDAIL 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2864 ERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLpAALRLVMLSGDWIPVALPDRIRA-LGRDVqVVSLGGATEASIWSIAY 2942
Cdd:cd17638 83 EAIERERITVLPGPPTLFQSLLDHPGRKKFDL-SSLRAAVTGAATVPVELVRRMRSeLGFET-VLTAYGLTEAGVATMCR 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2943 PigQVAPQWKSIPYGMPLANQRFHVLDgrlearpwwvPGELYIGGEGLAREYWRDEPLTATRFirhprTGERLYRTGDQG 3022
Cdd:cd17638 161 P--GDDAETVATTCGRACPGFEVRIAD----------DGEVLVRGYNVMQGYLDDPEATAEAI-----DADGWLHTGDVG 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3023 RMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAE 3102
Cdd:cd17638 224 ELDERGYLRITDRLKDMYIVGGFNVYPAEVEGALAEHPGVAQVAVIGVPDERMGEVGKAFVVARPGVTLTEEDVIAWCRE 303
|
330 340
....*....|....*....|....*..
gi 53747904 3103 RLPAYMVPSAFVLLESLPRSRNGKIAR 3129
Cdd:cd17638 304 RLANYKVPRFVRFLDELPRNASGKVMK 330
|
|
| A_NRPS_TubE_like |
cd05906 |
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) ... |
2726-3132 |
2.99e-16 |
|
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) synthesizing toxins and antitumor agents; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPSs that synthesize toxins and antitumor agents; for example, TubE for Tubulysine, CrpA for cryptophycin, TdiA for terrequinone A, KtzG for kutzneride, and Vlm1/Vlm2 for Valinomycin. Nonribosomal peptide synthetases are large multifunctional enzymes which synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341232 [Multi-domain] Cd Length: 540 Bit Score: 85.41 E-value: 2.99e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2726 RLHQLLEEGparVVLTQSSLLHTV-----PWP-PGVQVIAVDELePATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAI 2799
Cdd:cd05906 112 HIWQLLGSP---VVLTDAELVAEFagletLSGlPGIRVLSIEEL-LDTAADHDLPQSRPDDLALLMLTSGSTGFPKAVPL 187
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2800 EHRAALNTVVDLNTRFGVGPEDRvlGLSALTFD----LSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTV-W 2874
Cdd:cd05906 188 THRNILARSAGKIQHNGLTPQDV--FLNWVPLDhvggLVELHLRAVYLGCQQVHVPTEEILADPLRWLDLIDRYRVTItW 265
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2875 --NSTPALMLLLVEYAEQRGLKLpAALRLVMLSGDWIPVALPDR-IRAL---GRDVQVVSLG-GATEAS---IWSIAYPI 2944
Cdd:cd05906 266 apNFAFALLNDLLEEIEDGTWDL-SSLRYLVNAGEAVVAKTIRRlLRLLepyGLPPDAIRPAfGMTETCsgvIYSRSFPT 344
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2945 GQVAPQWKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFirhprTGERLYRTGDQGrM 3024
Cdd:cd05906 345 YDHSQALEFVSLGRPIPGVSMRIVDDEGQLLPEGEVGRLQVRGPVVTKGYYNNPEANAEAF-----TEDGWFRTGDLG-F 418
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3025 LPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVA---RGEPRGVRRLVAYAVPRSGQTPAAGEL----R 3097
Cdd:cd05906 419 LDNGNLTITGRTKDTIIVNGVNYYSHEIEAAVEEVPGVEPSFTAAfavRDPGAETEELAIFFVPEYDLQDALSETlraiR 498
|
410 420 430
....*....|....*....|....*....|....*...
gi 53747904 3098 RYLAERL---PAYMVPsafVLLESLPRSRNGKIARDQL 3132
Cdd:cd05906 499 SVVSREVgvsPAYLIP---LPKEEIPKTSLGKIQRSKL 533
|
|
| Zn_ADH7 |
cd08261 |
Alcohol dehydrogenases of the MDR family; This group contains members identified as related to ... |
1731-1978 |
3.08e-16 |
|
Alcohol dehydrogenases of the MDR family; This group contains members identified as related to zinc-dependent alcohol dehydrogenase and other members of the MDR family. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P)-binding Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group includes various activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176222 [Multi-domain] Cd Length: 337 Bit Score: 83.01 E-value: 3.08e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1731 VLGRECSGRIAAVGEGVSGLRVGD---------------------------EVLAV-APGCFRSYVLVDEsQVVRRPASL 1782
Cdd:cd08261 56 ILGHELSGEVVEVGEGVAGLKVGDrvvvdpyiscgecyacrkgrpnccenlQVLGVhRDGGFAEYIVVPA-DALLVPEGL 134
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1783 GLAEGAaqMV-PFATAYfalHTV--GRLRRGERILIhAAAGGLGLAAVQLASRTGAEILATAGSEQKREYLRSLGIAHVL 1859
Cdd:cd08261 135 SLDQAA--LVePLAIGA---HAVrrAGVTAGDTVLV-VGAGPIGLGVIQVAKARGARVIVVDIDDERLEFARELGADDTI 208
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1860 DSRSTSFVSEVRERTGGRGVDVVLNSL-AGELLLAGLSVLAPHGR--FLELGKRDL-YADQQVGLRTLA----RGQTfaA 1931
Cdd:cd08261 209 NVGDEDVAARLRELTDGEGADVVIDATgNPASMEEAVELVAHGGRvvLVGLSKGPVtFPDPEFHKKELTilgsRNAT--R 286
|
250 260 270 280
....*....|....*....|....*....|....*....|....*....
gi 53747904 1932 IDFgphhpdfravlEEVATQLTQGQLEPLP--TRLFPARQVAEAFSFMA 1978
Cdd:cd08261 287 EDF-----------PDVIDLLESGKVDPEAliTHRFPFEDVPEAFDLWE 324
|
|
| AACS_like |
cd05968 |
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This ... |
2662-3129 |
3.12e-16 |
|
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This uncharacterized acyl-CoA synthetase family (EC 6.2.1.16, or acetoacetate#CoA ligase or acetoacetate:CoA ligase (AMP-forming)) is highly homologous to acetoacetyl-CoA synthetase. However, the proteins in this family exist in only bacteria and archaea. AACS is a cytosolic ligase that specifically activates acetoacetate to its coenzyme A ester by a two-step reaction. Acetoacetate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is the first step of the mevalonate pathway of isoprenoid biosynthesis via isopentenyl diphosphate. Isoprenoids are a large class of compounds found in all living organisms.
Pssm-ID: 341272 [Multi-domain] Cd Length: 610 Bit Score: 85.62 E-value: 3.12e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2662 RTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLT 2741
Cdd:cd05968 90 RTLTYGELLYEVKRLANGLRALGVGKGDRVGIYLPMIPEIVPAFLAVARIGGIVVPIFSGFGKEAAATRLQDAEAKALIT 169
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2742 QSSLL-------------HTVPWPPGVQVIAV-------------DELEPATE---APPLPPRGTPEHLAYVIYTSGSTG 2792
Cdd:cd05968 170 ADGFTrrgrevnlkeeadKACAQCPTVEKVVVvrhlgndftpakgRDLSYDEEketAGDGAERTESEDPLMIIYTSGTTG 249
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2793 KPKGVAIEHRA-ALNTVVDLNTRFGVGPEDRVLGLSALTF---------------DLSVYDvlgllgaggalvlpAAEAE 2856
Cdd:cd05968 250 KPKGTVHVHAGfPLKAAQDMYFQFDLKPGDLLTWFTDLGWmmgpwlifgglilgaTMVLYD--------------GAPDH 315
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2857 KDPAHWWERLVAGRVTVWNSTP----ALMLLLVEYAEQRGLKlpaALRLVMLSGD-WIPVALPDRIRALGRD-VQVVSLG 2930
Cdd:cd05968 316 PKADRLWRMVEDHEITHLGLSPtlirALKPRGDAPVNAHDLS---SLRVLGSTGEpWNPEPWNWLFETVGKGrNPIINYS 392
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2931 GATEASIWSIA-YPIGQVAPqwksIPYGMPLANQRFHVLDGrlEARPwwVPGELyigGE--------GLAREYWRDEplt 3001
Cdd:cd05968 393 GGTEISGGILGnVLIKPIKP----SSFNGPVPGMKADVLDE--SGKP--ARPEV---GElvllapwpGMTRGFWRDE--- 458
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3002 aTRFIR-HPRTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLV 3080
Cdd:cd05968 459 -DRYLEtYWSRFDNVWVHGDFAYYDEEGYFYILGRSDDTINVAGKRVGPAEIESVLNAHPAVLESAAIGVPHPVKGEAIV 537
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|..
gi 53747904 3081 AYAVPRSGQTPAAG---ELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIAR 3129
Cdd:cd05968 538 CFVVLKPGVTPTEAlaeELMERVADELGKPLSPERILFVKDLPKTRNAKVMR 589
|
|
| 4CL |
cd05904 |
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the ... |
2645-3132 |
3.79e-16 |
|
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the phenylpropanoid metabolic pathway for monolignol and flavonoid biosynthesis. It catalyzes the synthesis of hydroxycinnamate-CoA thioesters in a two-step reaction, involving the formation of hydroxycinnamate-AMP anhydride and the nucleophilic substitution of AMP by CoA. The phenylpropanoid pathway is one of the most important secondary metabolism pathways in plants and hydroxycinnamate-CoA thioesters are the precursors of lignin and other important phenylpropanoids.
Pssm-ID: 341230 [Multi-domain] Cd Length: 505 Bit Score: 84.59 E-value: 3.79e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2645 FTQARLHPELPALL--APERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQ 2722
Cdd:cd05904 12 FLFASAHPSRPALIdaATGRALTYAELERRVRRLAAGLAKRGGRKGDVVLLLSPNSIEFPVAFLAVLSLGAVVTTANPLS 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2723 PPLRLHQLLEEGPARVVLTQSSLLHTVPwPPGVQVIAVDELE-----------PATEAPPLPPRGTPEHLAYVIYTSGST 2791
Cdd:cd05904 92 TPAEIAKQVKDSGAKLAFTTAELAEKLA-SLALPVVLLDSAEfdslsfsdllfEADEAEPPVVVIKQDDVAALLYSSGTT 170
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2792 GKPKGVAIEHR---AALNTVVDLnTRFGVGPEDRVLGLSAL--TFDLSVYDVLGLLGAGGALVLPAAEAEKdpahwwerL 2866
Cdd:cd05904 171 GRSKGVMLTHRnliAMVAQFVAG-EGSNSDSEDVFLCVLPMfhIYGLSSFALGLLRLGATVVVMPRFDLEE--------L 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2867 VAG----RVTVWNSTPALMLLLVEYAEQRGLKLPaALRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEASiwsiay 2942
Cdd:cd05904 242 LAAieryKVTHLPVVPPIVLALVKSPIVDKYDLS-SLRQIMSGAAPLGKELIEAFRAKFPNVDLGQGYGMTEST------ 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2943 PIGQV--APQWKSIPY---GMPLANQRFHVLD---GrlEARPWWVPGELYIGGEGLAREYWRDEPLTATRFirhprTGER 3014
Cdd:cd05904 315 GVVAMcfAPEKDRAKYgsvGRLVPNVEAKIVDpetG--ESLPPNQTGELWIRGPSIMKGYLNNPEATAATI-----DKEG 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3015 LYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVAR-----GE-PrgvrrlVAYAVPRSG 3088
Cdd:cd05904 388 WLHTGDLCYIDEDGYLFIVDRLKELIKYKGFQVAPAELEALLLSHPEILDAAVIPYpdeeaGEvP------MAFVVRKPG 461
|
490 500 510 520
....*....|....*....|....*....|....*....|....
gi 53747904 3089 QTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd05904 462 SSLTEDEIMDFVAKQVAPYKKVRKVAFVDAIPKSPSGKILRKEL 505
|
|
| PRK06839 |
PRK06839 |
o-succinylbenzoate--CoA ligase; |
2647-3134 |
4.44e-16 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 168698 [Multi-domain] Cd Length: 496 Bit Score: 84.53 E-value: 4.44e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2647 QARLHPELPALLAPERTLSYGEL-ARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPL 2725
Cdd:PRK06839 11 RAYLHPDRIAIITEEEEMTYKQLhEYVSKVAAYLIYELNVKKGERIAILSQNSLEYIVLLFAIAKVECIAVPLNIRLTEN 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2726 RLHQLLEEGPARVVLTQSSLLHTVPWPPGV----QVIAVDELEPATEAPPLPPRGTPEHLAYVI-YTSGSTGKPKGVAIE 2800
Cdd:PRK06839 91 ELIFQLKDSGTTVLFVEKTFQNMALSMQKVsyvqRVISITSLKEIEDRKIDNFVEKNESASFIIcYTSGTTGKPKGAVLT 170
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2801 HRA----ALNTVVDLNTRfgvgPEDRVLGLSALtFDLSVYDVLGLLGAGGALVLPAAEaEKDPAHWWERLVAGRVTVWNS 2876
Cdd:PRK06839 171 QENmfwnALNNTFAIDLT----MHDRSIVLLPL-FHIGGIGLFAFPTLFAGGVIIVPR-KFEPTKALSMIEKHKVTVVMG 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2877 TPALMLLLVEYAEQRGLKLpAALRLVMLSGDWIPVALpdrIRALGRDVQVVSLG-GATEASiwSIAYPIGQVAPQWKSIP 2955
Cdd:PRK06839 245 VPTIHQALINCSKFETTNL-QSVRWFYNGGAPCPEEL---MREFIDRGFLFGQGfGMTETS--PTVFMLSEEDARRKVGS 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2956 YGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFirhpRTGerLYRTGDQGRMLPEGSIEFLGR 3035
Cdd:PRK06839 319 IGKPVLFCDYELIDENKNKVEVGEVGELLIRGPNVMKEYWNRPDATEETI----QDG--WLCTGDLARVDEDGFVYIVGR 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3036 EDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVL 3115
Cdd:PRK06839 393 KKEMIISGGENIYPLEVEQVINKLSDVYEVAVVGRQHVKWGEIPIAFIVKKSSSVLIEKDVIEHCRLFLAKYKIPKEIVF 472
|
490
....*....|....*....
gi 53747904 3116 LESLPRSRNGKIARDQLPE 3134
Cdd:PRK06839 473 LKELPKNATGKIQKAQLVN 491
|
|
| PRK07967 |
PRK07967 |
beta-ketoacyl-ACP synthase I; |
106-435 |
4.73e-16 |
|
beta-ketoacyl-ACP synthase I;
Pssm-ID: 181184 [Multi-domain] Cd Length: 406 Bit Score: 83.57 E-value: 4.73e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 106 EALEDAGLRPDQLPG-WVGVYVGAGDTSYRFQLLRGhgDPLSGSKDVAGFfGNY--PDFLATRVAYKL----NLRGPALG 178
Cdd:PRK07967 81 QAIADAGLSEEQVSNpRTGLIAGSGGGSTRNQVEAA--DAMRGPRGPKRV-GPYavTKAMASTVSACLatpfKIKGVNYS 157
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 179 IHTACSTSLVSINMACSALRGFECDMALAGGVSlRLPARSGYLYEE-GGVASK-----DGHCRPFDARATGTVTGDGVGV 252
Cdd:PRK07967 158 ISSACATSAHCIGNAVEQIQLGKQDIVFAGGGE-ELDWEMSCLFDAmGALSTKyndtpEKASRAYDANRDGFVIAGGGGV 236
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 253 VVLKRLEDALKARDPIHAVIRGWALNNDGASragFTAPSVEGQseVIALAHAAAGISArDITYVEAHGTGTPLGDPIEVA 332
Cdd:PRK07967 237 VVVEELEHALARGAKIYAEIVGYGATSDGYD---MVAPSGEGA--VRCMQMALATVDT-PIDYINTHGTSTPVGDVKELG 310
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 333 ALTRAFRAHTAdtafcTLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERPNPAlhleqspffVNTQPLPWES 412
Cdd:PRK07967 311 AIREVFGDKSP-----AISATKSLTGHSLGAAGVQEAIYSLLMMEHGFIAPSANIEELDPQ---------AAGMPIVTET 376
|
330 340
....*....|....*....|....*
gi 53747904 413 PRGPRLAGV--SSFGIGGTNAHTLF 435
Cdd:PRK07967 377 TDNAELTTVmsNSFGFGGTNATLVF 401
|
|
| VL_LC_FACS_like |
cd05907 |
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA ... |
2660-3111 |
5.58e-16 |
|
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA synthetases; This family includes long-chain fatty acid (C12-C20) CoA synthetases and Bubblegum-like very long-chain (>C20) fatty acid CoA synthetases. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Drosophila melanogaster mutant bubblegum (BGM) have elevated levels of very-long-chain fatty acids (VLCFA) caused by a defective gene later named bubblegum. The human homolog (hsBG) of bubblegum has been characterized as a very long chain fatty acid CoA synthetase that functions specifically in the brain; hsBG may play a central role in brain VLCFA metabolism and myelinogenesis. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341233 [Multi-domain] Cd Length: 452 Bit Score: 83.80 E-value: 5.58e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2660 PERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVV 2739
Cdd:cd05907 2 VWQPITWAEFAEEVRALAKGLIALGVEPGDRVAILSRNRPEWTIADLAILAIGAVPVPIYPTSSAEQIAYILNDSEAKAL 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2740 LTqssllhtvpwppgvqviavdelepateapplpprGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGP 2819
Cdd:cd05907 82 FV----------------------------------EDPDDLATIIYTSGTTGRPKGVMLSHRNILSNALALAERLPATE 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2820 EDRVLGLSALtfdlsvydvlgllgaggalvlpaaeaekdpAHWWER-------LVAG-RVTVWNSTPALMLLLVE----- 2886
Cdd:cd05907 128 GDRHLSFLPL------------------------------AHVFERraglyvpLLAGaRIYFASSAETLLDDLSEvrptv 177
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2887 -----------YAEQRGLKLPAALRLVMLSgdwipvALPDRIRAlgrdvqVVSLGGATEASIWSIAYPIGqvapqwksIP 2955
Cdd:cd05907 178 flavprvwekvYAAIKVKAVPGLKRKLFDL------AVGGRLRF------AASGGAPLPAELLHFFRALG--------IP 237
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2956 ----YGM----------PLANQRF----HVLDG---RLEARpwwvpGELYIGGEGLAREYWRDEPLTATRFirhprTGER 3014
Cdd:cd05907 238 vyegYGLtetsavvtlnPPGDNRIgtvgKPLPGvevRIADD-----GEILVRGPNVMLGYYKNPEATAEAL-----DADG 307
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3015 LYRTGDQGRMLPEGSIEFLGR-EDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPrgvrRLVAYAVPRSGQtpaa 3093
Cdd:cd05907 308 WLHTGDLGEIDEDGFLHITGRkKDLIITSGGKNISPEPIENALKASPLISQAVVIGDGRP----FLVALIVPDPEA---- 379
|
490
....*....|....*...
gi 53747904 3094 geLRRYLAERLPAYMVPS 3111
Cdd:cd05907 380 --LEAWAEEHGIAYTDVA 395
|
|
| KR_1_FAS_SDR_x |
cd08954 |
beta-ketoacyl reductase (KR) domain of fatty acid synthase (FAS), subgroup 1, complex (x) SDRs; ... |
1237-1377 |
5.95e-16 |
|
beta-ketoacyl reductase (KR) domain of fatty acid synthase (FAS), subgroup 1, complex (x) SDRs; NADP-dependent KR domain of the multidomain type I FAS, a complex SDR family. This subfamily also includes proteins identified as polyketide synthase (PKS), a protein with related modular protein architecture and similar function. It includes the KR domains of mammalian and chicken FAS, and Dictyostelium discoideum putative polyketide synthases (PKSs). These KR domains contain two subdomains, each of which is related to SDR Rossmann fold domains. However, while the C-terminal subdomain has an active site similar to the other SDRs and a NADP-binding capability, the N-terminal SDR-like subdomain is truncated and lacks these functions, serving a supportive structural role. In some instances, such as porcine FAS, an enoyl reductase (a Rossman fold NAD-binding domain of the medium-chain dehydrogenase/reductase, MDR family) module is inserted between the sub-domains. Fatty acid synthesis occurs via the stepwise elongation of a chain (which is attached to acyl carrier protein, ACP) with 2-carbon units. Eukaryotic systems consists of large, multifunctional synthases (type I) while bacterial, type II systems, use single function proteins. Fungal fatty acid synthesis uses a dodecamer of 6 alpha and 6 beta subunits. In mammalian type FAS cycles, ketoacyl synthase forms acetoacetyl-ACP which is reduced by the NADP-dependent beta-ketoacyl reductase (KR), forming beta-hydroxyacyl-ACP, which is in turn dehydrated by dehydratase to a beta-enoyl intermediate, which is reduced by NADP-dependent beta-enoyl reductase (ER); this KR and ER are members of the SDR family. This KR subfamily has an active site tetrad with a similar 3D orientation compared to archetypical SDRs, but the active site Lys and Asn residue positions are swapped. The characteristic NADP-binding is typical of the multidomain complex SDRs, with a GGXGXXG NADP binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold (alpha/beta folding pattern with a central beta-sheet), an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Classical SDRs are typically about 250 residues long, while extended SDRs are approximately 350 residues. Sequence identity between different SDR enzymes are typically in the 15-30% range, but the enzymes share the Rossmann fold NAD-binding motif and characteristic NAD-binding and catalytic sequence patterns. These enzymes catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human prostaglandin dehydrogenase (PGDH) numbering). In addition to the Tyr and Lys, there is often an upstream Ser (Ser-138, PGDH numbering) and/or an Asn (Asn-107, PGDH numbering) contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Extended SDRs have additional elements in the C-terminal region, and typically have a TGXXGXXG cofactor binding motif. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type KRs have a TGXXXGX(1-2)G NAD(P)-binding motif. Some atypical SDRs have lost catalytic activity and/or have an unusual NAD(P)-binding motif and missing or unusual active site residues. Reactions catalyzed within the SDR family include isomerization, decarboxylation, epimerization, C=N bond reduction, dehydratase activity, dehalogenation, Enoyl-CoA reduction, and carbonyl-alcohol oxidoreduction.
Pssm-ID: 187657 [Multi-domain] Cd Length: 452 Bit Score: 83.65 E-value: 5.95e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1237 GAEVQVYTADVAeeaAVRSVVEQVHARW--GKIHGVLHAAATFDDGVIQLRTHEQSSRALRTKVRGSMVLHEVLASEG-- 1312
Cdd:cd08954 273 FHFVSVDVSDVS---SLEKAINLILNAPkiGPIGGIFHLAFVLIDKVLEIDTESLFISVNKAKVMGAINLHNQSIKRCwk 349
|
90 100 110 120 130 140
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 1313 LDWFALCSSLASALGSFGQADYCAANAFQDAYAHHLRRQGFTGaLALDWGTWRDTGaamrLVART 1377
Cdd:cd08954 350 LDYFVLFSSVSSIRGSAGQCNYVCANSVLDSLSRYRKSIGLPS-IAINWGAIGDVG----FVSRN 409
|
|
| FAA1 |
COG1022 |
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; |
2644-3073 |
1.02e-15 |
|
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism];
Pssm-ID: 440645 [Multi-domain] Cd Length: 603 Bit Score: 84.00 E-value: 1.02e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2644 FFTQARLHPELPALLAPE----RTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLD 2719
Cdd:COG1022 17 LRRRAARFPDRVALREKEdgiwQSLTWAEFAERVRALAAGLLALGVKPGDRVAILSDNRPEWVIADLAILAAGAVTVPIY 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2720 PEQPPLRLHQLLEEGPARVVLTQS---------------SLLHTV-----PWPPGVQVIAVDELEPATEAPPLPPR---- 2775
Cdd:COG1022 97 PTSSAEEVAYILNDSGAKVLFVEDqeqldkllevrdelpSLRHIVvldprGLRDDPRLLSLDELLALGREVADPAElear 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2776 ---GTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVL-------------GLSALTFDLSVYdvl 2839
Cdd:COG1022 177 raaVKPDDLATIIYTSGTTGRPKGVMLTHRNLLSNARALLERLPLGPGDRTLsflplahvfertvSYYALAAGATVA--- 253
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2840 gllgaggalvlpAAEAEKDPA--------HW-------WERLVAG-RVTVWNSTPALMLLL-------VEYAEQR--GLK 2894
Cdd:COG1022 254 ------------FAESPDTLAedlrevkpTFmlavprvWEKVYAGiQAKAEEAGGLKRKLFrwalavgRRYARARlaGKS 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2895 LPAALRLVMLSGDWIpVAlpDRIR-ALGRDVQV-VSLGGATEASI----WSIAYPIGQVapqwksipYGM---------- 2958
Cdd:COG1022 322 PSLLLRLKHALADKL-VF--SKLReALGGRLRFaVSGGAALGPELarffRALGIPVLEG--------YGLtetspvitvn 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2959 PLANQRFH----VLDG---RLEARpwwvpGELYIGGEGLAREYWRDEPLTATRFirhprTGERLYRTGDQGRMLPEGSIE 3031
Cdd:COG1022 391 RPGDNRIGtvgpPLPGvevKIAED-----GEILVRGPNVMKGYYKNPEATAEAF-----DADGWLHTGDIGELDEDGFLR 460
|
490 500 510 520
....*....|....*....|....*....|....*....|...
gi 53747904 3032 FLGR-EDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEP 3073
Cdd:COG1022 461 ITGRkKDLIVTSGGKNVAPQPIENALKASPLIEQAVVVGDGRP 503
|
|
| arabinose_DH_like |
cd05284 |
D-arabinose dehydrogenase; This group contains arabinose dehydrogenase (AraDH) and related ... |
1684-1883 |
1.29e-15 |
|
D-arabinose dehydrogenase; This group contains arabinose dehydrogenase (AraDH) and related alcohol dehydrogenases. AraDH is a member of the medium chain dehydrogenase/reductase family and catalyzes the NAD(P)-dependent oxidation of D-arabinose and other pentoses, the initial step in the metabolism of d-arabinose into 2-oxoglutarate. Like the alcohol dehydrogenases, AraDH binds a zinc in the catalytic cleft as well as a distal structural zinc. AraDH forms homotetramers as a dimer of dimers. AraDH replaces a conserved catalytic His with replace with Arg, compared to the canonical ADH site. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176187 [Multi-domain] Cd Length: 340 Bit Score: 81.45 E-value: 1.29e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1684 ESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVL-------GALGMMPALeaeesVLGRECSGRIAAVGEGVSGLRVGDEV 1756
Cdd:cd05284 11 KPLRLEDVPVPEPGPGQVLVRVGGAGVCHSDLHvidgvwgGILPYKLPF-----TLGHENAGWVEEVGSGVDGLKEGDPV 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1757 LAVAP-GC---------------------------FRSYVLVDESQVVRRPASLGLAEGAaqmvPFA----TAYFALHT- 1803
Cdd:cd05284 86 VVHPPwGCgtcrycrrgeenycenarfpgigtdggFAEYLLVPSRRLVKLPRGLDPVEAA----PLAdaglTAYHAVKKa 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1804 VGRLRRGERILI-------HAAagglglaaVQLASR-TGAEILATAGSEQKREYLRSLGIAHVLDSRSTSfVSEVRERTG 1875
Cdd:cd05284 162 LPYLDPGSTVVVigvgglgHIA--------VQILRAlTPATVIAVDRSEEALKLAERLGADHVLNASDDV-VEEVRELTG 232
|
....*...
gi 53747904 1876 GRGVDVVL 1883
Cdd:cd05284 233 GRGADAVI 240
|
|
| DCL_NRPS-like |
cd19536 |
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal ... |
2216-2605 |
1.43e-15 |
|
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal fungal CT domains and Dual Epimerization/Condensation (E/C) domains; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type [D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L))], which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380459 [Multi-domain] Cd Length: 419 Bit Score: 82.11 E-value: 1.43e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2216 LEVERFIQCWRQLLQRHDMLRMVVLPDGRQQ----VLEQVpEYTPEVVELRGLSPQEAESRRLQLRERMAHQVLRSDRWP 2291
Cdd:cd19536 36 LNLDLLLEALQVLIDRHDILRTSFIEDGLGQpvqvVHRQA-QVPVTELDLTPLEEQLDPLRAYKEETKIRRFDLGRAPLV 114
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2292 LFELVLCRYEGGVRIHMSMDALMLDAWSSAVLRQDFAQLYHEP--GRPLEPL-AITFRDYVLAERRLREGEAHERaraYW 2368
Cdd:cd19536 115 RAALVRKDERERFLLVISDHHSILDGWSLYLLVKEILAVYNQLleYKPLSLPpAQPYRDFVAHERASIQQAASER---YW 191
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2369 WARLD----TLPPPPELPLVKEPSQleharftHREARLEPHRWARLQERARAHGLTPSAACMAAFAEVLARWSRHPRFTL 2444
Cdd:cd19536 192 REYLAgatlATLPALSEAVGGGPEQ-------DSELLVSVPLPVRSRSLAKRSGIPLSTLLLAAWALVLSRHSGSDDVVF 264
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2445 NLTLFQRLPLHPQVDELVGDFTSLVLLEVEAhAASTFAERASRLQAQLWRDLEHGSVSavqlIRELVRTGRRSPGAIMPV 2524
Cdd:cd19536 265 GTVVHGRSEETTGAERLLGLFLNTLPLRVTL-SEETVEDLLKRAQEQELESLSHEQVP----LADIQRCSEGEPLFDSIV 339
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2525 VFTSILSLDARRGPQGSLSFFEGELVYSISQTPQVWLdhGVHEEEGALVLAWDSVEALFPPGMVDDMFHAYQRLLGALAE 2604
Cdd:cd19536 340 NFRHFDLDFGLPEWGSDEGMRRGLLFSEFKSNYDVNL--SVLPKQDRLELKLAYNSQVLDEEQAQRLAAYYKSAIAELAT 417
|
.
gi 53747904 2605 E 2605
Cdd:cd19536 418 A 418
|
|
| PRK07470 |
PRK07470 |
acyl-CoA synthetase; Validated |
2644-3134 |
1.62e-15 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 180988 [Multi-domain] Cd Length: 528 Bit Score: 82.78 E-value: 1.62e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2644 FFTQ-ARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQ 2722
Cdd:PRK07470 12 FLRQaARRFPDRIALVWGDRSWTWREIDARVDALAAALAARGVRKGDRILVHSRNCNQMFESMFAAFRLGAVWVPTNFRQ 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2723 PPLRLHQLLEEGPARVVLTQS-------SLLHTVPWPPGVQVIAVDELEPATEAPPLPPRGTPEHLAYV--------IYT 2787
Cdd:PRK07470 92 TPDEVAYLAEASGARAMICHAdfpehaaAVRAASPDLTHVVAIGGARAGLDYEALVARHLGARVANAAVdhddpcwfFFT 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2788 SGSTGKPKGVAIEH-RAAL---NTVVDLNTrfGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPaaeAEK-DPAHW 2862
Cdd:PRK07470 172 SGTTGRPKAAVLTHgQMAFvitNHLADLMP--GTTEQDASLVVAPLSHGAGIHQLCQVARGAATVLLP---SERfDPAEV 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2863 WeRLVAG-RVTVWNSTPALMLLLVEYaeqrglklPAA-------LRLVMLSGdwIPVALPDRIRALGR----DVQVVSLG 2930
Cdd:PRK07470 247 W-ALVERhRVTNLFTVPTILKMLVEH--------PAVdrydhssLRYVIYAG--APMYRADQKRALAKlgkvLVQYFGLG 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2931 GATeASIwSIAYPIGQVA---PQWKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFir 3007
Cdd:PRK07470 316 EVT-GNI-TVLPPALHDAedgPDARIGTCGFERTGMEVQIQDDEGRELPPGETGEICVIGPAVFAGYYNNPEANAKAF-- 391
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3008 hpRTGerLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRS 3087
Cdd:PRK07470 392 --RDG--WFRTGDLGHLDARGFLYITGRASDMYISGGSNVYPREIEEKLLTHPAVSEVAVLGVPDPVWGEVGVAVCVARD 467
|
490 500 510 520
....*....|....*....|....*....|....*....|....*..
gi 53747904 3088 GQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPE 3134
Cdd:PRK07470 468 GAPVDEAELLAWLDGKVARYKLPKRFFFWDALPKSGYGKITKKMVRE 514
|
|
| CAD |
cd08245 |
Cinnamyl alcohol dehydrogenases (CAD) and related proteins; Cinnamyl alcohol dehydrogenases ... |
1675-1903 |
2.98e-15 |
|
Cinnamyl alcohol dehydrogenases (CAD) and related proteins; Cinnamyl alcohol dehydrogenases (CAD), members of the medium chain dehydrogenase/reductase family, reduce cinnamaldehydes to cinnamyl alcohols in the last step of monolignal metabolism in plant cells walls. CAD binds 2 zinc ions and is NADPH- dependent. CAD family members are also found in non-plant species, e.g. in yeast where they have an aldehyde reductase activity. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P) binding-Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes, or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176207 [Multi-domain] Cd Length: 330 Bit Score: 80.06 E-value: 2.98e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1675 VAVGTPGLLESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALG-----MMPAleaeesVLGRECSGRIAAVGEGVSG 1749
Cdd:cd08245 1 KAAVVHAAGGPLEPEEVPVPEPGPGEVLIKIEACGVCHTDLHAAEGdwggsKYPL------VPGHEIVGEVVEVGAGVEG 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1750 LRVGDEV----LAVAPGC-------------------------FRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFA 1800
Cdd:cd08245 75 RKVGDRVgvgwLVGSCGRceycrrglenlcqkavntgyttqggYAEYMVADAEYTVLLPDGLPLAQAAPLLCAGITVYSA 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1801 LHTVGrLRRGERILI-------HAaagglglaAVQLASRTGAEILATAGSEQKREYLRSLGIAHVLDSRstsfvSEVRER 1873
Cdd:cd08245 155 LRDAG-PRPGERVAVlgigglgHL--------AVQYARAMGFETVAITRSPDKRELARKLGADEVVDSG-----AELDEQ 220
|
250 260 270
....*....|....*....|....*....|.
gi 53747904 1874 TGGRGVDVVLN-SLAGELLLAGLSVLAPHGR 1903
Cdd:cd08245 221 AAAGGADVILVtVVSGAAAEAALGGLRRGGR 251
|
|
| 23DHB-AMP_lg |
cd05920 |
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2, ... |
2870-3132 |
3.39e-15 |
|
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2,3-dihydroxybenzoate (DHB) by ligation of AMP from ATP with the release of pyrophosphate. However, it can also catalyze the ATP-PPi exchange for 2,3-DHB analogs, such as salicyclic acid (o-hydrobenzoate), as well as 2,4-DHB and 2,5-DHB, but with less efficiency. Proteins in this family are the stand-alone adenylation components of non-ribosomal peptide synthases (NRPSs) involved in the biosynthesis of siderophores, which are low molecular weight iron-chelating compounds synthesized by many bacteria to aid in the acquisition of this vital trace elements. In Escherichia coli, the 2,3-dihydroxybenzoate-AMP ligase is called EntE, the adenylation component of the enterobactin NRPS system.
Pssm-ID: 341244 [Multi-domain] Cd Length: 482 Bit Score: 81.61 E-value: 3.39e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2870 RVTVWNSTPALMLLLVEYAEQRGLKLPAaLRLVMLSGDWIPVALPDRIRA-LGRDVQVV-----------SLGGATEASI 2937
Cdd:cd05920 229 GVTVTALVPALVSLWLDAAASRRADLSS-LRLLQVGGARLSPALARRVPPvLGCTLQQVfgmaegllnytRLDDPDEVII 307
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2938 WSIAYPIGQ------VAPQWKSIPYGMPlanqrfhvldgrlearpwwvpGELYIGGEGLAREYWRDEPLTATRFirhprT 3011
Cdd:cd05920 308 HTQGRPMSPddeirvVDEEGNPVPPGEE---------------------GELLTRGPYTIRGYYRAPEHNARAF-----T 361
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3012 GERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRsGQTP 3091
Cdd:cd05920 362 PDGFYRTGDLVRRTPDGYLVVEGRIKDQINRGGEKIAAEEVENLLLRHPAVHDAAVVAMPDELLGERSCAFVVLR-DPPP 440
|
250 260 270 280
....*....|....*....|....*....|....*....|..
gi 53747904 3092 AAGELRRYLAER-LPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd05920 441 SAAQLRRFLRERgLAAYKLPDRIEFVDSLPLTAVGKIDKKAL 482
|
|
| PRK06164 |
PRK06164 |
acyl-CoA synthetase; Validated |
2646-3134 |
4.84e-15 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235722 [Multi-domain] Cd Length: 540 Bit Score: 81.33 E-value: 4.84e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2646 TQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHK-----GWEQATAVLGVL----------- 2709
Cdd:PRK06164 18 AHARARPDAVALIDEDRPLSRAELRALVDRLAAWLAAQGVRRGDRVAVWLPNciewvVLFLACARLGATviavntryrsh 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2710 -------QAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSLL------HTVPWP-PGVQVIAVDELEPATEAPPLPPR 2775
Cdd:PRK06164 98 evahilgRGRARWLVVWPGFKGIDFAAILAAVPPDALPPLRAIAvvddaaDATPAPaPGARVQLFALPDPAPPAAAGERA 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2776 GTPEHLAYVIYTSGSTGKPKGVAieHRAAlnTVVDLNTR----FGVGPEDRVlgLSALTFdLSVYDVLGLLGAGGALVLP 2851
Cdd:PRK06164 178 ADPDAGALLFTTSGTTSGPKLVL--HRQA--TLLRHARAiaraYGYDPGAVL--LAALPF-CGVFGFSTLLGALAGGAPL 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2852 AAEAEKDPAHWWERLVAGRVT-VWNSTPALMLLLVEYAEQRGLklpAALRLVMLsGDWIPVALPDRIRALGRDVQVVSLG 2930
Cdd:PRK06164 251 VCEPVFDAARTARALRRHRVThTFGNDEMLRRILDTAGERADF---PSARLFGF-ASFAPALGELAALARARGVPLTGLY 326
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2931 GATEA----SIWSIAYPigqVAPQWksIPYGMPLANQ-RFHV---LDGRLeaRPWWVPGELYIGGEGLAREYWRDEPLTA 3002
Cdd:PRK06164 327 GSSEVqalvALQPATDP---VSVRI--EGGGRPASPEaRVRArdpQDGAL--LPDGESGEIEIRAPSLMRGYLDNPDATA 399
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3003 TRFirhprTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVArGEPRGVRRLVAY 3082
Cdd:PRK06164 400 RAL-----TDDGYFRTGDLGYTRGDGQFVYQTRMGDSLRLGGFLVNPAEIEHALEALPGVAAAQVVG-ATRDGKTVPVAF 473
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 3083 AVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLP--RSRNG-KIARDQLPE 3134
Cdd:PRK06164 474 VIPTDGASPDEAGLMAACREALAGFKVPARVQVVEAFPvtESANGaKIQKHRLRE 528
|
|
| PRK07638 |
PRK07638 |
acyl-CoA synthetase; Validated |
2648-3129 |
6.28e-15 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236071 [Multi-domain] Cd Length: 487 Bit Score: 80.59 E-value: 6.28e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPqELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRL 2727
Cdd:PRK07638 11 ASLQPNKIAIKENDRVLTYKDWFESVCKVANWLNEKESKN-KTIAILLENRIEFLQLFAGAAMAGWTCVPLDIKWKQDEL 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2728 HQLLEEGPARVVLTQSSLLHTVPWPPGvQVIAVDELEPATE--APPLPPRGTPEHLA-YVIYTSGSTGKPKGVAIEHRAA 2804
Cdd:PRK07638 90 KERLAISNADMIVTERYKLNDLPDEEG-RVIEIDEWKRMIEkyLPTYAPIENVQNAPfYMGFTSGSTGKPKAFLRAQQSW 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2805 LNTVVDLNTRFGVGPEDRVL-------------GLSALTFDLSVYdvlgllgaggalvlpaAEAEKDPAHWWERLVAGRV 2871
Cdd:PRK07638 169 LHSFDCNVHDFHMKREDSVLiagtlvhslflygAISTLYVGQTVH----------------LMRKFIPNQVLDKLETENI 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2872 TVWNSTPALMLLLVEYAEQRGLKLpaalrLVMLSG-DWiPVALPDRIRALGRDVQVVSLGGATEASIWSIAYPigqvaPQ 2950
Cdd:PRK07638 233 SVMYTVPTMLESLYKENRVIENKM-----KIISSGaKW-EAEAKEKIKNIFPYAKLYEFYGASELSFVTALVD-----EE 301
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2951 WKSIPY--GMPLANQRFHVldgRLEARPWWVPGEL-------------YIGGEGLAREYWRDEPLTatrfirhprtgerl 3015
Cdd:PRK07638 302 SERRPNsvGRPFHNVQVRI---CNEAGEEVQKGEIgtvyvkspqffmgYIIGGVLARELNADGWMT-------------- 364
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3016 yrTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAvprSGQTPAAgE 3095
Cdd:PRK07638 365 --VRDVGYEDEEGFIYIVGREKNMILFGGINIFPEEIESVLHEHPAVDEIVVIGVPDSYWGEKPVAII---KGSATKQ-Q 438
|
490 500 510
....*....|....*....|....*....|....
gi 53747904 3096 LRRYLAERLPAYMVPSAFVLLESLPRSRNGKIAR 3129
Cdd:PRK07638 439 LKSFCLQRLSSFKIPKEWHFVDEIPYTNSGKIAR 472
|
|
| PrpE |
cd05967 |
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or ... |
2715-3129 |
6.60e-15 |
|
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or propionate#CoA ligase (PrpE) catalyzes the first step of the 2-methylcitric acid cycle for propionate catabolism. It activates propionate to propionyl-CoA in a two-step reaction, which proceeds through a propionyl-AMP intermediate and requires ATP and Mg2+. In Salmonella enterica, the PrpE protein is required for growth of Salmonella enterica on propionate and can substitute for the acetyl-CoA synthetase (Acs) enzyme during growth on acetate. PrpE can also activate acetate, 3HP, and butyrate to their corresponding CoA-thioesters, although with less efficiency.
Pssm-ID: 341271 [Multi-domain] Cd Length: 617 Bit Score: 81.21 E-value: 6.60e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2715 YLPLdpeqpplrLHQLLEEG---PARVVLTQSSLLHTVPWPPGVQVIAVDELEPATEAPPLPPRGTpeHLAYVIYTSGST 2791
Cdd:cd05967 173 YKPL--------LDKALELSghkPHHVLVLNRPQVPADLTKPGRDLDWSELLAKAEPVDCVPVAAT--DPLYILYTSGTT 242
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2792 GKPKGVAIE---HRAALNTVVDlnTRFGVGPEDR---------VLGLSaltfdLSVYDVLGLLGAG-----GALVLPaae 2854
Cdd:cd05967 243 GKPKGVVRDnggHAVALNWSMR--NIYGIKPGDVwwaasdvgwVVGHS-----YIVYGPLLHGATTvlyegKPVGTP--- 312
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2855 aekDPAHWWERLVAGRVTVWNSTPALMLLL------VEYAEQRGLKlpaALRLVMLSGD--------WIPVALPdriral 2920
Cdd:cd05967 313 ---DPGAFWRVIEKYQVNALFTAPTAIRAIrkedpdGKYIKKYDLS---SLRTLFLAGErldpptleWAENTLG------ 380
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2921 grdVQVVSLGGATEaSIWSI-AYPIGQVAPQWKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGE---GLAREYWR 2996
Cdd:cd05967 381 ---VPVIDHWWQTE-TGWPItANPVGLEPLPIKAGSPGKPVPGYQVQVLDEDGEPVGPNELGNIVIKLPlppGCLLTLWK 456
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2997 DEPLTATRFIRHPRTgerLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALS-ASVVVARGEPRG 3075
Cdd:cd05967 457 NDERFKKLYLSKFPG---YYDTGDAGYKDEDGYLFIMGRTDDVINVAGHRLSTGEMEESVLSHPAVAeCAVVGVRDELKG 533
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*...
gi 53747904 3076 vRRLVAYAVPRSGQTPAAGELRRYLA----ERLPAYMVPSAFVLLESLPRSRNGKIAR 3129
Cdd:cd05967 534 -QVPLGLVVLKEGVKITAEELEKELValvrEQIGPVAAFRLVIFVKRLPKTRSGKILR 590
|
|
| PRK05852 |
PRK05852 |
fatty acid--CoA ligase family protein; |
2648-3134 |
8.16e-15 |
|
fatty acid--CoA ligase family protein;
Pssm-ID: 235625 [Multi-domain] Cd Length: 534 Bit Score: 80.70 E-value: 8.16e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPALL-APERT-LSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPL 2725
Cdd:PRK05852 26 ATRLPEAPALVvTADRIaISYRDLARLVDDLAGQLTRSGLLPGDRVALRMGSNAEFVVALLAASRADLVVVPLDPALPIA 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2726 RLHQLLEEGPARVVLTQSSLLH-----TVP-WPPGVQVIAVDELEPATEAP-------PLPPRGTPEHL----AYVIYTS 2788
Cdd:PRK05852 106 EQRVRSQAAGARVVLIDADGPHdraepTTRwWPLTVNVGGDSGPSGGTLSVhldaatePTPATSTPEGLrpddAMIMFTG 185
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2789 GSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVA 2868
Cdd:PRK05852 186 GTTGLPKMVPWTHANIASSVRAIITGYRLSPRDATVAVMPLYHGHGLIAALLATLASGGAVLLPARGRFSAHTFWDDIKA 265
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2869 GRVTVWNSTPALMLLLVEYA-EQRGLKLPAALRLVM-LSGDWIP---VALPDRIRAlgrdvQVVSLGGATEASIWSIAYP 2943
Cdd:PRK05852 266 VGATWYTAVPTIHQILLERAaTEPSGRKPAALRFIRsCSAPLTAetaQALQTEFAA-----PVVCAFGMTEATHQVTTTQ 340
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2944 IGQVA----PQWKSIPYGMPLANQrFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIrhprtgERLYRTG 3019
Cdd:PRK05852 341 IEGIGqtenPVVSTGLVGRSTGAQ-IRIVGSDGLPLPAGAVGEVWLRGTTVVRGYLGDPTITAANFT------DGWLRTG 413
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3020 DQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRY 3099
Cdd:PRK05852 414 DLGSLSAAGDLSIRGRIKELINRGGEKISPERVEGVLASHPNVMEAAVFGVPDQLYGEAVAAVIVPRESAPPTAEELVQF 493
|
490 500 510
....*....|....*....|....*....|....*
gi 53747904 3100 LAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPE 3134
Cdd:PRK05852 494 CRERLAAFEIPASFQEASGLPHTAKGSLDRRAVAE 528
|
|
| PLN02860 |
PLN02860 |
o-succinylbenzoate-CoA ligase |
2723-3132 |
1.35e-14 |
|
o-succinylbenzoate-CoA ligase
Pssm-ID: 215464 [Multi-domain] Cd Length: 563 Bit Score: 80.23 E-value: 1.35e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2723 PPLRLHQLLEEGPARVVLTQSSLLHTvpwppgvqviavDELEPATEAPPLP-PRGTPEHLAYVIYTSGSTGKPKGVAIEH 2801
Cdd:PLN02860 127 PSLMWQVFLESPSSSVFIFLNSFLTT------------EMLKQRALGTTELdYAWAPDDAVLICFTSGTTGRPKGVTISH 194
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2802 RAALNTVVDLNTRFGVGPEDRVL---------GLS-ALT-------------FDLSVydvlgllgaggalvlpAAEAEKD 2858
Cdd:PLN02860 195 SALIVQSLAKIAIVGYGEDDVYLhtaplchigGLSsALAmlmvgachvllpkFDAKA----------------ALQAIKQ 258
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2859 pahwwerlvaGRVTVWNSTPALMLLLVEYA-EQRGLKLPAALRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEA-- 2935
Cdd:PLN02860 259 ----------HNVTSMITVPAMMADLISLTrKSMTWKVFPSVRKILNGGGSLSSRLLPDAKKLFPNAKLFSAYGMTEAcs 328
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2936 SIWSIAYPIGQVAPQWKSIPYGMPLANQRFHVLDGRLEARPwwVPG-ELYIGGEGLARE-------------YWRDEPLT 3001
Cdd:PLN02860 329 SLTFMTLHDPTLESPKQTLQTVNQTKSSSVHQPQGVCVGKP--APHvELKIGLDESSRVgriltrgphvmlgYWGQNSET 406
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3002 ATRfirhpRTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVA 3081
Cdd:PLN02860 407 ASV-----LSNDGWLDTGDIGWIDKAGNLWLIGRSNDRIKTGGENVYPEEVEAVLSQHPGVASVVVVGVPDSRLTEMVVA 481
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 53747904 3082 YAVPRSG------QTPAAG--------ELRRYLAER-LPAYMVPSAFVLLES-LPRSRNGKIARDQL 3132
Cdd:PLN02860 482 CVRLRDGwiwsdnEKENAKknltlsseTLRHHCREKnLSRFKIPKLFVQWRKpFPLTTTGKIRRDEV 548
|
|
| Nitroreductase |
pfam00881 |
Nitroreductase family; The nitroreductase family comprises a group of FMN- or FAD-dependent ... |
3282-3455 |
1.39e-14 |
|
Nitroreductase family; The nitroreductase family comprises a group of FMN- or FAD-dependent and NAD(P)H-dependent enzymes able to metabolize nitrosubstituted compounds.
Pssm-ID: 425926 [Multi-domain] Cd Length: 168 Bit Score: 74.35 E-value: 1.39e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3282 LERRRSVRTYSLEPVSHEQLGRLLAplrewevQGSRrylYASAGGLYPVQLYLhLKPGRARglepgtWYYDPSTHRLVLL 3361
Cdd:pfam00881 1 IRQRRSVRKFDPEPVPKEVLEEILE-------AARR---APSAGNLQPWRFYV-VTDGELR------YRLAEAALELLLV 63
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3362 SAGAGLDRRIHDPHQ----NQAIFDSAAFSLFLIARMGAVEPVYAEHALHFATLEAGLMTQLLDLGAAPSGLGLCHIGDL 3437
Cdd:pfam00881 64 EPAAALLLLLRRDANlkllLQDFLRGAPVLIVITASLSTYLRKAAERAYREALLDAGAAAQNLLLAATSLGLGSCPIGGF 143
|
170
....*....|....*...
gi 53747904 3438 DFAQARGLFHLEEEHVLL 3455
Cdd:pfam00881 144 DAAAVRELLGLPDDERLV 161
|
|
| AST1_like |
cd08247 |
AST1 is a cytoplasmic protein associated with the periplasmic membrane in yeast; This group ... |
1684-1885 |
1.52e-14 |
|
AST1 is a cytoplasmic protein associated with the periplasmic membrane in yeast; This group contains members identified in targeting of yeast membrane proteins ATPase. AST1 is a cytoplasmic protein associated with the periplasmic membrane in yeast, identified as a multicopy suppressor of pma1 mutants which cause temperature sensitive growth arrest due to the inability of ATPase to target to the cell surface. This family is homologous to the medium chain family of dehydrogenases and reductases. Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P) binding-Rossmann fold domain of an beta-alpha form and an N-terminal catalytic domain with distant homology to GroES.
Pssm-ID: 176209 [Multi-domain] Cd Length: 352 Bit Score: 78.08 E-value: 1.52e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1684 ESLGLRRCTrpapGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGV-SGLRVGDEVLAVAP- 1761
Cdd:cd08247 18 IKLPLPNCY----KDNEIVVKVHAAALNPVDLKLYNSYTFHFKVKEKGLGRDYSGVIVKVGSNVaSEWKVGDEVCGIYPh 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1762 -----GCFRSYVLVDESQ----VVRRPASLGLAEGAAQMVPFATAYFALHTVGR-LRRGERILIHAAAGGLGLAAVQLAS 1831
Cdd:cd08247 94 pyggqGTLSQYLLVDPKKdkksITRKPENISLEEAAAWPLVLGTAYQILEDLGQkLGPDSKVLVLGGSTSVGRFAIQLAK 173
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1832 RTGA--EILATAgSEQKREYLRSLGIAHVLDSRSTS---FVSEVRERTGGRG-VDVVLNS 1885
Cdd:cd08247 174 NHYNigTVVGTC-SSRSAELNKKLGADHFIDYDAHSgvkLLKPVLENVKGQGkFDLILDC 232
|
|
| EntE |
COG1021 |
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase ... |
2980-3132 |
1.85e-14 |
|
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440644 [Multi-domain] Cd Length: 533 Bit Score: 79.42 E-value: 1.85e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2980 PGELYIGGEGLAREYWRDEPLTATRFirhprTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQH 3059
Cdd:COG1021 380 VGELLTRGPYTIRGYYRAPEHNARAF-----TPDGFYRTGDLVRRTPDGYLVVEGRAKDQINRGGEKIAAEEVENLLLAH 454
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 53747904 3060 PALSASVVVARGEPRGVRRLVAYAVPRsGQTPAAGELRRYLAER-LPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:COG1021 455 PAVHDAAVVAMPDEYLGERSCAFVVPR-GEPLTLAELRRFLRERgLAAFKLPDRLEFVDALPLTAVGKIDKKAL 527
|
|
| PRK06018 |
PRK06018 |
putative acyl-CoA synthetase; Provisional |
2786-3134 |
2.04e-14 |
|
putative acyl-CoA synthetase; Provisional
Pssm-ID: 235673 [Multi-domain] Cd Length: 542 Bit Score: 79.41 E-value: 2.04e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2786 YTSGSTGKPKGVAIEHRA-ALNTVVDLNTrfgvgpedRVLGLSALTFDLSVYDVLGLLGAGGALVLPAA-------EAEK 2857
Cdd:PRK06018 184 YTSGTTGDPKGVLYSHRSnVLHALMANNG--------DALGTSAADTMLPVVPLFHANSWGIAFSAPSMgtklvmpGAKL 255
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2858 DPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPaALRLVMLSGDWIPVALpdrIRA-LGRDVQVVSLGGATEAS 2936
Cdd:PRK06018 256 DGASVYELLDTEKVTFTAGVPTVWLMLLQYMEKEGLKLP-HLKMVVCGGSAMPRSM---IKAfEDMGVEVRHAWGMTEMS 331
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2937 iwsiayPIGQVA---PQWKSIPY----------GMPLANQRFHVLDGRLEARPW--WVPGELYIGGEGLAREYWR--DEP 2999
Cdd:PRK06018 332 ------PLGTLAalkPPFSKLPGdarldvlqkqGYPPFGVEMKITDDAGKELPWdgKTFGRLKVRGPAVAAAYYRvdGEI 405
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3000 LTATRFirhprtgerlYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRL 3079
Cdd:PRK06018 406 LDDDGF----------FDTGDVATIDAYGYMRITDRSKDVIKSGGEWISSIDLENLAVGHPKVAEAAVIGVYHPKWDERP 475
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 3080 VAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPE 3134
Cdd:PRK06018 476 LLIVQLKPGETATREEILKYMDGKIAKWWMPDDVAFVDAIPHTATGKILKTALRE 530
|
|
| MDR4 |
cd08270 |
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; ... |
1685-1982 |
2.32e-14 |
|
Medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family; This group is a member of the medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, but lacks the zinc-binding sites of the zinc-dependent alcohol dehydrogenases. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P)-binding Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176231 [Multi-domain] Cd Length: 305 Bit Score: 77.03 E-value: 2.32e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1685 SLGLRRCTRPAPGPRQVEIEVEAAGLNFldvlGALGMMPALEAEEsVLGRECSGRIAAVGEGVSGLRVGDEVLA-VAPGC 1763
Cdd:cd08270 13 RLRLGEVPDPQPAPHEALVRVAAISLNR----GELKFAAERPDGA-VPGWDAAGVVERAAADGSGPAVGARVVGlGAMGA 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1764 FRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRrGERILIHAAAGGLGLAAVQLASRTGAEILATAGS 1843
Cdd:cd08270 88 WAELVAVPTGWLAVLPDGVSFAQAATLPVAGVTALRALRRGGPLL-GRRVLVTGASGGVGRFAVQLAALAGAHVVAVVGS 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1844 EQKREYLRSLGIAHVldsrstsfVSEVRERTGGRgVDVVLNSLAGELLLAGLSVLAPHGRFLELGKRD-----LYADQQV 1918
Cdd:cd08270 167 PARAEGLRELGAAEV--------VVGGSELSGAP-VDLVVDSVGGPQLARALELLAPGGTVVSVGSSSgepavFNPAAFV 237
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 1919 GLRTLARGQTFAAIDFGPHHPDFRAVLEEVAtqltQGQLEPLPTRLFPARQVAEAF-SFMARALH 1982
Cdd:cd08270 238 GGGGGRRLYTFFLYDGEPLAADLARLLGLVA----AGRLDPRIGWRGSWTEIDEAAeALLARRFR 298
|
|
| Zn_ADH4 |
cd08258 |
Alcohol dehydrogenases of the MDR family; This group shares the zinc coordination sites of the ... |
1685-1883 |
2.81e-14 |
|
Alcohol dehydrogenases of the MDR family; This group shares the zinc coordination sites of the zinc-dependent alcohol dehydrogenases. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P)-binding Rossmann fold domain of an beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176219 [Multi-domain] Cd Length: 306 Bit Score: 76.59 E-value: 2.81e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1685 SLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLgalgmmpALEAEE------SVLGRECSGRIAAVGEGVSGLRVGDEVLA 1758
Cdd:cd08258 13 NVELREVPEPEPGPGEVLIKVAAAGICGSDLH-------IYKGDYdpvetpVVLGHEFSGTIVEVGPDVEGWKVGDRVVS 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1759 VA--------PGC---------------------FRSYVLVDESQVVRRPASLGLaEGAAQMVPFATAYFALHTVGRLRR 1809
Cdd:cd08258 86 ETtfstcgrcPYCrrgdynlcphrkgigtqadggFAEYVLVPEESLHELPENLSL-EAAALTEPLAVAVHAVAERSGIRP 164
|
170 180 190 200 210 220 230
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 53747904 1810 GERILIhAAAGGLGLAAVQLASRTGAEILATaGSEQKREYL---RSLGIAHVlDSRSTSFVSEVRERTGGRGVDVVL 1883
Cdd:cd08258 165 GDTVVV-FGPGPIGLLAAQVAKLQGATVVVV-GTEKDEVRLdvaKELGADAV-NGGEEDLAELVNEITDGDGADVVI 238
|
|
| sorbitol_DH |
cd05285 |
Sorbitol dehydrogenase; Sorbitol and aldose reductase are NAD(+) binding proteins of the ... |
1686-1883 |
3.82e-14 |
|
Sorbitol dehydrogenase; Sorbitol and aldose reductase are NAD(+) binding proteins of the polyol pathway, which interconverts glucose and fructose. Sorbitol dehydrogenase is tetrameric and has a single catalytic zinc per subunit. Aldose reductase catalyzes the NADP(H)-dependent conversion of glucose to sorbital, and SDH uses NAD(H) in the conversion of sorbitol to fructose. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. The medium chain alcohol dehydrogenase family (MDR) have a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The N-terminal region typically has an all-beta catalytic domain. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit.
Pssm-ID: 176188 [Multi-domain] Cd Length: 343 Bit Score: 76.76 E-value: 3.82e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1686 LGLRRCTRPAPGPRQVEIEVEAAGLNFLDVL----GALGMMPAleAEESVLGRECSGRIAAVGEGVSGLRVGDEV----- 1756
Cdd:cd05285 10 LRLEERPIPEPGPGEVLVRVRAVGICGSDVHyykhGRIGDFVV--KEPMVLGHESAGTVVAVGSGVTHLKVGDRVaiepg 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1757 ----------------------LAVAP--GCFRSYVLVDESQVVRRPASLGLAEGAaqMV-PFATayfALHTVGR--LRR 1809
Cdd:cd05285 88 vpcrtcefcksgrynlcpdmrfAATPPvdGTLCRYVNHPADFCHKLPDNVSLEEGA--LVePLSV---GVHACRRagVRP 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1810 GERILIhaaagglglaavqlasrTGA-----------------EILATAGSEQKREYLRSLGIAHVLDSRSTS---FVSE 1869
Cdd:cd05285 163 GDTVLV-----------------FGAgpiglltaavakafgatKVVVTDIDPSRLEFAKELGATHTVNVRTEDtpeSAEK 225
|
250
....*....|....
gi 53747904 1870 VRERTGGRGVDVVL 1883
Cdd:cd05285 226 IAELLGGKGPDVVI 239
|
|
| threonine_DH_like |
cd08234 |
L-threonine dehydrogenase; L-threonine dehydrogenase (TDH) catalyzes the zinc-dependent ... |
1694-1882 |
3.86e-14 |
|
L-threonine dehydrogenase; L-threonine dehydrogenase (TDH) catalyzes the zinc-dependent formation of 2-amino-3-ketobutyrate from L-threonine, via NAD(H)-dependent oxidation. THD is a member of the zinc-requiring, medium chain NAD(H)-dependent alcohol dehydrogenase family (MDR). MDRs have a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. The N-terminal region typically has an all-beta catalytic domain. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit. Sorbitol and aldose reductase are NAD(+) binding proteins of the polyol pathway, which interconverts glucose and fructose.
Pssm-ID: 176196 [Multi-domain] Cd Length: 334 Bit Score: 76.80 E-value: 3.86e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAGLNFLDVL---GALGMMPALeaeesVLGRECSGRIAAVGEGVSGLRVGDEVlAVAP--------- 1761
Cdd:cd08234 20 PEPGPDEVLIKVAACGICGTDLHiyeGEFGAAPPL-----VPGHEFAGVVVAVGSKVTGFKVGDRV-AVDPniycgecfy 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1762 --------------------GCFRSYVLVDESQVVRRPASLGLAEGAaqMV-PFATayfALHTVGRL--RRGERILI--- 1815
Cdd:cd08234 94 crrgrpnlcenltavgvtrnGGFAEYVVVPAKQVYKIPDNLSFEEAA--LAePLSC---AVHGLDLLgiKPGDSVLVfga 168
|
170 180 190 200 210 220 230
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 53747904 1816 ------HaaagglglaaVQLASRTGAEILATAG-SEQKREYLRSLGIAHVLDsrSTSFVSEVRERTGGRGVDVV 1882
Cdd:cd08234 169 gpigllL----------AQLLKLNGASRVTVAEpNEEKLELAKKLGATETVD--PSREDPEAQKEDNPYGFDVV 230
|
|
| PRK12492 |
PRK12492 |
long-chain-fatty-acid--CoA ligase; Provisional |
2931-3135 |
3.91e-14 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 171539 [Multi-domain] Cd Length: 562 Bit Score: 78.71 E-value: 3.91e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2931 GATEASIWSIAYPIGQVApqwKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFirhpr 3010
Cdd:PRK12492 366 GLTETSPVASTNPYGELA---RLGTVGIPVPGTALKVIDDDGNELPLGERGELCIKGPQVMKGYWQQPEATAEAL----- 437
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3011 TGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGqT 3090
Cdd:PRK12492 438 DAEGWFKTGDIAVIDPDGFVRIVDRKKDLIIVSGFNVYPNEIEDVVMAHPKVANCAAIGVPDERSGEAVKLFVVARDP-G 516
|
170 180 190 200
....*....|....*....|....*....|....*....|....*
gi 53747904 3091 PAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPEP 3135
Cdd:PRK12492 517 LSVEELKAYCKENFTGYKVPKHIVLRDSLPMTPVGKILRRELRDI 561
|
|
| ADH_zinc_N_2 |
pfam13602 |
Zinc-binding dehydrogenase; |
1853-1988 |
4.20e-14 |
|
Zinc-binding dehydrogenase;
Pssm-ID: 433341 [Multi-domain] Cd Length: 131 Bit Score: 71.59 E-value: 4.20e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1853 LGIAHVLDSRSTSFVsevrERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELGKRDLYADqqVGLRTLAR-GQTFAA 1931
Cdd:pfam13602 1 LGADEVIDYRTTDFV----QATGGEGVDVVLDTVGGEAFEASLRVLPGGGRLVTIGGPPLSAG--LLLPARKRgGRGVKY 74
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*..
gi 53747904 1932 IDFGPHHPDFRAVLEEVATQLTQGQLEPLPTRLFPARQVAEAFSFMARALHIGRVAV 1988
Cdd:pfam13602 75 LFLFVRPNLGADILQELADLIEEGKLRPVIDRVFPLEEAAEAHRYLESGRARGKIVL 131
|
|
| AcpA |
COG3433 |
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites ... |
2938-3216 |
6.65e-14 |
|
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442659 [Multi-domain] Cd Length: 295 Bit Score: 75.56 E-value: 6.65e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2938 WSIAYPIGQVAPQWKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHPRTGERLYR 3017
Cdd:COG3433 1 IAIATPPPAPPTPDEPPPVIPPAIVQARALLLIVDLQGYFGGFGGEGGLLGAGLLLRIRLLAAAARAPFIPVPYPAQPGR 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3018 TGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTP-AAGEL 3096
Cdd:COG3433 81 QADDLRLLLRRGLGPGGGLERLVQQVVIRAERGEEEELLLVLRAAAVVRVAVLAALRGAGVGLLLIVGAVAALDgLAAAA 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3097 RRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLP-----EPQQTQGLAAQAAAADPLVERLAALVKEALRL--ERVE 3169
Cdd:COG3433 161 ALAALDKVPPDVVAASAVVALDALLLLALKVVARAAPalaaaEALLAAASPAPALETALTEEELRADVAELLGVdpEEID 240
|
250 260 270 280
....*....|....*....|....*....|....*....|....*..
gi 53747904 3170 PQDSLLDLGADSVALIRLINRLEAElQFRPRLADIYENPTVQGLATL 3216
Cdd:COG3433 241 PDDNLFDLGLDSIRLMQLVERWRKA-GLDVSFADLAEHPTLAAWWAL 286
|
|
| FACL_like_4 |
cd05944 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
2778-3132 |
6.76e-14 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341266 [Multi-domain] Cd Length: 359 Bit Score: 76.37 E-value: 6.76e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2778 PEHLAYVIYTSGSTGKPKGVAIEH--RAALNTVVDLNTRFGvgPEDRVL-GLSALTFDLSVYDVLGLLGAGGALVLPAAE 2854
Cdd:cd05944 1 SDDVAAYFHTGGTTGTPKLAQHTHsnEVYNAWMLALNSLFD--PDDVLLcGLPLFHVNGSVVTLLTPLASGAHVVLAGPA 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2855 AEKDPA---HWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLklpAALRLVMLSGDWIPVALPDRIR-ALGrdVQVVSLG 2930
Cdd:cd05944 79 GYRNPGlfdNFWKLVERYRITSLSTVPTVYAALLQVPVNADI---SSLRFAMSGAAPLPVELRARFEdATG--LPVVEGY 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2931 GATEAS-IWSIAYPIGQVAPqwKSIPYGMPLANQRFHVLDG----RLEARPWWVpGELYIGGEGLAREYWRDEpltatrF 3005
Cdd:cd05944 154 GLTEATcLVAVNPPDGPKRP--GSVGLRLPYARVRIKVLDGvgrlLRDCAPDEV-GEICVAGPGVFGGYLYTE------G 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3006 IRHPRTGERLYRTGDQGRMLPEGSIEFLGR-EDLQVKvQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAV 3084
Cdd:cd05944 225 NKNAFVADGWLNTGDLGRLDADGYLFITGRaKDLIIR-GGHNIDPALIEEALLRHPAVAFAGAVGQPDAHAGELPVAYVQ 303
|
330 340 350 360
....*....|....*....|....*....|....*....|....*....
gi 53747904 3085 PRSGQTPAAGELRRYLAERLPAY-MVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd05944 304 LKPGAVVEEEELLAWARDHVPERaAVPKHIEVLEELPVTAVGKVFKPAL 352
|
|
| PRK05677 |
PRK05677 |
long-chain-fatty-acid--CoA ligase; Validated |
2931-3132 |
1.03e-13 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 168170 [Multi-domain] Cd Length: 562 Bit Score: 77.11 E-value: 1.03e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2931 GATEASiwsiayPIGQVAP----QWKSIpyGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFi 3006
Cdd:PRK05677 359 GMTETS------PVVSVNPsqaiQVGTI--GIPVPSTLCKVIDDDGNELPLGEVGELCVKGPQVMKGYWQRPEATDEIL- 429
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3007 rhprTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPR 3086
Cdd:PRK05677 430 ----DSDGWLKTGDIALIQEDGYMRIVDRKKDMILVSGFNVYPNELEDVLAALPGVLQCAAIGVPDEKSGEAIKVFVVVK 505
|
170 180 190 200
....*....|....*....|....*....|....*....|....*.
gi 53747904 3087 SGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PRK05677 506 PGETLTKEQVMEHMRANLTGYKVPKAVEFRDELPTTNVGKILRREL 551
|
|
| AAS_C |
cd05909 |
C-terminal domain of the acyl-acyl carrier protein synthetase (also called ... |
2778-3127 |
1.25e-13 |
|
C-terminal domain of the acyl-acyl carrier protein synthetase (also called 2-acylglycerophosphoethanolamine acyltransferase, Aas); Acyl-acyl carrier protein synthase (Aas) is a membrane protein responsible for a minor pathway of incorporating exogenous fatty acids into membrane phospholipids. Its in vitro activity is characterized by the ligation of free fatty acids between 8 and 18 carbons in length to the acyl carrier protein sulfydryl group (ACP-SH) in the presence of ATP and Mg2+. However, its in vivo function is as a 2-acylglycerophosphoethanolamine (2-acyl-GPE) acyltransferase. The reaction occurs in two steps: the acyl chain is first esterified to acyl carrier protein (ACP) via a thioester bond, followed by a second step where the acyl chain is transferred to a 2-acyllysophospholipid, thus completing the transacylation reaction. This model represents the C-terminal domain of the enzyme, which belongs to the class I adenylate-forming enzyme family, including acyl-CoA synthetases.
Pssm-ID: 341235 [Multi-domain] Cd Length: 490 Bit Score: 76.60 E-value: 1.25e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2778 PEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGlsAL----TFDLSVYDVLGLLGAGGALVLPAA 2853
Cdd:cd05909 146 PDDPAVILFTSGSEGLPKGVVLSHKNLLANVEQITAIFDPNPEDVVFG--ALpffhSFGLTGCLWLPLLSGIKVVFHPNP 223
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2854 -EAEKDPAHWWERlvagRVTVWNSTPALMLLLVEYAEQRGLklpAALRLVMLSGDwipvALPDRIRALGRD---VQVVSL 2929
Cdd:cd05909 224 lDYKKIPELIYDK----KATILLGTPTFLRGYARAAHPEDF---SSLRLVVAGAE----KLKDTLRQEFQEkfgIRILEG 292
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2930 GGATEAS-IWSIAYP-----IGQVapqwksipyGMPLANQRFHVLDGR-LEARPWWVPGELYIGGEGLAREYWRDEPLTA 3002
Cdd:cd05909 293 YGTTECSpVISVNTPqspnkEGTV---------GRPLPGMEVKIVSVEtHEEVPIGEGGLLLVRGPNVMLGYLNEPELTS 363
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3003 TRFirhprtGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQH-PALSASVVVA-----RGEprgv 3076
Cdd:cd05909 364 FAF------GDGWYDTGDIGKIDGEGFLTITGRLSRFAKIAGEMVSLEAIEDILSEIlPEDNEVAVVSvpdgrKGE---- 433
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|..
gi 53747904 3077 rRLVAYAVPRSgQTPAagELRRYLAE-RLPAYMVPSAFVLLESLPRSRNGKI 3127
Cdd:cd05909 434 -KIVLLTTTTD-TDPS--SLNDILKNaGISNLAKPSYIHQVEEIPLLGTGKP 481
|
|
| PRK07786 |
PRK07786 |
long-chain-fatty-acid--CoA ligase; Validated |
2646-3134 |
1.56e-13 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 169098 [Multi-domain] Cd Length: 542 Bit Score: 76.74 E-value: 1.56e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2646 TQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPL 2725
Cdd:PRK07786 25 RHALMQPDAPALRFLGNTTTWRELDDRVAALAGALSRRGVGFGDRVLILMLNRTEFVESVLAANMLGAIAVPVNFRLTPP 104
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2726 RLHQLLEEGPARVVLTQSSLLHTVpwppgvqvIAVDELEP-----------------------ATEAPPLPPRGTPEHL- 2781
Cdd:PRK07786 105 EIAFLVSDCGAHVVVTEAALAPVA--------TAVRDIVPllstvvvaggssddsvlgyedllAEAGPAHAPVDIPNDSp 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2782 AYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAH 2861
Cdd:PRK07786 177 ALIMYTSGTTGRPKGAVLTHANLTGQAMTCLRTNGADINSDVGFVGVPLFHIAGIGSMLPGLLLGAPTVIYPLGAFDPGQ 256
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2862 WWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLpaALRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEASiwsia 2941
Cdd:PRK07786 257 LLDVLEAEKVTGIFLVPAQWQAVCAEQQARPRDL--ALRVLSWGAAPASDTLLRQMAATFPEAQILAAFGQTEMS----- 329
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2942 yPI-----GQVAPQwKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFirhprtGERLY 3016
Cdd:PRK07786 330 -PVtcmllGEDAIR-KLGSVGKVIPTVAARVVDENMNDVPVGEVGEIVYRAPTLMSGYWNNPEATAEAF------AGGWF 401
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3017 RTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTP-AAGE 3095
Cdd:PRK07786 402 HSGDLVRQDEEGYVWVVDRKKDMIISGGENIYCAEVENVLASHPDIVEVAVIGRADEKWGEVPVAVAAVRNDDAAlTLED 481
|
490 500 510
....*....|....*....|....*....|....*....
gi 53747904 3096 LRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPE 3134
Cdd:PRK07786 482 LAEFLTDRLARYKHPKALEIVDALPRNPAGKVLKTELRE 520
|
|
| YqjQ |
COG0300 |
Short-chain dehydrogenase [General function prediction only]; |
1232-1350 |
1.83e-13 |
|
Short-chain dehydrogenase [General function prediction only];
Pssm-ID: 440069 [Multi-domain] Cd Length: 252 Bit Score: 72.98 E-value: 1.83e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1232 ELEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAATFDDGVIQLRTHEQSSRALRTKVRGSMVLHEVLA-- 1309
Cdd:COG0300 48 ELRAAGARVEVVALDVTDPDAVAALAEAVLARFGPIDVLVNNAGVGGGGPFEELDLEDLRRVFEVNVFGPVRLTRALLpl 127
|
90 100 110 120
....*....|....*....|....*....|....*....|...
gi 53747904 1310 --SEGLDWFALCSSLASALGSFGQADYCAANAFQDAYAHHLRR 1350
Cdd:COG0300 128 mrARGRGRIVNVSSVAGLRGLPGMAAYAASKAALEGFSESLRA 170
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
2083-2468 |
5.17e-13 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 75.97 E-value: 5.17e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2083 PPSSLEQLIEQVWRKHLGVERVQPTDSFFQLGGDSLLGIQVAADLRRHlGVELPTATLFSHPTLAALAAALRARQGeaaa 2162
Cdd:PRK12467 2094 PQSELEQRLAAIWQDVLGLEQVGLHDNFFELGGDSIISIQVVSRARQA-GIRFTPKDLFQHQTVQSLAAVAQEGDG---- 2168
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2163 ptapapALVPDPAARFEPFPLTDVQEAYwvgrrsaFELGGVAAHGYFE--IESPG--LEVERFIQCWRQLLQRHDMLRMV 2238
Cdd:PRK12467 2169 ------TVSIDQGPVTGDLPLLPIQQMF-------FADDIPERHHWNQsvLLEPReaLDAELLEAALQALLVHHDALRLG 2235
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2239 -VLPDGRQQVleqvpEYTPEVVELRGLSPQEAESRRLQLrERMAHQVLRS---DRWPLFELVLCRY-EGGVRIHMSMDAL 2313
Cdd:PRK12467 2236 fVQEDGGWSA-----MHRAPEQERRPLLWQVVVADKEEL-EALCEQAQRSldlEEGPLLRAVLATLpDGSQRLLLVIHHL 2309
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2314 MLDAWSSAVLRQDFAQLYHE--PGRPLEPLAIT--FRDYvlAERRlrEGEAHERA----RAYWWARLDTLPPPPELPLVK 2385
Cdd:PRK12467 2310 VVDGVSWRILLEDLQTAYRQlqGGQPVKLPAKTsaFKAW--AERL--QTYAASAAladeLGYWQAQLQGASTELPCDHPQ 2385
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2386 EPSQLEHARF--THREARlephrWAR--LQERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRLPLHPQVD-- 2459
Cdd:PRK12467 2386 GGLQRRHAASvtTHLDSE-----WTRrlLQEAPAAYRTQVNDLLLTALARVIARWTGQASTLIQLEGHGREDLFDEIDlt 2460
|
....*....
gi 53747904 2460 ELVGDFTSL 2468
Cdd:PRK12467 2461 RTVGWFTSL 2469
|
|
| PKS_DH |
smart00826 |
Dehydratase domain in polyketide synthase (PKS) enzymes; |
1400-1534 |
7.24e-13 |
|
Dehydratase domain in polyketide synthase (PKS) enzymes;
Pssm-ID: 214837 Cd Length: 167 Bit Score: 69.18 E-value: 7.24e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1400 EPGGTHWLGlTLRGGEDWVVDEHRLQGVPTLPGVAYLELARAACAQALGAEAVELAELLLLEPLTVPRGESRQVRVVLQP 1479
Cdd:smart00826 12 DGGGVVLTG-RLSLRTHPWLADHRVGGTVVLPGAAYVELALAAADEVGGGAPARLEELTLEAPLVLPEDGAVRVQVVVGA 90
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*..
gi 53747904 1480 EGQAH--ALRVESRSEEARGWNEHARGRVRAVPRLAERIQPELLRAACEHEQPVPGE 1534
Cdd:smart00826 91 PDEDGrrTFTVYSRPDGDGPWTRHATGTLRPAAAAPAAPAADLAAWPPAGAEPVDVD 147
|
|
| THR_DH_like |
cd08239 |
L-threonine dehydrogenase (TDH)-like; MDR/AHD-like proteins, including a protein annotated as ... |
1694-1979 |
7.54e-13 |
|
L-threonine dehydrogenase (TDH)-like; MDR/AHD-like proteins, including a protein annotated as a threonine dehydrogenase. L-threonine dehydrogenase (TDH) catalyzes the zinc-dependent formation of 2-amino-3-ketobutyrate from L-threonine via NAD(H)-dependent oxidation. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Zinc-dependent ADHs are medium chain dehydrogenase/reductase type proteins (MDRs) and have a NAD(P)(H)-binding domain in a Rossmann fold of an beta-alpha form. The N-terminal region typically has an all-beta catalytic domain. In addition to alcohol dehydrogenases, this group includes quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176201 [Multi-domain] Cd Length: 339 Bit Score: 72.74 E-value: 7.54e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGDEVLAV-------------- 1759
Cdd:cd08239 20 PVPGPGEVLLRVKASGLCGSDLHYYYHGHRAPAYQGVIPGHEPAGVVVAVGPGVTHFRVGDRVMVYhyvgcgacrncrrg 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1760 ---------------APGCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGeRILIHAAAGGLGL 1824
Cdd:cd08239 100 wmqlctskraaygwnRDGGHAEYMLVPEKTLIPLPDDLSFADGALLLCGIGTAYHALRRVGVSGRD-TVLVVGAGPVGLG 178
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1825 AAVQLASRTGAEILATAGSEQKREYLRSLGIAHVLDSRSTSfVSEVRERTGGRGVDVVLN-SLAGELLLAGLSVLAPHGR 1903
Cdd:cd08239 179 ALMLARALGAEDVIGVDPSPERLELAKALGADFVINSGQDD-VQEIRELTSGAGADVAIEcSGNTAARRLALEAVRPWGR 257
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1904 FLELGK---------RDLYADQqvglRTLARGQTFAAidfgphhPDFRAVLEEVATQLTqgQLEPLPTRLFPARQVAEAF 1974
Cdd:cd08239 258 LVLVGEggeltievsNDLIRKQ----RTLIGSWYFSV-------PDMEECAEFLARHKL--EVDRLVTHRFGLDQAPEAY 324
|
....*
gi 53747904 1975 SFMAR 1979
Cdd:cd08239 325 ALFAQ 329
|
|
| PRK09116 |
PRK09116 |
beta-ketoacyl-ACP synthase; |
107-394 |
7.99e-13 |
|
beta-ketoacyl-ACP synthase;
Pssm-ID: 181657 [Multi-domain] Cd Length: 405 Bit Score: 73.48 E-value: 7.99e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 107 ALEDAGLRPDQL--PGWVGVYVG--AGDTsyrfQLLRGHGDPLSgSKDVAGFFGN-Y----PDFLATRVAYKLNLRGPAL 177
Cdd:PRK09116 84 ALEDAGLLGDPIltDGRMGIAYGssTGST----DPIGAFGTMLL-EGSMSGITATtYvrmmPHTTAVNVGLFFGLKGRVI 158
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 178 GIHTACSTSLVSINMACSALRGFECDMALAGGVSLRLPARSGY---LYeegGVASKDGHC----RPFDARATGTVTGDGV 250
Cdd:PRK09116 159 PTSSACTSGSQGIGYAYEAIKYGYQTVMLAGGAEELCPTEAAVfdtLF---ATSTRNDAPeltpRPFDANRDGLVIGEGA 235
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 251 GVVVLKRLEDAlKARD-PIHAVIRGWALNNDGASragFTAPSVEGQSEVIALAHAAAGISARDITYVEAHGTGTPLGDPI 329
Cdd:PRK09116 236 GTLVLEELEHA-KARGaTIYAEIVGFGTNSDGAH---VTQPQAETMQIAMELALKDAGLAPEDIGYVNAHGTATDRGDIA 311
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 330 EVAALTRAFRAHTAdtafctLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERPNPAL 394
Cdd:PRK09116 312 ESQATAAVFGARMP------ISSLKSYFGHTLGACGALEAWMSIEMMNEGWFAPTLNLTQVDPAC 370
|
|
| PRK06710 |
PRK06710 |
long-chain-fatty-acid--CoA ligase; Validated |
2778-3134 |
9.16e-13 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 180666 [Multi-domain] Cd Length: 563 Bit Score: 74.30 E-value: 9.16e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2778 PEH-LAYVIYTSGSTGKPKGVAIEHRAAL-NTVVDLNTRFG-VGPEDRVLGLsaLTFdLSVYDVLGLLGAGGALVLPAAE 2854
Cdd:PRK06710 204 PENdLALLQYTGGTTGFPKGVMLTHKNLVsNTLMGVQWLYNcKEGEEVVLGV--LPF-FHVYGMTAVMNLSIMQGYKMVL 280
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2855 AEK-DPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLpAALRLVMLSGDWIPVALPDRIRALGRDvQVVSLGGAT 2933
Cdd:PRK06710 281 IPKfDMKMVFEAIKKHKVTLFPGAPTIYIALLNSPLLKEYDI-SSIRACISGSAPLPVEVQEKFETVTGG-KLVEGYGLT 358
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2934 EAS-------IWSIAYPiGQVAPQWksipygmPLANQRFHVLDGRLEARPWWVpGELYIGGEGLAREYWRDEPLTATRFi 3006
Cdd:PRK06710 359 ESSpvthsnfLWEKRVP-GSIGVPW-------PDTEAMIMSLETGEALPPGEI-GEIVVKGPQIMKGYWNKPEETAAVL- 428
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3007 rhprtGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPR 3086
Cdd:PRK06710 429 -----QDGWLHTGDVGYMDEDGFFYVKDRKKDMIVASGFNVYPREVEEVLYEHEKVQEVVTIGVPDPYRGETVKAFVVLK 503
|
330 340 350 360
....*....|....*....|....*....|....*....|....*...
gi 53747904 3087 SGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPE 3134
Cdd:PRK06710 504 EGTECSEEELNQFARKYLAAYKVPKVYEFRDELPKTTVGKILRRVLIE 551
|
|
| PRK06155 |
PRK06155 |
crotonobetaine/carnitine-CoA ligase; Provisional |
2636-3134 |
1.05e-12 |
|
crotonobetaine/carnitine-CoA ligase; Provisional
Pssm-ID: 235719 [Multi-domain] Cd Length: 542 Bit Score: 74.02 E-value: 1.05e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2636 PSGRLEEGFFT-QARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAA 2714
Cdd:PRK06155 18 PSERTLPAMLArQAERYPDRPLLVFGGTRWTYAEAARAAAAAAHALAAAGVKRGDRVALMCGNRIEFLDVFLGCAWLGAI 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2715 YLPLDPEQPPLRLHQLLEEGPARVVLTQSSLLHTV-PWPPGV----QVIAVDElEPATEAP------PLPPRG------- 2776
Cdd:PRK06155 98 AVPINTALRGPQLEHILRNSGARLLVVEAALLAALeAADPGDlplpAVWLLDA-PASVSVPagwstaPLPPLDapapaaa 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2777 -TPEHLAYVIYTSGSTGKPKGVAIEHRA----ALNTVVDLntrfGVGPEDRVLGlsalTFDLSVYDVLGLLGAGGALVLP 2851
Cdd:PRK06155 177 vQPGDTAAILYTSGTTGPSKGVCCPHAQfywwGRNSAEDL----EIGADDVLYT----TLPLFHTNALNAFFQALLAGAT 248
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2852 AAEAEKDPAH-WWERLVAGRVTVWNSTPALMLLLV---EYAEQRGLKLPAALrlvmlsGDWIPVALPDRIRA-LGrdVQV 2926
Cdd:PRK06155 249 YVLEPRFSASgFWPAVRRHGATVTYLLGAMVSILLsqpARESDRAHRVRVAL------GPGVPAALHAAFRErFG--VDL 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2927 VSLGGATEASiwsiaYPIGQVAPQWKsiPYGMPLANQRFH--VLDGRLEARPWWVPGELyiggegLAREywrDEPLT-AT 3003
Cdd:PRK06155 321 LDGYGSTETN-----FVIAVTHGSQR--PGSMGRLAPGFEarVVDEHDQELPDGEPGEL------LLRA---DEPFAfAT 384
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3004 RFIRHPRTGERLYR-----TGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRR 3078
Cdd:PRK06155 385 GYFGMPEKTVEAWRnlwfhTGDRVVRDADGWFRFVDRIKDAIRRRGENISSFEVEQVLLSHPAVAAAAVFPVPSELGEDE 464
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*.
gi 53747904 3079 LVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPE 3134
Cdd:PRK06155 465 VMAAVVLRDGTALEPVALVRHCEPRLAYFAVPRYVEFVAALPKTENGKVQKFVLRE 520
|
|
| PRK09274 |
PRK09274 |
peptide synthase; Provisional |
2761-3132 |
1.47e-12 |
|
peptide synthase; Provisional
Pssm-ID: 236443 [Multi-domain] Cd Length: 552 Bit Score: 73.39 E-value: 1.47e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2761 DELEPATEAPPLPPRGTPEH-LAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGlsalTFDL-SVYDV 2838
Cdd:PRK09274 155 ATLLRDGAAAPFPMADLAPDdMAAILFTSGSTGTPKGVVYTHGMFEAQIEALREDYGIEPGEIDLP----TFPLfALFGP 230
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2839 LGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPaALRLVMLSGDWIPVALPDRIR 2918
Cdd:PRK09274 231 ALGMTSVIPDMDPTRPATVDPAKLFAAIERYGVTNLFGSPALLERLGRYGEANGIKLP-SLRRVISAGAPVPIAVIERFR 309
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2919 A-LGRDVQVVSLGGATEA----SIWS------------------IAYPIGQVapQWKSIpygmPLANQRFHVLDGRLEAR 2975
Cdd:PRK09274 310 AmLPPDAEILTPYGATEAlpisSIESreilfatraatdngagicVGRPVDGV--EVRII----AISDAPIPEWDDALRLA 383
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2976 PWWVpGELYIGGEGLAREY-WRDEpltATRF--IRHPRTGERlYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEI 3052
Cdd:PRK09274 384 TGEI-GEIVVAGPMVTRSYyNRPE---ATRLakIPDGQGDVW-HRMGDLGYLDAQGRLWFCGRKAHRVETAGGTLYTIPC 458
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3053 EAALAQHPALSASVVVARGEPRGVRRLVAYAvPRSGQTPAAGELR---RYLAERLPAYMVPSAFVLLESLP---RsRNGK 3126
Cdd:PRK09274 459 ERIFNTHPGVKRSALVGVGVPGAQRPVLCVE-LEPGVACSKSALYqelRALAAAHPHTAGIERFLIHPSFPvdiR-HNAK 536
|
....*.
gi 53747904 3127 IARDQL 3132
Cdd:PRK09274 537 IFREKL 542
|
|
| CLF |
cd00832 |
Chain-length factor (CLF) is a factor required for polyketide chain initiation of aromatic ... |
94-431 |
1.53e-12 |
|
Chain-length factor (CLF) is a factor required for polyketide chain initiation of aromatic antibiotic-producing polyketide synthases (PKSs) of filamentous bacteria. CLFs have been shown to have decarboxylase activity towards malonyl-acyl carrier protein (ACP). CLFs are similar to other elongation ketosynthase domains, but their active site cysteine is replaced by a conserved glutamine.
Pssm-ID: 238428 [Multi-domain] Cd Length: 399 Bit Score: 72.39 E-value: 1.53e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 94 DPQQRLLLECSWEALEDAGLRPDQLPGW-VGVYVGAGDTSYRF-----QLLRGHGDP-LSGSKDVAGFFGNYPDFLATRv 166
Cdd:cd00832 69 DRMTRLALAAADWALADAGVDPAALPPYdMGVVTASAAGGFEFgqrelQKLWSKGPRhVSAYQSFAWFYAVNTGQISIR- 147
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 167 aykLNLRGPALGIHTACSTSLVSINMACSALRGfECDMALAGGVSLRLPARSGYLYEEGGVASKDGH----CRPFDARAT 242
Cdd:cd00832 148 ---HGMRGPSGVVVAEQAGGLDALAQARRLVRR-GTPLVVSGGVDSALCPWGWVAQLSSGRLSTSDDparaYLPFDAAAA 223
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 243 GTVTGDGVGVVVLKRLEDALKARDPIHAVIRGWALNNDGASRAGftapSVEGQSEVIALAHAAAGISARDITYVEAHGTG 322
Cdd:cd00832 224 GYVPGEGGAILVLEDAAAARERGARVYGEIAGYAATFDPPPGSG----RPPGLARAIRLALADAGLTPEDVDVVFADAAG 299
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 323 TPLGDPIEVAALTRAFRAHTADTAfctlgAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERPNPALHLEqspfF 402
Cdd:cd00832 300 VPELDRAEAAALAAVFGPRGVPVT-----APKTMTGRLYAGGAPLDVATALLALRDGVIPPTVNVTDVPPAYGLD----L 370
|
330 340
....*....|....*....|....*....
gi 53747904 403 VNTQPLPWEsprgPRLAGVSSFGIGGTNA 431
Cdd:cd00832 371 VTGRPRPAA----LRTALVLARGRGGFNS 395
|
|
| Zn_ADH_class_III |
cd08279 |
Class III alcohol dehydrogenase; Glutathione-dependent formaldehyde dehydrogenases (FDHs, ... |
1694-1883 |
1.73e-12 |
|
Class III alcohol dehydrogenase; Glutathione-dependent formaldehyde dehydrogenases (FDHs, Class III ADH) are members of the zinc-dependent/medium chain alcohol dehydrogenase family. FDH converts formaldehyde and NAD(P) to formate and NAD(P)H. The initial step in this process the spontaneous formation of a S-(hydroxymethyl)glutathione adduct from formaldehyde and glutathione, followed by FDH-mediated oxidation (and detoxification) of the adduct to S-formylglutathione. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. Class III ADH are also known as glutathione-dependent formaldehyde dehydrogenase (FDH), which convert aldehydes to corresponding carboxylic acid and alcohol. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of an beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding.
Pssm-ID: 176240 [Multi-domain] Cd Length: 363 Bit Score: 72.19 E-value: 1.73e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAGL-----NFLDvlGALG-MMPAleaeesVLGRECSGRIAAVGEGVSGLRVGDEV-LAVAPGC--- 1763
Cdd:cd08279 21 DDPGPGEVLVRIAAAGLchsdlHVVT--GDLPaPLPA------VLGHEGAGVVEEVGPGVTGVKPGDHVvLSWIPACgtc 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1764 --------------------------------------------FRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYF 1799
Cdd:cd08279 93 rycsrgqpnlcdlgagilggqlpdgtrrftadgepvgamcglgtFAEYTVVPEASVVKIDDDIPLDRAALLGCGVTTGVG 172
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1800 ALHTVGRLRRGERILIhaaaggLGLAAVQLASRTGAEIlATAG-------SEQKREYLRSLGIAHVLDSRSTSFVSEVRE 1872
Cdd:cd08279 173 AVVNTARVRPGDTVAV------IGCGGVGLNAIQGARI-AGASriiavdpVPEKLELARRFGATHTVNASEDDAVEAVRD 245
|
250
....*....|.
gi 53747904 1873 RTGGRGVDVVL 1883
Cdd:cd08279 246 LTDGRGADYAF 256
|
|
| ACS |
cd05966 |
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); ... |
2731-3129 |
1.82e-12 |
|
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); Acetyl-CoA synthetase (ACS, EC 6.2.1.1, acetate#CoA ligase or acetate:CoA ligase (AMP-forming)) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is widely present in all living organisms. The activity of this enzyme is crucial for maintaining the required levels of acetyl-CoA, a key intermediate in many important biosynthetic and catabolic processes. Acetyl-CoA is used in the biosynthesis of glucose, fatty acids, and cholesterol. It can also be used in the production of energy in the citric acid cycle. Eukaryotes typically have two isoforms of acetyl-CoA synthetase, a cytosolic form involved in biosynthetic processes and a mitochondrial form primarily involved in energy generation.
Pssm-ID: 341270 [Multi-domain] Cd Length: 608 Bit Score: 73.36 E-value: 1.82e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2731 LEEGPA-RVVLTQSSLLHTVPWPPGVQVIAVDELE-PATEAPPLPPrgTPEHLAYVIYTSGSTGKPKGVaiEHRAA---L 2805
Cdd:cd05966 183 LEKCPSvEKVLVVKRTGGEVPMTEGRDLWWHDLMAkQSPECEPEWM--DSEDPLFILYTSGSTGKPKGV--VHTTGgylL 258
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2806 NTVVDLNTRFGVGPEDRV---------------------LGLSALTFDlsvydvlgllgaggalvlpAAEAEKDPAHWWE 2864
Cdd:cd05966 259 YAATTFKYVFDYHPDDIYwctadigwitghsyivygplaNGATTVMFE-------------------GTPTYPDPGRYWD 319
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2865 RLVAGRVTVWnstpalmlllveYAEqrglklPAALRLVMLSGDWIPVALpDR--IRALG--------------------R 2922
Cdd:cd05966 320 IVEKHKVTIF------------YTA------PTAIRALMKFGDEWVKKH-DLssLRVLGsvgepinpeawmwyyevigkE 380
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2923 DVQVVS--------------LGGATEASIWSIAYPIGQVAPQwksI--PYGMPLANQRfhvlDGRLEA-RPWwvPGelyi 2985
Cdd:cd05966 381 RCPIVDtwwqtetggimitpLPGATPLKPGSATRPFFGIEPA---IldEEGNEVEGEV----EGYLVIkRPW--PG---- 447
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2986 ggegLAREYWRDEpltaTRFIR---HPRTGerLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPAL 3062
Cdd:cd05966 448 ----MARTIYGDH----ERYEDtyfSKFPG--YYFTGDGARRDEDGYYWITGRVDDVINVSGHRLGTAEVESALVAHPAV 517
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3063 SASVVVARGEPRGVRRLVAYAVPRSGQTPA---AGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIAR 3129
Cdd:cd05966 518 AEAAVVGRPHDIKGEAIYAFVTLKDGEEPSdelRKELRKHVRKEIGPIATPDKIQFVPGLPKTRSGKIMR 587
|
|
| CAD_like |
cd08296 |
Cinnamyl alcohol dehydrogenases (CAD); Cinnamyl alcohol dehydrogenases (CAD), members of the ... |
1694-1908 |
2.20e-12 |
|
Cinnamyl alcohol dehydrogenases (CAD); Cinnamyl alcohol dehydrogenases (CAD), members of the medium chain dehydrogenase/reductase family, reduce cinnamaldehydes to cinnamyl alcohols in the last step of monolignal metabolism in plant cells walls. CAD binds 2 zinc ions and is NADPH- dependent. CAD family members are also found in non-plant species, e.g. in yeast where they have an aldehyde reductase activity. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P) binding-Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADHs), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176256 [Multi-domain] Cd Length: 333 Bit Score: 71.51 E-value: 2.20e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEaEESVLGRECSGRIAAVGEGVSGLRVGDEVlAVA------------- 1760
Cdd:cd08296 21 PLPGPGEVLIKVEACGVCHSDAFVKEGAMPGLS-YPRVPGHEVVGRIDAVGEGVSRWKVGDRV-GVGwhgghcgtcdacr 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1761 -----------------PGCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGrLRRGERILI-------H 1816
Cdd:cd08296 99 rgdfvhcengkvtgvtrDGGYAEYMLAPAEALARIPDDLDAAEAAPLLCAGVTTFNALRNSG-AKPGDLVAVqgigglgH 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1817 AaagglglaAVQLASRTGAEILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRErTGgrGVDVVLNSLAGELL-LAGL 1895
Cdd:cd08296 178 L--------AVQYAAKMGFRTVAISRGSDKADLARKLGAHHYIDTSKEDVAEALQE-LG--GAKLILATAPNAKAiSALV 246
|
250
....*....|...
gi 53747904 1896 SVLAPHGRFLELG 1908
Cdd:cd08296 247 GGLAPRGKLLILG 259
|
|
| PRK08308 |
PRK08308 |
acyl-CoA synthetase; Validated |
3010-3133 |
2.20e-12 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236231 [Multi-domain] Cd Length: 414 Bit Score: 72.38 E-value: 2.20e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3010 RTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQ 3089
Cdd:PRK08308 287 KMGDKEIFTKDLGYKSERGTLHFMGRMDDVINVSGLNVYPIEVEDVMLRLPGVQEAVVYRGKDPVAGERVKAKVISHEEI 366
|
90 100 110 120
....*....|....*....|....*....|....*....|....
gi 53747904 3090 TPAagELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLP 3133
Cdd:PRK08308 367 DPV--QLREWCIQHLAPYQVPHEIESVTEIPKNANGKVSRKLLE 408
|
|
| PRK06188 |
PRK06188 |
acyl-CoA synthetase; Validated |
2651-3132 |
2.48e-12 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235731 [Multi-domain] Cd Length: 524 Bit Score: 72.71 E-value: 2.48e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2651 HPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAI--------------AMHKGWeQATAV--LGVLQ---- 2710
Cdd:PRK06188 25 YPDRPALVLGDTRLTYGQLADRISRYIQAFEALGLGTGDAVALlslnrpevlmaigaAQLAGL-RRTALhpLGSLDdhay 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2711 ----AAAAYLPLDPEQPPLRLHQLLEEGParvvltqsSLLHTVPWPPGVqvIAVDELEPATEAPPLP--PRGTPEHLAYV 2784
Cdd:PRK06188 104 vledAGISTLIVDPAPFVERALALLARVP--------SLKHVLTLGPVP--DGVDLLAAAAKFGPAPlvAAALPPDIAGL 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2785 IYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAeaekDPAHWWE 2864
Cdd:PRK06188 174 AYTGGTTGKPKGVMGTHRSIATMAQIQLAEWEWPADPRFLMCTPLSHAGGAFFLPTLLRGGTVIVLAKF----DPAEVLR 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2865 RLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPAaLRLVMLSGDWI-PVALPDRIRALGrdvQVVS-LGGATEAsiwsiAY 2942
Cdd:PRK06188 250 AIEEQRITATFLVPTMIYALLDHPDLRTRDLSS-LETVYYGASPMsPVRLAEAIERFG---PIFAqYYGQTEA-----PM 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2943 PIGQVAPQ--WKSIPY-----GMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFirhpRTGerL 3015
Cdd:PRK06188 321 VITYLRKRdhDPDDPKrltscGRPTPGLRVALLDEDGREVAQGEVGEICVRGPLVMDGYWNRPEETAEAF----RDG--W 394
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3016 YRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGE 3095
Cdd:PRK06188 395 LHTGDVAREDEDGFYYIVDRKKDMIVTGGFNVFPREVEDVLAEHPAVAQVAVIGVPDEKWGEAVTAVVVLRPGAAVDAAE 474
|
490 500 510
....*....|....*....|....*....|....*..
gi 53747904 3096 LRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PRK06188 475 LQAHVKERKGSVHAPKQVDFVDSLPLTALGKPDKKAL 511
|
|
| TDH |
cd05281 |
Threonine dehydrogenase; L-threonine dehydrogenase (TDH) catalyzes the zinc-dependent ... |
1694-1883 |
3.84e-12 |
|
Threonine dehydrogenase; L-threonine dehydrogenase (TDH) catalyzes the zinc-dependent formation of 2-amino-3-ketobutyrate from L-threonine via NAD(H)- dependent oxidation. THD is a member of the zinc-requiring, medium chain NAD(H)-dependent alcohol dehydrogenase family (MDR). MDRs have a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. The N-terminal region typically has an all-beta catalytic domain. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria) and have 2 tightly bound zinc atoms per subunit. Sorbitol and aldose reductase are NAD(+) binding proteins of the polyol pathway, which interconverts glucose and fructose.
Pssm-ID: 176184 [Multi-domain] Cd Length: 341 Bit Score: 70.73 E-value: 3.84e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAGLNFLDV-------LGALGMMPALeaeesVLGRECSGRIAAVGEGVSGLRVGD------------ 1754
Cdd:cd05281 21 PKPGPGEVLIKVLAASICGTDVhiyewdeWAQSRIKPPL-----IFGHEFAGEVVEVGEGVTRVKVGDyvsaethivcgk 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1755 ---------------EVLAV-APGCFRSYVLVDESQVVRRPASLGLaEGAAQMVPFATAyfaLHTV--GRLRrGERILIh 1816
Cdd:cd05281 96 cyqcrtgnyhvcqntKILGVdTDGCFAEYVVVPEENLWKNDKDIPP-EIASIQEPLGNA---VHTVlaGDVS-GKSVLI- 169
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 53747904 1817 AAAGGLGLAAVQLASRTGAE-ILATAGSEQKREYLRSLGIAHVLDSRSTSfVSEVRERTGGRGVDVVL 1883
Cdd:cd05281 170 TGCGPIGLMAIAVAKAAGASlVIASDPNPYRLELAKKMGADVVINPREED-VVEVKSVTDGTGVDVVL 236
|
|
| PRK07824 |
PRK07824 |
o-succinylbenzoate--CoA ligase; |
2782-3132 |
6.00e-12 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 236108 [Multi-domain] Cd Length: 358 Bit Score: 70.46 E-value: 6.00e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2782 AYVIYTSGSTGKPKGvAIEHRAALNTVVDLNTRFGVGPEDRVLGLSA-------------------LTFDLSvydvlgll 2842
Cdd:PRK07824 38 ALVVATSGTTGTPKG-AMLTAAALTASADATHDRLGGPGQWLLALPAhhiaglqvlvrsviagsepVELDVS-------- 108
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2843 GAGGALVLPAAEAEKDPAHWWERLVAgrvtvwnstpalMLLLVEYAEQRGLKLPAALRLVMLSGDWIPVALPDRIRALGr 2922
Cdd:PRK07824 109 AGFDPTALPRAVAELGGGRRYTSLVP------------MQLAKALDDPAATAALAELDAVLVGGGPAPAPVLDAAAAAG- 175
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2923 dVQVVSLGGATEASIwsiaypiGQVapqwksipY-GMPLANQRFHVLDGRLEarpwwvpgelyIGGEGLAREYwRDEPlt 3001
Cdd:PRK07824 176 -INVVRTYGMSETSG-------GCV--------YdGVPLDGVRVRVEDGRIA-----------LGGPTLAKGY-RNPV-- 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3002 atrfIRHPRTGERLYRTGDQGrMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVA 3081
Cdd:PRK07824 226 ----DPDPFAEPGWFRTDDLG-ALDDGVLTVLGRADDAISTGGLTVLPQVVEAALATHPAVADCAVFGLPDDRLGQRVVA 300
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|.
gi 53747904 3082 YAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PRK07824 301 AVVGDGGPAPTLEALRAHVARTLDRTAAPRELHVVDELPRRGIGKVDRRAL 351
|
|
| AcpP |
COG0236 |
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the ... |
2083-2145 |
1.21e-11 |
|
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the Pathway/BioSystem: Fatty acid biosynthesis
Pssm-ID: 440006 [Multi-domain] Cd Length: 80 Bit Score: 62.95 E-value: 1.21e-11
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 53747904 2083 PPSSLEQLIEQVWRKHLGV--ERVQPTDSFFQ-LGGDSLLGIQVAADLRRHLGVELPTATLFSHPT 2145
Cdd:COG0236 2 PREELEERLAEIIAEVLGVdpEEITPDDSFFEdLGLDSLDAVELIAALEEEFGIELPDTELFEYPT 67
|
|
| starter-C_NRPS |
cd19533 |
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases ... |
2182-2518 |
1.22e-11 |
|
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. While standard C-domains catalyze peptide bond formation between two amino acids, an initial, ('starter') C-domain may instead acylate an amino acid with a fatty acid. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380456 [Multi-domain] Cd Length: 419 Bit Score: 70.09 E-value: 1.22e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2182 PLTDVQEAYWVGRRSAFELGGVAAHGYFEIESPgLEVERFIQCWRQLLQRHDMLRM--VVLPDGRQQVLEQVPEYTPEVV 2259
Cdd:cd19533 3 PLTSAQRGVWFAEQLDPEGSIYNLAEYLEITGP-VDLAVLERALRQVIAEAETLRLrfTEEEGEPYQWIDPYTPVPIRHI 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2260 ELRGLSPQEAESRRLqLRERMAHQVLRSDRwPLFELVLCRYEGG-----VRIHMsmdaLMLDAWSSAVLRQDFAQLYHE- 2333
Cdd:cd19533 82 DLSGDPDPEGAAQQW-MQEDLRKPLPLDND-PLFRHALFTLGDNrhfwyQRVHH----IVMDGFSFALFGQRVAEIYTAl 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2334 -PGRPLEPLAIT-FRDYVLAERRLREGEAHERARAYWwarLDTLPPPPELPLVKEPSQLEHARFTHREARLEPHRWARLQ 2411
Cdd:cd19533 156 lKGRPAPPAPFGsFLDLVEEEQAYRQSERFERDRAFW---TEQFEDLPEPVSLARRAPGRSLAFLRRTAELPPELTRTLL 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2412 ERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRlpLHPQVDELVGDFTSLVLLEVEAHAASTFAERASRLQAQ 2491
Cdd:cd19533 233 EAAEAHGASWPSFFIALVAAYLHRLTGANDVVLGVPVMGR--LGAAARQTPGMVANTLPLRLTVDPQQTFAELVAQVSRE 310
|
330 340
....*....|....*....|....*..
gi 53747904 2492 LWRDLEHGSVSAVQLIRELVRTGRRSP 2518
Cdd:cd19533 311 LRSLLRHQRYRYEDLRRDLGLTGELHP 337
|
|
| PP-binding |
pfam00550 |
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ... |
2089-2145 |
1.30e-11 |
|
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.
Pssm-ID: 425746 [Multi-domain] Cd Length: 62 Bit Score: 62.20 E-value: 1.30e-11
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*....
gi 53747904 2089 QLIEQVWRKHLGV--ERVQPTDSFFQLGGDSLLGIQVAADLRRHLGVELPTATLFSHPT 2145
Cdd:pfam00550 1 ERLRELLAEVLGVpaEEIDPDTDLFDLGLDSLLAVELIARLEEEFGVEIPPSDLFEHPT 59
|
|
| PRK07788 |
PRK07788 |
acyl-CoA synthetase; Validated |
2752-3134 |
1.50e-11 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236097 [Multi-domain] Cd Length: 549 Bit Score: 70.34 E-value: 1.50e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2752 PPGVQVIAVDELEPATEAPPLPPRGTPEHLayVIYTSGSTGKPKGVAIEHRAALNTVVDLNTR--FGVG-------PEDR 2822
Cdd:PRK07788 182 PSGSTDETLDDLIAGSSTAPLPKPPKPGGI--VILTSGTTGTPKGAPRPEPSPLAPLAGLLSRvpFRAGettllpaPMFH 259
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2823 VLGLSALTFDLSVYDVLGLLGAGgalvlpaaeaekDPAHWWERLVAGRVTVWNSTPaLMLllveyaeQRGLKLPA----- 2897
Cdd:PRK07788 260 ATGWAHLTLAMALGSTVVLRRRF------------DPEATLEDIAKHKATALVVVP-VML-------SRILDLGPevlak 319
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2898 ----ALRLVMLSGDWIPVALPDRIRALGRDVqVVSLGGATEASIWSIAYPI------GQVAPqwksIPYGMPLAnqrfhV 2967
Cdd:PRK07788 320 ydtsSLKIIFVSGSALSPELATRALEAFGPV-LYNLYGSTEVAFATIATPEdlaeapGTVGR----PPKGVTVK-----I 389
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2968 LDGRLEARPWWVPGELYIGGEGLAREYwrdeplTATRfirHPRTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRV 3047
Cdd:PRK07788 390 LDENGNEVPRGVVGRIFVGNGFPFEGY------TDGR---DKQIIDGLLSSGDVGYFDEDGLLFVDGRDDDMIVSGGENV 460
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3048 ELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKI 3127
Cdd:PRK07788 461 FPAEVEDLLAGHPDVVEAAVIGVDDEEFGQRLRAFVVKAPGAALDEDAIKDYVRDNLARYKVPRDVVFLDELPRNPTGKV 540
|
....*..
gi 53747904 3128 ARDQLPE 3134
Cdd:PRK07788 541 LKRELRE 547
|
|
| MDR_TM0436_like |
cd08231 |
Hypothetical enzyme TM0436 resembles the zinc-dependent alcohol dehydrogenases (ADH); This ... |
1694-1988 |
1.59e-11 |
|
Hypothetical enzyme TM0436 resembles the zinc-dependent alcohol dehydrogenases (ADH); This group contains the hypothetical TM0436 alcohol dehydrogenase from Thermotoga maritima, proteins annotated as 5-exo-alcohol dehydrogenase, and other members of the medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family. MDR, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P) binding-Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability.
Pssm-ID: 176193 [Multi-domain] Cd Length: 361 Bit Score: 69.21 E-value: 1.59e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAGLNFLDV---LGALGMMPAleaeESVLGRECSGRIAAVGEGVS------GLRVGDEV-------- 1756
Cdd:cd08231 21 PDLEPGAVLVRVRLAGVCGSDVhtvAGRRPRVPL----PIILGHEGVGRVVALGGGVTtdvagePLKVGDRVtwsvgapc 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1757 ------------------------LAVAP---GCFRSYVLVDESQ-VVRRPASLGLAEGAAQMVPFATAYFALHTVGRLR 1808
Cdd:cd08231 97 grcyrclvgdptkcenrkkygheaSCDDPhlsGGYAEHIYLPPGTaIVRVPDNVPDEVAAPANCALATVLAALDRAGPVG 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1809 RGERILIHAAAGGLGLAAVQLASRTGAEILATAGSEQKREYLRSLGIAHVLDSRSTSFVSE---VRERTGGRGVDVVLN- 1884
Cdd:cd08231 177 AGDTVVVQGAGPLGLYAVAAAKLAGARRVIVIDGSPERLELAREFGADATIDIDELPDPQRraiVRDITGGRGADVVIEa 256
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1885 SLAGELLLAGLSVLAPHGRFLELGKRDLYADQQVGLRTLARGQ-TFAaidfGPHHPDFRAVLEEVATQLTQGQLEP---L 1960
Cdd:cd08231 257 SGHPAAVPEGLELLRRGGTYVLVGSVAPAGTVPLDPERIVRKNlTII----GVHNYDPSHLYRAVRFLERTQDRFPfaeL 332
|
330 340
....*....|....*....|....*...
gi 53747904 1961 PTRLFPARQVAEAFSFMaRALHIGRVAV 1988
Cdd:cd08231 333 VTHRYPLEDINEALELA-ESGTALKVVI 359
|
|
| ETR_like_2 |
cd08292 |
2-enoyl thioester reductase (ETR) like proteins, child 2; 2-enoyl thioester reductase (ETR) ... |
1693-1908 |
2.02e-11 |
|
2-enoyl thioester reductase (ETR) like proteins, child 2; 2-enoyl thioester reductase (ETR) like proteins. ETR catalyzes the NADPH-dependent conversion of trans-2-enoyl acyl carrier protein/coenzyme A (ACP/CoA) to acyl-(ACP/CoA) in fatty acid synthesis. 2-enoyl thioester reductase activity has been linked in Candida tropicalis as essential in maintaining mitiochondrial respiratory function. This ETR family is a part of the medium chain dehydrogenase/reductase family, but lack the zinc coordination sites characteristic of the 2-enoyl thioester reductase (ETR) like proteins. ETR catalyzes the NADPH-dependent dependent conversion of trans-2-enoyl acyl carrier protein/coenzyme A (ACP/CoA) to acyl-(ACP/CoA) in fatty acid synthesis. 2-enoyl thioester reductase activity has been linked in Candida tropicalis as essential in maintaining mitiochondrial respiratory function. This ETR family is a part of the medium chain dehydrogenase/reductase family, but lack the zinc coordination sites characteristic of the alcohol dehydrogenases in this family. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site, and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains, at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. Candida tropicalis enoyl thioester reductase (Etr1p) catalyzes the NADPH-dependent reduction of trans-2-enoyl thioesters in mitochondrial fatty acid synthesis. Etr1p forms homodimers, with each subunit containing a nucleotide-binding Rossmann fold domain and a catalytic domain.
Pssm-ID: 176252 [Multi-domain] Cd Length: 324 Bit Score: 68.13 E-value: 2.02e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1693 RPAPGPRQVEIEVEAAGLNFLDVL---GALGMMPALEAeesVLGRECSGRIAAVGEGVSGLRVGDEVlAVAP--GCFRSY 1767
Cdd:cd08292 23 KPTPGAGEVLVRTTLSPIHNHDLWtirGTYGYKPELPA---IGGSEAVGVVDAVGEGVKGLQVGQRV-AVAPvhGTWAEY 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1768 VLVDESQVVRRPASLGLaEGAAQMV--PFaTAYFALHTVGrLRRGERILIHAAAGGLGLAAVQLASRTGAEILATAGSEQ 1845
Cdd:cd08292 99 FVAPADGLVPLPDGISD-EVAAQLIamPL-SALMLLDFLG-VKPGQWLIQNAAGGAVGKLVAMLAAARGINVINLVRRDA 175
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 53747904 1846 KREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELG 1908
Cdd:cd08292 176 GVAELRALGIGPVVSTEQPGWQDKVREAAGGAPISVALDSVGGKLAGELLSLLGEGGTLVSFG 238
|
|
| ETR |
cd08290 |
2-enoyl thioester reductase (ETR); 2-enoyl thioester reductase (ETR) catalyzes the ... |
1694-1811 |
2.19e-11 |
|
2-enoyl thioester reductase (ETR); 2-enoyl thioester reductase (ETR) catalyzes the NADPH-dependent conversion of trans-2-enoyl acyl carrier protein/coenzyme A (ACP/CoA) to acyl-(ACP/CoA) in fatty acid synthesis. 2-enoyl thioester reductase activity has been linked in Candida tropicalis as essential in maintaining mitiochondrial respiratory function. This ETR family is a part of the medium chain dehydrogenase/reductase family, but lack the zinc coordination sites characteristic of the alcohol dehydrogenases in this family. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site, and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains, at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. Candida tropicalis enoyl thioester reductase (Etr1p) catalyzes the NADPH-dependent reduction of trans-2-enoyl thioesters in mitochondrial fatty acid synthesis. Etr1p forms homodimers, with each subunit containing a nucleotide-binding Rossmann fold domain and a catalytic domain.
Pssm-ID: 176250 [Multi-domain] Cd Length: 341 Bit Score: 68.40 E-value: 2.19e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAGLNFLDVL---GALGMMPALEAE-ESVLGRECSGRIAAVGEGVSGLRVGDEVLAVAPGC--FRSY 1767
Cdd:cd08290 25 PPGPPNEVLVKMLAAPINPADINqiqGVYPIKPPTTPEpPAVGGNEGVGEVVKVGSGVKSLKPGDWVIPLRPGLgtWRTH 104
|
90 100 110 120
....*....|....*....|....*....|....*....|....
gi 53747904 1768 VLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGE 1811
Cdd:cd08290 105 AVVPADDLIKVPNDVDPEQAATLSVNPCTAYRLLEDFVKLQPGD 148
|
|
| PRK13382 |
PRK13382 |
bile acid CoA ligase; |
2643-3135 |
2.84e-11 |
|
bile acid CoA ligase;
Pssm-ID: 172019 [Multi-domain] Cd Length: 537 Bit Score: 69.40 E-value: 2.84e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2643 GFFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAM--HKGWEQATAVLGVLQAAAAYLPLDP 2720
Cdd:PRK13382 48 GFAIAAQRCPDRPGLIDELGTLTWRELDERSDALAAALQALPIGEPRVVGIMCrnHRGFVEALLAANRIGADILLLNTSF 127
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2721 EQPPLRlhQLLEEGPARVVLTQSSLLHTVP--------------WPPGVQVIAVDEL--EPATEAPPlpprGTPEHLAYV 2784
Cdd:PRK13382 128 AGPALA--EVVTREGVDTVIYDEEFSATVDraladcpqatrivaWTDEDHDLTVEVLiaAHAGQRPE----PTGRKGRVI 201
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2785 IYTSGSTGKPKGVaieHRAALNTVVDLN------------TRFGVGPEDRVLGLSALTFDLSVydvlgllgaggalVLPA 2852
Cdd:PRK13382 202 LLTSGTTGTPKGA---RRSGPGGIGTLKaildrtpwraeePTVIVAPMFHAWGFSQLVLAASL-------------ACTI 265
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2853 AEAEK-DPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQ-------RGLKLPAAlrlvmlSGDWIPvalPDRIRALGR-- 2922
Cdd:PRK13382 266 VTRRRfDPEATLDLIDRHRATGLAVVPVMFDRIMDLPAEvrnrysgRSLRFAAA------SGSRMR---PDVVIAFMDqf 336
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2923 -DVqVVSLGGATEASIWSIAYPIG-QVAPQwksiPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYwrdEPL 3000
Cdd:PRK13382 337 gDV-IYNNYNATEAGMIATATPADlRAAPD----TAGRPAEGTEIRILDQDFREVPTGEVGTIFVRNDTQFDGY---TSG 408
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3001 TATRFIrhprtgERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLV 3080
Cdd:PRK13382 409 STKDFH------DGFMASGDVGYLDENGRLFVVGRDDEMIVSGGENVYPIEVEKTLATHPDVAEAAVIGVDDEQYGQRLA 482
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 3081 AYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPEP 3135
Cdd:PRK13382 483 AFVVLKPGASATPETLKQHVRDNLANYKVPRDIVVLDELPRGATGKILRRELQAR 537
|
|
| PRK07867 |
PRK07867 |
acyl-CoA synthetase; Validated |
2736-3132 |
2.92e-11 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236120 [Multi-domain] Cd Length: 529 Bit Score: 69.32 E-value: 2.92e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2736 ARVVLTQSSLLHTV-PWPPGVQVIAVD------ELEPATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTV 2808
Cdd:PRK07867 102 CQLVLTESAHAELLdGLDPGVRVINVDspawadELAAHRDAEPPFRVADPDDLFMLIFTSGTSGDPKAVRCTHRKVASAG 181
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2809 VDLNTRFGVGPEDrVLGLSaltfdlsvydvlgllgaggalvLPAAEAEKDPAHWWERLVAG-------RVTVWNSTPALM 2881
Cdd:PRK07867 182 VMLAQRFGLGPDD-VCYVS----------------------MPLFHSNAVMAGWAVALAAGasialrrKFSASGFLPDVR 238
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2882 LLLVEYAEQRG------LKLPAA-------LRLVMlsGDwipVALPDRIRALGR--DVQVVSLGGATEASI---WSIAYP 2943
Cdd:PRK07867 239 RYGATYANYVGkplsyvLATPERpddadnpLRIVY--GN---EGAPGDIARFARrfGCVVVDGFGSTEGGVaitRTPDTP 313
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2944 IGQVAPQWKSIPY-----GMPLANQRFHVlDGRLEARPwwVPGELY-IGGEGLAREYWRDEPLTATRfIRHPRtgerlYR 3017
Cdd:PRK07867 314 PGALGPLPPGVAIvdpdtGTECPPAEDAD-GRLLNADE--AIGELVnTAGPGGFEGYYNDPEADAER-MRGGV-----YW 384
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3018 TGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELR 3097
Cdd:PRK07867 385 SGDLAYRDADGYAYFAGRLGDWMRVDGENLGTAPIERILLRYPDATEVAVYAVPDPVVGDQVMAALVLAPGAKFDPDAFA 464
|
410 420 430
....*....|....*....|....*....|....*..
gi 53747904 3098 RYLAER--LPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PRK07867 465 EFLAAQpdLGPKQWPSYVRVCAELPRTATFKVLKRQL 501
|
|
| FabG |
COG1028 |
NAD(P)-dependent dehydrogenase, short-chain alcohol dehydrogenase family [Lipid transport and ... |
1232-1362 |
3.32e-11 |
|
NAD(P)-dependent dehydrogenase, short-chain alcohol dehydrogenase family [Lipid transport and metabolism]; NAD(P)-dependent dehydrogenase, short-chain alcohol dehydrogenase family is part of the Pathway/BioSystem: Fatty acid biosynthesis
Pssm-ID: 440651 [Multi-domain] Cd Length: 249 Bit Score: 66.35 E-value: 3.32e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1232 ELEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAATFDDGVIQLRTHEQSSRALRTKVRGSMVL-HEVL-- 1308
Cdd:COG1028 49 ELRAAGGRALAVAADVTDEAAVEALVAAAVAAFGRLDILVNNAGITPPGPLEELTEEDWDRVLDVNLKGPFLLtRAALph 128
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*..
gi 53747904 1309 ---ASEGLdwFALCSSLASALGSFGQADYCAANAFQDayahhlrrqGFTGALALDWG 1362
Cdd:COG1028 129 mreRGGGR--IVNISSIAGLRGSPGQAAYAASKAAVV---------GLTRSLALELA 174
|
|
| AcpP |
COG0236 |
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the ... |
3149-3216 |
3.41e-11 |
|
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the Pathway/BioSystem: Fatty acid biosynthesis
Pssm-ID: 440006 [Multi-domain] Cd Length: 80 Bit Score: 61.41 E-value: 3.41e-11
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 53747904 3149 DPLVERLAALVKEALRL--ERVEPQDSLL-DLGADSVALIRLINRLEAELQFRPRLADIYENPTVQGLATL 3216
Cdd:COG0236 4 EELEERLAEIIAEVLGVdpEEITPDDSFFeDLGLDSLDAVELIAALEEEFGIELPDTELFEYPTVADLADY 74
|
|
| FrmA |
COG1062 |
Zn-dependent alcohol/formaldehyde dehydrogenase [Energy production and conversion]; |
1694-1883 |
3.64e-11 |
|
Zn-dependent alcohol/formaldehyde dehydrogenase [Energy production and conversion];
Pssm-ID: 440682 [Multi-domain] Cd Length: 355 Bit Score: 67.80 E-value: 3.64e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAG-----LNFLDvlGALGM-MPAleaeesVLGRECSGRIAAVGEGVSGLRVGDEV-LAVAPGC--- 1763
Cdd:COG1062 12 DEPRPGEVLVRIVAAGlchsdLHVRD--GDLPVpLPA------VLGHEGAGVVEEVGPGVTGVAPGDHVvLSFIPSCghc 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1764 ----------------------------------------------FRSYVLVDESQVVRRPASLGLAEGAaqmvPFA-- 1795
Cdd:COG1062 84 rycasgrpalceagaalngkgtlpdgtsrlssadgepvghffgqssFAEYAVVPERSVVKVDKDVPLELAA----LLGcg 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1796 --TAYFALHTVGRLRRGERILIhaaagglglaaVQLASRTGA-EILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRE 1872
Cdd:COG1062 160 vqTGAGAVLNTAKVRPGDTVAVfglgg-vglsaVQGARIAGAsRIIAVDPVPEKLELARELGATHTVNPADEDAVEAVRE 238
|
250
....*....|.
gi 53747904 1873 RTGGrGVDVVL 1883
Cdd:COG1062 239 LTGG-GVDYAF 248
|
|
| MACS_euk |
cd05928 |
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step ... |
3016-3132 |
3.64e-11 |
|
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes. MACS enzymes are localized to mitochondria. Two murine MACS family proteins are found in liver and kidney. In rodents, a MACS member is detected particularly in the olfactory epithelium and is called O-MACS. O-MACS demonstrates substrate preference for the fatty acid lengths of C6-C12.
Pssm-ID: 341251 [Multi-domain] Cd Length: 530 Bit Score: 69.03 E-value: 3.64e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3016 YRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEP-RG--VRRLVAYAVPRSGQTPA 3092
Cdd:cd05928 404 YLTGDRGIMDEDGYFWFMGRADDVINSSGYRIGPFEVESALIEHPAVVESAVVSSPDPiRGevVKAFVVLAPQFLSHDPE 483
|
90 100 110 120
....*....|....*....|....*....|....*....|..
gi 53747904 3093 A--GELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd05928 484 QltKELQQHVKSVTAPYKYPRKVEFVQELPKTVTGKIQRNEL 525
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
2684-3241 |
6.05e-11 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 69.43 E-value: 6.05e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2684 EVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQ-----LLEEGPARVVLTQSSL------LHTVPWP 2752
Cdd:PRK05691 60 RASFGDRAVLLFPSGPDYVAAFFGCLYAGVIAVPAYPPESARRHHQerllsIIADAEPRLLLTVADLrdsllqMEELAAA 139
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2753 PGVQVIAVDELEPATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFG--VGPEDRVLGLSALT 2830
Cdd:PRK05691 140 NAPELLCVDTLDPALAEAWQEPALQPDDIAFLQYTSGSTALPKGVQVSHGNLVANEQLIRHGFGidLNPDDVIVSWLPLY 219
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2831 FDLSVYDVLGLLGAGGA---LVLPAAEAEKdPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQrglklpAALRLVMLSGd 2907
Cdd:PRK05691 220 HDMGLIGGLLQPIFSGVpcvLMSPAYFLER-PLRWLEAISEYGGTISGGPDFAYRLCSERVSE------SALERLDLSR- 291
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2908 WiPVAL----PDRIRALGRDVQVVSLGGATEASIWSiAYPIGQV------APQWKSIPY----GMPLANQRFHVLDG--- 2970
Cdd:PRK05691 292 W-RVAYsgsePIRQDSLERFAEKFAACGFDPDSFFA-SYGLAEAtlfvsgGRRGQGIPAleldAEALARNRAEPGTGsvl 369
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2971 ------------------RLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHprTGERLYRTGDQGrMLPEGSIEF 3032
Cdd:PRK05691 370 mscgrsqpghavlivdpqSLEVLGDNRVGEIWASGPSIAHGYWRNPEASAKTFVEH--DGRTWLRTGDLG-FLRDGELFV 446
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3033 LGREDLQVKVQGFRVELGEIEAALAQHPAlsasvVVARGeprgvrRLVAYAVPRSGQTP--AAGELRRYLAERLPA---- 3106
Cdd:PRK05691 447 TGRLKDMLIVRGHNLYPQDIEKTVEREVE-----VVRKG------RVAAFAVNHQGEEGigIAAEISRSVQKILPPqali 515
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3107 -----------YMVPSAFVLLE--SLPRSRNGKIARD---------------QLPEpQQTQGLAAQAAAADPLVERLAAL 3158
Cdd:PRK05691 516 ksirqavaeacQEAPSVVLLLNpgALPKTSSGKLQRSacrlrladgsldsyaLFPA-LQAVEAAQTAASGDELQARIAAI 594
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3159 VKEALRLERVEPQDSLLDLGADSVALIRLINRLEAELQFRPRLADIYENPTVQGLATL--HQEKTKSQGEGGAPRLtaPR 3236
Cdd:PRK05691 595 WCEQLKVEQVAADDHFFLLGGNSIAATQVVARLRDELGIDLNLRQLFEAPTLAAFSAAvaRQLAGGGAAQAAIARL--PR 672
|
....*
gi 53747904 3237 STLLP 3241
Cdd:PRK05691 673 GQALP 677
|
|
| FUM14_C_NRPS-like |
cd19545 |
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond ... |
2181-2604 |
6.57e-11 |
|
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond forming Fusarium verticillioides FUM14 protein; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) typically catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. However, some C-domains have ester-bond forming activity. This subfamily includes Fusarium verticillioides FUM14 (also known as NRPS8), a bi-domain protein with an ester-bond forming NRPS C-domain, which catalyzes linkages between an aminoacyl/peptidyl-PCP donor and a hydroxyl-containing acceptor. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. FUM14 has an altered active site motif DHTHCD instead of the typical HHxxxD motif seen in other subfamily members. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380467 [Multi-domain] Cd Length: 395 Bit Score: 67.32 E-value: 6.57e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2181 FPLTDVQE-----------AYwVGRRsAFELggvaahgyfeieSPGLEVERFIQCWRQLLQRHDMLR--MVVLPDGR-QQ 2246
Cdd:cd19545 2 YPCTPLQEglmaltarqpgAY-VGQR-VFEL------------PPDIDLARLQAAWEQVVQANPILRtrIVQSDSGGlLQ 67
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2247 VleQVPEYTPEVVELRGLS--PQEAESRRLQLRERMAHQVLRSDRWPLFELVLCryeggvrIHMSmdalMLDAWSSAVLR 2324
Cdd:cd19545 68 V--VVKESPISWTESTSLDeyLEEDRAAPMGLGGPLVRLALVEDPDTERYFVWT-------IHHA----LYDGWSLPLIL 134
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2325 QDFAQLYHepGRPLEPLAiTFRDYVlaeRRLREGEaHERARAYWWARLdtlppppelplvKEPSQLEHARFTHreARLEP 2404
Cdd:cd19545 135 RQVLAAYQ--GEPVPQPP-PFSRFV---KYLRQLD-DEAAAEFWRSYL------------AGLDPAVFPPLPS--SRYQP 193
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2405 HRWARLQERARA-----HGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQR-LPLhPQVDELVGDFTSLVLLEVEAHAA 2478
Cdd:cd19545 194 RPDATLEHSISLpssasSGVTLATVLRAAWALVLSRYTGSDDVVFGVTLSGRnAPV-PGIEQIVGPTIATVPLRVRIDPE 272
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2479 STFAERASRLQAQLWRDLEHGSvSAVQLIRELvrtgrrSPGAIMPVVFTSILSLDARRGPQGSLSFFEGelVYSISQTPQ 2558
Cdd:cd19545 273 QSVEDFLQTVQKDLLDMIPFEH-TGLQNIRRL------GPDARAACNFQTLLVVQPALPSSTSESLELG--IEEESEDLE 343
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|..
gi 53747904 2559 VWLDHGVHEE----EGALVL--AWDSVeaLFPPGMVDDMFHAYQRLLGALAE 2604
Cdd:cd19545 344 DFSSYGLTLEcqlsGSGLRVraRYDSS--VISEEQVERLLDQFEHVLQQLAS 393
|
|
| PRK09029 |
PRK09029 |
O-succinylbenzoic acid--CoA ligase; Provisional |
2648-3132 |
7.22e-11 |
|
O-succinylbenzoic acid--CoA ligase; Provisional
Pssm-ID: 236363 [Multi-domain] Cd Length: 458 Bit Score: 67.59 E-value: 7.22e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIamhKGWEQATAV---LGVLQAAAAYLPLDPEQPP 2724
Cdd:PRK09029 13 AQVRPQAIALRLNDEVLTWQQLCARIDQLAAGFAQQGVVEGSGVAL---RGKNSPETLlayLALLQCGARVLPLNPQLPQ 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2725 LRLHQLLEEGPARVVLTqsslLHTVPWPPGVQVIAVDELEPATEAPPLPPRgtpehLAYVIYTSGSTGKPKGVAIEHRAA 2804
Cdd:PRK09029 90 PLLEELLPSLTLDFALV----LEGENTFSALTSLHLQLVEGAHAVAWQPQR-----LATMTLTSGSTGLPKAAVHTAQAH 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2805 LNTVVDLNTRFGVGPEDRVLgLSALTFDLS----VydvlgllgaggalvlpaaeaekdpahwWERLVAG-RVTVWNSTP- 2878
Cdd:PRK09029 161 LASAEGVLSLMPFTAQDSWL-LSLPLFHVSgqgiV---------------------------WRWLYAGaTLVVRDKQPl 212
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2879 ALMLLLVEYAE------QRGLK---LPAALRLVMLSGDWIPVALPDRIRALGrdvqVVS-LG-GATE-ASiwsiaypigQ 2946
Cdd:PRK09029 213 EQALAGCTHASlvptqlWRLLDnrsEPLSLKAVLLGGAAIPVELTEQAEQQG----IRCwCGyGLTEmAS---------T 279
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2947 V-APQWKSIP-YGMPLANQRFhvldgRLearpwwVPGELYIGGEGLAREYWRDEPLTatrfirhPRTGER-LYRTGDQGR 3023
Cdd:PRK09029 280 VcAKRADGLAgVGSPLPGREV-----KL------VDGEIWLRGASLALGYWRQGQLV-------PLVNDEgWFATRDRGE 341
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3024 MLpEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAgeLRRYLAER 3103
Cdd:PRK09029 342 WQ-NGELTILGRLDNLFFSGGEGIQPEEIERVINQHPLVQQVFVVPVADAEFGQRPVAVVESDSEAAVVN--LAEWLQDK 418
|
490 500
....*....|....*....|....*....
gi 53747904 3104 LPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PRK09029 419 LARFQQPVAYYLLPPELKNGGIKISRQAL 447
|
|
| PP-binding |
pfam00550 |
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ... |
3153-3211 |
8.03e-11 |
|
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.
Pssm-ID: 425746 [Multi-domain] Cd Length: 62 Bit Score: 59.88 E-value: 8.03e-11
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 53747904 3153 ERLAALVKEALRL--ERVEPQDSLLDLGADSVALIRLINRLEAELQFRPRLADIYENPTVQ 3211
Cdd:pfam00550 1 ERLRELLAEVLGVpaEEIDPDTDLFDLGLDSLLAVELIARLEEEFGVEIPPSDLFEHPTLA 61
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
2083-2145 |
8.65e-11 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 68.65 E-value: 8.65e-11
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 53747904 2083 PPSSLEQLIEQVWRKHLGVERVQPTDSFFQLGGDSLLGIQVAADLRRHLGVELPTATLFSHPT 2145
Cdd:PRK12467 3602 PRSEVEQQLAAIWADVLGVEQVGVTDNFFELGGDSLLALQVLSRIRQSLGLKLSLRDLMSAPT 3664
|
|
| LC_FACL_like |
cd05914 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are ... |
2663-3129 |
9.71e-11 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are bacterial long-chain fatty acid CoA synthetase, most of which are as yet uncharacterized. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341240 [Multi-domain] Cd Length: 463 Bit Score: 67.47 E-value: 9.71e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2663 TLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTq 2742
Cdd:cd05914 7 PLTYKDLADNIAKFALLLKINGVGTGDRVALMGENRPEWGIAFFAIWTYGAIAVPILAEFTADEVHHILNHSEAKAIFV- 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2743 ssllhtvpwppgvqviavdelepateapplpprGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDR 2822
Cdd:cd05914 86 ---------------------------------SDEDDVALINYTSGTTGNSKGVMLTYRNIVSNVDGVKEVVLLGKGDK 132
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2823 VLGL------SALTFDLsVYDVLGLLGAGGALVLPAAEAEKdpahwwERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLP 2896
Cdd:cd05914 133 ILSIlplhhiYPLTFTL-LLPLLNGAHVVFLDKIPSAKIIA------LAFAQVTPTLGVPVPLVIEKIFKMDIIPKLTLK 205
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2897 AALRLVMlsgdwIPVaLPDRIR---------ALGRDVQVVSLGGA-----TEASIWSIAYPIgqvapqwkSIPYGM---- 2958
Cdd:cd05914 206 KFKFKLA-----KKI-NNRKIRklafkkvheAFGGNIKEFVIGGAkinpdVEEFLRTIGFPY--------TIGYGMteta 271
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2959 ------PLANQRF----HVLDGrLEAR-----PWWVPGELYIGGEGLAREYWRDEPLTATRFirhprTGERLYRTGDQGR 3023
Cdd:cd05914 272 piisysPPNRIRLgsagKVIDG-VEVRidspdPATGEGEIIVRGPNVMKGYYKNPEATAEAF-----DKDGWFHTGDLGK 345
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3024 MLPEGSIEFLGR-EDLQVKVQGFRVELGEIEAALAQHPALSASVVVARgEPRGVrrLVAYAVPRSGQTPAAG-------- 3094
Cdd:cd05914 346 IDAEGYLYIRGRkKEMIVLSSGKNIYPEEIEAKINNMPFVLESLVVVQ-EKKLV--ALAYIDPDFLDVKALKqrniidai 422
|
490 500 510
....*....|....*....|....*....|....*...
gi 53747904 3095 --ELRRYLAERLPAYMVPSAFVLL-ESLPRSRNGKIAR 3129
Cdd:cd05914 423 kwEVRDKVNQKVPNYKKISKVKIVkEEFEKTPKGKIKR 460
|
|
| E_NRPS |
cd19534 |
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
2180-2494 |
1.08e-10 |
|
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Epimerization (E) domains of nonribosomal peptide synthetases (NRPS) flip the chirality of the end amino acid of a peptide being manufactured by the NRPS. E-domains are homologous to the Condensation (C) domains. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Specialized tailoring NRPS domains such as E-domains greatly increase the range of possible peptide products created by the NRPS machinery. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the E-domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380457 [Multi-domain] Cd Length: 428 Bit Score: 66.89 E-value: 1.08e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2180 PFPLTDVQEAYwvgrrsaFELGGVAAHGY-----FEIeSPGLEVERFIQCWRQLLQRHDMLRMVVL-PDGR-QQVLEQVP 2252
Cdd:cd19534 1 EVPLTPIQRWF-------FEQNLAGRHHFnqsvlLRV-PQGLDPDALRQALRALVEHHDALRMRFRrEDGGwQQRIRGDV 72
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2253 E--YTPEVVELRGLSPQEAesrrlqLRERM--AHQVLRSDRWPLFELVLC-RYEGGVRIHMSMDALMLDAWSSAVLRQDF 2327
Cdd:cd19534 73 EelFRLEVVDLSSLAQAAA------IEALAaeAQSSLDLEEGPLLAAALFdGTDGGDRLLLVIHHLVVDGVSWRILLEDL 146
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2328 AQLYH--EPGRPLE-PLAITFRDYVLAERRLREGEAHERARAYWWARLDTLPPPPELPLVKepsqlEHARFTHREARLEP 2404
Cdd:cd19534 147 EAAYEqaLAGEPIPlPSKTSFQTWAELLAEYAQSPALLEELAYWRELPAADYWGLPKDPEQ-----TYGDARTVSFTLDE 221
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2405 HRWARL-QERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRLPLHPQVD--ELVGDFTSL--VLLEVEahAAS 2479
Cdd:cd19534 222 EETEALlQEANAAYRTEINDLLLAALALAFQDWTGRAPPAIFLEGHGREEIDPGLDlsRTVGWFTSMypVVLDLE--ASE 299
|
330
....*....|....*
gi 53747904 2480 TFAERASRLQAQLWR 2494
Cdd:cd19534 300 DLGDTLKRVKEQLRR 314
|
|
| PRK07769 |
PRK07769 |
long-chain-fatty-acid--CoA ligase; Validated |
2686-2831 |
1.22e-10 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 181109 [Multi-domain] Cd Length: 631 Bit Score: 67.45 E-value: 1.22e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2686 QPQELVAIAMHKGWEQATAVLGVLQAAAAYLPL-DPEQPPL--RLHQLLEEGPARVVLTQSS-------LLHTVPWPPGV 2755
Cdd:PRK07769 77 KPGDRVAILAPQNLDYLIAFFGALYAGRIAVPLfDPAEPGHvgRLHAVLDDCTPSAILTTTDsaegvrkFFRARPAKERP 156
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 53747904 2756 QVIAVDELEPATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRvlGLSALTF 2831
Cdd:PRK07769 157 RVIAVDAVPDEVGATWVPPEANEDTIAYLQYTSGSTRIPAGVQITHLNLPTNVLQVIDALEGQEGDR--GVSWLPF 230
|
|
| Zn_ADH10 |
cd08263 |
Alcohol dehydrogenases of the MDR family; NAD(P)(H)-dependent oxidoreductases are the major ... |
1694-1989 |
1.28e-10 |
|
Alcohol dehydrogenases of the MDR family; NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which have a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H)-binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176224 [Multi-domain] Cd Length: 367 Bit Score: 66.24 E-value: 1.28e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAGLNFLDVLGALGMMPAleAEESVLGRECSGRIAAVGEGV---SGLRVGDEVLA--VAP------- 1761
Cdd:cd08263 21 PRPKEGEILIRVAACGVCHSDLHVLKGELPF--PPPFVLGHEISGEVVEVGPNVenpYGLSVGDRVVGsfIMPcgkcryc 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1762 -----------------------------------------GCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFA 1800
Cdd:cd08263 99 argkenlcedffaynrlkgtlydgttrlfrldggpvymysmGGLAEYAVVPATALAPLPESLDYTESAVLGCAGFTAYGA 178
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1801 LHTVGRLRRGERILIhAAAGGLGLAAVQLASRTGA-EILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGV 1879
Cdd:cd08263 179 LKHAADVRPGETVAV-IGVGGVGSSAIQLAKAFGAsPIIAVDVRDEKLAKAKELGATHTVNAAKEDAVAAIREITGGRGV 257
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1880 DVVLNSL-AGELLLAGLSVLAPHGRFLELGKRDLYADQQVGLRTLARGQTFAAIDFGpHHPdfRAVLEEVATQLTQGQLE 1958
Cdd:cd08263 258 DVVVEALgKPETFKLALDVVRDGGRAVVVGLAPGGATAEIPITRLVRRGIKIIGSYG-ARP--RQDLPELVGLAASGKLD 334
|
330 340 350
....*....|....*....|....*....|...
gi 53747904 1959 P--LPTRLFPARQVAEAFSFMARALHIGRVAVS 1989
Cdd:cd08263 335 PeaLVTHKYKLEEINEAYENLRKGLIHGRAIVE 367
|
|
| PLN02330 |
PLN02330 |
4-coumarate--CoA ligase-like 1 |
2662-3134 |
1.73e-10 |
|
4-coumarate--CoA ligase-like 1
Pssm-ID: 215189 [Multi-domain] Cd Length: 546 Bit Score: 66.93 E-value: 1.73e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2662 RTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLT 2741
Cdd:PLN02330 54 KAVTYGEVVRDTRRFAKALRSLGLRKGQVVVVVLPNVAEYGIVALGIMAAGGVFSGANPTALESEIKKQAEAAGAKLIVT 133
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2742 QSSLLHTVPwPPGVQVIAVDE--LEPATEAPPLPPRG-----TPEH-------LAYVIYTSGSTGKPKGVAIEHRaalNT 2807
Cdd:PLN02330 134 NDTNYGKVK-GLGLPVIVLGEekIEGAVNWKELLEAAdragdTSDNeeilqtdLCALPFSSGTTGISKGVMLTHR---NL 209
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2808 VVDL-NTRFGVGPE--DRVLGLSALTFdLSVYDVLGLLGAGGALVLPAAEAEK-DPAHWWERLVAGRVTVWNSTPALMLL 2883
Cdd:PLN02330 210 VANLcSSLFSVGPEmiGQVVTLGLIPF-FHIYGITGICCATLRNKGKVVVMSRfELRTFLNALITQEVSFAPIVPPIILN 288
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2884 LVE--YAEQRGL-KLpaALRLVMLSGdwIPVAlPDRIRALGR---DVQVVSLGGATEASIWSIAY---PIGQVAPQWKSI 2954
Cdd:PLN02330 289 LVKnpIVEEFDLsKL--KLQAIMTAA--APLA-PELLTAFEAkfpGVQVQEAYGLTEHSCITLTHgdpEKGHGIAKKNSV 363
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2955 PYGMPLANQRFHVLDGRLeARPWWVPGELYIGGEGLAREYWRDEPLTAtrfirhpRTGER--LYRTGDQGRMLPEGSIEF 3032
Cdd:PLN02330 364 GFILPNLEVKFIDPDTGR-SLPKNTPGELCVRSQCVMQGYYNNKEETD-------RTIDEdgWLHTGDIGYIDDDGDIFI 435
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3033 LGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSA 3112
Cdd:PLN02330 436 VDRIKELIKYKGFQVAPAELEAILLTHPSVEDAAVVPLPDEEAGEIPAACVVINPKAKESEEDILNFVAANVAHYKKVRV 515
|
490 500
....*....|....*....|..
gi 53747904 3113 FVLLESLPRSRNGKIARDQLPE 3134
Cdd:PLN02330 516 VQFVDSIPKSLSGKIMRRLLKE 537
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
2083-2498 |
1.80e-10 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 67.50 E-value: 1.80e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2083 PPSSLEQLIEQVWRKHLGVERVQPTDSFFQLGGDSLLGIQVAADLRRhLGVELPTATLFSHPTLAALAAALRARQgeaaa 2162
Cdd:PRK05691 2706 PRSELEQQLAQIWREVLNVERVGLGDNFFELGGDSILSIQVVSRARQ-LGIHFSPRDLFQHQTVQTLAAVATHSE----- 2779
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2163 ptapapALVPDPAARFEPFPLTDVQeaywvgrrsafelggvaaHGYFEIESP---------------GLEVERFIQCWRQ 2227
Cdd:PRK05691 2780 ------AAQAEQGPLQGASGLTPIQ------------------HWFFDSPVPqpqhwnqallleprqALDPALLEQALQA 2835
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2228 LLQRHDMLRMVV-----------LPDGRQQVLEQVPeyTPEVVELRGLSPQEAESRRLQlrermahqvlrsdRWPLFELV 2296
Cdd:PRK05691 2836 LVEHHDALRLRFsqadgrwqaeyRAVTAQELLWQVT--VADFAECAALFADAQRSLDLQ-------------QGPLLRAL 2900
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2297 LCR-YEGGVRIHMSMDALMLDAWSSAVLRQDFAQLYH--EPGRPLEPLAIT--FRDYVLAERRLREGEAHERARAYWWAR 2371
Cdd:PRK05691 2901 LVDgPQGQQRLLLAIHHLVVDGVSWRVLLEDLQALYRqlSAGAEPALPAKTsaFRDWAARLQAYAGSESLREELGWWQAQ 2980
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2372 LDTLPPPPELPLVKEPSQLEHARFThrEARLEPHRWARLQERARAHGLTP-SAACMAAFAEVLARWSRHPRFTLNLTLFQ 2450
Cdd:PRK05691 2981 LGGPRAELPCDRPQGGNLNRHAQTV--SVRLDAERTRQLLQQAPAAYRTQvNDLLLTALARVLCRWSGQPSVLVQLEGHG 3058
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|..
gi 53747904 2451 RLPLHPQVD--ELVGDFTSLVLLEVEAHAASTFAERAS--RLQAQLwRDLEH 2498
Cdd:PRK05691 3059 REALFDDIDltRSVGWFTSAYPLRLTPAPGDDAARGESikAIKEQL-RAVPH 3109
|
|
| PLN02574 |
PLN02574 |
4-coumarate--CoA ligase-like |
2704-3132 |
1.84e-10 |
|
4-coumarate--CoA ligase-like
Pssm-ID: 215312 [Multi-domain] Cd Length: 560 Bit Score: 66.79 E-value: 1.84e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2704 AVLGVLQAAAAYLPLDPEQPPLRLHQlleegpaRVVLTQSSLLHTVP------WPPGVQVIAVDEL----EPATEAPPL- 2772
Cdd:PLN02574 108 IFLAVLSLGGIVTTMNPSSSLGEIKK-------RVVDCSVGLAFTSPenveklSPLGVPVIGVPENydfdSKRIEFPKFy 180
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2773 ------------PPRGTpEHLAYVIYTSGSTGKPKGVAIEHRAALNTVvDLNTRF---------------GVGPEDRVLG 2825
Cdd:PLN02574 181 elikedfdfvpkPVIKQ-DDVAAIMYSSGTTGASKGVVLTHRNLIAMV-ELFVRFeasqyeypgsdnvylAALPMFHIYG 258
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2826 LSALTFDLsvydVLGLLGAGGALVLPAAEAEKDPAHWwerlvagRVTVWNSTPALMLLLVEYAEQRGLKLPAALRLVM-- 2903
Cdd:PLN02574 259 LSLFVVGL----LSLGSTIVVMRRFDASDMVKVIDRF-------KVTHFPVVPPILMALTKKAKGVCGEVLKSLKQVScg 327
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2904 ---LSGDWIPvalpDRIRALGRdVQVVSLGGATEASIWSIAYPIGQVAPQWKSIpyGMPLANQRFHVLDgrLEARPWWVP 2980
Cdd:PLN02574 328 aapLSGKFIQ----DFVQTLPH-VDFIQGYGMTESTAVGTRGFNTEKLSKYSSV--GLLAPNMQAKVVD--WSTGCLLPP 398
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2981 G---ELYIGGEGLAREYWRDEPLTATRFIRhprtgERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALA 3057
Cdd:PLN02574 399 GncgELWIQGPGVMKGYLNNPKATQSTIDK-----DGWLRTGDIAYFDEDGYLYIVDRLKEIIKYKGFQIAPADLEAVLI 473
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 3058 QHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PLN02574 474 SHPEIIDAAVTAVPDKECGEIPVAFVVRRQGSTLSQEAVINYVAKQVAPYKKVRKVVFVQSIPKSPAGKILRREL 548
|
|
| Ac_CoA_lig_AcsA |
TIGR02188 |
acetate--CoA ligase; This model describes acetate-CoA ligase (EC 6.2.1.1), also called ... |
2778-3129 |
2.26e-10 |
|
acetate--CoA ligase; This model describes acetate-CoA ligase (EC 6.2.1.1), also called acetyl-CoA synthetase and acetyl-activating enzyme. It catalyzes the reaction ATP + acetate + CoA = AMP + diphosphate + acetyl-CoA and belongs to the family of AMP-binding enzymes described by pfam00501.
Pssm-ID: 274022 [Multi-domain] Cd Length: 626 Bit Score: 66.50 E-value: 2.26e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2778 PEHLAYVIYTSGSTGKPKGVAieHRAA---LNTVVDLNTRFGVGPEDR---------VLGLSALtfdlsVYdvlgllgag 2845
Cdd:TIGR02188 236 SEDPLFILYTSGSTGKPKGVL--HTTGgylLYAAMTMKYVFDIKDGDIfwctadvgwITGHSYI-----VY--------- 299
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2846 galvLPAAE-----------AEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQ--RGLKLpAALRLVMLSGDWI-PV 2911
Cdd:TIGR02188 300 ----GPLANgattvmfegvpTYPDPGRFWEIIEKHKVTIFYTAPTAIRALMRLGDEwvKKHDL-SSLRLLGSVGEPInPE 374
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2912 ALPDRIRALGR-DVQVVS--------------LGGATEASIWSIAYPIGQVAPQwksipygmpLANQRFHVLDGRLE--- 2973
Cdd:TIGR02188 375 AWMWYYKVVGKeRCPIVDtwwqtetggimitpLPGATPTKPGSATLPFFGIEPA---------VVDEEGNPVEGPGEggy 445
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2974 ---ARPWwvPgelyiggeGLAREYWRDEpltaTRFIR-HPRTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVEL 3049
Cdd:TIGR02188 446 lviKQPW--P--------GMLRTIYGDH----ERFVDtYFSPFPGYYFTGDGARRDKDGYIWITGRVDDVINVSGHRLGT 511
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3050 GEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAG---ELRRYLAERLPAYMVPSAFVLLESLPRSRNGK 3126
Cdd:TIGR02188 512 AEIESALVSHPAVAEAAVVGIPDDIKGQAIYAFVTLKDGYEPDDElrkELRKHVRKEIGPIAKPDKIRFVPGLPKTRSGK 591
|
...
gi 53747904 3127 IAR 3129
Cdd:TIGR02188 592 IMR 594
|
|
| AACS |
cd05943 |
Acetoacetyl-CoA synthetase (acetoacetate-CoA ligase, AACS); AACS is a cytosolic ligase that ... |
2738-3127 |
2.39e-10 |
|
Acetoacetyl-CoA synthetase (acetoacetate-CoA ligase, AACS); AACS is a cytosolic ligase that specifically activates acetoacetate to its coenzyme A ester by a two-step reaction. Acetoacetate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is the first step of the mevalonate pathway of isoprenoid biosynthesis via isopentenyl diphosphate. Isoprenoids are a large class of compounds found in all living organisms. AACS is widely distributed in bacteria, archaea and eukaryotes. In bacteria, AACS is known to exhibit an important role in the metabolism of poly-b-hydroxybutyrate, an intracellular reserve of organic carbon and chemical energy by some microorganisms. In mammals, AACS influences the rate of ketone body utilization for the formation of physiologically important fatty acids and cholesterol.
Pssm-ID: 341265 [Multi-domain] Cd Length: 629 Bit Score: 66.53 E-value: 2.39e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2738 VVLTQSSLLHTVPWPPGVQVIAVDELEPATEAPPLPPRGTP-EHLAYVIYTSGSTGKPK-------GVAIEHRAALNTVV 2809
Cdd:cd05943 207 VVVPYTVAAGQPDLSKIAKALTLEDFLATGAAGELEFEPLPfDHPLYILYSSGTTGLPKcivhgagGTLLQHLKEHILHC 286
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2810 DLntrfgvGPEDRVL-------------------GLSALTFDLSvydvlgllgaggalvlPAAEAekdpAHWWERLVAG- 2869
Cdd:cd05943 287 DL------RPGDRLFyyttcgwmmwnwlvsglavGATIVLYDGS----------------PFYPD----TNALWDLADEe 340
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2870 RVTVWNSTPALMLLLveyaEQRGLKLPA-----ALRLVMLSG--------DWIPvalpdriRALGRDVQVVSLGGATE-A 2935
Cdd:cd05943 341 GITVFGTSAKYLDAL----EKAGLKPAEthdlsSLRTILSTGsplkpesfDYVY-------DHIKPDVLLASISGGTDiI 409
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2936 SIWSIAYPIgqvAPQWKS----IPYGMPLAnqrfhVLDGrlEARPWW-VPGELYI--GGEGLAREYWRDEPLT---ATRF 3005
Cdd:cd05943 410 SCFVGGNPL---LPVYRGeiqcRGLGMAVE-----AFDE--EGKPVWgEKGELVCtkPFPSMPVGFWNDPDGSryrAAYF 479
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3006 IRHPRtgerLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVP 3085
Cdd:cd05943 480 AKYPG----VWAHGDWIEITPRGGVVILGRSDGTLNPGGVRIGTAEIYRVVEKIPEVEDSLVVGQEWKDGDERVILFVKL 555
|
410 420 430 440
....*....|....*....|....*....|....*....|....*
gi 53747904 3086 RSGQT---PAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKI 3127
Cdd:cd05943 556 REGVElddELRKRIRSTIRSALSPRHVPAKIIAVPDIPRTLSGKK 600
|
|
| 2-desacetyl-2-hydroxyethyl_bacteriochlorophyllide_ |
cd08255 |
2-desacetyl-2-hydroxyethyl bacteriochlorophyllide and other MDR family members; This subgroup ... |
1731-1974 |
2.42e-10 |
|
2-desacetyl-2-hydroxyethyl bacteriochlorophyllide and other MDR family members; This subgroup of the medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family has members identified as 2-desacetyl-2-hydroxyethyl bacteriochlorophyllide A dehydrogenase and alcohol dehydrogenases. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P) binding-Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability.
Pssm-ID: 176217 [Multi-domain] Cd Length: 277 Bit Score: 64.21 E-value: 2.42e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1731 VLGRECSGRIAAVGEGVSGLRVGDEVlaVAPGCFRSYVLVDESQVVRRPASLGLAEGaaqmVPFATAYFALHTV--GRLR 1808
Cdd:cd08255 23 PPGYSSVGRVVEVGSGVTGFKPGDRV--FCFGPHAERVVVPANLLVPLPDGLPPERA----ALTALAATALNGVrdAEPR 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1809 RGERILIhaaagglglaaV----------QLASRTGA-EILATAGSEQKREYLRSLGIAHVLdsrstsfVSEVRERTGGR 1877
Cdd:cd08255 97 LGERVAV-----------VglglvgllaaQLAKAAGArEVVGVDPDAARRELAEALGPADPV-------AADTADEIGGR 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1878 GVDVVLN-SLAGELLLAGLSVLAPHGRFLELGKrdlyadqqVGLRTLARGQTF---------------AAIDFGPHHPDF 1941
Cdd:cd08255 159 GADVVIEaSGSPSALETALRLLRDRGRVVLVGW--------YGLKPLLLGEEFhfkrlpirssqvygiGRYDRPRRWTEA 230
|
250 260 270
....*....|....*....|....*....|...
gi 53747904 1942 RAvLEEVATQLTQGQLEPLPTRLFPARQVAEAF 1974
Cdd:cd08255 231 RN-LEEALDLLAEGRLEALITHRVPFEDAPEAY 262
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
2083-2145 |
2.49e-10 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 67.29 E-value: 2.49e-10
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 53747904 2083 PPSSLEQLIEQVWRKHLGVERVQPTDSFFQLGGDSLLGIQVAADLRRHLGVELPTATLFSHPT 2145
Cdd:PRK12316 5069 PRSELEQQVAAIWAEVLQLERVGLDDNFFELGGHSLLAIQVTSRIQLELGLELPLRELFQTPT 5131
|
|
| PRK12406 |
PRK12406 |
long-chain-fatty-acid--CoA ligase; Provisional |
2656-3135 |
2.67e-10 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 183506 [Multi-domain] Cd Length: 509 Bit Score: 66.26 E-value: 2.67e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2656 ALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGP 2735
Cdd:PRK12406 4 TIISGDRRRSFDELAQRAARAAGGLAALGVRPGDCVALLMRNDFAFFEAAYAAMRLGAYAVPVNWHFKPEEIAYILEDSG 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2736 ARVVLTQSSLLHTVP--WPPGVQVIAVD---------ELEPATEAPPL-------------PPRGTP-EHLAYVIYTSGS 2790
Cdd:PRK12406 84 ARVLIAHADLLHGLAsaLPAGVTVLSVPtppeiaaayRISPALLTPPAgaidwegwlaqqePYDGPPvPQPQSMIYTSGT 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2791 TGKPKGV-----AIEHRAALNTVVDLNtrFGVGPEDRVL-------------GLSALTFDLSVydvlgllgaggalvlpA 2852
Cdd:PRK12406 164 TGHPKGVrraapTPEQAAAAEQMRALI--YGLKPGIRALltgplyhsapnayGLRAGRLGGVL----------------V 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2853 AEAEKDPAHWWERLVAGRVTVWNSTPALMLllveyaeqRGLKLPAA---------LRLVMLSGDWIPVALPDRIRALGRD 2923
Cdd:PRK12406 226 LQPRFDPEELLQLIERHRITHMHMVPTMFI--------RLLKLPEEvrakydvssLRHVIHAAAPCPADVKRAMIEWWGP 297
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2924 VqVVSLGGATEASIWSIAypigqVAPQWKSIP--YGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYW--RDEP 2999
Cdd:PRK12406 298 V-IYEYYGSTESGAVTFA-----TSEDALSHPgtVGKAAPGAELRFVDEDGRPLPQGEIGEIYSRIAGNPDFTYhnKPEK 371
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3000 LTATRfirhpRTGerLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRL 3079
Cdd:PRK12406 372 RAEID-----RGG--FITSGDVGYLDADGYLFLCDRKRDMVISGGVNIYPAEIEAVLHAVPGVHDCAVFGIPDAEFGEAL 444
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*.
gi 53747904 3080 VAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPEP 3135
Cdd:PRK12406 445 MAVVEPQPGATLDEADIRAQLKARLAGYKVPKHIEIMAELPREDSGKIFKRRLRDP 500
|
|
| PRK08633 |
PRK08633 |
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated |
2777-3127 |
3.19e-10 |
|
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated
Pssm-ID: 236315 [Multi-domain] Cd Length: 1146 Bit Score: 66.49 E-value: 3.19e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2777 TPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVL---------GLSALTFdlsvydvlgllgagga 2847
Cdd:PRK08633 780 KPDDTATIIFSSGSEGEPKGVMLSHHNILSNIEQISDVFNLRNDDVILsslpffhsfGLTVTLW---------------- 843
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2848 lvLPAAEAEK-----DP--AHWWERLVAG-RVTVWNSTPALMLLlveYAeqRGLKLP----AALRLVMLSGDwipvALPD 2915
Cdd:PRK08633 844 --LPLLEGIKvvyhpDPtdALGIAKLVAKhRATILLGTPTFLRL---YL--RNKKLHplmfASLRLVVAGAE----KLKP 912
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2916 RIRALGRD---VQVVSLGGATEAS-IWSIAYP---IGQVAPQWKSIP--YGMPLANQRFHVLD-GRLEARPWWVPGELYI 2985
Cdd:PRK08633 913 EVADAFEEkfgIRILEGYGATETSpVASVNLPdvlAADFKRQTGSKEgsVGMPLPGVAVRIVDpETFEELPPGEDGLILI 992
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2986 GGEGLAREYWRDEPLTAtRFIRHPrTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSAS 3065
Cdd:PRK08633 993 GGPQVMKGYLGDPEKTA-EVIKDI-DGIGWYVTGDKGHLDEDGFLTITDRYSRFAKIGGEMVPLGAVEEELAKALGGEEV 1070
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 53747904 3066 VVVARG---EPRGVRRLVAYAvprSGQTPAAgELRRYLAE-RLPAYMVPSAFVLLESLPRSRNGKI 3127
Cdd:PRK08633 1071 VFAVTAvpdEKKGEKLVVLHT---CGAEDVE-ELKRAIKEsGLPNLWKPSRYFKVEALPLLGSGKL 1132
|
|
| PLN03102 |
PLN03102 |
acyl-activating enzyme; Provisional |
2786-3132 |
3.28e-10 |
|
acyl-activating enzyme; Provisional
Pssm-ID: 215576 [Multi-domain] Cd Length: 579 Bit Score: 65.81 E-value: 3.28e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2786 YTSGSTGKPKGVAIEHRAALNTVVD--LNTRFGVGP----EDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAeaekdp 2859
Cdd:PLN03102 193 YTSGTTADPKGVVISHRGAYLSTLSaiIGWEMGTCPvylwTLPMFHCNGWTFTWGTAARGGTSVCMRHVTAPEI------ 266
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2860 ahwWERLVAGRVTVWNSTPALMLLLVEyAEQRGLKLPAALRLVMLSGDWIPVALPDRIRALGrdVQVVSLGGATEASiws 2939
Cdd:PLN03102 267 ---YKNIEMHNVTHMCCVPTVFNILLK-GNSLDLSPRSGPVHVLTGGSPPPAALVKKVQRLG--FQVMHAYGLTEAT--- 337
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2940 iaYPI--GQVAPQWKSIPYGMPL---ANQRFHVL-----DGRLEARPWWVP------GELYIGGEGLAREYWRDEPLTAT 3003
Cdd:PLN03102 338 --GPVlfCEWQDEWNRLPENQQMelkARQGVSILgladvDVKNKETQESVPrdgktmGEIVIKGSSIMKGYLKNPKATSE 415
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3004 RFiRHPrtgerLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYA 3083
Cdd:PLN03102 416 AF-KHG-----WLNTGDVGVIHPDGHVEIKDRSKDIIISGGENISSVEVENVLYKYPKVLETAVVAMPHPTWGETPCAFV 489
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*....
gi 53747904 3084 VPRSGQTPAA----------GELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PLN03102 490 VLEKGETTKEdrvdklvtreRDLIEYCRENLPHFMCPRKVVFLQELPKNGNGKILKPKL 548
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
2083-2492 |
3.63e-10 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 66.52 E-value: 3.63e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2083 PPSSLEQLIEQVWRKHLGVERVQPTDSFFQLGGDSLLGIQVAADLRRHlGVELPTATLFSHPTLAALAAALRARQGEAAA 2162
Cdd:PRK12316 1015 PRNALERTLAAIWQDVLGVERVGLDDNFFELGGDSIVSIQVVSRARQA-GIQLSPRDLFQHQTIRSLALVAKAGQATAAD 1093
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2163 PtapapalvpDPAArfEPFPLTDVQeaywvgrRSAFELGGVAAHGY-----FEIESPgLEVERFIQCWRQLLQRHDMLRM 2237
Cdd:PRK12316 1094 Q---------GPAS--GEVALAPVQ-------RWFFEQAIPQRQHWnqsllLQARQP-LDPDRLGRALERLVAHHDALRL 1154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2238 -VVLPDGRQQVLEQVPEYTpEVVELRGLSPQEAesrrLQLRERMAHQVLRSDRWPLFELVLCRY-EGGVRIHMSMDALML 2315
Cdd:PRK12316 1155 rFREEDGGWQQAYAAPQAG-EVLWQRQAASEEE----LLALCEEAQRSLDLEQGPLLRALLVDMaDGSQRLLLVIHHLVV 1229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2316 DAWSSAVLRQDFAQLYHEPGRPLEPLAITFRDYvlAERRLREGEAHERARAYWWARLDTLPPPPELPLVKEPSQLEHARf 2395
Cdd:PRK12316 1230 DGVSWRILLEDLQRAYADLDADLPARTSSYQAW--ARRLHEHAGARAEELDYWQAQLEDAPHELPCENPDGALENRHER- 1306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2396 tHREARLEPHRWAR-LQERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRLPLHPQVD--ELVGDFTSlvLLE 2472
Cdd:PRK12316 1307 -KLELRLDAERTRQlLQEAPAAYRTQVNDLLLTALARVTCRWSGQASVLVQLEGHGREDLFEDIDlsRTVGWFTS--LFP 1383
|
410 420
....*....|....*....|
gi 53747904 2473 VEAHAASTFAERASRLQAQL 2492
Cdd:PRK12316 1384 VRLTPAADLGESIKAIKEQL 1403
|
|
| C_PKS-NRPS |
cd19532 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
2208-2604 |
3.76e-10 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHxxxD motif, a few such as Monascus pilosus lovastatin nonaketide synthase MokA have a non-canonical HRxxxD motif in the C-domain and are unable to catalyze amide-bond formation. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380455 [Multi-domain] Cd Length: 421 Bit Score: 65.17 E-value: 3.76e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2208 YFEIESPgLEVERFIQCWRQLLQRHDMLRM---VVLPDGR--QQVLEQVPeytPEVVELRGLSPQEAEsrrlQLRERMAH 2282
Cdd:cd19532 29 SYRLTGP-LDVARLERAVRAVGQRHEALRTcffTDPEDGEpmQGVLASSP---LRLEHVQISDEAEVE----EEFERLKN 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2283 QVLRSDRWPLFELVLCRYEGGVRI------HMSMDAlmldaWSSAVLRQDFAQLYHepGRPLEPLAITFRDYVLAERRLR 2356
Cdd:cd19532 101 HVYDLESGETMRIVLLSLSPTEHYlifgyhHIAMDG-----VSFQIFLRDLERAYN--GQPLLPPPLQYLDFAARQRQDY 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2357 EGEAHERARAYWWARLDTLppppelplvkePSQLE-------HAR------FTHR-EARLEPHRWARLQERARAHGLTPS 2422
Cdd:cd19532 174 ESGALDEDLAYWKSEFSTL-----------PEPLPllpfakvKSRppltryDTHTaERRLDAALAARIKEASRKLRVTPF 242
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2423 AACMAAFAEVLARWSRHPRFTLNLTLFQRlpLHPQVDELVGDFTSLVLLEVEAHAASTFAE--RASR---LQAqlwrdLE 2497
Cdd:cd19532 243 HFYLAALQVLLARLLDVDDICIGIADANR--TDEDFMETIGFFLNLLPLRFRRDPSQTFADvlKETRdkaYAA-----LA 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2498 HGSVSAVQLIRELVRTgrRSPGAiMPV--VFtsilsLDARRGPQGSLSFFEGELV---YSISQTPQ-VWLDhgVHE-EEG 2570
Cdd:cd19532 316 HSRVPFDVLLDELGVP--RSATH-SPLfqVF-----INYRQGVAESRPFGDCELEgeeFEDARTPYdLSLD--IIDnPDG 385
|
410 420 430
....*....|....*....|....*....|....
gi 53747904 2571 ALVLAWDSVEALFPPGMVDDMFHAYQRLLGALAE 2604
Cdd:cd19532 386 DCLLTLKVQSSLYSEEDAELLLDSYVNLLEAFAR 419
|
|
| PtmA |
cd17636 |
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, ... |
2964-3125 |
4.81e-10 |
|
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341291 [Multi-domain] Cd Length: 331 Bit Score: 64.25 E-value: 4.81e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2964 RFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFirhpRTGerLYRTGDQGRMLPEGSIEFLGREDLQVKVQ 3043
Cdd:cd17636 173 QVRILDEDGREVPDGEVGEIVARGPTVMAGYWNRPEVNARRT----RGG--WHHTNDLGRREPDGSLSFVGPKTRMIKSG 246
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3044 GFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSR 3123
Cdd:cd17636 247 AENIYPAEVERCLRQHPAVADAAVIGVPDPRWAQSVKAIVVLKPGASVTEAELIEHCRARIASYKKPKSVEFADALPRTA 326
|
..
gi 53747904 3124 NG 3125
Cdd:cd17636 327 GG 328
|
|
| MACS_AAE_MA_like |
cd05970 |
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation ... |
2989-3129 |
5.25e-10 |
|
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This family of MACS enzymes is found in archaea and bacteria. It is represented by the acyl-adenylating enzyme from Methanosarcina acetivorans (AAE_MA). AAE_MA is most active with propionate, butyrate, and the branched analogs: 2-methyl-propionate, butyrate, and pentanoate. The specific activity is weaker for smaller or larger acids.
Pssm-ID: 341274 [Multi-domain] Cd Length: 537 Bit Score: 65.21 E-value: 5.25e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2989 GLAREYWRDEPLTATRFirhprtGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVV 3068
Cdd:cd05970 393 GLFGGYYKDAEKTAEVW------HDGYYHTGDAAWMDEDGYLWFVGRTDDLIKSSGYRIGPFEVESALIQHPAVLECAVT 466
|
90 100 110 120 130 140
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 53747904 3069 arGEPRGVRRLV--AYAVPRSGQTPA---AGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIAR 3129
Cdd:cd05970 467 --GVPDPIRGQVvkATIVLAKGYEPSeelKKELQDHVKKVTAPYKYPRIVEFVDELPKTISGKIRR 530
|
|
| caiC |
PRK08008 |
putative crotonobetaine/carnitine-CoA ligase; Validated |
2764-3132 |
8.80e-10 |
|
putative crotonobetaine/carnitine-CoA ligase; Validated
Pssm-ID: 181195 [Multi-domain] Cd Length: 517 Bit Score: 64.32 E-value: 8.80e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2764 EPAT--EAPPLPPRGTPEhlayVIYTSGSTGKPKGVAIEHraalntvvdLNTRFG---------VGPEDRVLG-LSALTF 2831
Cdd:PRK08008 160 QPATlcYAPPLSTDDTAE----ILFTSGTTSRPKGVVITH---------YNLRFAgyysawqcaLRDDDVYLTvMPAFHI 226
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2832 DLSVydvlgllgaggALVLPAAEA-------EKDPAH-WWERLVAGRVTVWNSTP----ALMLLLVEYAEQRglklpAAL 2899
Cdd:PRK08008 227 DCQC-----------TAAMAAFSAgatfvllEKYSARaFWGQVCKYRATITECIPmmirTLMVQPPSANDRQ-----HCL 290
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2900 RLVMLsgdWIPVALPDRIRALGR-DVQVVSLGGATEASIWSIAYPIGQvAPQWKSIpyGMPLANQRFHVLDGRLEARPWW 2978
Cdd:PRK08008 291 REVMF---YLNLSDQEKDAFEERfGVRLLTSYGMTETIVGIIGDRPGD-KRRWPSI--GRPGFCYEAEIRDDHNRPLPAG 364
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2979 VPGELYIGGE---GLAREYWRDEPLTATRFirhprTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAA 3055
Cdd:PRK08008 365 EIGEICIKGVpgkTIFKEYYLDPKATAKVL-----EADGWLHTGDTGYVDEEGFFYFVDRRCNMIKRGGENVSCVELENI 439
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 53747904 3056 LAQHPALSASVVVarGEPRGVR--RLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PRK08008 440 IATHPKIQDIVVV--GIKDSIRdeAIKAFVVLNEGETLSEEEFFAFCEQNMAKFKVPSYLEIRKDLPRNCSGKIIKKNL 516
|
|
| PRK07008 |
PRK07008 |
long-chain-fatty-acid--CoA ligase; Validated |
2786-3134 |
8.96e-10 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235908 [Multi-domain] Cd Length: 539 Bit Score: 64.34 E-value: 8.96e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2786 YTSGSTGKPKGVAIEHR--------AALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVydvlGLLGAGGALVLPAAeaek 2857
Cdd:PRK07008 183 YTSGTTGNPKGALYSHRstvlhaygAALPDAMGLSARDAVLPVVPMFHVNAWGLPYSA----PLTGAKLVLPGPDL---- 254
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2858 DPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLpAALRLVMLSGDWIPvalPDRIRALGRD--VQVVSLGGATEA 2935
Cdd:PRK07008 255 DGKSLYELIEAERVTFSAGVPTVWLGLLNHMREAGLRF-STLRRTVIGGSACP---PAMIRTFEDEygVEVIHAWGMTEM 330
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2936 SiwsiayPIGQVA-PQWKSIpyGMPLANQR--------------FHVLDGRLEARPW--WVPGELYIGGEGLAREYWRDE 2998
Cdd:PRK07008 331 S------PLGTLCkLKWKHS--QLPLDEQRkllekqgrviygvdMKIVGDDGRELPWdgKAFGDLQVRGPWVIDRYFRGD 402
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2999 --PLTATRFirhPrtgerlyrTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGV 3076
Cdd:PRK07008 403 asPLVDGWF---P--------TGDVATIDADGFMQITDRSKDVIKSGGEWISSIDIENVAVAHPAVAEAACIACAHPKWD 471
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*...
gi 53747904 3077 RRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPE 3134
Cdd:PRK07008 472 ERPLLVVVKRPGAEVTREELLAFYEGKVAKWWIPDDVVFVDAIPHTATGKLQKLKLRE 529
|
|
| E-C_NRPS |
cd19544 |
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); ... |
2218-2435 |
1.03e-09 |
|
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); Dual function Epimerization/Condensation (E/C) domains have both an epimerization and a DCL condensation activity. Dual E/C domains first epimerize the substrate amino acid to produce a D-configuration, then catalyze the condensation between the D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. They are D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. These Dual E/C domains contain an extended His-motif (HHx(N)GD) near the N-terminus of the domain in addition to the standard Condensation (C) domain active site motif (HHxxxD). C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains, these include the DCL-type, LCL-type, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C domains, and the X-domain.
Pssm-ID: 380466 [Multi-domain] Cd Length: 413 Bit Score: 63.61 E-value: 1.03e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2218 VERFIQCWRQLLQRHDMLRMVVLPDGRQQ----VLEQVPeytpevVELRGLSPQEAESRRLQLRERMAHQVLRSD--RWP 2291
Cdd:cd19544 38 LDAFLAALQQVIDRHDILRTAILWEGLSEpvqvVWRQAE------LPVEELTLDPGDDALAQLRARFDPRRYRLDlrQAP 111
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2292 LFELVLCRYEGGVRIHMSMDA--LMLDAWSSAVLRQDF-AQLYHEPGRPLEPLAitFRDYVLaerRLREGEAHERARAYW 2368
Cdd:cd19544 112 LLRAHVAEDPANGRWLLLLLFhhLISDHTSLELLLEEIqAILAGRAAALPPPVP--YRNFVA---QARLGASQAEHEAFF 186
|
170 180 190 200 210 220 230
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 2369 WARLDTlppppelplVKEPS--------QLEHARFTHREARLEPHRWARLQERARAHGLTPSAACMAAFAEVLAR 2435
Cdd:cd19544 187 REMLGD---------VDEPTapfglldvQGDGSDITEARLALDAELAQRLRAQARRLGVSPASLFHLAWALVLAR 252
|
|
| LC_FACS_bac |
cd05932 |
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter ... |
2769-3104 |
1.06e-09 |
|
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase; The members of this family are bacterial long-chain fatty acid CoA synthetase. Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase in this family is involved in the synthesis of isoprenoid wax ester storage compounds when grown on phytol as the sole carbon source. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341255 [Multi-domain] Cd Length: 508 Bit Score: 64.03 E-value: 1.06e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2769 APPL---PPRGtPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTfdlSVYDVLGLLGAG 2845
Cdd:cd05932 125 HPPLeerPTRF-PEQLATLIYTSGTTGQPKGVMLTFGSFAWAAQAGIEHIGTEENDRMLSYLPLA---HVTERVFVEGGS 200
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2846 GALVLPAAEAEKDPAhWWERLVAGRVTVWNSTPALMLLLveyaeQRGL--KLPAALRLVMLSgdwIPV--ALPDR--IRA 2919
Cdd:cd05932 201 LYGGVLVAFAESLDT-FVEDVQRARPTLFFSVPRLWTKF-----QQGVqdKIPQQKLNLLLK---IPVvnSLVKRkvLKG 271
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2920 LGRDVQVVSLGGATEAS----IW--SIAYPIGQVapqwksipYGMPlANQRFHVLDGRLEARPWWV-------------P 2980
Cdd:cd05932 272 LGLDQCRLAGCGSAPVPpallEWyrSLGLNILEA--------YGMT-ENFAYSHLNYPGRDKIGTVgnagpgvevriseD 342
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2981 GELYIGGEGLAREYWRDEPLTATRFirhprTGERLYRTGDQGRMLPEGSIEFLGR-EDLQVKVQGFRVELGEIEAALAQH 3059
Cdd:cd05932 343 GEILVRSPALMMGYYKDPEATAEAF-----TADGFLRTGDKGELDADGNLTITGRvKDIFKTSKGKYVAPAPIENKLAEH 417
|
330 340 350 360
....*....|....*....|....*....|....*....|....*.
gi 53747904 3060 PALSASVVVARGEPRGVRRLVAYAVPRSGQTPAA-GELRRYLAERL 3104
Cdd:cd05932 418 DRVEMVCVIGSGLPAPLALVVLSEEARLRADAFArAELEASLRAHL 463
|
|
| FADD10 |
cd17635 |
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain ... |
2779-3129 |
1.27e-09 |
|
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain fatty acid CoA ligases, including FadD10 which is involved in the synthesis of a virulence-related lipopeptide. FadD10 is a fatty acyl-AMP ligase (FAAL) that transfers fatty acids to an acyl carrier protein. Structures of FadD10 in apo- and complexed form with dodecanoyl-AMP, show a novel open conformation, facilitated by its unique inter-domain and intermolecular interactions, which is critical for the enzyme to carry out the acyl transfer onto the acyl carrier protein (Rv0100) rather than coenzyme A.
Pssm-ID: 341290 [Multi-domain] Cd Length: 340 Bit Score: 63.05 E-value: 1.27e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2779 EHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTR-FGVGPEDRVLGLSALTFDLSVYdvLGLLGAGGALVLPAAEAEK 2857
Cdd:cd17635 1 EDPLAVIFTSGTTGEPKAVLLANKTFFAVPDILQKEgLNWVVGDVTYLPLPATHIGGLW--WILTCLIHGGLCVTGGENT 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2858 DPAHWWERLVAGRVTVWNSTPALMLLLV-EYAEQrgLKLPAALRLVMLSGDWiPVALPDRIRALGRDVQVVSLGGATEAS 2936
Cdd:cd17635 79 TYKSLFKILTTNAVTTTCLVPTLLSKLVsELKSA--NATVPSLRLIGYGGSR-AIAADVRFIEATGLTNTAQVYGLSETG 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2937 IwSIAYPIGQVAPQWKSIpyGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIrhprtGERLY 3016
Cdd:cd17635 156 T-ALCLPTDDDSIEINAV--GRPYPGVDVYLAATDGIAGPSASFGTIWIKSPANMLGYWNNPERTAEVLI-----DGWVN 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3017 rTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVA-----RGEprgvrrLVAYAVPRSGQ-- 3089
Cdd:cd17635 228 -TGDLGERREDGFLFITGRSSESINCGGVKIAPDEVERIAEGVSGVQECACYEisdeeFGE------LVGLAVVASAEld 300
|
330 340 350 360
....*....|....*....|....*....|....*....|
gi 53747904 3090 TPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIAR 3129
Cdd:cd17635 301 ENAIRALKHTIRRELEPYARPSTIVIVTDIPRTQSGKVKR 340
|
|
| idonate-5-DH |
cd08232 |
L-idonate 5-dehydrogenase; L-idonate 5-dehydrogenase (L-ido 5-DH ) catalyzes the conversion of ... |
1694-1986 |
1.29e-09 |
|
L-idonate 5-dehydrogenase; L-idonate 5-dehydrogenase (L-ido 5-DH ) catalyzes the conversion of L-lodonate to 5-ketogluconate in the metabolism of L-Idonate to 6-P-gluconate. In E. coli, this GntII pathway is a subsidiary pathway to the canonical GntI system, which also phosphorylates and transports gluconate. L-ido 5-DH is found in an operon with a regulator indR, transporter idnT, 5-keto-D-gluconate 5-reductase, and Gnt kinase. L-ido 5-DH is a zinc-dependent alcohol dehydrogenase-like protein. The alcohol dehydrogenase ADH-like family of proteins is a diverse group of proteins related to the first identified member, class I mammalian ADH. This group is also called the medium chain dehydrogenases/reductase family (MDR) which displays a broad range of activities and are distinguished from the smaller short chain dehydrogenases(~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P) binding-Rossmann fold domain of a beta-alpha form and an N-terminal GroES-like catalytic domain. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176194 [Multi-domain] Cd Length: 339 Bit Score: 63.02 E-value: 1.29e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAGLNFLDVL----GALGmmPALEAEESVLGRECSGRIAAVGEGVSGLRVGDEVlAVAP-------- 1761
Cdd:cd08232 17 PEPGPGEVRVRVAAGGICGSDLHyyqhGGFG--TVRLREPMVLGHEVSGVVEAVGPGVTGLAPGQRV-AVNPsrpcgtcd 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1762 --------------------------GCFRSYVLVDESQVVRRPASLGLAEGA-AQmvPFATAYFALHTVGRLRrGERIL 1814
Cdd:cd08232 94 ycragrpnlclnmrflgsamrfphvqGGFREYLVVDASQCVPLPDGLSLRRAAlAE--PLAVALHAVNRAGDLA-GKRVL 170
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1815 IHAAAGGLGLAAVQLASRTGAEILATAGSEQKREYLRSLGIAHVLDSRSTSFVsevRERTGGRGVDVVLN-SLAGELLLA 1893
Cdd:cd08232 171 VTGAGPIGALVVAAARRAGAAEIVATDLADAPLAVARAMGADETVNLARDPLA---AYAADKGDFDVVFEaSGAPAALAS 247
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1894 GLSVLAPHGRFLELGKrdLYADQQVGLRTL-ARGQTFAAidfgphhpDFRAVLE--EVATQLTQGQLEPLP--TRLFPAR 1968
Cdd:cd08232 248 ALRVVRPGGTVVQVGM--LGGPVPLPLNALvAKELDLRG--------SFRFDDEfaEAVRLLAAGRIDVRPliTAVFPLE 317
|
330
....*....|....*...
gi 53747904 1969 QVAEAFSFMARALHIGRV 1986
Cdd:cd08232 318 EAAEAFALAADRTRSVKV 335
|
|
| PRK08974 |
PRK08974 |
long-chain-fatty-acid--CoA ligase FadD; |
2931-3132 |
2.71e-09 |
|
long-chain-fatty-acid--CoA ligase FadD;
Pssm-ID: 236359 [Multi-domain] Cd Length: 560 Bit Score: 63.15 E-value: 2.71e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2931 GATEASIWSIAYPIgQVAPQWKSIpyGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRdepltatrfiRHPR 3010
Cdd:PRK08974 358 GLTECSPLVSVNPY-DLDYYSGSI--GLPVPSTEIKLVDDDGNEVPPGEPGELWVKGPQVMLGYWQ----------RPEA 424
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3011 TGERL----YRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVarGEPRGVR-RLVAYAVP 3085
Cdd:PRK08974 425 TDEVIkdgwLATGDIAVMDEEGFLRIVDRKKDMILVSGFNVYPNEIEDVVMLHPKVLEVAAV--GVPSEVSgEAVKIFVV 502
|
170 180 190 200
....*....|....*....|....*....|....*....|....*..
gi 53747904 3086 RSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PRK08974 503 KKDPSLTEEELITHCRRHLTGYKVPKLVEFRDELPKSNVGKILRREL 549
|
|
| ADH_N |
pfam08240 |
Alcohol dehydrogenase GroES-like domain; This is the catalytic domain of alcohol ... |
1700-1776 |
3.99e-09 |
|
Alcohol dehydrogenase GroES-like domain; This is the catalytic domain of alcohol dehydrogenases. Many of them contain an inserted zinc binding domain. This domain has a GroES-like structure.
Pssm-ID: 400513 [Multi-domain] Cd Length: 106 Bit Score: 56.46 E-value: 3.99e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1700 QVEIEVEAAGLNFLDVLGALGMMPALEAEeSVLGRECSGRIAAVGEGVSGLRVGDEVLAVA------------------- 1760
Cdd:pfam08240 2 EVLVKVKAAGICGSDLHIYKGGNPPVKLP-LILGHEFAGEVVEVGPGVTGLKVGDRVVVEPlipcgkceycregrynlcp 80
|
90 100
....*....|....*....|....*
gi 53747904 1761 ---------PGCFRSYVLVDESQVV 1776
Cdd:pfam08240 81 ngrflgydrDGGFAEYVVVPERNLV 105
|
|
| PRK07529 |
PRK07529 |
AMP-binding domain protein; Validated |
2648-3132 |
1.04e-08 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236043 [Multi-domain] Cd Length: 632 Bit Score: 61.12 E-value: 1.04e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPAL--------LAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVlQAAAAYLPLD 2719
Cdd:PRK07529 35 AARHPDAPALsflldadpLDRPETWTYAELLADVTRTANLLHSLGVGPGDVVAFLLPNLPETHFALWGG-EAAGIANPIN 113
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2720 PEQPPLRLHQLLEEGPARVVLTQSSLLHTVPWP---------PGVQ-VIAVDELE----PATEAPPL------------- 2772
Cdd:PRK07529 114 PLLEPEQIAELLRAAGAKVLVTLGPFPGTDIWQkvaevlaalPELRtVVEVDLARylpgPKRLAVPLirrkaharildfd 193
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2773 -------------PPRGTPEHLAYVIYTSGSTGKPKGVAIEHRaalNTVVD---LNTRFGVGPEDRVL------------ 2824
Cdd:PRK07529 194 aelarqpgdrlfsGRPIGPDDVAAYFHTGGTTGMPKLAQHTHG---NEVANawlGALLLGLGPGDTVFcglplfhvnall 270
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2825 --GLSALTFDLSVydvlgllgaggalVLPAAEAEKDP---AHWWERLVAGRVTVWNSTPALMLLLveyaeqrgLKLPAA- 2898
Cdd:PRK07529 271 vtGLAPLARGAHV-------------VLATPQGYRGPgviANFWKIVERYRINFLSGVPTVYAAL--------LQVPVDg 329
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2899 -----LRLVMLSGDWIPVALPDRI-RALGrdVQVVSLGGATEA-SIWSIAYPIGQVAPQWKSIPygMPLANQRFHVLDgr 2971
Cdd:PRK07529 330 hdissLRYALCGAAPLPVEVFRRFeAATG--VRIVEGYGLTEAtCVSSVNPPDGERRIGSVGLR--LPYQRVRVVILD-- 403
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2972 lEARPWWVP------GELYIGGEGLAREYwrdeplTATRFIRHPRTGERLYRTGDQGRMLPEGSIEFLGR-EDLQVKvQG 3044
Cdd:PRK07529 404 -DAGRYLRDcavdevGVLCIAGPNVFSGY------LEAAHNKGLWLEDGWLNTGDLGRIDADGYFWLTGRaKDLIIR-GG 475
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3045 FRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLP---AymVPSAFVLLESLPR 3121
Cdd:PRK07529 476 HNIDPAAIEEALLRHPAVALAAAVGRPDAHAGELPVAYVQLKPGASATEAELLAFARDHIAeraA--VPKHVRILDALPK 553
|
570
....*....|.
gi 53747904 3122 SRNGKIARDQL 3132
Cdd:PRK07529 554 TAVGKIFKPAL 564
|
|
| liver_ADH_like1 |
cd08281 |
Zinc-dependent alcohol dehydrogenases (ADH) and class III ADG (AKA formaldehyde dehydrogenase); ... |
1692-1883 |
1.72e-08 |
|
Zinc-dependent alcohol dehydrogenases (ADH) and class III ADG (AKA formaldehyde dehydrogenase); NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes or ketones. This group contains members identified as zinc dependent alcohol dehydrogenases (ADH), and class III ADG (aka formaldehyde dehydrogenase, FDH). Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. Class III ADH are also know as glutathione-dependent formaldehyde dehydrogenase (FDH), which convert aldehydes to the corresponding carboxylic acid and alcohol. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which have a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176241 [Multi-domain] Cd Length: 371 Bit Score: 59.70 E-value: 1.72e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1692 TRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPalEAEESVLGRECSGRIAAVGEGVSGLRVGDEVLAV-APGC------- 1763
Cdd:cd08281 27 ELDPPGPGEVLVKIAAAGLCHSDLSVINGDRP--RPLPMALGHEAAGVVVEVGEGVTDLEVGDHVVLVfVPSCghcrpca 104
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1764 -----------------------------------------FRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALH 1802
Cdd:cd08281 105 egrpalcepgaaangagtllsggrrlrlrggeinhhlgvsaFAEYAVVSRRSVVKIDKDVPLEIAALFGCAVLTGVGAVV 184
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1803 TVGRLRRGERILIhaaaggLGLAAVQLASRTGA------EILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGG 1876
Cdd:cd08281 185 NTAGVRPGQSVAV------VGLGGVGLSALLGAvaagasQVVAVDLNEDKLALARELGATATVNAGDPNAVEQVRELTGG 258
|
....*..
gi 53747904 1877 rGVDVVL 1883
Cdd:cd08281 259 -GVDYAF 264
|
|
| NfnB |
COG0778 |
Nitroreductase [Energy production and conversion]; Nitroreductase is part of the Pathway ... |
3279-3455 |
2.18e-08 |
|
Nitroreductase [Energy production and conversion]; Nitroreductase is part of the Pathway/BioSystem: Pyrimidine degradation
Pssm-ID: 440541 [Multi-domain] Cd Length: 163 Bit Score: 56.01 E-value: 2.18e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3279 LTALERRRSVRTYSLEPVSHEQLGRLL-----APlrewevqgsrrylyaSAGGLYPvqlylhlkpgrarglepgtWyydp 3353
Cdd:COG0778 2 LELLLTRRSVRKFTDKPVSDEELEELLeaarlAP---------------SAGNLQP-------------------W---- 43
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3354 sthRLVLLSaGAGLDRRIHD--PHQNQAIFDSAAFSLFLIARMGAvepvYAEHALHFATLEAGLMTQLLDLGAAPSGLGL 3431
Cdd:COG0778 44 ---RFVVVR-DPELRERLAEalAEANQEWVADAPVLIVVCADPDR----SEKVPERYALLDAGIAAQNLLLAARALGLGT 115
|
170 180
....*....|....*....|....
gi 53747904 3432 CHIGDLDFAQARGLFHLEEEHVLL 3455
Cdd:COG0778 116 CWIGGFDPEKVRELLGLPEGEEPV 139
|
|
| PGDH |
cd05288 |
Prostaglandin dehydrogenases; Prostaglandins and related eicosanoids are metabolized by the ... |
1742-1988 |
2.27e-08 |
|
Prostaglandin dehydrogenases; Prostaglandins and related eicosanoids are metabolized by the oxidation of the 15(S)-hydroxyl group of the NAD+-dependent (type I 15-PGDH) 15-prostaglandin dehydrogenase (15-PGDH) followed by reduction by NADPH/NADH-dependent (type II 15-PGDH) delta-13 15-prostaglandin reductase (13-PGR) to 15-keto-13,14,-dihydroprostaglandins. 13-PGR is a bifunctional enzyme, since it also has leukotriene B(4) 12-hydroxydehydrogenase activity. These 15-PGDH and related enzymes are members of the medium chain dehydrogenase/reductase family. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P) binding-Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES.
Pssm-ID: 176190 [Multi-domain] Cd Length: 329 Bit Score: 59.03 E-value: 2.27e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1742 AVGEGV----SGLRVGDEVLAVAPgcFRSYVLVDESQVVRR-----PASLGLAEGAAQMVPFaTAYFALHTVGRLRRGER 1812
Cdd:cd05288 72 GVGEVVesrsPDFKVGDLVSGFLG--WQEYAVVDGASGLRKldpslGLPLSAYLGVLGMTGL-TAYFGLTEIGKPKPGET 148
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1813 ILIHAAAGGLGLAAVQLASRTGAEILATAGSEQKREYLRS-LGIAHVLDSRSTSFVSEVRERTGGrGVDV---------- 1881
Cdd:cd05288 149 VVVSAAAGAVGSVVGQIAKLLGARVVGIAGSDEKCRWLVEeLGFDAAINYKTPDLAEALKEAAPD-GIDVyfdnvggeil 227
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1882 --VLNslagelllaglsVLAPHGRFLELGKRDLY-ADQQVGLRTLA---------RGqtFAAIDFGPHHPDFravLEEVA 1949
Cdd:cd05288 228 daALT------------LLNKGGRIALCGAISQYnATEPPGPKNLGniitkrltmQG--FIVSDYADRFPEA---LAELA 290
|
250 260 270
....*....|....*....|....*....|....*....
gi 53747904 1950 TQLTQGQLEPLPTRLFPARQVAEAFSFMARALHIGRVAV 1988
Cdd:cd05288 291 KWLAEGKLKYREDVVEGLENAPEAFLGLFTGKNTGKLVV 329
|
|
| PRK07059 |
PRK07059 |
Long-chain-fatty-acid--CoA ligase; Validated |
2957-3132 |
2.33e-08 |
|
Long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235923 [Multi-domain] Cd Length: 557 Bit Score: 60.03 E-value: 2.33e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2957 GMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTAtRFIrhprTGERLYRTGDQGRMLPEGSIEFLGRE 3036
Cdd:PRK07059 383 GLPLPSTEVSIRDDDGNDLPLGEPGEICIRGPQVMAGYWNRPDETA-KVM----TADGFFRTGDVGVMDERGYTKIVDRK 457
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3037 DLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVpRSGQTPAAGELRRYLAERLPAYMVPSAFVLL 3116
Cdd:PRK07059 458 KDMILVSGFNVYPNEIEEVVASHPGVLEVAAVGVPDEHSGEAVKLFVV-KKDPALTEEDVKAFCKERLTNYKRPKFVEFR 536
|
170
....*....|....*.
gi 53747904 3117 ESLPRSRNGKIARDQL 3132
Cdd:PRK07059 537 TELPKTNVGKILRREL 552
|
|
| PKS_PP |
smart00823 |
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the ... |
2079-2145 |
2.35e-08 |
|
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the prosthetic group of acyl carrier proteins (ACP) in some multienzyme complexes where it serves as a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups.
Pssm-ID: 214834 [Multi-domain] Cd Length: 86 Bit Score: 53.79 E-value: 2.35e-08
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 53747904 2079 PQALPPSSLEQLIEQVWRKHLGV-------ERVQPTDSFFQLGGDSLLGIQVAADLRRHLGVELPTATLFSHPT 2145
Cdd:smart00823 1 LAALPPAERRRLLLDLVREQVAAvlghaaaEAIDPDRPFRDLGLDSLMAVELRNRLEAATGLRLPATLVFDHPT 74
|
|
| MACS_like_1 |
cd05974 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
2786-3132 |
2.59e-08 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341278 [Multi-domain] Cd Length: 432 Bit Score: 59.50 E-value: 2.59e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2786 YTSGSTGKPKGVaiEHRAALNTVVDLNTRFGVG--PEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWW 2863
Cdd:cd05974 92 FTSGTTSKPKLV--EHTHRSYPVGHLSTMYWIGlkPGDVHWNISSPGWAKHAWSCFFAPWNAGATVFLFNYARFDAKRVL 169
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2864 ERLVAGRVTVWNSTPALMLLLVEyaeQRGLKLPAALRLVMLSGDWIPVALPDRIRAL-GRDVQvvSLGGATEASIWSIAY 2942
Cdd:cd05974 170 AALVRYGVTTLCAPPTVWRMLIQ---QDLASFDVKLREVVGAGEPLNPEVIEQVRRAwGLTIR--DGYGQTETTALVGNS 244
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2943 PiGQVApqwKSIPYGMPLANQRFHVLDGrlEARPWwVPGE--LYIGGE---GLAREYWRDEPLTATRFirhprtGERLYR 3017
Cdd:cd05974 245 P-GQPV---KAGSMGRPLPGYRVALLDP--DGAPA-TEGEvaLDLGDTrpvGLMKGYAGDPDKTAHAM------RGGYYR 311
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3018 TGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPA---AG 3094
Cdd:cd05974 312 TGDIAMRDEDGYLTYVGRADDVFKSSDYRISPFELESVLIEHPAVAEAAVVPSPDPVRLSVPKAFIVLRAGYEPSpetAL 391
|
330 340 350
....*....|....*....|....*....|....*...
gi 53747904 3095 ELRRYLAERLPAYMVPSAFVLLEsLPRSRNGKIARDQL 3132
Cdd:cd05974 392 EIFRFSRERLAPYKRIRRLEFAE-LPKTISGKIRRVEL 428
|
|
| LC-FACS_euk |
cd05927 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are ... |
2753-2822 |
2.60e-08 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are eukaryotic fatty acid CoA synthetases that activate fatty acids with chain lengths of 12 to 20. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells.
Pssm-ID: 341250 [Multi-domain] Cd Length: 545 Bit Score: 59.92 E-value: 2.60e-08
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 2753 PGVQVIAVDELEP-ATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNT----RFGVGPEDR 2822
Cdd:cd05927 87 AGVKVYSLEEFEKlGKKNKVPPPPPKPEDLATICYTSGTTGNPKGVMLTHGNIVSNVAGVFKileiLNKINPTDV 161
|
|
| SDR_c |
cd05233 |
classical (c) SDRs; SDRs are a functionally diverse family of oxidoreductases that have a ... |
1222-1362 |
2.73e-08 |
|
classical (c) SDRs; SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold (alpha/beta folding pattern with a central beta-sheet), an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Classical SDRs are typically about 250 residues long, while extended SDRs are approximately 350 residues. Sequence identity between different SDR enzymes are typically in the 15-30% range, but the enzymes share the Rossmann fold NAD-binding motif and characteristic NAD-binding and catalytic sequence patterns. These enzymes catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human prostaglandin dehydrogenase (PGDH) numbering). In addition to the Tyr and Lys, there is often an upstream Ser (Ser-138, PGDH numbering) and/or an Asn (Asn-107, PGDH numbering) contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Extended SDRs have additional elements in the C-terminal region, and typically have a TGXXGXXG cofactor binding motif. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif. Some atypical SDRs have lost catalytic activity and/or have an unusual NAD(P)-binding motif and missing or unusual active site residues. Reactions catalyzed within the SDR family include isomerization, decarboxylation, epimerization, C=N bond reduction, dehydratase activity, dehalogenation, Enoyl-CoA reduction, and carbonyl-alcohol oxidoreduction.
Pssm-ID: 212491 [Multi-domain] Cd Length: 234 Bit Score: 57.29 E-value: 2.73e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1222 RTQHRIRCLLELEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAATFDDGVIQLRTHEQSSRALRTKVRGS 1301
Cdd:cd05233 30 RNEEALAELAAIEALGGNAVAVQADVSDEEDVEALVEEALEEFGRLDILVNNAGIARPGPLEELTDEDWDRVLDVNLTGV 109
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 53747904 1302 M-VLHEVLAsegldwfALC----------SSLASALGSFGQADYCAANAFQDayahhlrrqGFTGALALDWG 1362
Cdd:cd05233 110 FlLTRAALP-------HMKkqgggrivniSSVAGLRPLPGQAAYAASKAALE---------GLTRSLALELA 165
|
|
| CAD1 |
cd05283 |
Cinnamyl alcohol dehydrogenases (CAD); Cinnamyl alcohol dehydrogenases (CAD), members of the ... |
1692-1908 |
2.91e-08 |
|
Cinnamyl alcohol dehydrogenases (CAD); Cinnamyl alcohol dehydrogenases (CAD), members of the medium chain dehydrogenase/reductase family, reduce cinnamaldehydes to cinnamyl alcohols in the last step of monolignal metabolism in plant cells walls. CAD binds 2 zinc ions and is NADPH- dependent. CAD family members are also found in non-plant species, e.g. in yeast where they have an aldehyde reductase activity. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P) binding-Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176186 [Multi-domain] Cd Length: 337 Bit Score: 58.66 E-value: 2.91e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1692 TRPAPGPRQVEIEVEAAGLNFLDVL---GALGMMPAleaeESVLGRECSGRIAAVGEGVSGLRVGDEVlAVapGCFR--- 1765
Cdd:cd05283 18 ERRPLGPDDVDIKITYCGVCHSDLHtlrNEWGPTKY----PLVPGHEIVGIVVAVGSKVTKFKVGDRV-GV--GCQVdsc 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1766 ------------------------------------SYVLVDESQVVRRPASLGLAEGAaqmvPF----ATAYFALHTVG 1805
Cdd:cd05283 91 gtceqcksgeeqycpkgvvtyngkypdgtitqggyaDHIVVDERFVFKIPEGLDSAAAA----PLlcagITVYSPLKRNG 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1806 rLRRGERI-------LIHAaagglglaAVQLASRTGAEILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRertggRG 1878
Cdd:cd05283 167 -VGPGKRVgvvgiggLGHL--------AVKFAKALGAEVTAFSRSPSKKEDALKLGADEFIATKDPEAMKKAA-----GS 232
|
250 260 270
....*....|....*....|....*....|.
gi 53747904 1879 VDVVLNSLAGELLLAG-LSVLAPHGRFLELG 1908
Cdd:cd05283 233 LDLIIDTVSASHDLDPyLSLLKPGGTLVLVG 263
|
|
| 6_hydroxyhexanoate_dh_like |
cd08240 |
6-hydroxyhexanoate dehydrogenase; 6-hydroxyhexanoate dehydrogenase, an enzyme of the ... |
1693-1883 |
3.05e-08 |
|
6-hydroxyhexanoate dehydrogenase; 6-hydroxyhexanoate dehydrogenase, an enzyme of the zinc-dependent alcohol dehydrogenase-like family of medium chain dehydrogenases/reductases catalyzes the conversion of 6-hydroxyhexanoate and NAD(+) to 6-oxohexanoate + NADH and H+. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H)-binding occurs in the cleft between the catalytic and coenzyme-binding domains, at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176202 [Multi-domain] Cd Length: 350 Bit Score: 58.78 E-value: 3.05e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1693 RPAPGPRQVEIEVEAAGL---------NFLDvLGALGMMPALEAEES---VLGRECSGRIAAVGEGVSGLRVGDEVLA-- 1758
Cdd:cd08240 20 TPKPPGTEVLVKVTACGVchsdlhiwdGGYD-LGGGKTMSLDDRGVKlplVLGHEIVGEVVAVGPDAADVKVGDKVLVyp 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1759 --------------------------VAPGCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGER 1812
Cdd:cd08240 99 wigcgecpvclagdenlcakgralgiFQDGGYAEYVIVPHSRYLVDPGGLDPALAATLACSGLTAYSAVKKLMPLVADEP 178
|
170 180 190 200 210 220 230
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 53747904 1813 ILIhAAAGGLGLAAVQLASRTG-AEILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGrGVDVVL 1883
Cdd:cd08240 179 VVI-IGAGGLGLMALALLKALGpANIIVVDIDEAKLEAAKAAGADVVVNGSDPDAAKRIIKAAGG-GVDAVI 248
|
|
| ETR_like_1 |
cd08291 |
2-enoyl thioester reductase (ETR) like proteins, child 1; 2-enoyl thioester reductase (ETR) ... |
1676-1872 |
4.04e-08 |
|
2-enoyl thioester reductase (ETR) like proteins, child 1; 2-enoyl thioester reductase (ETR) like proteins. ETR catalyzes the NADPH-dependent conversion of trans-2-enoyl acyl carrier protein/coenzyme A (ACP/CoA) to acyl-(ACP/CoA) in fatty acid synthesis. 2-enoyl thioester reductase activity has been linked in Candida tropicalis as essential in maintaining mitiochondrial respiratory function. This ETR family is a part of the medium chain dehydrogenase/reductase family, but lack the zinc coordination sites characteristic of the 2-enoyl thioester reductase (ETR) like proteins. ETR catalyzes the NADPH-dependent dependent conversion of trans-2-enoyl acyl carrier protein/coenzyme A (ACP/CoA) to acyl-(ACP/CoA) in fatty acid synthesis. 2-enoyl thioester reductase activity has been linked in Candida tropicalis as essential in maintaining mitiochondrial respiratory function. This ETR family is a part of the medium chain dehydrogenase/reductase family, but lack the zinc coordination sites characteristic of the alcohol dehydrogenases in this family. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. Candida tropicalis enoyl thioester reductase (Etr1p) catalyzes the NADPH-dependent reduction of trans-2-enoyl thioesters in mitochondrial fatty acid synthesis. Etr1p forms homodimers, with each subunit containing a nucleotide-binding Rossmann fold domain and a catalytic domain.
Pssm-ID: 176251 [Multi-domain] Cd Length: 324 Bit Score: 58.00 E-value: 4.04e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1676 AVGTPGLLESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVL---GALGMMPALEAeesVLGRECSGRIAAVGEG-VSGLR 1751
Cdd:cd08291 8 EYGKPLEVKELSLPEPEVPEPGPGEVLIKVEAAPINPSDLGflkGQYGSTKALPV---PPGFEGSGTVVAAGGGpLAQSL 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1752 VGDEVLAVAP--GCFRSYVLVDESQVVRRPASLGLAEGAAQMV-PFaTAYFALHTVgrLRRGERILIHAAAGGLG-LAAV 1827
Cdd:cd08291 85 IGKRVAFLAGsyGTYAEYAVADAQQCLPLPDGVSFEQGASSFVnPL-TALGMLETA--REEGAKAVVHTAAASALgRMLV 161
|
170 180 190 200
....*....|....*....|....*....|....*....|....*
gi 53747904 1828 QLASRTGAEILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRE 1872
Cdd:cd08291 162 RLCKADGIKVINIVRRKEQVDLLKKIGAEYVLNSSDPDFLEDLKE 206
|
|
| YdfG |
COG4221 |
NADP-dependent 3-hydroxy acid dehydrogenase YdfG [Energy production and conversion]; ... |
1234-1351 |
4.76e-08 |
|
NADP-dependent 3-hydroxy acid dehydrogenase YdfG [Energy production and conversion]; NADP-dependent 3-hydroxy acid dehydrogenase YdfG is part of the Pathway/BioSystem: Pyrimidine degradation
Pssm-ID: 443365 [Multi-domain] Cd Length: 240 Bit Score: 56.73 E-value: 4.76e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1234 EQLGAEVQVYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAATFDDGVIQLRTHEQSSRALRTKVRGSM-VLHEVL---- 1308
Cdd:COG4221 47 AELGGRALAVPLDVTDEAAVEAAVAAAVAEFGRLDVLVNNAGVALLGPLEELDPEDWDRMIDVNVKGVLyVTRAALpamr 126
|
90 100 110 120
....*....|....*....|....*....|....*....|....
gi 53747904 1309 -ASEGLdwFALCSSLASALGSFGQADYCAANAFQDAYAHHLRRQ 1351
Cdd:COG4221 127 aRGSGH--IVNISSIAGLRPYPGGAVYAATKAAVRGLSESLRAE 168
|
|
| PLN02246 |
PLN02246 |
4-coumarate--CoA ligase |
2662-3132 |
5.66e-08 |
|
4-coumarate--CoA ligase
Pssm-ID: 215137 [Multi-domain] Cd Length: 537 Bit Score: 58.45 E-value: 5.66e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2662 RTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLT 2741
Cdd:PLN02246 49 RVYTYADVELLSRRVAAGLHKLGIRQGDVVMLLLPNCPEFVLAFLGASRRGAVTTTANPFYTPAEIAKQAKASGAKLIIT 128
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2742 QSSLLHTVP---WPPGVQVIAVD----------ELEPATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTV 2808
Cdd:PLN02246 129 QSCYVDKLKglaEDDGVTVVTIDdppegclhfsELTQADENELPEVEISPDDVVALPYSSGTTGLPKGVMLTHKGLVTSV 208
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2809 ---VD-LNTRFGVGPEDRVL-----------------GL---SALT----FDLsvydvlgllgaggalvlpAAEAEKDPA 2860
Cdd:PLN02246 209 aqqVDgENPNLYFHSDDVILcvlpmfhiyslnsvllcGLrvgAAILimpkFEI------------------GALLELIQR 270
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2861 HwwerlvagRVTVWNSTPALMLLLVE--YAEQRGLklpAALRLVMlSGdwipvALP------DRIRAlgRDVQVVsLG-- 2930
Cdd:PLN02246 271 H--------KVTIAPFVPPIVLAIAKspVVEKYDL---SSIRMVL-SG-----AAPlgkeleDAFRA--KLPNAV-LGqg 330
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2931 -GATEAS---IWSIAY-----PIgqvapqwKSIPYGMPLANQRFHVLD---GrlEARPWWVPGELYIGGEGLAREYWRDE 2998
Cdd:PLN02246 331 yGMTEAGpvlAMCLAFakepfPV-------KSGSCGTVVRNAELKIVDpetG--ASLPRNQPGEICIRGPQIMKGYLNDP 401
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2999 PLTAtrfirhprtgerlyRTGDQGRMLPEGSIEFLGRED-------LQ--VKVQGFRVELGEIEAALAQHPALSASVVVA 3069
Cdd:PLN02246 402 EATA--------------NTIDKDGWLHTGDIGYIDDDDelfivdrLKelIKYKGFQVAPAELEALLISHPSIADAAVVP 467
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 53747904 3070 RGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PLN02246 468 MKDEVAGEVPVAFVVRSNGSEITEDEIKQFVAKQVVFYKRIHKVFFVDSIPKAPSGKILRKDL 530
|
|
| LC_FACS_euk1 |
cd17639 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The ... |
2776-3069 |
9.39e-08 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The members of this family are eukaryotic fatty acid CoA synthetases (EC 6.2.1.3) that activate fatty acids with chain lengths of 12 to 20 and includes fungal proteins. They act on a wide range of long-chain saturated and unsaturated fatty acids, but the enzymes from different tissues show some variation in specificity. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. In Schizosaccharomyces pombe, lcf1 gene encodes a new fatty acyl-CoA synthetase that preferentially recognizes myristic acid as a substrate.
Pssm-ID: 341294 [Multi-domain] Cd Length: 507 Bit Score: 58.00 E-value: 9.39e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2776 GTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFG--VGPEDRVLGL-------------------------SA 2828
Cdd:cd17639 85 GKPDDLACIMYTSGSTGNPKGVMLTHGNLVAGIAGLGDRVPelLGPDDRYLAYlplahifelaaenvclyrggtigygSP 164
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2829 LTF----------DLSVYdvlgllGAGGALVLPAAeaekdpahwWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKlpaA 2898
Cdd:cd17639 165 RTLtdkskrgckgDLTEF------KPTLMVGVPAI---------WDTIRKGVLAKLNPMGGLKRTLFWTAYQSKLK---A 226
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2899 LRLVMLSGDWIPVALpDRIR-ALGRDVQVVSLGGA-----TEASIWSIAYPIGQ-------VA-------PQWKSIPYGM 2958
Cdd:cd17639 227 LKEGPGTPLLDELVF-KKVRaALGGRLRYMLSGGAplsadTQEFLNIVLCPVIQgygltetCAggtvqdpGDLETGRVGP 305
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2959 PLANQRFHVLD----GRLEARPwwVP-GELYIGGEGLAREYWRDEPLTATRFirhprTGERLYRTGDQGRMLPEGSIEFL 3033
Cdd:cd17639 306 PLPCCEIKLVDweegGYSTDKP--PPrGEILIRGPNVFKGYYKNPEKTKEAF-----DGDGWFHTGDIGEFHPDGTLKII 378
|
330 340 350
....*....|....*....|....*....|....*...
gi 53747904 3034 GR-EDLqVKVQ-GFRVELGEIEAALAQHPALSASVVVA 3069
Cdd:cd17639 379 DRkKDL-VKLQnGEYIALEKLESIYRSNPLVNNICVYA 415
|
|
| alpha_am_amid |
TIGR03443 |
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are ... |
2072-2145 |
1.02e-07 |
|
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), product of the LYS2 gene. It is also called alpha-aminoadipate reductase. In fungi, lysine is synthesized via aminoadipate. Currently, all members of this family are fungal.
Pssm-ID: 274582 [Multi-domain] Cd Length: 1389 Bit Score: 58.54 E-value: 1.02e-07
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 53747904 2072 GRAAAAEPQALppSSLEQLIEQVWRKHL--GVERVQPTDSFFQLGGDSLLGIQVAADLRRHLGVELPTATLFSHPT 2145
Cdd:TIGR03443 836 NRSASAADEEF--TETEREIRDLWLELLpnRPATISPDDSFFDLGGHSILATRMIFELRKKLNVELPLGLIFKSPT 909
|
|
| PRK05850 |
PRK05850 |
acyl-CoA synthetase; Validated |
2691-2802 |
1.17e-07 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235624 [Multi-domain] Cd Length: 578 Bit Score: 57.64 E-value: 1.17e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2691 VAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPL---RLHQLLEEGPARVVLTQSSLLHTV-------PWPPGVQVIAV 2760
Cdd:PRK05850 62 AVILAPQGLEYIVAFLGALQAGLIAVPLSVPQGGAhdeRVSAVLRDTSPSVVLTTSAVVDDVteyvapqPGQSAPPVIEV 141
|
90 100 110 120
....*....|....*....|....*....|....*....|..
gi 53747904 2761 DELEPATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHR 2802
Cdd:PRK05850 142 DLLDLDSPRGSDARPRDLPSTAYLQYTSGSTRTPAGVMVSHR 183
|
|
| PRK08162 |
PRK08162 |
acyl-CoA synthetase; Validated |
2786-3134 |
1.30e-07 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236169 [Multi-domain] Cd Length: 545 Bit Score: 57.65 E-value: 1.30e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2786 YTSGSTGKPKGVAIEHR-AALNTVVDLnTRFGVGPedRVLGLSAL--------TFDLSVydvlgllgaggalvlpAAEA- 2855
Cdd:PRK08162 189 YTSGTTGNPKGVVYHHRgAYLNALSNI-LAWGMPK--HPVYLWTLpmfhcngwCFPWTV----------------AARAg 249
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2856 ------EKDPAHWWERLVAGRVTVWNSTPALMLLLV--EYAEQRGLKLPAAlrlVMLSGDWIPVALPDRIRALGRDVQVV 2927
Cdd:PRK08162 250 tnvclrKVDPKLIFDLIREHGVTHYCGAPIVLSALInaPAEWRAGIDHPVH---AMVAGAAPPAAVIAKMEEIGFDLTHV 326
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2928 SlgGATEasiwsiAY-PIGQVA--PQWKSipygMPLANQ---------RFHVLDG-------RLEARPW--WVPGELYIG 2986
Cdd:PRK08162 327 Y--GLTE------TYgPATVCAwqPEWDA----LPLDERaqlkarqgvRYPLQEGvtvldpdTMQPVPAdgETIGEIMFR 394
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2987 GEGLAREYWRDEPLTATRFirhpRTGerLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASV 3066
Cdd:PRK08162 395 GNIVMKGYLKNPKATEEAF----AGG--WFHTGDLAVLHPDGYIKIKDRSKDIIISGGENISSIEVEDVLYRHPAVLVAA 468
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 53747904 3067 VVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLEsLPRSRNGKIARDQLPE 3134
Cdd:PRK08162 469 VVAKPDPKWGEVPCAFVELKDGASATEEEIIAHCREHLAGFKVPKAVVFGE-LPKTSTGKIQKFVLRE 535
|
|
| tdh |
PRK05396 |
L-threonine 3-dehydrogenase; Validated |
1694-1883 |
1.44e-07 |
|
L-threonine 3-dehydrogenase; Validated
Pssm-ID: 180054 [Multi-domain] Cd Length: 341 Bit Score: 56.37 E-value: 1.44e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAGLNFLDV------LGALGMMPAleaeESVLGRECSGRIAAVGEGVSGLRVGDEV----------- 1756
Cdd:PRK05396 21 PEPGPNDVLIKVKKTAICGTDVhiynwdEWAQKTIPV----PMVVGHEFVGEVVEVGSEVTGFKVGDRVsgeghivcghc 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1757 ----------------LAV-APGCFRSYVLVDESQVVRRPASLGLAEGAAQMvPFATAyfaLHTV--GRLRrGERILIha 1817
Cdd:PRK05396 97 rncragrrhlcrntkgVGVnRPGAFAEYLVIPAFNVWKIPDDIPDDLAAIFD-PFGNA---VHTAlsFDLV-GEDVLI-- 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1818 aagglglaavqlasrTGA-----------------EILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVD 1880
Cdd:PRK05396 170 ---------------TGAgpigimaaavakhvgarHVVITDVNEYRLELARKMGATRAVNVAKEDLRDVMAELGMTEGFD 234
|
...
gi 53747904 1881 VVL 1883
Cdd:PRK05396 235 VGL 237
|
|
| PLN02479 |
PLN02479 |
acetate-CoA ligase |
3016-3132 |
1.73e-07 |
|
acetate-CoA ligase
Pssm-ID: 178097 [Multi-domain] Cd Length: 567 Bit Score: 57.16 E-value: 1.73e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3016 YRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSG-----QT 3090
Cdd:PLN02479 432 FHSGDLGVKHPDGYIEIKDRSKDIIISGGENISSLEVENVVYTHPAVLEASVVARPDERWGESPCAFVTLKPGvdksdEA 511
|
90 100 110 120
....*....|....*....|....*....|....*....|..
gi 53747904 3091 PAAGELRRYLAERLPAYMVPSAfVLLESLPRSRNGKIARDQL 3132
Cdd:PLN02479 512 ALAEDIMKFCRERLPAYWVPKS-VVFGPLPKTATGKIQKHVL 552
|
|
| PRK13390 |
PRK13390 |
acyl-CoA synthetase; Provisional |
2646-3132 |
1.76e-07 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139538 [Multi-domain] Cd Length: 501 Bit Score: 56.94 E-value: 1.76e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2646 TQARLHPELPALLAPE--RTLSYGELARRAQALAARLRELEVQPQELVAIaMHKGWEQATAVLGVLQAAAAYL-PLDPEQ 2722
Cdd:PRK13390 5 THAQIAPDRPAVIVAEtgEQVSYRQLDDDSAALARVLYDAGLRTGDVVAL-LSDNSPEALVVLWAALRSGLYItAINHHL 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2723 PPLRLHQLLEEGPARVVLTQSSL---LHTVPWPPGVQVIAVDELE-----PATEAPPLPPRGTPEHLAYVIYTSGSTGKP 2794
Cdd:PRK13390 84 TAPEADYIVGDSGARVLVASAALdglAAKVGADLPLRLSFGGEIDgfgsfEAALAGAGPRLTEQPCGAVMLYSSGTTGFP 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2795 KGVAiehraalntvVDLNTRFGVGPEDRVLGLSALTFDLSVYDvlgllgaGGALVLPAAEAEkdPAHWW----------- 2863
Cdd:PRK13390 164 KGIQ----------PDLPGRDVDAPGDPIVAIARAFYDISESD-------IYYSSAPIYHAA--PLRWCsmvhalggtvv 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2864 --ERLVAG---------RVTVWNSTPALMLLLVEY-AEQRGLKLPAALRLVMLSGDWIPV----ALPDRIRALgrdvqVV 2927
Cdd:PRK13390 225 laKRFDAQatlghveryRITVTQMVPTMFVRLLKLdADVRTRYDVSSLRAVIHAAAPCPVdvkhAMIDWLGPI-----VY 299
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2928 SLGGATEASIWSIAYpigqvAPQWKSIP--YGMPLANQrFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATrf 3005
Cdd:PRK13390 300 EYYSSTEAHGMTFID-----SPDWLAHPgsVGRSVLGD-LHICDDDGNELPAGRIGTVYFERDRLPFRYLNDPEKTAA-- 371
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3006 IRHPrtGERLYRT-GDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEP---RGVRRLVA 3081
Cdd:PRK13390 372 AQHP--AHPFWTTvGDLGSVDEDGYLYLADRKSFMIISGGVNIYPQETENALTMHPAVHDVAVIGVPDPemgEQVKAVIQ 449
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|.
gi 53747904 3082 YAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PRK13390 450 LVEGIRGSDELARELIDYTRSRIAHYKAPRSVEFVDELPRTPTGKLVKGLL 500
|
|
| FCS |
cd05921 |
Feruloyl-CoA synthetase (FCS); Feruloyl-CoA synthetase is an essential enzyme in the feruloyl ... |
2648-3107 |
1.77e-07 |
|
Feruloyl-CoA synthetase (FCS); Feruloyl-CoA synthetase is an essential enzyme in the feruloyl acid degradation pathway and enables some proteobacteria to grow on media containing feruloyl acid as the sole carbon source. It catalyzes the transfer of CoA to the carboxyl group of ferulic acid, which then forms feruloyl-CoA in the presence of ATP and Mg2. The resulting feruloyl-CoA is further degraded to vanillin and acetyl-CoA. Feruloyl-CoA synthetase (FCS) is a subfamily of the adenylate-forming enzymes superfamily.
Pssm-ID: 341245 [Multi-domain] Cd Length: 561 Bit Score: 57.06 E-value: 1.77e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPALLAPE-----RTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPE- 2721
Cdd:cd05921 5 ARQAPDRTWLAEREgnggwRRVTYAEALRQVRAIAQGLLDLGLSAERPLLILSGNSIEHALMALAAMYAGVPAAPVSPAy 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2722 ----QPPLRLHQLLEEGPARVVLTQS----------------SLLHTVPWPPGVQVIAVDEL---EPATEAPPLPPRGTP 2778
Cdd:cd05921 85 slmsQDLAKLKHLFELLKPGLVFAQDaapfaralaaifplgtPLVVSRNAVAGRGAISFAELaatPPTAAVDAAFAAVGP 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2779 EHLAYVIYTSGSTGKPKGVAIEHRA-ALNTVVDLNTRFGVGPEDRVL----------GLSAlTFDLSVYDVLGLLGAgga 2847
Cdd:cd05921 165 DTVAKFLFTSGSTGLPKAVINTQRMlCANQAMLEQTYPFFGEEPPVLvdwlpwnhtfGGNH-NFNLVLYNGGTLYID--- 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2848 lvlpaaEAEKDPAHWWERLVAGR---VTVWNSTPALMLLLVEYAEQ-RGL--KLPAALRLVMLSGDWIPVALPDRIRAL- 2920
Cdd:cd05921 241 ------DGKPMPGGFEETLRNLReisPTVYFNVPAGWEMLVAALEKdEALrrRFFKRLKLMFYAGAGLSQDVWDRLQALa 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2921 ----GRDVQVVSLGGATEASIWSiaypIGQVAPQWKSIPYGMPLANQRFHVL--DGRLEAR---PWWVPGelyiggegla 2991
Cdd:cd05921 315 vatvGERIPMMAGLGATETAPTA----TFTHWPTERSGLIGLPAPGTELKLVpsGGKYEVRvkgPNVTPG---------- 380
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2992 reYWRDEPLTATRFirhprTGERLYRTGDQGRML----PEGSIEFLGR--EDLQVKvQGFRVELGEIEAAL--AQHPALS 3063
Cdd:cd05921 381 --YWRQPELTAQAF-----DEEGFYCLGDAAKLAdpddPAKGLVFDGRvaEDFKLA-SGTWVSVGPLRARAvaACAPLVH 452
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....
gi 53747904 3064 ASVVVARGE----------PRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAY 3107
Cdd:cd05921 453 DAVVAGEDRaevgalvfpdLLACRRLVGLQEASDAEVLRHAKVRAAFRDRLAAL 506
|
|
| Zn_ADH1 |
cd05279 |
Liver alcohol dehydrogenase and related zinc-dependent alcohol dehydrogenases; NAD(P)(H) ... |
1676-1880 |
2.02e-07 |
|
Liver alcohol dehydrogenase and related zinc-dependent alcohol dehydrogenases; NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. There are 7 vertebrate ADH 7 classes, 6 of which have been identified in humans. Class III, glutathione-dependent formaldehyde dehydrogenase, has been identified as the primordial form and exists in diverse species, including plants, micro-organisms, vertebrates, and invertebrates. Class I, typified by liver dehydrogenase, is an evolving form. Gene duplication and functional specialization of ADH into ADH classes and subclasses created numerous forms in vertebrates. For example, the A, B and C (formerly alpha, beta, gamma) human class I subunits have high overall structural similarity, but differ in the substrate binding pocket and therefore in substrate specificity. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine (His-51), the ribose of NAD, a serine (Ser-48), then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of an beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding.
Pssm-ID: 176182 [Multi-domain] Cd Length: 365 Bit Score: 56.29 E-value: 2.02e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1676 AVGTPGLLESLGLRrctrpAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAeeSVLGRECSGRIAAVGEGVSGLRVGDE 1755
Cdd:cd05279 8 EKGKPLSIEEIEVA-----PPKAGEVRIKVVATGVCHTDLHVIDGKLPTPLP--VILGHEGAGIVESIGPGVTTLKPGDK 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1756 VLAV-APGC------------------------------------------------FRSYVLVDESQVVRRPASLGLAE 1786
Cdd:cd05279 81 VIPLfGPQCgkckqclnprpnlcsksrgtngrglmsdgtsrftckgkpihhflgtstFAEYTVVSEISLAKIDPDAPLEK 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1787 GAAQMVPFATAYFALHTVGRLRRGERILIhaaaggLGLAAVQLASRTGAE------ILATAGSEQKREYLRSLGIAHVLD 1860
Cdd:cd05279 161 VCLIGCGFSTGYGAAVNTAKVTPGSTCAV------FGLGGVGLSVIMGCKaagasrIIAVDINKDKFEKAKQLGATECIN 234
|
250 260
....*....|....*....|..
gi 53747904 1861 SRSTSF-VSEV-RERTGGrGVD 1880
Cdd:cd05279 235 PRDQDKpIVEVlTEMTDG-GVD 255
|
|
| LC_FACS_like |
cd17640 |
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA ... |
2777-3085 |
2.84e-07 |
|
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA synthetases, including an Arabidopsis gene At4g14070 that plays a role in activation and elongation of exogenous fatty acids. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341295 [Multi-domain] Cd Length: 468 Bit Score: 56.21 E-value: 2.84e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2777 TPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLsaltfdLSVYDVLGLLGAGGALVLPAAEAE 2856
Cdd:cd17640 86 DSDDLATIIYTSGTTGNPKGVMLTHANLLHQIRSLSDIVPPQPGDRFLSI------LPIWHSYERSAEYFIFACGCSQAY 159
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2857 KDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPAALRLV---MLSGDWIPV------ALPDRI----RALGRD 2923
Cdd:cd17640 160 TSIRTLKDDLKRVKPHYIVSVPRLWESLYSGIQKQVSKSSPIKQFLflfFLSGGIFKFgisgggALPPHVdtffEAIGIE 239
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2924 VQVvslG-GATEASiwsiayPIGQVAPQWKSI--PYGMPLANQRFHVLD--GRlEARPWWVPGELYIGGEGLAREYWRDe 2998
Cdd:cd17640 240 VLN---GyGLTETS------PVVSARRLKCNVrgSVGRPLPGTEIKIVDpeGN-VVLPPGEKGIVWVRGPQVMKGYYKN- 308
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2999 PLTATRFIrhprTGERLYRTGDQGRMLPEGSIEFLGRE-DLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEprgvR 3077
Cdd:cd17640 309 PEATSKVL----DSDGWFNTGDLGWLTCGGELVLTGRAkDTIVLSNGENVEPQPIEEALMRSPFIEQIMVVGQDQ----K 380
|
....*...
gi 53747904 3078 RLVAYAVP 3085
Cdd:cd17640 381 RLGALIVP 388
|
|
| fabG |
PRK05653 |
3-oxoacyl-ACP reductase FabG; |
1232-1362 |
3.67e-07 |
|
3-oxoacyl-ACP reductase FabG;
Pssm-ID: 235546 [Multi-domain] Cd Length: 246 Bit Score: 54.40 E-value: 3.67e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1232 ELEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAATFDDGVIQLRTHEQSSRALRTKVRGSM-VLHEVLAS 1310
Cdd:PRK05653 48 ELRAAGGEARVLVFDVSDEAAVRALIEAAVEAFGALDILVNNAGITRDALLPRMSEEDWDRVIDVNLTGTFnVVRAALPP 127
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 1311 ---EGLDWFALCSSLASALGSFGQADYCAANAFQdayahhlrrQGFTGALALDWG 1362
Cdd:PRK05653 128 mikARYGRIVNISSVSGVTGNPGQTNYSAAKAGV---------IGFTKALALELA 173
|
|
| MDR_yhdh_yhfp |
cd05280 |
Yhdh and yhfp-like putative quinone oxidoreductases; Yhdh and yhfp-like putative quinone ... |
1685-1860 |
4.04e-07 |
|
Yhdh and yhfp-like putative quinone oxidoreductases; Yhdh and yhfp-like putative quinone oxidoreductases (QOR). QOR catalyzes the conversion of a quinone + NAD(P)H to a hydroquinone + NAD(P)+. Quinones are cyclic diones derived from aromatic compounds. Membrane bound QOR actin the respiratory chains of bacteria and mitochondria, while soluble QOR acts to protect from toxic quinones (e.g. DT-diaphorase) or as a soluble eye-lens protein in some vertebrates (e.g. zeta-crystalin). QOR reduces quinones through a semi-quinone intermediate via a NAD(P)H-dependent single electron transfer. QOR is a member of the medium chain dehydrogenase/reductase family, but lacks the zinc-binding sites of the prototypical alcohol dehydrogenases of this group. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176183 [Multi-domain] Cd Length: 325 Bit Score: 54.86 E-value: 4.04e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1685 SLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGvsGLRVGDEVLAVA---- 1760
Cdd:cd05280 14 SLFLRTLPLDDLPEGDVLIRVHYSSLNYKDALAATGNGGVTRNYPHTPGIDAAGTVVSSDDP--RFREGDEVLVTGydlg 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1761 ---PGCFRSYVLVDESQVVRRPASLGLAEGAAqmvpFATAYFA--------LHTVGRLRRGErILIHAAAGGLGLAAVQL 1829
Cdd:cd05280 92 mntDGGFAEYVRVPADWVVPLPEGLSLREAMI----LGTAGFTaalsvhrlEDNGQTPEDGP-VLVTGATGGVGSIAVAI 166
|
170 180 190
....*....|....*....|....*....|.
gi 53747904 1830 ASRTGAEILATAGSEQKREYLRSLGIAHVLD 1860
Cdd:cd05280 167 LAKLGYTVVALTGKEEQADYLKSLGASEVLD 197
|
|
| PRK00174 |
PRK00174 |
acetyl-CoA synthetase; Provisional |
3016-3129 |
5.70e-07 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 234677 [Multi-domain] Cd Length: 637 Bit Score: 55.53 E-value: 5.70e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3016 YRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVAR-----GEprGVrrlVAYAVPRSGQT 3090
Cdd:PRK00174 485 YFTGDGARRDEDGYYWITGRVDDVLNVSGHRLGTAEIESALVAHPKVAEAAVVGRpddikGQ--GI---YAFVTLKGGEE 559
|
90 100 110 120
....*....|....*....|....*....|....*....|..
gi 53747904 3091 PAAG---ELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIAR 3129
Cdd:PRK00174 560 PSDElrkELRNWVRKEIGPIAKPDVIQFAPGLPKTRSGKIMR 601
|
|
| prpE |
PRK10524 |
propionyl-CoA synthetase; Provisional |
2995-3129 |
5.82e-07 |
|
propionyl-CoA synthetase; Provisional
Pssm-ID: 182517 [Multi-domain] Cd Length: 629 Bit Score: 55.34 E-value: 5.82e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2995 WRDEpltaTRFIRH--PRTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGE 3072
Cdd:PRK10524 456 WGDD----DRFVKTywSLFGRQVYSTFDWGIRDADGYYFILGRTDDVINVAGHRLGTREIEESISSHPAVAEVAVVGVKD 531
|
90 100 110 120 130 140
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 3073 PRGVRRLVAYAVPRSG---QTPAA-----GELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIAR 3129
Cdd:PRK10524 532 ALKGQVAVAFVVPKDSdslADREArlaleKEIMALVDSQLGAVARPARVWFVSALPKTRSGKLLR 596
|
|
| Zn_ADH8 |
cd08262 |
Alcohol dehydrogenases of the MDR family; The medium chain dehydrogenases/reductase (MDR) ... |
1694-1883 |
6.76e-07 |
|
Alcohol dehydrogenases of the MDR family; The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P)-binding Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176223 [Multi-domain] Cd Length: 341 Bit Score: 54.62 E-value: 6.76e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1694 PAPGPRQVEIEVEAAG-----LNFLD-----VLGALGMMPALEAEESVLGRECSGRIAAVGEGVSG-LRVGDEVLAV--- 1759
Cdd:cd08262 19 PEPGPGQVLVKVLACGicgsdLHATAhpeamVDDAGGPSLMDLGADIVLGHEFCGEVVDYGPGTERkLKVGTRVTSLpll 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1760 ---------------APGCFRSYVLVDESQVVRRPASLGLAEgAAQMVPFATAYFALhTVGRLRRGERILIHAAAGGLGL 1824
Cdd:cd08262 99 lcgqgascgiglspeAPGGYAEYMLLSEALLLRVPDGLSMED-AALTEPLAVGLHAV-RRARLTPGEVALVIGCGPIGLA 176
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 53747904 1825 AAVQLASRTGAEILATAGSEQKREYLRSLGIAHVLDSRSTS---FVSEVRERTGGRGVDVVL 1883
Cdd:cd08262 177 VIAALKARGVGPIVASDFSPERRALALAMGADIVVDPAADSpfaAWAAELARAGGPKPAVIF 238
|
|
| PRK08276 |
PRK08276 |
long-chain-fatty-acid--CoA ligase; Validated |
2966-3135 |
1.13e-06 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236215 [Multi-domain] Cd Length: 502 Bit Score: 54.52 E-value: 1.13e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2966 HVLDGRLEARPWWVPGELYIGGEGLAREYWRDEplTATRFIRHPRTgerLYRTGDQGRMLPEGSIEFLGREDLQVKVQGF 3045
Cdd:PRK08276 326 RILDEDGNELPPGEIGTVYFEMDGYPFEYHNDP--EKTAAARNPHG---WVTVGDVGYLDEDGYLYLTDRKSDMIISGGV 400
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3046 RVELGEIEAALAQHPA-LSASVVVARGEPRGvRRLVAYAVPRSGQTPA---AGELRRYLAERLPAYMVPSAFVLLESLPR 3121
Cdd:PRK08276 401 NIYPQEIENLLVTHPKvADVAVFGVPDEEMG-ERVKAVVQPADGADAGdalAAELIAWLRGRLAHYKCPRSIDFEDELPR 479
|
170
....*....|....
gi 53747904 3122 SRNGKIARDQLPEP 3135
Cdd:PRK08276 480 TPTGKLYKRRLRDR 493
|
|
| PRK07514 |
PRK07514 |
malonyl-CoA synthase; Validated |
2652-2824 |
1.24e-06 |
|
malonyl-CoA synthase; Validated
Pssm-ID: 181011 [Multi-domain] Cd Length: 504 Bit Score: 54.11 E-value: 1.24e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2652 PELPALLAPE-RTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQL 2730
Cdd:PRK07514 16 RDAPFIETPDgLRYTYGDLDAASARLANLLVALGVKPGDRVAVQVEKSPEALALYLATLRAGAVFLPLNTAYTLAELDYF 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2731 LEE-GPARVVLTQSSL--LHTVPWPPGVQ-VIAVDE------LEPATEAPPL---PPRGtPEHLAYVIYTSGSTGKPKGV 2797
Cdd:PRK07514 96 IGDaEPALVVCDPANFawLSKIAAAAGAPhVETLDAdgtgslLEAAAAAPDDfetVPRG-ADDLAAILYTSGTTGRSKGA 174
|
170 180
....*....|....*....|....*..
gi 53747904 2798 AIEHRAALNTVVDLNTRFGVGPEDRVL 2824
Cdd:PRK07514 175 MLSHGNLLSNALTLVDYWRFTPDDVLI 201
|
|
| entE |
PRK10946 |
(2,3-dihydroxybenzoyl)adenylate synthase; |
3016-3132 |
2.04e-06 |
|
(2,3-dihydroxybenzoyl)adenylate synthase;
Pssm-ID: 236803 [Multi-domain] Cd Length: 536 Bit Score: 53.46 E-value: 2.04e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3016 YRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAge 3095
Cdd:PRK10946 411 YCSGDLVSIDPDGYITVVGREKDQINRGGEKIAAEEIENLLLRHPAVIHAALVSMEDELMGEKSCAFLVVKEPLKAVQ-- 488
|
90 100 110
....*....|....*....|....*....|....*...
gi 53747904 3096 LRRYLAERLPA-YMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PRK10946 489 LRRFLREQGIAeFKLPDRVECVDSLPLTAVGKVDKKQL 526
|
|
| X-Domain_NRPS |
cd19546 |
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to ... |
2179-2489 |
2.22e-06 |
|
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to the non-ribosomal peptide synthetase (NRPS); The X-domain is a catalytically inactive member of the Condensation (C) domain family of non-ribosomal peptide synthetase (NRPS). It has been shown to recruit oxygenases to the NRPS to perform side-chain crosslinking in the production of glycopeptide antibiotics. C-domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as this X-domain, the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, and dual E/C (epimerization and condensation) domains. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity; members of this X-domain subfamily lack the second H of this motif.
Pssm-ID: 380468 [Multi-domain] Cd Length: 440 Bit Score: 53.25 E-value: 2.22e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2179 EPFPLTDVQEAYWvgRRSAFELGGVAAHGYFEIESPG-LEVERFIQCWRQLLQRHDMLRmVVLPDGRQQVLEQVPEYTPE 2257
Cdd:cd19546 3 DEVPATAGQLRTW--LLARLDEETRGRHLSVALRLRGrLDRDALEAALGDVAARHEILR-TTFPGDGGDVHQRILDADAA 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2258 VVELRGLSPQEAESRRLqLRERMAHQ--VLRSDRW--PLFELVlcryEGGVRIHMSMDALMLDAWSSAVLRQDFAQLY-- 2331
Cdd:cd19546 80 RPELPVVPATEEELPAL-LADRAAHLfdLTRETPWrcTLFALS----DTEHVLLLVVHRIAADDESLDVLVRDLAAAYga 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2332 HEPGRPLE--PLAITFRDYVLAERRLREGEAHERAR-----AYWWARLDTLPPPPELPLVKEPSQLEHARFTHREARLEP 2404
Cdd:cd19546 155 RREGRAPEraPLPLQFADYALWERELLAGEDDRDSLigdqiAYWRDALAGAPDELELPTDRPRPVLPSRRAGAVPLRLDA 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2405 HRWARLQERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNlTLFQRLPLHPQVDELVGDFTSLVLLEVEAHAASTFAER 2484
Cdd:cd19546 235 EVHARLMEAAESAGATMFTVVQAALAMLLTRLGAGTDVTVG-TVLPRDDEEGDLEGMVGPFARPLALRTDLSGDPTFREL 313
|
....*
gi 53747904 2485 ASRLQ 2489
Cdd:cd19546 314 LGRVR 318
|
|
| PRK13388 |
PRK13388 |
acyl-CoA synthetase; Provisional |
2981-3132 |
2.49e-06 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237374 [Multi-domain] Cd Length: 540 Bit Score: 53.49 E-value: 2.49e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2981 GELY-IGGEGLAREYWRDEPLTATRfIRHPRtgerlYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQH 3059
Cdd:PRK13388 352 GELVnTAGAGFFEGYYNNPEATAER-MRHGM-----YWSGDLAYRDADGWIYFAGRTADWMRVDGENLSAAPIERILLRH 425
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 3060 PALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAER--LPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PRK13388 426 PAINRVAVYAVPDERVGDQVMAALVLRDGATFDPDAFAAFLAAQpdLGTKAWPRYVRIAADLPSTATNKVLKREL 500
|
|
| PLN02736 |
PLN02736 |
long-chain acyl-CoA synthetase |
2704-2802 |
2.71e-06 |
|
long-chain acyl-CoA synthetase
Pssm-ID: 178337 [Multi-domain] Cd Length: 651 Bit Score: 53.18 E-value: 2.71e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2704 AVLGVLQAAAAYLPLDPEQPPLRLhqlleegpARVVLTQSSLLHTVPWPPGVQVIAVDELEP---ATEAPPLPPRgtPEH 2780
Cdd:PLN02736 153 AIFCVPQTLNTLLSCLSEIPSVRL--------IVVVGGADEPLPSLPSGTGVEIVTYSKLLAqgrSSPQPFRPPK--PED 222
|
90 100
....*....|....*....|..
gi 53747904 2781 LAYVIYTSGSTGKPKGVAIEHR 2802
Cdd:PLN02736 223 VATICYTSGTTGTPKGVVLTHG 244
|
|
| NADP_ADH |
cd08285 |
NADP(H)-dependent alcohol dehydrogenases; This group is predominated by atypical alcohol ... |
1673-1883 |
3.06e-06 |
|
NADP(H)-dependent alcohol dehydrogenases; This group is predominated by atypical alcohol dehydrogenases; they exist as tetramers and exhibit specificity for NADP(H) as a cofactor in the interconversion of alcohols and aldehydes, or ketones. Like other zinc-dependent alcohol dehydrogenases (ADH) of the medium chain alcohol dehydrogenase/reductase family (MDR), tetrameric ADHs have a catalytic zinc that resides between the catalytic and NAD(H)binding domains; however, they do not have and a structural zinc in a lobe of the catalytic domain. The medium chain alcohol dehydrogenase family (MDR) has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The N-terminal region typically has an all-beta catalytic domain. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit.
Pssm-ID: 176245 [Multi-domain] Cd Length: 351 Bit Score: 52.24 E-value: 3.06e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1673 VEVAVGTPGLLESlglrrcTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPAlEAEESVLGRECSGRIAAVGEGVSGLRV 1752
Cdd:cd08285 5 AMLGIGKVGWIEK------PIPVCGPNDAIVRPTAVAPCTSDVHTVWGGAPG-ERHGMILGHEAVGVVEEVGSEVKDFKP 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1753 GDEVL--AVAP-----------------------------GCFRSYVLVDESQVVRRPASLGLAEGAAQMVP-FATAYFA 1800
Cdd:cd08285 78 GDRVIvpAITPdwrsvaaqrgypsqsggmlggwkfsnfkdGVFAEYFHVNDADANLAPLPDGLTDEQAVMLPdMMSTGFH 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1801 LHTVGRLRRGERILIhaaaggLGLAAVQLASRTGAE------ILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERT 1874
Cdd:cd08285 158 GAELANIKLGDTVAV------FGIGPVGLMAVAGARlrgagrIIAVGSRPNRVELAKEYGATDIVDYKNGDVVEQILKLT 231
|
....*....
gi 53747904 1875 GGRGVDVVL 1883
Cdd:cd08285 232 GGKGVDAVI 240
|
|
| PRK12583 |
PRK12583 |
acyl-CoA synthetase; Provisional |
2786-3134 |
3.06e-06 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237145 [Multi-domain] Cd Length: 558 Bit Score: 53.24 E-value: 3.06e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2786 YTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSAL--TFDLsVYDVLGLLGAGGALVLPAAEAekDPAHWW 2863
Cdd:PRK12583 208 YTSGTTGFPKGATLSHHNILNNGYFVAESLGLTEHDRLCVPVPLyhCFGM-VLANLGCMTVGACLVYPNEAF--DPLATL 284
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2864 ERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLpAALRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEASiwsiayP 2943
Cdd:PRK12583 285 QAVEEERCTALYGVPTMFIAELDHPQRGNFDL-SSLRTGIMAGAPCPIEVMRRVMDEMHMAEVQIAYGMTETS------P 357
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2944 IGQVAPQWKSIP-----YGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFirhprTGERLYRT 3018
Cdd:PRK12583 358 VSLQTTAADDLErrvetVGRTQPHLEVKVVDPDGATVPRGEIGELCTRGYSVMKGYWNNPEATAESI-----DEDGWMHT 432
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3019 GDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRR 3098
Cdd:PRK12583 433 GDLATMDEQGYVRIVGRSKDMIIRGGENIYPREIEEFLFTHPAVADVQVFGVPDEKYGEEIVAWVRLHPGHAASEEELRE 512
|
330 340 350
....*....|....*....|....*....|....*.
gi 53747904 3099 YLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPE 3134
Cdd:PRK12583 513 FCKARIAHFKVPRYFRFVDEFPMTVTGKVQKFRMRE 548
|
|
| FDH_like_2 |
cd08284 |
Glutathione-dependent formaldehyde dehydrogenase related proteins, child 2; ... |
1692-1883 |
3.46e-06 |
|
Glutathione-dependent formaldehyde dehydrogenase related proteins, child 2; Glutathione-dependent formaldehyde dehydrogenases (FDHs) are members of the zinc-dependent/medium chain alcohol dehydrogenase family. Formaldehyde dehydrogenase (FDH) is a member of the zinc-dependent/medium chain alcohol dehydrogenase family. FDH converts formaldehyde and NAD to formate and NADH. The initial step in this process the spontaneous formation of a S-(hydroxymethyl)glutathione adduct from formaldehyde and glutathione, followed by FDH-mediated oxidation (and detoxification) of the adduct to S-formylglutathione. These tetrameric FDHs have a catalytic zinc that resides between the catalytic and NAD(H)binding domains and a structural zinc in a lobe of the catalytic domain. The medium chain alcohol dehydrogenase family (MDR) has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The N-terminal region typically has an all-beta catalytic domain. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit.
Pssm-ID: 176244 [Multi-domain] Cd Length: 344 Bit Score: 52.26 E-value: 3.46e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1692 TRPAP---GPRQVEIEVEAAGLNFLDVLGALGMMPalEAEESVLGRECSGRIAAVGEGVSGLRVGDEVLAVA-------P 1761
Cdd:cd08284 16 EVPIPqiqDPTDAIVKVTAAAICGSDLHIYRGHIP--STPGFVLGHEFVGEVVEVGPEVRTLKVGDRVVSPFtiacgecF 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1762 GCFRSYV-LVDESQVVRRPASLGLAEGAAQM--VPFA------------------------TAYFALHTvGRLRRGERIL 1814
Cdd:cd08284 94 YCRRGQSgRCAKGGLFGYAGSPNLDGAQAEYvrVPFAdgtllklpdglsdeaalllgdilpTGYFGAKR-AQVRPGDTVA 172
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 53747904 1815 IHAAAGGLGLAAVQLASRTGAEILATAGSEQKREYLRSLGiAHVLDSRSTSFVSEVRERTGGRGVDVVL 1883
Cdd:cd08284 173 VIGCGPVGLCAVLSAQVLGAARVFAVDPVPERLERAAALG-AEPINFEDAEPVERVREATEGRGADVVL 240
|
|
| PKS_PP |
smart00823 |
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the ... |
3149-3214 |
3.53e-06 |
|
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the prosthetic group of acyl carrier proteins (ACP) in some multienzyme complexes where it serves as a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups.
Pssm-ID: 214834 [Multi-domain] Cd Length: 86 Bit Score: 47.63 E-value: 3.53e-06
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 53747904 3149 DPLVERLAALVKEALRL---ERVEPQDSLLDLGADSVALIRLINRLEAELQFRPRLADIYENPTVQGLA 3214
Cdd:smart00823 11 RLLLDLVREQVAAVLGHaaaEAIDPDRPFRDLGLDSLMAVELRNRLEAATGLRLPATLVFDHPTPAALA 79
|
|
| PRK08751 |
PRK08751 |
long-chain fatty acid--CoA ligase; |
2957-3132 |
3.81e-06 |
|
long-chain fatty acid--CoA ligase;
Pssm-ID: 181546 [Multi-domain] Cd Length: 560 Bit Score: 52.57 E-value: 3.81e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2957 GMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTAtrfirHPRTGERLYRTGDQGRMLPEGSIEFLGRE 3036
Cdd:PRK08751 385 GLPIPSTDACIKDDAGTVLAIGEIGELCIKGPQVMKGYWKRPEETA-----KVMDADGWLHTGDIARMDEQGFVYIVDRK 459
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3037 DLQVKVQGFRVELGEIEAALAQHPA-LSASVVVARGEPRGvrRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVL 3115
Cdd:PRK08751 460 KDMILVSGFNVYPNEIEDVIAMMPGvLEVAAVGVPDEKSG--EIVKVVIVKKDPALTAEDVKAHARANLTGYKQPRIIEF 537
|
170
....*....|....*..
gi 53747904 3116 LESLPRSRNGKIARDQL 3132
Cdd:PRK08751 538 RKELPKTNVGKILRREL 554
|
|
| SDR |
cd02266 |
Short-chain dehydrogenases/reductases (SDR); SDRs are a functionally diverse family of ... |
1270-1370 |
3.86e-06 |
|
Short-chain dehydrogenases/reductases (SDR); SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold (alpha/beta folding pattern with a central beta-sheet), an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Classical SDRs are typically about 250 residues long, while extended SDRs are approximately 350 residues. Sequence identity between different SDR enzymes are typically in the 15-30% range, but the enzymes share the Rossmann fold NAD-binding motif and characteristic NAD-binding and catalytic sequence patterns. These enzymes catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human prostaglandin dehydrogenase (PGDH) numbering). In addition to the Tyr and Lys, there is often an upstream Ser (Ser-138, PGDH numbering) and/or an Asn (Asn-107, PGDH numbering) contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Extended SDRs have additional elements in the C-terminal region, and typically have a TGXXGXXG cofactor binding motif. Complex (multidomain) SDRs such as ketoreductase (KR) domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type KRs have a TGXXXGX(1-2)G NAD(P)-binding motif. Some atypical SDRs have lost catalytic activity and/or have an unusual NAD(P)-binding motif and missing or unusual active site residues. Reactions catalyzed within the SDR family include isomerization, decarboxylation, epimerization, C=N bond reduction, dehydratase activity, dehalogenation, Enoyl-CoA reduction, and carbonyl-alcohol oxidoreduction.
Pssm-ID: 187535 [Multi-domain] Cd Length: 186 Bit Score: 50.21 E-value: 3.86e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1270 VLHAAATFDDGVIQLRTHEQSSRALRTKVRGSMVLHE----VLASEGLDWFALCSSLASALGSFGQADYCAANAFQDAYA 1345
Cdd:cd02266 35 VVHNAAILDDGRLIDLTGSRIERAIRANVVGTRRLLEaareLMKAKRLGRFILISSVAGLFGAPGLGGYAASKAALDGLA 114
|
90 100
....*....|....*....|....*...
gi 53747904 1346 HHLRRQGFTGAL---ALDWGTWRDTGAA 1370
Cdd:cd02266 115 QQWASEGWGNGLpatAVACGTWAGSGMA 142
|
|
| CurA |
COG2130 |
NADPH-dependent curcumin reductase CurA [Secondary metabolites biosynthesis, transport and ... |
1741-1957 |
4.13e-06 |
|
NADPH-dependent curcumin reductase CurA [Secondary metabolites biosynthesis, transport and catabolism, General function prediction only];
Pssm-ID: 441733 [Multi-domain] Cd Length: 333 Bit Score: 51.98 E-value: 4.13e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1741 AAVGEGV----SGLRVGDEVLAVAPgcFRSYVLVDESQVVR---RPASLGLAEGAAQMVPFaTAYFALHTVGRLRRGERI 1813
Cdd:COG2130 74 GAVGEVVesrhPDFAVGDLVLGMLG--WQDYAVSDGAGLRKvdpSLAPLSAYLGVLGMPGL-TAYFGLLDIGKPKAGETV 150
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1814 LihaaagglglaaV------------QLASRTGAEILATAGSEQKREYLRS-LGIAHVLDSRSTSFVSEVRERTGGrGVD 1880
Cdd:COG2130 151 V------------VsaaagavgsvvgQIAKLKGCRVVGIAGGAEKCRYLVEeLGFDAAIDYKAGDLAAALAAACPD-GID 217
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1881 V------------VLNslagelllaglsVLAPHGRFLELGKRDLY--ADQQVGLRTL-------ARGQTFAAIDFGPHHP 1939
Cdd:COG2130 218 VyfdnvggeildaVLP------------LLNTFARIAVCGAISQYnaTEPPPGPRNLgqllvkrLRMQGFIVFDHADRFP 285
|
250
....*....|....*...
gi 53747904 1940 DFravLEEVATQLTQGQL 1957
Cdd:COG2130 286 EF---LAELAGWVAEGKL 300
|
|
| FATP_chFAT1_like |
cd05937 |
Uncharacterized subfamily of bifunctional fatty acid transporter/very-long-chain acyl-CoA ... |
2980-3132 |
5.76e-06 |
|
Uncharacterized subfamily of bifunctional fatty acid transporter/very-long-chain acyl-CoA synthetase in fungi; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis. Members of this family are fungal FATPs, including FAT1 from Cochliobolus heterostrophus.
Pssm-ID: 341260 [Multi-domain] Cd Length: 468 Bit Score: 52.05 E-value: 5.76e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2980 PGE----LYIGGEGLAREYWRDEPLTATRFIRHP-RTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEA 3054
Cdd:cd05937 299 PGEmlgrVPFKNREAFQGYLHNEDATESKLVRDVfRKGDIYFRTGDLLRQDADGRWYFLDRLGDTFRWKSENVSTTEVAD 378
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3055 ALAQHPALSASVVVARGEPR--GVRRLVAYAVPRSGQTPAA---GELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIAR 3129
Cdd:cd05937 379 VLGAHPDIAEANVYGVKVPGhdGRAGCAAITLEESSAVPTEftkSLLASLARKNLPSYAVPLFLRLTEEVATTDNHKQQK 458
|
...
gi 53747904 3130 DQL 3132
Cdd:cd05937 459 GVL 461
|
|
| PaaK |
COG1541 |
Phenylacetate-coenzyme A ligase PaaK, adenylate-forming domain family [Coenzyme transport and ... |
2787-3129 |
5.84e-06 |
|
Phenylacetate-coenzyme A ligase PaaK, adenylate-forming domain family [Coenzyme transport and metabolism];
Pssm-ID: 441150 [Multi-domain] Cd Length: 423 Bit Score: 51.69 E-value: 5.84e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2787 TSGSTGKPKGVAIEhRAALNTVVDLNTRF----GVGPEDRVL-----GL--SALTFDLSvydvlgllgaggalvlpaaeA 2855
Cdd:COG1541 91 SSGTTGKPTVVGYT-RKDLDRWAELFARSlraaGVRPGDRVQnafgyGLftGGLGLHYG--------------------A 149
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2856 EK-----------DPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPA-ALRLVMLSGDWIPVALPDRI-RALGr 2922
Cdd:COG1541 150 ERlgatvipagggNTERQLRLMQDFGPTVLVGTPSYLLYLAEVAEEEGIDPRDlSLKKGIFGGEPWSEEMRKEIeERWG- 228
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2923 dVQVVSLGGATEASIWsIAY--PIGQvapqwksipyGMPLANQRFHV--LD-GRLEARPwwvPGELyigGE----GLARE 2993
Cdd:COG1541 229 -IKAYDIYGLTEVGPG-VAYecEAQD----------GLHIWEDHFLVeiIDpETGEPVP---EGEE---GElvvtTLTKE 290
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2994 -YwrdePLtatrfIRhprtgerlYRTGDQGRMLPEGS--------IEF-LGREDLQVKVQGFRVELGEIEAALAQHPALS 3063
Cdd:COG1541 291 aM----PL-----IR--------YRTGDLTRLLPEPCpcgrthprIGRiLGRADDMLIIRGVNVFPSQIEEVLLRIPEVG 353
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3064 AS--VVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLpayMVPSAFVLLE--SLPRSrNGKIAR 3129
Cdd:COG1541 354 PEyqIVVDREGGLDELTVRVELAPGASLEALAEAIAAALKAVL---GLRAEVELVEpgSLPRS-EGKAKR 419
|
|
| BACL_like |
cd05929 |
Bacterial Bile acid CoA ligases and similar proteins; Bile acid-Coenzyme A ligase catalyzes ... |
2763-3129 |
7.17e-06 |
|
Bacterial Bile acid CoA ligases and similar proteins; Bile acid-Coenzyme A ligase catalyzes the formation of bile acid-CoA conjugates in a two-step reaction: the formation of a bile acid-AMP molecule as an intermediate, followed by the formation of a bile acid-CoA. This ligase requires a bile acid with a free carboxyl group, ATP, Mg2+, and CoA for synthesis of the final bile acid-CoA conjugate. The bile acid-CoA ligation is believed to be the initial step in the bile acid 7alpha-dehydroxylation pathway in the intestinal bacterium Eubacterium sp.
Pssm-ID: 341252 [Multi-domain] Cd Length: 473 Bit Score: 51.61 E-value: 7.17e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2763 LEPATEAPPLPPrgtPEHLA---YVIYTSGSTGKPKGVAIEHRAALN---TVVDLNTRFGVGPEDRVLglsaltfdlsvy 2836
Cdd:cd05929 109 YEAAEGGSPETP---IEDEAagwKMLYSGGTTGRPKGIKRGLPGGPPdndTLMAAALGFGPGADSVYL------------ 173
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2837 dvlgllgaggalvLPAAEAEKDPAHW-------------WERLVAG---------RVTVWNSTPALMlllveyaeQRGLK 2894
Cdd:cd05929 174 -------------SPAPLYHAAPFRWsmtalfmggtlvlMEKFDPEeflrlieryRVTFAQFVPTMF--------VRLLK 232
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2895 LP---------AALRLVMLSGDWIPVALPDRIRALGRDVqVVSLGGATEASIWSIAYpigqvAPQWKSIP--YGMPLANq 2963
Cdd:cd05929 233 LPeavrnaydlSSLKRVIHAAAPCPPWVKEQWIDWGGPI-IWEYYGGTEGQGLTIIN-----GEEWLTHPgsVGRAVLG- 305
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2964 RFHVLDGRLEARPWWVPGELYIGGeGLAREYWRDEPLTAtrfirhPRTGERLYRT-GDQGRMLPEGSIEFLGREDLQVKV 3042
Cdd:cd05929 306 KVHILDEDGNEVPPGEIGEVYFAN-GPGFEYTNDPEKTA------AARNEGGWSTlGDVGYLDEDGYLYLTDRRSDMIIS 378
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3043 QGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPA---AGELRRYLAERLPAYMVPSAFVLLESL 3119
Cdd:cd05929 379 GGVNIYPQEIENALIAHPKVLDAAVVGVPDEELGQRVHAVVQPAPGADAGtalAEELIAFLRDRLSRYKCPRSIEFVAEL 458
|
410
....*....|
gi 53747904 3120 PRSRNGKIAR 3129
Cdd:cd05929 459 PRDDTGKLYR 468
|
|
| fabG |
PRK08217 |
3-ketoacyl-(acyl-carrier-protein) reductase; Provisional |
1232-1339 |
7.77e-06 |
|
3-ketoacyl-(acyl-carrier-protein) reductase; Provisional
Pssm-ID: 181297 [Multi-domain] Cd Length: 253 Bit Score: 50.34 E-value: 7.77e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1232 ELEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAATFDDGV-IQLRTHEQSSRalrtkvrgsMVLHE---V 1307
Cdd:PRK08217 48 ECGALGTEVRGYAANVTDEEDVEATFAQIAEDFGQLNGLINNAGILRDGLlVKAKDGKVTSK---------MSLEQfqsV 118
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|..
gi 53747904 1308 LASEGLDWFaLC--------------------SSLASAlGSFGQADYCAANA 1339
Cdd:PRK08217 119 IDVNLTGVF-LCgreaaakmiesgskgviiniSSIARA-GNMGQTNYSASKA 168
|
|
| PRK12476 |
PRK12476 |
putative fatty-acid--CoA ligase; Provisional |
2685-2809 |
9.47e-06 |
|
putative fatty-acid--CoA ligase; Provisional
Pssm-ID: 171527 [Multi-domain] Cd Length: 612 Bit Score: 51.67 E-value: 9.47e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2685 VQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPL-DPEQP--PLRLHQLLEEGPARVVLTQS-------SLLHTVPWPPG 2754
Cdd:PRK12476 89 AGPGDRVAILAPQGIDYVAGFFAAIKAGTIAVPLfAPELPghAERLDTALRDAEPTVVLTTTaaaeaveGFLRNLPRLRR 168
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 2755 VQVIAVDELEPATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVV 2809
Cdd:PRK12476 169 PRVIAIDAIPDSAGESFVPVELDTDDVSHLQYTSGSTRPPVGVEITHRAVGTNLV 223
|
|
| PLN02387 |
PLN02387 |
long-chain-fatty-acid-CoA ligase family protein |
2756-3060 |
1.06e-05 |
|
long-chain-fatty-acid-CoA ligase family protein
Pssm-ID: 215217 [Multi-domain] Cd Length: 696 Bit Score: 51.27 E-value: 1.06e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2756 QVIAVDELEPATEAPPLPPR-GTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRF-GVGPEDRVLGLSALTFDL 2833
Cdd:PLN02387 226 TVSSFSEVEKLGKENPVDPDlPSPNDIAVIMYTSGSTGLPKGVMMTHGNIVATVAGVMTVVpKLGKNDVYLAYLPLAHIL 305
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2834 SVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNST-----PALM-------LLLVEyaEQRGL-----KLP 2896
Cdd:PLN02387 306 ELAAESVMAAVGAAIGYGSPLTLTDTSNKIKKGTKGDASALKPTlmtavPAILdrvrdgvRKKVD--AKGGLakklfDIA 383
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2897 AALRLVMLSGDWIPVALPDR----------IRA-LGRDVQVVSLGGA-----TEASIwSIAY--PIGQvapqwksiPYGM 2958
Cdd:PLN02387 384 YKRRLAAIEGSWFGAWGLEKllwdalvfkkIRAvLGGRIRFMLSGGAplsgdTQRFI-NICLgaPIGQ--------GYGL 454
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2959 --PLANQRFHVLD----GRLEArPwwVP-----------------------GELYIGGEGLAREYWRDEPLTATRFIRHP 3009
Cdd:PLN02387 455 teTCAGATFSEWDdtsvGRVGP-P--LPccyvklvsweeggylisdkpmprGEIVIGGPSVTLGYFKNQEKTDEVYKVDE 531
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|..
gi 53747904 3010 RtGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQ-GFRVELGEIEAALAQHP 3060
Cdd:PLN02387 532 R-GMRWFYTGDIGQFHPDGCLEIIDRKKDIVKLQhGEYVSLGKVEAALSVSP 582
|
|
| adh_short_C2 |
pfam13561 |
Enoyl-(Acyl carrier protein) reductase; This domain is found in Enoyl-(Acyl carrier protein) ... |
1234-1275 |
1.41e-05 |
|
Enoyl-(Acyl carrier protein) reductase; This domain is found in Enoyl-(Acyl carrier protein) reductases.
Pssm-ID: 433310 [Multi-domain] Cd Length: 236 Bit Score: 49.35 E-value: 1.41e-05
10 20 30 40
....*....|....*....|....*....|....*....|..
gi 53747904 1234 EQLGAEVqvYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAA 1275
Cdd:pfam13561 41 EELGAAV--LPCDVTDEEQVEALVAAAVEKFGRLDILVNNAG 80
|
|
| CAD2 |
cd08298 |
Cinnamyl alcohol dehydrogenases (CAD); These alcohol dehydrogenases are related to the ... |
1679-1861 |
1.51e-05 |
|
Cinnamyl alcohol dehydrogenases (CAD); These alcohol dehydrogenases are related to the cinnamyl alcohol dehydrogenases (CAD), members of the medium chain dehydrogenase/reductase family. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Cinnamyl alcohol dehydrogenases (CAD) reduce cinnamaldehydes to cinnamyl alcohols in the last step of monolignal metabolism in plant cells walls. CAD binds 2 zinc ions and is NADPH- dependent. CAD family members are also found in non-plant species, e.g. in yeast where they have an aldehyde reductase activity. The medium chain dehydrogenases/reductase (MDR)/zinc-dependent alcohol dehydrogenase-like family, which contains the zinc-dependent alcohol dehydrogenase (ADH-Zn) and related proteins, is a diverse group of proteins related to the first identified member, class I mammalian ADH. MDRs display a broad range of activities and are distinguished from the smaller short chain dehydrogenases (~ 250 amino acids vs. the ~ 350 amino acids of the MDR). The MDR proteins have 2 domains: a C-terminal NAD(P) binding-Rossmann fold domain of a beta-alpha form and an N-terminal catalytic domain with distant homology to GroES. The MDR group contains a host of activities, including the founding alcohol dehydrogenase (ADH), quinone reductase, sorbitol dehydrogenase, formaldehyde dehydrogenase, butanediol DH, ketose reductase, cinnamyl reductase, and numerous others. The zinc-dependent alcohol dehydrogenases (ADHs) catalyze the NAD(P)(H)-dependent interconversion of alcohols to aldehydes or ketones. Active site zinc has a catalytic role, while structural zinc aids in stability. ADH-like proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and generally have 2 tightly bound zinc atoms per subunit. The active site zinc is coordinated by a histidine, two cysteines, and a water molecule. The second zinc seems to play a structural role, affects subunit interactions, and is typically coordinated by 4 cysteines.
Pssm-ID: 176258 [Multi-domain] Cd Length: 329 Bit Score: 50.26 E-value: 1.51e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1679 TPGLLES--LGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALeAEESVLGRECSGRIAAVGEGVSGLRVGDEV 1756
Cdd:cd08298 8 KPGPIEEnpLRLTEVPVPEPGPGEVLIKVEACGVCRTDLHIVEGDLPPP-KLPLIPGHEIVGRVEAVGPGVTRFSVGDRV 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1757 lAVAP------------------------------GCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGr 1806
Cdd:cd08298 87 -GVPWlgstcgecrycrsgrenlcdnarftgytvdGGYAEYMVADERFAYPIPEDYDDEEAAPLLCAGIIGYRALKLAG- 164
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 53747904 1807 LRRGERILI-------HAAagglglaaVQLASRTGAEILATAGSEQKREYLRSLGIAHVLDS 1861
Cdd:cd08298 165 LKPGQRLGLygfgasaHLA--------LQIARYQGAEVFAFTRSGEHQELARELGADWAGDS 218
|
|
| C_PKS-NRPS |
cd20483 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
2218-2469 |
1.85e-05 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHXXXD motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380471 [Multi-domain] Cd Length: 430 Bit Score: 50.34 E-value: 1.85e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2218 VERFIQCWRQLLQRHDMLRMVVL---PDGRQQVLEQvPEYTPEVVELRGLSPQEAESRRL--QLRE-----------RMA 2281
Cdd:cd20483 38 VNLLQKALSELVRRHEVLRTAYFegdDFGEQQVLDD-PSFHLIVIDLSEAADPEAALDQLvrNLRRqeldieegeviRGW 116
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2282 HQVLRSDRWPLFelvlcryeggVRIHMsmdaLMLDAWSSAVLRQDFAQLY-----HEPGRPLEPLAITFRDYVLAERRLR 2356
Cdd:cd20483 117 LVKLPDEEFALV----------LASHH----IAWDRGSSKSIFEQFTALYdalraGRDLATVPPPPVQYIDFTLWHNALL 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2357 EGEAHERARAYWWARLDTLPPPPEL---PLVKEPSQLEHARFTHrEARLEPHRWARLQERARAHGLTPSAACMAAFAEVL 2433
Cdd:cd20483 183 QSPLVQPLLDFWKEKLEGIPDASKLlpfAKAERPPVKDYERSTV-EATLDKELLARMKRICAQHAVTPFMFLLAAFRAFL 261
|
250 260 270
....*....|....*....|....*....|....*.
gi 53747904 2434 ARWSRHPRFTLNLTLFQRlPlHPQVDELVGDFTSLV 2469
Cdd:cd20483 262 YRYTEDEDLTIGMVDGDR-P-HPDFDDLVGFFVNML 295
|
|
| Firefly_Luc |
cd17642 |
insect luciferase, similar to plant 4-coumarate: CoA ligases; This family contains insect ... |
2981-3134 |
2.78e-05 |
|
insect luciferase, similar to plant 4-coumarate: CoA ligases; This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341297 [Multi-domain] Cd Length: 532 Bit Score: 49.83 E-value: 2.78e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2981 GELYIGGEGLAREYWRDEPLTATRFIRhprtgERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHP 3060
Cdd:cd17642 382 GELCVKGPMIMKGYVNNPEATKALIDK-----DGWLHSGDIAYYDEDGHFFIVDRLKSLIKYKGYQVPPAELESILLQHP 456
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 3061 ALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERL-PAYMVPSAFVLLESLPRSRNGKIARDQLPE 3134
Cdd:cd17642 457 KIFDAGVAGIPDEDAGELPAAVVVLEAGKTMTEKEVMDYVASQVsTAKRLRGGVKFVDEVPKGLTGKIDRRKIRE 531
|
|
| LC_FACS_bac1 |
cd17641 |
bacterial long-chain fatty acid CoA synthetase; The members of this family are bacterial ... |
2775-3074 |
3.29e-05 |
|
bacterial long-chain fatty acid CoA synthetase; The members of this family are bacterial long-chain fatty acid CoA synthetase, most of which are as yet uncharacterized. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341296 [Multi-domain] Cd Length: 569 Bit Score: 49.73 E-value: 3.29e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2775 RGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLS-VYDVLGLLGAGGALVLP-- 2851
Cdd:cd17641 154 AGKGEDVAVLCTTSGTTGKPKLAMLSHGNFLGHCAAYLAADPLGPGDEYVSVLPLPWIGEqMYSVGQALVCGFIVNFPee 233
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2852 AAEAEKD-----------PAHWWERLVAG-RVTVWNSTP-------ALMLLLVEYAEQ--RGLKLPAALRLVMLSGDWIP 2910
Cdd:cd17641 234 PETMMEDlreigptfvllPPRVWEGIAADvRARMMDATPfkrfmfeLGMKLGLRALDRgkRGRPVSLWLRLASWLADALL 313
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2911 V-ALPDRI------------RALGRD---------VQVVSLGGATEASIWSIAYPIGQVAPQwksiPYGMPLANQRFHVL 2968
Cdd:cd17641 314 FrPLRDRLgfsrlrsaatggAALGPDtfrffhaigVPLKQLYGQTELAGAYTVHRDGDVDPD----TVGVPFPGTEVRID 389
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2969 DgrlearpwwvPGELYIGGEGLAREYWRDEPLTATRFirhprTGERLYRTGDQGRMLPEGSIEFLGR-EDLQVKVQGFRV 3047
Cdd:cd17641 390 E----------VGEILVRSPGVFVGYYKNPEATAEDF-----DEDGWLHTGDAGYFKENGHLVVIDRaKDVGTTSDGTRF 454
|
330 340
....*....|....*....|....*..
gi 53747904 3048 ELGEIEAALAQHPALSASVVVARGEPR 3074
Cdd:cd17641 455 SPQFIENKLKFSPYIAEAVVLGAGRPY 481
|
|
| A_NRPS_MycA_like |
cd05908 |
The adenylation domain of nonribosomal peptide synthetases (NRPS) similar to mycosubtilin ... |
2778-2833 |
3.70e-05 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS) similar to mycosubtilin synthase subunit A (MycA); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPS similar to mycosubtilin synthase subunit A (MycA). Mycosubtilin, which is characterized by a beta-amino fatty acid moiety linked to the circular heptapeptide Asn-Tyr-Asn-Gln-Pro-Ser-Asn, belongs to the iturin family of lipopeptide antibiotics. The mycosubtilin synthase subunit A (MycA) combines functional domains derived from peptide synthetases, amino transferases, and fatty acid synthases. Nonribosomal peptide synthetases are large multifunction enzymes that synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341234 [Multi-domain] Cd Length: 499 Bit Score: 49.41 E-value: 3.70e-05
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*.
gi 53747904 2778 PEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDL 2833
Cdd:cd05908 105 ADELAFIQFSSGSTGDPKGVMLTHENLVHNMFAILNSTEWKTKDRILSWMPLTHDM 160
|
|
| AcpA |
COG3433 |
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites ... |
2020-2145 |
5.20e-05 |
|
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442659 [Multi-domain] Cd Length: 295 Bit Score: 48.21 E-value: 5.20e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2020 AGGISSEEGAEAFLRALEQGAPQLIISPQDFSSLLRGLGGSQGVREKERLVTGR----AAAAEPQALPPSSLEQLIEQVW 2095
Cdd:COG3433 149 AVAALDGLAAAAALAALDKVPPDVVAASAVVALDALLLLALKVVARAAPALAAAeallAAASPAPALETALTEEELRADV 228
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|..
gi 53747904 2096 RKHLGV--ERVQPTDSFFQLGGDSLLGIQVAADLRRHlGVELPTATLFSHPT 2145
Cdd:COG3433 229 AELLGVdpEEIDPDDNLFDLGLDSIRLMQLVERWRKA-GLDVSFADLAEHPT 279
|
|
| SDR_c3 |
cd05360 |
classical (c) SDR, subgroup 3; These proteins are members of the classical SDR family, with a ... |
1232-1392 |
5.58e-05 |
|
classical (c) SDR, subgroup 3; These proteins are members of the classical SDR family, with a canonical active site triad (and also active site Asn) and a typical Gly-rich NAD-binding motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold (alpha/beta folding pattern with a central beta-sheet), an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Classical SDRs are typically about 250 residues long, while extended SDRS are approximately 350 residues. Sequence identity between different SDR enzymes are typically in the 15-30% range, but the enzymes share the Rossmann fold NAD-binding motif and characteristic NAD-binding and catalytic sequence patterns. These enzymes have a 3-glycine N-terminal NAD(P)(H)-binding pattern (typically, TGxxxGxG in classical SDRs and TGxxGxxG in extended SDRs), while substrate binding is in the C-terminal region. A critical catalytic Tyr residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase (15-PGDH) numbering), is often found in a conserved YXXXK pattern. In addition to the Tyr and Lys, there is often an upstream Ser (Ser-138, 15-PGDH numbering) and/or an Asn (Asn-107, 15-PGDH numbering) or additional Ser, contributing to the active site. Substrates for these enzymes include sugars, steroids, alcohols, and aromatic compounds. The standard reaction mechanism is a proton relay involving the conserved Tyr and Lys, as well as Asn (or Ser). Some SDR family members, including 17 beta-hydroxysteroid dehydrogenase contain an additional helix-turn-helix motif that is not generally found among SDRs.
Pssm-ID: 187618 [Multi-domain] Cd Length: 233 Bit Score: 47.38 E-value: 5.58e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1232 ELEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAATFDDGVIQLRTHEQSSRALRTK----VRGSMVLHEV 1307
Cdd:cd05360 43 EVRELGGEAIAVVADVADAAQVERAADTAVERFGRIDTWVNNAGVAVFGRFEDVTPEEFRRVFDVNylghVYGTLAALPH 122
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1308 LASEGLDWFALCSSLASALGSFGQADYCAAN----AFQDAYAHHLRRQGFTGALALDWGTWRDTGAAMRlvARTRRGGHE 1383
Cdd:cd05360 123 LRRRGGGALINVGSLLGYRSAPLQAAYSASKhavrGFTESLRAELAHDGAPISVTLVQPTAMNTPFFGH--ARSYMGKKP 200
|
....*....
gi 53747904 1384 KPPTPLTHP 1392
Cdd:cd05360 201 KPPPPIYQP 209
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
2083-2145 |
5.79e-05 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 49.27 E-value: 5.79e-05
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 53747904 2083 PPSSLEQLIEQVWRKHLGVERVQPTDSFFQLGGDSLLGIQVAADLRRHLGVELPTATLFSHPT 2145
Cdd:PRK10252 975 PKTGTETIIAAAFSSLLGCDVVDADADFFALGGHSLLAMKLAAQLSRQFARQVTPGQVMVAST 1037
|
|
| PRK07445 |
PRK07445 |
O-succinylbenzoic acid--CoA ligase; Reviewed |
2981-3134 |
6.03e-05 |
|
O-succinylbenzoic acid--CoA ligase; Reviewed
Pssm-ID: 236019 [Multi-domain] Cd Length: 452 Bit Score: 48.84 E-value: 6.03e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2981 GELYIGGEGLAREYWrdePltatrfirHPRTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHP 3060
Cdd:PRK07445 302 GNITIQAQSLALGYY---P--------QILDSQGIFETDDLGYLDAQGYLHILGRNSQKIITGGENVYPAEVEAAILATG 370
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 53747904 3061 ALSASVVVARGEPRGVRRLVAYAVPRSGQtPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPE 3134
Cdd:PRK07445 371 LVQDVCVLGLPDPHWGEVVTAIYVPKDPS-ISLEELKTAIKDQLSPFKQPKHWIPVPQLPRNPQGKINRQQLQQ 443
|
|
| B4_12hDH |
TIGR02825 |
leukotriene B4 12-hydroxydehydrogenase/15-oxo-prostaglandin 13-reductase; Leukotriene B4 ... |
1748-1880 |
6.50e-05 |
|
leukotriene B4 12-hydroxydehydrogenase/15-oxo-prostaglandin 13-reductase; Leukotriene B4 12-hydroxydehydrogenase is an NADP-dependent enzyme of arachidonic acid metabolism, responsible for converting leukotriene B4 to the much less active metabolite 12-oxo-leukotriene B4. The BRENDA database lists leukotriene B4 12-hydroxydehydrogenase as one of the synonyms of 2-alkenal reductase (EC 1.3.1.74), while 1.3.1.48 is 15-oxoprostaglandin 13-reductase.
Pssm-ID: 131872 [Multi-domain] Cd Length: 325 Bit Score: 48.07 E-value: 6.50e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1748 SGLRVGDEVLAvAPGcFRSYVLVDESQVVRRPAS------LGLAEGAAQMvPFATAYFALHTVGRLRRGERILIHAAAGG 1821
Cdd:TIGR02825 74 VALPKGTIVLA-SPG-WTSHSISDGKDLEKLLTEwpdtlpLSLALGTVGM-PGLTAYFGLLEICGVKGGETVMVNAAAGA 150
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*....
gi 53747904 1822 LGLAAVQLASRTGAEILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVD 1880
Cdd:TIGR02825 151 VGSVVGQIAKLKGCKVVGAAGSDEKVAYLKKLGFDVAFNYKTVKSLEETLKKASPDGYD 209
|
|
| PRK07514 |
PRK07514 |
malonyl-CoA synthase; Validated |
2994-3131 |
7.69e-05 |
|
malonyl-CoA synthase; Validated
Pssm-ID: 181011 [Multi-domain] Cd Length: 504 Bit Score: 48.33 E-value: 7.69e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2994 YWRDEPLTATRFirhprTGERLYRTGDQGRMLPEGSIEFLGRE-DLqVKVQGFRVELGEIEAALAQHPALSASVVVAR-- 3070
Cdd:PRK07514 362 YWRMPEKTAEEF-----RADGFFITGDLGKIDERGYVHIVGRGkDL-IISGGYNVYPKEVEGEIDELPGVVESAVIGVph 435
|
90 100 110 120 130 140
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 53747904 3071 ---GEprGVrrlVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGK----IARDQ 3131
Cdd:PRK07514 436 pdfGE--GV---TAVVVPKPGAALDEAAILAALKGRLARFKQPKRVFFVDELPRNTMGKvqknLLREQ 498
|
|
| benzyl_alcohol_DH |
cd08278 |
Benzyl alcohol dehydrogenase; Benzyl alcohol dehydrogenase is similar to liver alcohol ... |
1676-1883 |
9.86e-05 |
|
Benzyl alcohol dehydrogenase; Benzyl alcohol dehydrogenase is similar to liver alcohol dehydrogenase, but has some amino acid substitutions near the active site, which may determine the enzyme's specificity of oxidizing aromatic substrates. Also known as aryl-alcohol dehydrogenases, they catalyze the conversion of an aromatic alcohol + NAD+ to an aromatic aldehyde + NADH + H+. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176239 [Multi-domain] Cd Length: 365 Bit Score: 47.88 E-value: 9.86e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1676 AVGTPGLLESLGLRrctrpAPGPRQVEIEVEAAGLNFLDVLGALGMMPA-LEAeesVLGRECSGRIAAVGEGVSGLRVGD 1754
Cdd:cd08278 10 EPGGPFVLEDVELD-----DPRPDEVLVRIVATGICHTDLVVRDGGLPTpLPA---VLGHEGAGVVEAVGSAVTGLKPGD 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1755 EVLAVAPGC--------------------------------------------------FRSYVLVDESQVVRRPASL-- 1782
Cdd:cd08278 82 HVVLSFASCgecanclsghpaycenffplnfsgrrpdgstplslddgtpvhghffgqssFATYAVVHERNVVKVDKDVpl 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1783 --------GLAEGAAqmvpfatayfALHTVGRLRRGERILIhaaaggLGLAAVQLASRTGA------EILATAGSEQKRE 1848
Cdd:cd08278 162 ellaplgcGIQTGAG----------AVLNVLKPRPGSSIAV------FGAGAVGLAAVMAAkiagctTIIAVDIVDSRLE 225
|
250 260 270
....*....|....*....|....*....|....*
gi 53747904 1849 YLRSLGIAHVLDSRSTSFVSEVRERTGGrGVDVVL 1883
Cdd:cd08278 226 LAKELGATHVINPKEEDLVAAIREITGG-GVDYAL 259
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
2083-2141 |
1.01e-04 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 48.63 E-value: 1.01e-04
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*....
gi 53747904 2083 PPSSLEQLIEQVWRKHLGVERVQPTDSFFQLGGDSLLGIQVAADLRRHLGVELPTATLF 2141
Cdd:PRK05691 4238 PRNELEQTLATIWADVLKVERVGVHDNFFELGGHSLLATQIASRVQKALQRNVPLRAMF 4296
|
|
| PRK09192 |
PRK09192 |
fatty acyl-AMP ligase; |
2753-2822 |
1.20e-04 |
|
fatty acyl-AMP ligase;
Pssm-ID: 236403 [Multi-domain] Cd Length: 579 Bit Score: 48.08 E-value: 1.20e-04
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 53747904 2753 PGVQVIAVDELEpATEAPPLP-PRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLnTRFG--VGPEDR 2822
Cdd:PRK09192 150 PLLHVLSHAWFK-ALPEADVAlPRPTPDDIAYLQYSSGSTRFPRGVIITHRALMANLRAI-SHDGlkVRPGDR 220
|
|
| PLN02654 |
PLN02654 |
acetate-CoA ligase |
3016-3129 |
1.28e-04 |
|
acetate-CoA ligase
Pssm-ID: 215353 [Multi-domain] Cd Length: 666 Bit Score: 47.97 E-value: 1.28e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3016 YRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHP-ALSASVVVARGEPRGvRRLVAYAVPRSGqTPAAG 3094
Cdd:PLN02654 515 YFSGDGCSRDKDGYYWLTGRVDDVINVSGHRIGTAEVESALVSHPqCAEAAVVGIEHEVKG-QGIYAFVTLVEG-VPYSE 592
|
90 100 110
....*....|....*....|....*....|....*....
gi 53747904 3095 ELRRYLA----ERLPAYMVPSAFVLLESLPRSRNGKIAR 3129
Cdd:PLN02654 593 ELRKSLIltvrNQIGAFAAPDKIHWAPGLPKTRSGKIMR 631
|
|
| PRK12582 |
PRK12582 |
acyl-CoA synthetase; Provisional |
2648-2802 |
1.42e-04 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237144 [Multi-domain] Cd Length: 624 Bit Score: 47.73 E-value: 1.42e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPALL------APERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDP- 2720
Cdd:PRK12582 59 AAEAPDRPWLAqrepghGQWRKVTYGEAKRAVDALAQALLDLGLDPGRPVMILSGNSIEHALMTLAAMQAGVPAAPVSPa 138
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2721 ----EQPPLRLHQLLEEGPARVVLTQS----------------SLLHTVPWPPGVQVIAVDEL---EPATEAPPLPPRGT 2777
Cdd:PRK12582 139 yslmSHDHAKLKHLFDLVKPRVVFAQSgapfaralaaldlldvTVVHVTGPGEGIASIAFADLaatPPTAAVAAAIAAIT 218
|
170 180
....*....|....*....|....*
gi 53747904 2778 PEHLAYVIYTSGSTGKPKGVAIEHR 2802
Cdd:PRK12582 219 PDTVAKYLFTSGSTGMPKAVINTQR 243
|
|
| ttLC_FACS_like |
cd05915 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes ... |
2786-3132 |
1.99e-04 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes fatty acyl-CoA synthetases that can activate medium-chain to long-chain fatty acids. They catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family has been shown to catalyze the long-chain fatty acid, myristoyl acid, while another member in this family, the AlkK protein identified in Pseudomonas oleovorans, targets medium chain fatty acids. This family also includes an uncharacterized subgroup of FACS.
Pssm-ID: 213283 [Multi-domain] Cd Length: 509 Bit Score: 47.04 E-value: 1.99e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2786 YTSGSTGKPKGVAIEHRAA-LN-TVVDLNTRFGVGPEDRVLgLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAhWW 2863
Cdd:cd05915 160 YTTGTTGLPKGVVYSHRALvLHsLAASLVDGTALSEKDVVL-PVVPMFHVNAWCLPYAATLVGAKQVLPGPRLDPAS-LV 237
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2864 ERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPAALRLvmLSGDWIPVALPDRIRALGRDVQVVSLG-----GATEASIW 2938
Cdd:cd05915 238 ELFDGEGVTFTAGVPTVWLALADYLESTGHRLKTLRRL--VVGGSAAPRSLIARFERMGVEVRQGYGltetsPVVVQNFV 315
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2939 siaypigqvAPQWKSIPYGMPLanqRFHVLDGR---------LEARPWWVPGE------LYIGGEGLAREYWRDEPLTAT 3003
Cdd:cd05915 316 ---------KSHLESLSEEEKL---TLKAKTGLpiplvrlrvADEEGRPVPKDgkalgeVQLKGPWITGGYYGNEEATRS 383
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3004 RFIRHPrtgerLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYA 3083
Cdd:cd05915 384 ALTPDG-----FFRTGDIAVWDEEGYVEIKDRLKDLIKSGGEWISSVDLENALMGHPKVKEAAVVAIPHPKWQERPLAVV 458
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|
gi 53747904 3084 VPRSGQTPAAgELRRYLAERLPAY-MVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:cd05915 459 VPRGEKPTPE-ELNEHLLKAGFAKwQLPDAYVFAEEIPRTSAGKFLKRAL 507
|
|
| PRK08279 |
PRK08279 |
long-chain-acyl-CoA synthetase; Validated |
2613-2806 |
2.14e-04 |
|
long-chain-acyl-CoA synthetase; Validated
Pssm-ID: 236217 [Multi-domain] Cd Length: 600 Bit Score: 47.18 E-value: 2.14e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2613 LPELLPPAQRELLARYNATQAPRPSGR-----LEEgfftQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQP 2687
Cdd:PRK08279 11 LPRRLPDLPGILRGLKRTALITPDSKRslgdvFEE----AAARHPDRPALLFEDQSISYAELNARANRYAHWAAARGVGK 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2688 QELVAIAMHKGWEQATAVLGV--LQAAAAYL-------PL--------------DPEqpplrLHQLLEEGPARVVLTQSS 2744
Cdd:PRK08279 87 GDVVALLMENRPEYLAAWLGLakLGAVVALLntqqrgaVLahslnlvdakhlivGEE-----LVEAFEEARADLARPPRL 161
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 2745 LLH---TVPWPPGVQVIAVDELEPATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALN 2806
Cdd:PRK08279 162 WVAggdTLDDPEGYEDLAAAAAGAPTTNPASRSGVTAKDTAFYIYTSGTTGLPKAAVMSHMRWLK 226
|
|
| PRK05857 |
PRK05857 |
fatty acid--CoA ligase; |
2642-3132 |
2.23e-04 |
|
fatty acid--CoA ligase;
Pssm-ID: 180293 [Multi-domain] Cd Length: 540 Bit Score: 46.93 E-value: 2.23e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2642 EGFFTQARLHPELPALLAPERT--LSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLD 2719
Cdd:PRK05857 18 DRVFEQARQQPEAIALRRCDGTsaLRYRELVAEVGGLAADLRAQSVSRGSRVLVISDNGPETYLSVLACAKLGAIAVMAD 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2720 PEQPPLRLHQLLE-EGPARVVLTQSSLLHTVPWPPG---VQVIAVDELEPATEAPPLPPR---------GTPEHLAyVIY 2786
Cdd:PRK05857 98 GNLPIAAIERFCQiTDPAAALVAPGSKMASSAVPEAlhsIPVIAVDIAAVTRESEHSLDAaslagnadqGSEDPLA-MIF 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2787 TSGSTGKPKGVAIEHRaalntvvdlnTRFGVGPEDRVLGLSALTFdlsvydvlgllgaggalvlPAAEAEKDP---AH-- 2861
Cdd:PRK05857 177 TSGTTGEPKAVLLANR----------TFFAVPDILQKEGLNWVTW-------------------VVGETTYSPlpaTHig 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2862 --WW----------------------ERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPaALRLVMLSGDwipvalpdri 2917
Cdd:PRK05857 228 glWWiltclmhgglcvtggenttsllEILTTNAVATTCLVPTLLSKLVSELKSANATVP-SLRLVGYGGS---------- 296
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2918 RALGRDVQVVSLGGATEASIWSIAyPIGQVApqwksipYGMPLANQRFHVLDGRLEARPWwvPG-ELYIGGEGLAREYWR 2996
Cdd:PRK05857 297 RAIAADVRFIEATGVRTAQVYGLS-ETGCTA-------LCLPTDDGSIVKIEAGAVGRPY--PGvDVYLAATDGIGPTAP 366
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2997 DEPLTA---TRFIRHP-----------RTGERL----YRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQ 3058
Cdd:PRK05857 367 GAGPSAsfgTLWIKSPanmlgywnnpeRTAEVLidgwVNTGDLLERREDGFFYIKGRSSEMIICGGVNIAPDEVDRIAEG 446
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3059 HPALSASVVVARGEPRgVRRLVAYAVPRSGQTPAAG--ELRRYLAERL----PAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PRK05857 447 VSGVREAACYEIPDEE-FGALVGLAVVASAELDESAarALKHTIAARFrresEPMARPSTIVIVTDIPRTQSGKVMRASL 525
|
|
| fabG |
PRK12825 |
3-ketoacyl-(acyl-carrier-protein) reductase; Provisional |
1232-1339 |
2.62e-04 |
|
3-ketoacyl-(acyl-carrier-protein) reductase; Provisional
Pssm-ID: 237218 [Multi-domain] Cd Length: 249 Bit Score: 45.63 E-value: 2.62e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1232 ELEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAATFDDGVIQLRTHEQSSRALRTKVRGSM-VLHEVL-- 1308
Cdd:PRK12825 50 AVEALGRRAQAVQADVTDKAALEAAVAAAVERFGRIDILVNNAGIFEDKPLADMSDDEWDEVIDVNLSGVFhLLRAVVpp 129
|
90 100 110
....*....|....*....|....*....|..
gi 53747904 1309 -ASEGLDWFALCSSLASALGSFGQADYCAANA 1339
Cdd:PRK12825 130 mRKQRGGRIVNISSVAGLPGWPGRSNYAAAKA 161
|
|
| SCP-x_thiolase |
cd00829 |
Thiolase domain associated with sterol carrier protein (SCP)-x isoform and related proteins; ... |
99-210 |
5.41e-04 |
|
Thiolase domain associated with sterol carrier protein (SCP)-x isoform and related proteins; SCP-2 has multiple roles in intracellular lipid circulation and metabolism. The N-terminal presequence in the SCP-x isoform represents a peroxisomal 3-ketacyl-Coa thiolase specific for branched-chain acyl CoAs, which is proteolytically cleaved from the sterol carrier protein.
Pssm-ID: 238425 [Multi-domain] Cd Length: 375 Bit Score: 45.33 E-value: 5.41e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 99 LLLECSWEALEDAGLRPDQLPgwvGVYVGAGDTsyrfqllrghgdplsgskdvagffGNYPDFLATRVAYKLNLRG-PAL 177
Cdd:cd00829 19 LAAEAARAALDDAGLEPADID---AVVVGNAAG------------------------GRFQSFPGALIAEYLGLLGkPAT 71
|
90 100 110
....*....|....*....|....*....|...
gi 53747904 178 GIHTACSTSLVSINMACSALRGFECDMALAGGV 210
Cdd:cd00829 72 RVEAAGASGSAAVRAAAAAIASGLADVVLVVGA 104
|
|
| LCL_NRPS-like |
cd19540 |
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; ... |
2316-2483 |
5.67e-04 |
|
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380463 [Multi-domain] Cd Length: 433 Bit Score: 45.49 E-value: 5.67e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2316 DAWSSAVLRQDFAQLY------HEPGRPlePLAITFRDYVLAERRLREGEAHERAR-----AYWWARLDTLppppelplv 2384
Cdd:cd19540 134 DGWSMAPLARDLATAYaarragRAPDWA--PLPVQYADYALWQRELLGDEDDPDSLaarqlAYWRETLAGL--------- 202
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2385 kePSQLE-------HARFTHR----EARLEPHRWARLQERARAHGLTPSAACMAAFAEVLARWSRHprftlnltlfQRLP 2453
Cdd:cd19540 203 --PEELElptdrprPAVASYRggtvEFTIDAELHARLAALAREHGATLFMVLHAALAVLLSRLGAG----------DDIP 270
|
170 180 190
....*....|....*....|....*....|....*...
gi 53747904 2454 L--------HPQVDELVGDFTSLVLLEVEAHAASTFAE 2483
Cdd:cd19540 271 IgtpvagrgDEALDDLVGMFVNTLVLRTDVSGDPTFAE 308
|
|
| FabI |
COG0623 |
Enoyl-[acyl-carrier-protein] reductase FabI [Lipid transport and metabolism]; Enoyl- ... |
1234-1275 |
6.56e-04 |
|
Enoyl-[acyl-carrier-protein] reductase FabI [Lipid transport and metabolism]; Enoyl-[acyl-carrier-protein] reductase FabI is part of the Pathway/BioSystem: Fatty acid biosynthesis
Pssm-ID: 440388 [Multi-domain] Cd Length: 254 Bit Score: 44.24 E-value: 6.56e-04
10 20 30 40
....*....|....*....|....*....|....*....|..
gi 53747904 1234 EQLGAEVqVYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAA 1275
Cdd:COG0623 52 EELGSAL-VLPCDVTDDEQIDALFDEIKEKWGKLDFLVHSIA 92
|
|
| liver_alcohol_DH_like |
cd08277 |
Liver alcohol dehydrogenase; NAD(P)(H)-dependent oxidoreductases are the major enzymes in the ... |
1696-1763 |
7.33e-04 |
|
Liver alcohol dehydrogenase; NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. There are 7 vertebrate ADH 7 classes, 6 of which have been identified in humans. Class III, glutathione-dependent formaldehyde dehydrogenase, has been identified as the primordial form and exists in diverse species, including plants, micro-organisms, vertebrates, and invertebrates. Class I, typified by liver dehydrogenase, is an evolving form. Gene duplication and functional specialization of ADH into ADH classes and subclasses created numerous forms in vertebrates. For example, the A, B and C (formerly alpha, beta, gamma) human class I subunits have high overall structural similarity, but differ in the substrate binding pocket and therefore in substrate specificity. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine (His-51), the ribose of NAD, a serine (Ser-48) , then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of an beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding.
Pssm-ID: 176238 [Multi-domain] Cd Length: 365 Bit Score: 45.02 E-value: 7.33e-04
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 53747904 1696 PGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEesVLGRECSGRIAAVGEGVSGLRVGDEVLAV-APGC 1763
Cdd:cd08277 25 PKANEVRIKMLATSVCHTDILAIEGFKATLFPV--ILGHEGAGIVESVGEGVTNLKPGDKVIPLfIGQC 91
|
|
| PRK06814 |
PRK06814 |
acyl-[ACP]--phospholipid O-acyltransferase; |
2774-2823 |
9.06e-04 |
|
acyl-[ACP]--phospholipid O-acyltransferase;
Pssm-ID: 235865 [Multi-domain] Cd Length: 1140 Bit Score: 45.34 E-value: 9.06e-04
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|
gi 53747904 2774 PRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRV 2823
Cdd:PRK06814 788 CNRDPDDPAVILFTSGSEGTPKGVVLSHRNLLANRAQVAARIDFSPEDKV 837
|
|
| PRK12826 |
PRK12826 |
SDR family oxidoreductase; |
1233-1354 |
1.06e-03 |
|
SDR family oxidoreductase;
Pssm-ID: 183775 [Multi-domain] Cd Length: 251 Bit Score: 43.75 E-value: 1.06e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1233 LEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAATFDDGVIQLRTHEQSSRALRTKVRGSMVLHEVLaseg 1312
Cdd:PRK12826 50 VEAAGGKARARQVDVRDRAALKAAVAAGVEDFGRLDILVANAGIFPLTPFAEMDDEQWERVIDVNLTGTFLLTQAA---- 125
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*
gi 53747904 1313 LDWF--------ALCSSLA-SALGSFGQADYCAA----NAFQDAYAHHLRRQGFT 1354
Cdd:PRK12826 126 LPALiragggriVLTSSVAgPRVGYPGLAHYAASkaglVGFTRALALELAARNIT 180
|
|
| PRK05620 |
PRK05620 |
long-chain fatty-acid--CoA ligase; |
2745-3132 |
1.15e-03 |
|
long-chain fatty-acid--CoA ligase;
Pssm-ID: 180167 [Multi-domain] Cd Length: 576 Bit Score: 44.77 E-value: 1.15e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2745 LLHTVPWPPGVQVIAVDEL-EPATEAPP----------LPPRGT-------PEHLAYVI-YTSGSTGKPKGVAIEHRAAL 2805
Cdd:PRK05620 128 ILKECPCVRAVVFIGPSDAdSAAAHMPEgikvysyealLDGRSTvydwpelDETTAAAIcYSTGTTGAPKGVVYSHRSLY 207
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2806 NTVVDLNT--RFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAekDPAHWWERLVAGRVTVWNSTPAL-ML 2882
Cdd:PRK05620 208 LQSLSLRTtdSLAVTHGESFLCCVPIYHVLSWGVPLAAFMSGTPLVFPGPDL--SAPTLAKIIATAMPRVAHGVPTLwIQ 285
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2883 LLVEYAEQRGLKLpaALRLVMLSGDWIPVALPDRIRA-LGrdVQVVSLGGATEAS-IWSIAYPIGQVAPQ--WK-SIPYG 2957
Cdd:PRK05620 286 LMVHYLKNPPERM--SLQEIYVGGSAVPPILIKAWEErYG--VDVVHVWGMTETSpVGTVARPPSGVSGEarWAyRVSQG 361
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2958 MPLANQRFHVLD------------GRLEARPWWVPGELY---IGGEGLAREYWRDEPL--TATRFirhprTGERLYRTGD 3020
Cdd:PRK05620 362 RFPASLEYRIVNdgqvmestdrneGEIQVRGNWVTASYYhspTEEGGGAASTFRGEDVedANDRF-----TADGWLRTGD 436
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3021 QGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRR-----LVAYAVPRSGQTpaAGE 3095
Cdd:PRK05620 437 VGSVTRDGFLTIHDRARDVIRSGGEWIYSAQLENYIMAAPEVVECAVIGYPDDKWGERplavtVLAPGIEPTRET--AER 514
|
410 420 430
....*....|....*....|....*....|....*..
gi 53747904 3096 LRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQL 3132
Cdd:PRK05620 515 LRDQLRDRLPNWMLPEYWTFVDEIDKTSVGKFDKKDL 551
|
|
| PTZ00342 |
PTZ00342 |
acyl-CoA synthetase; Provisional |
2778-2811 |
1.29e-03 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 240370 [Multi-domain] Cd Length: 746 Bit Score: 44.71 E-value: 1.29e-03
10 20 30
....*....|....*....|....*....|....
gi 53747904 2778 PEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDL 2811
Cdd:PTZ00342 303 PDFITSIVYTSGTSGKPKGVMLSNKNLYNTVVPL 336
|
|
| AFD_CAR-like |
cd17632 |
adenylation domain of carboxylic acid reductase (CAR); This family contains the adenylation ... |
2623-2802 |
1.73e-03 |
|
adenylation domain of carboxylic acid reductase (CAR); This family contains the adenylation domain of carboxylic acid reductase enzymes (CARs), and performs an equivalent function to that of the ANL superfamily of adenylating enzymes. It takes a carboxylic acid substrate and ATP, and produces an AMP-acyl phosphoester intermediate, releasing pyrophosphate. Kinetic analysis using various substrates shows that this enzyme has a broad but similar substrate specificity, preferring electron-rich acids. This suggests that attack by the carboxylate on the alpha-phosphate of adenosine triphosphate (ATP) is the step that determines the substrate specificity and reaction kinetics. CAR is an important enzyme for use as a biocatalyst providing regiospecific route to aldehydes from their respective carboxylic acids.
Pssm-ID: 341287 [Multi-domain] Cd Length: 588 Bit Score: 43.98 E-value: 1.73e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2623 ELLARYNATQAPRPS-GRLEEGFFTQARLHPELPALLAPERTLSYGEL-ARRAQALAARLRELEVQPQELVAIAMHKGWE 2700
Cdd:cd17632 26 QIIATVMTGYADRPAlGQRATELVTDPATGRTTLRLLPRFETITYAELwERVGAVAAAHDPEQPVRPGDFVAVLGFTSPD 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2701 QATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEE------------------------GPARVVL---------TQSSL-- 2745
Cdd:cd17632 106 YATVDLALTRLGAVSVPLQAGASAAQLAPILAEteprllavsaehldlaveavleggTPPRLVVfdhrpevdaHRAALes 185
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 53747904 2746 ----LHTVPWPPGVQVIAVDELEPATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHR 2802
Cdd:cd17632 186 arerLAAVGIPVTTLTLIAVRGRDLPPAPLFRPEPDDDPLALLIYTSGSTGTPKGAMYTER 246
|
|
| PRK07768 |
PRK07768 |
long-chain-fatty-acid--CoA ligase; Validated |
2754-2802 |
1.97e-03 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236091 [Multi-domain] Cd Length: 545 Bit Score: 43.83 E-value: 1.97e-03
10 20 30 40
....*....|....*....|....*....|....*....|....*....
gi 53747904 2754 GVQVIAVDELEPATEAPPLPPrgTPEHLAYVIYTSGSTGKPKGVAIEHR 2802
Cdd:PRK07768 129 GIRVLTVADLLAADPIDPVET--GEDDLALMQLTSGSTGSPKAVQITHG 175
|
|
| FDH_like_ADH2 |
cd08286 |
formaldehyde dehydrogenase (FDH)-like; This group is related to formaldehyde dehydrogenase ... |
1731-1883 |
2.01e-03 |
|
formaldehyde dehydrogenase (FDH)-like; This group is related to formaldehyde dehydrogenase (FDH), which is a member of the zinc-dependent/medium chain alcohol dehydrogenase family. This family uses NAD(H) as a cofactor in the interconversion of alcohols and aldehydes, or ketones. Another member is identified as a dihydroxyacetone reductase. Like the zinc-dependent alcohol dehydrogenases (ADH) of the medium chain alcohol dehydrogenase/reductase family (MDR), tetrameric FDHs have a catalytic zinc that resides between the catalytic and NAD(H)binding domains and a structural zinc in a lobe of the catalytic domain. Unlike ADH, where NAD(P)(H) acts as a cofactor, NADH in FDH is a tightly bound redox cofactor (similar to nicotinamide proteins). The medium chain alcohol dehydrogenase family (MDR) has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The N-terminal region typically has an all-beta catalytic domain. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit.
Pssm-ID: 176246 [Multi-domain] Cd Length: 345 Bit Score: 43.39 E-value: 2.01e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1731 VLGRECSGRIAAVGEGVSGLRVGDEVL-------AVAPGCFRS---------YVL---VDESQV--VRRP---ASL---- 1782
Cdd:cd08286 57 ILGHEGVGVVEEVGSAVTNFKVGDRVLiscisscGTCGYCRKGlyshcesggWILgnlIDGTQAeyVRIPhadNSLyklp 136
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1783 -GLAEGAAQMVP--FATAYFALHTVGRLRRGERILIhaaaggLGLAAVQLAS------RTGAEILATAGSEQKREYLRSL 1853
Cdd:cd08286 137 eGVDEEAAVMLSdiLPTGYECGVLNGKVKPGDTVAI------VGAGPVGLAAlltaqlYSPSKIIMVDLDDNRLEVAKKL 210
|
170 180 190
....*....|....*....|....*....|
gi 53747904 1854 GIAHVLDSRSTSFVSEVRERTGGRGVDVVL 1883
Cdd:cd08286 211 GATHTVNSAKGDAIEQVLELTDGRGVDVVI 240
|
|
| PksD |
COG3321 |
Acyl transferase domain in polyketide synthase (PKS) enzymes [Secondary metabolites ... |
2369-2912 |
2.38e-03 |
|
Acyl transferase domain in polyketide synthase (PKS) enzymes [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442550 [Multi-domain] Cd Length: 1386 Bit Score: 44.09 E-value: 2.38e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2369 WARLDTLPPPpelplvkEPSQLEHARFTHREARLEPHRWARLQERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTL 2448
Cdd:COG3321 849 WSALYPGRGR-------RRVPLPTYPFQREDAAAALLAAALAAALAAAAALGALLLAALAAALAAALLALAAAAAAALAL 921
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2449 FQRLPLHPQVDELVGDFTSLVLLEVEAHAASTFAERASRLQAQLWRDLEHGSVSAVQLIRELVRTGRRSPGAIMPVVFTS 2528
Cdd:COG3321 922 AAAALAALLALVALAAAAAALLALAAAAAAAAAALAAAEAGALLLLAAAAAAAAAAAAAAAAAAAAAAAAAAAALAAAAA 1001
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2529 ILSLDARRGPQGSLSFFEGELVYSISQTPQVWLDHGVHEEEGALVLAWDSVEALFPPGMVDDMFHAYQRLLGALAEEEQA 2608
Cdd:COG3321 1002 LALLAAAALLLAAAAAAAALLALAALLAAAAAALAAAAAAAAAAAALAALAAAAAAAAALALALAALLLLAALAELALAA 1081
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2609 WEGELPELLPPAQRELLARYNATQAPRPSGRLEEGFFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQ 2688
Cdd:COG3321 1082 AALALAAALAAAALALALAALAAALLLLALLAALALAAAAAALLALAALLAAAAAAAALAAAAAAAAALALAAAAAALAA 1161
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2689 ELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSLLHTVPWPPGVQVIAVDELEPATE 2768
Cdd:COG3321 1162 ALAAALLAAAALLLALALALAAALAAALAGLAALLLAALLAALLAALLALALAALAAAAAALLAAAAAAAALALLALAAA 1241
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2769 APPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGAL 2848
Cdd:COG3321 1242 AAAVAALAAAAAALLAALAALALLAAAAGLAALAAAAAAAAAALALAAAAAAAAAALAALLAAAAAAAAAAAAAAAAAAL 1321
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 53747904 2849 VLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPAALRLVMLSGDWIPVA 2912
Cdd:COG3321 1322 AAALLAAALAALAAAVAAALALAAAAAAAAAAAAAAAAAAALAAAAGAAAAAAALALAALAAAV 1385
|
|
| PLN02702 |
PLN02702 |
L-idonate 5-dehydrogenase |
1694-1765 |
3.07e-03 |
|
L-idonate 5-dehydrogenase
Pssm-ID: 215378 [Multi-domain] Cd Length: 364 Bit Score: 42.84 E-value: 3.07e-03
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 53747904 1694 PAPGPRQVEIEVEAAGLNFLDV--LGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGDEVlAVAPG--CFR 1765
Cdd:PLN02702 37 PPLGPHDVRVRMKAVGICGSDVhyLKTMRCADFVVKEPMVIGHECAGIIEEVGSEVKHLVVGDRV-ALEPGisCWR 111
|
|
| MDR_yhdh |
cd08288 |
Yhdh putative quinone oxidoreductases; Yhdh putative quinone oxidoreductases (QOR). QOR ... |
1687-1882 |
3.95e-03 |
|
Yhdh putative quinone oxidoreductases; Yhdh putative quinone oxidoreductases (QOR). QOR catalyzes the conversion of a quinone + NAD(P)H to a hydroquinone + NAD(P)+. Quinones are cyclic diones derived from aromatic compounds. Membrane bound QOR actin the respiratory chains of bacteria and mitochondria, while soluble QOR acts to protect from toxic quinones (e.g. DT-diaphorase) or as a soluble eye-lens protein in some vertebrates (e.g. zeta-crystalin). QOR reduces quinones through a semi-quinone intermediate via a NAD(P)H-dependent single electron transfer. QOR is a member of the medium chain dehydrogenase/reductase family, but lacks the zinc-binding sites of the prototypical alcohol dehydrogenases of this group. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes, or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.
Pssm-ID: 176248 [Multi-domain] Cd Length: 324 Bit Score: 42.52 E-value: 3.95e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1687 GLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGrecsgrIAAVGEGVS----GLRVGDEVLA---- 1758
Cdd:cd08288 16 ELRELDESDLPEGDVTVEVHYSTLNYKDGLAITGKGGIVRTFPLVPG------IDLAGTVVEssspRFKPGDRVVLtgwg 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 1759 ---VAPGCFRSYVLVDESQVVRRPASLGLAEGAAqmvpFATAYF-------ALHTVGRLRRGERILIHAAAGGLGLAAVQ 1828
Cdd:cd08288 90 vgeRHWGGYAQRARVKADWLVPLPEGLSARQAMA----IGTAGFtamlcvmALEDHGVTPGDGPVLVTGAAGGVGSVAVA 165
|
170 180 190 200 210
....*....|....*....|....*....|....*....|....*....|....*...
gi 53747904 1829 LASRTGAEILATAGSEQKREYLRSLGIAHVLDsRSTsFVSEVR----ERTGGrGVDVV 1882
Cdd:cd08288 166 LLARLGYEVVASTGRPEEADYLRSLGASEIID-RAE-LSEPGRplqkERWAG-AVDTV 220
|
|
| ENR_SDR |
cd05372 |
Enoyl acyl carrier protein (ACP) reductase (ENR), divergent SDR; This bacterial subgroup of ... |
1233-1293 |
4.15e-03 |
|
Enoyl acyl carrier protein (ACP) reductase (ENR), divergent SDR; This bacterial subgroup of ENRs includes Escherichia coli ENR. ENR catalyzes the NAD(P)H-dependent reduction of enoyl-ACP in the last step of fatty acid biosynthesis. De novo fatty acid biosynthesis is catalyzed by the fatty acid synthetase complex, through the serial addition of 2-carbon subunits. In bacteria and plants,ENR catalyzes one of six synthetic steps in this process. Oilseed rape ENR, and also apparently the NADH-specific form of Escherichia coli ENR, is tetrameric. Although similar to the classical SDRs, this group does not have the canonical catalytic tetrad, nor does it have the typical Gly-rich NAD-binding pattern. Such so-called divergent SDRs have a GXXXXXSXA NAD-binding motif and a YXXMXXXK (or YXXXMXXXK) active site motif. SDRs are a functionally diverse family of oxidoreductases that have a single domain with a structurally conserved Rossmann fold (alpha/beta folding pattern with a central beta-sheet), an NAD(P)(H)-binding region, and a structurally diverse C-terminal region. Classical SDRs are typically about 250 residues long, while extended SDRs are approximately 350 residues. Sequence identity between different SDR enzymes are typically in the 15-30% range, but the enzymes share the Rossmann fold NAD-binding motif and characteristic NAD-binding and catalytic sequence patterns. These enzymes catalyze a wide range of activities including the metabolism of steroids, cofactors, carbohydrates, lipids, aromatic compounds, and amino acids, and act in redox sensing. Classical SDRs have an TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr residue of the active site motif serving as a critical catalytic residue (Tyr-151, human 15-hydroxyprostaglandin dehydrogenase (15-PGDH) numbering). In addition to the Tyr and Lys, there is often an upstream Ser (Ser-138, 15-PGDH numbering) and/or an Asn (Asn-107, 15-PGDH numbering) contributing to the active site; while substrate binding is in the C-terminal region, which determines specificity. The standard reaction mechanism is a 4-pro-S hydride transfer and proton relay involving the conserved Tyr and Lys, a water molecule stabilized by Asn, and nicotinamide. Extended SDRs have additional elements in the C-terminal region, and typically have a TGXXGXXG cofactor binding motif. Complex (multidomain) SDRs such as ketoreductase domains of fatty acid synthase have a GGXGXXG NAD(P)-binding motif and an altered active site motif (YXXXN). Fungal type ketoacyl reductases have a TGXXXGX(1-2)G NAD(P)-binding motif. Some atypical SDRs have lost catalytic activity and/or have an unusual NAD(P)-binding motif and missing or unusual active site residues. Reactions catalyzed within the SDR family include isomerization, decarboxylation, epimerization, C=N bond reduction, dehydratase activity, dehalogenation, Enoyl-CoA reduction, and carbonyl-alcohol oxidoreduction.
Pssm-ID: 187630 [Multi-domain] Cd Length: 250 Bit Score: 41.80 E-value: 4.15e-03
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 53747904 1233 LEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAAtFDDGVIQLRTHEQSSRA 1293
Cdd:cd05372 47 AERLGESALVLPCDVSNDEEIKELFAEVKKDWGKLDGLVHSIA-FAPKVQLKGPFLDTSRK 106
|
|
| PRK13391 |
PRK13391 |
acyl-CoA synthetase; Provisional |
2966-3127 |
4.32e-03 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 184022 [Multi-domain] Cd Length: 511 Bit Score: 42.76 E-value: 4.32e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2966 HVLDGRLEARPWWVPGELYIGGeGLAREYWRDEPLTATRfiRHPRTGerLYRTGDQGRMLPEGSIEFLGREDLQVKVQGF 3045
Cdd:PRK13391 339 HILDDDGAELPPGEPGTIWFEG-GRPFEYLNDPAKTAEA--RHPDGT--WSTVGDIGYVDEDGYLYLTDRAAFMIISGGV 413
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 3046 RVELGEIEAALAQHP-ALSASVVVARGEPRG-VRRLVAYAVPRSGQTPA-AGELRRYLAERLPAYMVPSAFVLLESLPRS 3122
Cdd:PRK13391 414 NIYPQEAENLLITHPkVADAAVFGVPNEDLGeEVKAVVQPVDGVDPGPAlAAELIAFCRQRLSRQKCPRSIDFEDELPRL 493
|
....*
gi 53747904 3123 RNGKI 3127
Cdd:PRK13391 494 PTGKL 498
|
|
| PRK00174 |
PRK00174 |
acetyl-CoA synthetase; Provisional |
2779-2797 |
4.57e-03 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 234677 [Multi-domain] Cd Length: 637 Bit Score: 42.82 E-value: 4.57e-03
|
| PRK08180 |
PRK08180 |
feruloyl-CoA synthase; Reviewed |
2648-2802 |
6.07e-03 |
|
feruloyl-CoA synthase; Reviewed
Pssm-ID: 236175 [Multi-domain] Cd Length: 614 Bit Score: 42.56 E-value: 6.07e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2648 ARLHPELPAL-----LAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPE- 2721
Cdd:PRK08180 49 AQEAPDRVFLaergaDGGWRRLTYAEALERVRAIAQALLDRGLSAERPLMILSGNSIEHALLALAAMYAGVPYAPVSPAy 128
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 53747904 2722 ----QPPLRLHQLLE----------EGPA------RVVLTQSSLLHTVPWPPGVQVIAVDELEPATEAPPLP---PRGTP 2778
Cdd:PRK08180 129 slvsQDFGKLRHVLElltpglvfadDGAAfaralaAVVPADVEVVAVRGAVPGRAATPFAALLATPPTAAVDaahAAVGP 208
|
170 180
....*....|....*....|....
gi 53747904 2779 EHLAYVIYTSGSTGKPKGVAIEHR 2802
Cdd:PRK08180 209 DTIAKFLFTSGSTGLPKAVINTHR 232
|
|
| PRK08628 |
PRK08628 |
SDR family oxidoreductase; |
1232-1281 |
8.86e-03 |
|
SDR family oxidoreductase;
Pssm-ID: 181508 [Multi-domain] Cd Length: 258 Bit Score: 41.10 E-value: 8.86e-03
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|
gi 53747904 1232 ELEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAATfDDGV 1281
Cdd:PRK08628 49 ELRALQPRAEFVQVDLTDDAQCRDAVEQTVAKFGRIDGLVNNAGV-NDGV 97
|
|
| hsFATP4_like |
cd05939 |
Fatty acid transport proteins (FATP), including FATP4 and FATP1, and similar proteins; Fatty ... |
2767-2823 |
9.50e-03 |
|
Fatty acid transport proteins (FATP), including FATP4 and FATP1, and similar proteins; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. At least five copies of FATPs are identified in mammalian cells. This family includes FATP4, FATP1, and homologous proteins. Each FATP has unique patterns of tissue distribution. FATP4 is mainly expressed in the brain, testis, colon and kidney. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341262 [Multi-domain] Cd Length: 474 Bit Score: 41.64 E-value: 9.50e-03
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*..
gi 53747904 2767 TEAPPLPPRGTPEHLAYvIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRV 2823
Cdd:cd05939 93 TEPPSQDDVNFRDKLFY-IYTSGTTGLPKAAVIVHSRYYRIAAGAYYAFGMRPEDVV 148
|
|
| PRK06198 |
PRK06198 |
short chain dehydrogenase; Provisional |
1232-1282 |
9.57e-03 |
|
short chain dehydrogenase; Provisional
Pssm-ID: 180462 [Multi-domain] Cd Length: 260 Bit Score: 40.76 E-value: 9.57e-03
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|.
gi 53747904 1232 ELEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAATFDDGVI 1282
Cdd:PRK06198 50 ELEALGAKAVFVQADLSDVEDCRRVVAAADEAFGRLDALVNAAGLTDRGTI 100
|
|
|